*

fimmtudagur, 23. maí 2019

mars, 2007

 

Vancouver, March 30, 2007 - GUANGZHOU, CHINA -- (MARKET WIRE) -- BioLife Remedies Inc. (PINKSHEETS: BLRS) Bio Life Remedies, Inc. is pleased to announce that CHOLESSRATM will be available for sale within 30 days. CHOLESSRATM is a herbal product developed by the company for people with a high cholesterol level. People with a high level of cholesterol in the blood are at high risk of cardiovascular diseases (heart disease and stroke). The President and CEO of the Company, Jack Guo commented, "CHOLESSRATM is developed from a century-old TCM herbal formula used traditionally for heart problems; our researchers did extensive research and tests on the formula and identified the herbs that are effective in lowering Cholesterol. After decades of effort, we have refined the century-old formula into a herbal formulation for the condition of high cholesterol. Currently we are in the final stage of getting ready to distribute the product into the market." With the recent business report released by LehmanBrown stating an estimated 83.5 million USD valuation based on the two diabetes products Betatrol tm and Zutrol tm. President of BioLife Jack Guo is excited about the announcement of this quality new product and looks forward expanding the line of TCM products over the coming year. For a copy of the recent business valuation report of BioLife please visit the official company website at www.blfrproducts.com About Bio Life Remedies, Inc BIO LIFE REMEDIES, INC. combines Traditional Chinese Medicine and Western academic research and development practices with the newest scientific technology to produce effective medical and health-care products to combat serious diseases. The Bio Life Group has developed 108 master medical formulas to treat various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, and sexual disorders in men and women. Please visit http://www.blfrproducts.com for more information. Forward-Looking Statements You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as ``will,'' ``anticipates,'' ``believes,'' ``plans,'' ``goal,'' ``expects,'' ``future,'' ``intends,'' and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Bio Life Remedies Inc. please refer to its Web site at http://www.blfrproducts.com Contact: For Further Information: Call: Jesse Keller Toll Free: 1-888-470-1960 Email: info@blfrproducts.com http://www.blfrproducts.com


 

* Retrospective analysis of pooled clinical trial data shows numerical imbalance in cardiovascular events in patients taking Zelnorm compared to those on placebo * FDA asks Novartis to suspend marketing and sales to permit further discussion of benefits and risks of Zelnorm * Novartis believes Zelnorm provides important benefits for appropriate patients suffering from irritable bowel syndrome with constipation * Discussions ongoing with FDA to evaluate best way to continue to make Zelnorm available to appropriate US patients Basel, March 30, 2007 - Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm®[*] (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation. This action has been taken after Novartis notified the FDA about a retrospective analysis of data from more than 18,000 patients in the clinical trial database. This was the result of an ongoing review involving a number of health authorities including the FDA. A small (but not statistically significant) imbalance in cases of angina pectoris was recorded and included in the US label when Zelnorm was approved in 2002. A recent analysis of the entire clinical database revealed a statistically significant imbalance in the incidence of cardiovascular ischemic events in patients taking Zelnorm/Zelmac compared to those taking placebo. These events included myocardial infarction, stroke, and unstable angina pectoris. The data, which were reviewed by independent experts, showed that events occurred in 13 out of 11,614 patients treated with Zelnorm/Zelmac (0.11%), compared to one case in 7,031 placebo-treated patients (0.01%). All patients affected had pre-existing cardiovascular disease and/or CV risk factors. The rate of cardiovascular ischemic events seen in Zelnorm/Zelmac-treated patients in controlled trials corresponds approximately with the expected rates for such events in the general population. "My review of the data suggested that a causal relationship is unlikely between tegaserod and the rare cardiovascular ischemic events observed in clinical trials," said Jeffrey L. Anderson, MD, Professor of Internal Medicine at the University of Utah and Associate Chief, Cardiology Division, LDS Hospital in Salt Lake City and an independent cardiologist who reviewed the data. "Furthermore, the data did not show any consistent pattern of event type, time to event or dose relationship in tegaserod-treated patients." Multiple studies do not suggest any constrictive effects of Zelnorm on coronary arteries. An estimated 12 million Americans suffer from the painful and disruptive symptoms of IBS with constipation. Many have symptoms for five to 10 years, which trigger missed work-days and often prevent them from participating in everyday activities with their family and friends. "Zelnorm/Zelmac provides unique benefits to patients by treating the multiple symptoms of abdominal pain, bloating and constipation that are associated with IBS with constipation," said James Shannon, MD, Global Head of Development at Novartis Pharma AG. "Although we have complied with the FDA's request and are collaborating with the agency, we continue to believe that Zelnorm/Zelmac provides important benefits for appropriate patients." Nevertheless, Novartis has suspended the marketing, sales and distribution of Zelnorm in response to the FDA's request, so that public discussion and an Advisory Committee meeting can take place to determine the risks and benefits of this medicine. Novartis and the FDA will communicate this information to physicians and patients, and will discuss the best way to continue to make Zelnorm available to appropriate patients, including through a Treatment IND. US patients taking Zelnorm are being advised to consult their physicians. Novartis is in discussion with health authorities in other countries where Zelnorm/Zelmac is available to determine next steps. Patients outside the US who have any concerns about Zelnorm/Zelmac should discuss the situation with their healthcare professional. About Zelnorm Zelnorm received FDA approval for the short-term treatment of women with IBS in the US on July 24, 2002. Zelnorm also received FDA approval for the treatment of men and women less than 65 years of age with chronic idiopathic constipation in the US on August 20, 2004. Zelnorm/Zelmac is approved for the treatment of IBS with constipation in 50 countries including Australia, Switzerland, Canada, the US, Mexico, China and Brazil. Zelnorm/Zelmac is also approved for the treatment of chronic constipation in more than 20 countries including the US, Canada and Mexico. Novartis markets the therapy under the trademark Zelnorm (tegaserod maleate) in the US, Canada, Philippines and South Africa; and as Zelmac (tegaserod) in Switzerland, Latin America and the Asia-Pacific region. Financial update For its 2007 financial guidance, Novartis has revised its outlook for net sales growth, barring unforeseen events, for the Group to above five percent, and for the Pharmaceuticals division to a low- to mid-single-digit rate, both in local currencies. Novartis is still evaluating the impact on the full-year 2007 operating and net income results from continuing operations (excluding the announced divestiture of Medical Nutrition expected to be completed in 2007). An invitation will be issued to financial analysts to join an update telephone conference call at 19:00 Central European Summer Time (CEST) on Friday, March 30. A listen-only version of this event will be available on the Internet at www.novartis.com, where a recorded version of this conference call will be made available after the event. Disclaimer The foregoing release contains certain forward-looking statements that can be identified by terminology such as "will," "outlook," or similar expressions, or by express or implied discussions regarding potential future approvals to return Zelnorm/Zelmac to the market, or potential future sales of Zelnorm/Zelmac, or the potential impact of Zelnorm/Zelmac on the potential future sales or earnings of the Novartis Group or its Pharmaceuticals Division. Such forward-looking statements involve known and unknown risks, uncertainties or other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. There can be no guarantee that Zelnorm/Zelmac will be approved by the FDA or other health authorities for return to the market for any indication, or that Zelnorm/Zelmac will achieve any particular level of sales. Nor can there be any guarantees that the Novartis Group, or the Pharmaceuticals Division, will achieve any particular financial results. In particular, management's expectations regarding these matters could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results or results of data analysis, including additional analysis of existing clinical data and other data regarding patients' experience with Zelnorm/Zelmac, or unexpected new clinical or other such data; competition in general; government, industry and general public pricing pressures; the ability to obtain or maintain patent or other proprietary intellectual property protection; as well as factors discussed in the Company's Form 20-F filed with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. # # # Novartis Media Relations John Gilardi Novartis Global Media Relations +41 61 324 3018 (direct) +41 79 596 1408 (mobile) john.gilardi@novartis.com Novartis Investor Relations International: Ruth Metzler-Arnold +41 61 324 7944 Katharina Ambühl +41 61 324 5316 Nafida Bendali +41 61 324 3514 Jason Hannon +41 61 324 2152 Thomas Hungerbuehler +41 61 324 8425 Richard Jarvis +41 61 324 4353 North America: Ronen Tamir +1 212 830 2433 Arun Nadiga +1 212 830 2444 Jill Pozarek +1 212 830 2445 Edwin Valeriano +1 212 830 2456 e-mail: investor.relations@novartis.com [*] Also marketed as Zelmac in some countries --- End of Message --- Novartis International AG Posfach Basel WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

Centrom Group plc has received the following notification of a major interest in its shares. TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): Centrom Group plc.. 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( Yes) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify): ( ) 3. Full name of person(s) subject to the notification obligation (iii): Hargreave Hale Limited 4. Full name of shareholder(s) (if different from 3.) (iv): ....... 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 29 March 2007....... 6. Date on which issuer notified: 30 March 2007 7. Threshold(s) that is/are crossed or reached: 16%....... 8. Notified details: ....... A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering using the ISIN CODE transaction (vi) Number of shares Number of voting Rights (viii) Ordinary shares 33,450,000 33,450,000 GB00B08N4R59 Resulting situation after the triggering transaction (vii) Class/type of shares Number of Number of voting % of voting if possible using the shares rights (ix) rights ISIN CODE Direct Direct (x) Indirect Direct Indirect (xi) Ordinary shares 33,150,000 33,150,000 15.88% GB00B08N4R59 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/Conversion Number of voting % of financial Date (xiii) Period/ Date (xiv) rights that may be voting instrument acquired if the rights instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 33,150,000 15.88% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): 17,000,000 of these shares are for unit trusts operated by Marlborough Fund Managers Ltd, for which Hargreave Hale manages the investments on a discretionary basis. The remaining balance is held on behalf of other discretionary clients. Proxy Voting: 10. Name of the proxy holder: ....... 11. Number of voting rights proxy holder will cease to hold: ....... 12. Date on which proxy holder will cease to hold voting rights: ....... 13. Additional information: The denominator used in calculating the percentage holdings is 208,783'400 as reported in the company's announcement dated 21st December 2006....... 14. Contact name: David Clueit 15. Contact telephone number: 01253 754739 Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): Hargreave Hale Limited Contact address (registered office for legal entities): Marsden House 4-10 Springfield Road Blackpool FY1 1 QW .... Phone number: 01253 621575. Other useful information (at least legal representative for legal persons): ....... B: Identity of the notifier, if applicable (xvii) Full name: ....... Contact address: Phone number: .. Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation): C: Additional information : Name of person issuing this announcement on behalf of Centrom Group plc John Webb Marshall Securities Limited (Nominated Adviser) 020 7490 3788 ---END OF MESSAGE---


 

Centrom Group plc has received the following notification of a major interest in its shares. TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): Centrom Group plc 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) Initial Disclosure: ( Yes ) 3. Full name of person(s) subject to the notification obligation (iii): AIM Realisation Fund Limited 4. Full name of shareholder(s) (if different from 3.) (iv): ....... 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 16/03/07....... 6. Date on which issuer notified: 16/03/07..- .... 7. Threshold(s) that is/are crossed or reached: 8%....... 8. Notified details: ....... A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering using the ISIN CODE transaction (vi) Number of shares Number of voting Rights (viii) Ordinary shares of 1p 17,150,000 17,150,000 GB00B08N4R59 Resulting situation after the triggering transaction (vii) Class/type of shares Number of Number of voting % of voting if possible using the shares rights (ix) rights ISIN CODE Direct Direct (x) Indirect Direct Indirect (xi) Ordinary shares of 1p 17,150,000 17,150,000 8.21% GB00B08N4R59 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/Conversion Number of voting % of financial Date (xiii) Period/ Date (xiv) rights that may be voting instrument acquired if the rights instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 17,150,000 8.21% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): ....... Proxy Voting: 10. Name of the proxy holder: ....... 11. Number of voting rights proxy holder will cease to hold: ....... 12. Date on which proxy holder will cease to hold voting rights: ....... 13. Additional information: The shares are registered in the name of Forest Nominees Limited....... 14. Contact name: ....... 15. Contact telephone number: ....... Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): AIM Realisation Fund Limited Contact address (registered office for legal entities): PO Box 650, 2nd Floor, No 1 Le Truchot, St Peter Port, Guernsey GY1 3JX....... Phone number: 01481 731 987.. Other useful information (at least legal representative for legal persons): ....... B: Identity of the notifier, if applicable (xvii) Full name: Kevin Robins....... Contact address: PO Box 650, 2nd Floor, No 1 Le Truchot, St Peter Port, Guernsey GY1 3JX Phone number: 01481 731 987.. Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation): Employee of legal entity's appointed administrator....... C: Additional information : This is the initial disclosure made by the AIM Realisation Fund Limited based on holdings in accordance with DTR 5.1. On an ongoing basis, additional disclosures will be made when a notifiable threshold is crossed... This announcement was sent to the Company's former head office, resulting in a delay in it being announced. Name of person issuing this announcement on behalf of Centrom Group plc John Webb Marshall Securities Limited (Nominated Adviser) 020 7490 3788 ---END OF MESSAGE---


 

Finnish real estate investment company Sponda Plc has today signed a final agreement on the sale of shares in certain real estate companies, real estate properties and land sites to Whitehall Street Real Estate Limited and Niam Nordic Investment Fund III for approximately EUR 401 million. Sponda will record a profit of roughly EUR 15 million on the transaction. The sold properties comprise 43 investment properties as well as almost the entire Sales Properties portfolio that Sponda obtained through the Kapiteeli acquisition. Sponda announced the signing of a binding agreement on this matter on 16 February 2007 Sponda Plc Further information: Kari Inkinen, President and CEO, Sponda Plc, tel. +358 20 631 3311, +358 400-402 653 Johan Bergman, Managing Director, Niam, tel. +46 8 5175 8595, +46 8 708 244 095 Felicia Wipp, Communication Manager, Niam, tel. +46 8 5175 8529, +46 8 708 44 30 29 Sponda Plc is a real estate company specializing in commercial properties in the largest cities in Finland and Russia. Sponda's business concept is to own, lease and develop office, retail and logistics properties into environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 2.6 billion and the leasable area is around 2 million m². Sponda is the largest real estate investment company listed on the Helsinki Stock Exchange. The Whitehall Street Real Estate Funds, established in 1991, are a series of real estate investment funds sponsored and managed by the Goldman Sachs Group, Inc. and its affiliates. The Whitehall Street Real Estate Funds invest in real estate and real estate related assets, principally through the acquisition of real estate companies, real property and mortgage loans. Investments span across various product and investment types, including retail, hospitality, office, and residential, with interests in real-estate portfolios, non-performing loans and corporate restructurings. Niam Nordic Investment Fund III is a fund managed by Niam, the leading private equity firm in Northern Europe specialising in property. Niam offer financial investors a high return via investments in funds that in turn invest in all types of properties. The funds are raised and managed on a discretionary basis. Since the company was founded in 1998, properties with a total value of ¤3.9 billion have been acquired by Niam's funds or in association with international real estate funds. Today, Niam has owner responsibility for properties valued at ¤2 billion. Niam Nordic Investment Fund III is one of the largest property funds in Northern Europe.


 

` FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Scottish Power Plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 42p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 29 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------------+---------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------------+------------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (2) Derivatives (other than | 17,560,000 | 1.1790 | | | | options) | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (3) Options and agreements | | | | | | to purchase/sell | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | Total | 17,560,000 | 1.1790 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | | | | | | CFD | LONG | 500,000 | 802.0000 | | CFD | LONG | 250,000 | 802.3574 | | CFD | LONG | 200,000 | 803.3000 | | CFD | LONG | 450,000 | 802.9320 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 30th March 2007 | |-------------------------------------------------+-----------------| | Contact name | James Feast | |-------------------------------------------------+-----------------| | Telephone number | 0207 469 1901 | |-------------------------------------------------+-----------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |-------------------------------------------------+-----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Stavanger, Norway The Board of Directors of Ocean Rig ASA has approved the Company's Financial Statements for 2006. There are no deviations in the final Financial Statements compared to the preliminary report published on February 15, 2007, as part of the Q4 interim reporting. Please find attached Ocean Rig's Financial Statements for 2006. The Financial Statements are also available at www.newsweb.no or can be downloaded from www.ocean-rig.com. The full version of the Annual Report will be sent to registered shareholders and the Oslo Stock Exchange when completed. Ocean Rig owns and operates two of the world's largest and most modern drilling rigs, built for ultra deep waters and extreme weather conditions. The units are currently operating offshore Angola and Canada. NOTE: This press release contains forward-looking statements (within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended) which reflect the Company's current views with respect to certain future events and financial performance. Actual events or results may differ materially from those projected or implied in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or otherwise. The following important factors, among other, could cause actual results to differ materially from those projected or implied in any forward-looking statements: (i) our results of operation and financial conditions in the future; (ii) the performance of our rigs, including the sufficiency of their design and their ability to prevent discharges of hazardous materials and pollutants; (iii) our ability to generate sufficient cash-flow to meet our debt service requirements; (iv) our ability to retain existing contracts and secure future drilling contracts for our rigs at attractive day rates; (v) our ability to perform our operations in accordance with our plans; (vi) the impact of changed conditions in the oil and gas industry; (vii) the occurrence of any accidents involving the Company or its assets; (viii) changes in governmental regulations, particularly with respect to environmental matters; (ix) increased competition or the entry of new competitors into the Company's markets; and (x) unforeseen occurrences in any of the areas in which the Company may conduct its operations, such as war, expropriation, nationalization, renegotiation or nullification of existing licenses or treaties, taxation and resource development policies, foreign exchange restrictions, changing political conditions and other risks relating to foreign governmental sovereignty over certain areas in which the Company will conduct operations. Due to such uncertainties and risks, investors are cautioned not to place undue reliance upon such forward-looking statements. For further information, please contact Press contact: CEO Trygve Arnesen, tel +47 5196 9000 Analyst contact: CFO Jan Rune Steinsland, tel +47 5196 9000 Stavanger, March 30, 2007 Ocean Rig ASA


 

BERLIN, GERMANY -- (MARKET WIRE) -- March 30, 2007 -- The consortium comprising Bombardier Transportation and Alstom Transport has received a firm order from the French National Railways (SNCF) for 16 TER 2N NG (SNCF Trains Express Regionaux 2 Niveaux Nouvelle Generation) electrical multiple unit trainsets for the region Haute Normandie. As each trainset is composed of 5 car-units, the order covers a total of 80 car-units. Bombardier will build 32 of these car-units, as well as all of the 80 power bogies. This entire order is valued at 170 million euros ($ 227 million US), of which Bombardier Transportation's share is about 37 million euros ($ 50 million US). Deliveries are scheduled to begin by the end of 2008 and will take place until 2010. This contract comes as an option to a contract signed in September 2000 and brings the total SNCF order to 219 TER 2N NG trainsets as part of the modernization program of their regional express train fleet. The TER 2N NG, built at the Bombardier Transportation Crespin site in the North of France, is a double deck electrical regional express train which can run at a maximum speed of 160km/h. Note to editors: Useful market and company background facts and contact details follow. Background facts and figures Bombardier in France Bombardier Transportation in France operates primarily at its Crespin facility in the Valenciennes region, employs 1,600 people and is the leading French manufacturing site in the railway industry. Bombardier Transportation has been involved in all SNCF TGV French high-speed rail programs. The group manufactures a wide range of rolling stock for public transport. Among these products are the RATP MF2000 vehicles for the Paris metro, the Marseille, Nantes and Saint-Etienne tramways. Bombardier is a major player in regional transportation with the SNCF TER 2N NG railcars and the Bombardier AGC (Autorail Grande Capacite/high-capacity rail liner) which 21 French regions have ordered to date. Bombardier also currently develops and will build commuter trains to be used on the Ile-de-France suburban network. Bombardier Transportation is recognized as a global partner of the transport authorities in France. About Bombardier Transportation Bombardier Transportation has its global headquarters in Berlin, Germany with a presence in over 60 countries. It has an installed base of over 100,000 vehicles worldwide. The Group offers the broadest product portfolio and is recognized as the leader in the global rail sector. About Bombardier A world-leading manufacturer of innovative transportation solutions, from regional aircraft and business jets to rail transportation equipment, systems and services, Bombardier Inc. is a global corporation headquartered in Canada. Its revenues for the fiscal year ended Jan. 31, 2007, were $14.8 billion US, and its shares are traded on the Toronto Stock Exchange (BBD). News and information are available at www.bombardier.com. Contacts: Americas David Slack: + 1 450 441 3190 Germany, Austria Birgit Stallmann: + 49 30 986 07 1136 Switzerland Fiona Flannery: +41 44 318 29 91 Central and Eastern Europe, Russia Natalia Kourakina-Lattner: + 49 30 986 07 1137 UK, Ireland, Nordic Countries, Australia, New Zealand, other countries Neil Harvey: + 44 1332 2664703 Benelux Anne Froger: + 33 6 07 78 95 38 France Jean-Pierre Hulot: +33 1 41 34 08 45 Spain, Portugal, Italy, Greece, Turkey, India Luis Ramos: + 35 1 919 693 728


 

Message to the Copenhagen Stock Exchange, No. 07 - 2007, 30 March 2007 FFE Minerals, the minerals processing arm of FLSmidth, has acquired the materials handling business of US based RAHCO International, Inc., a world leader in the supply of mobile conveying solutions. The transaction, valued at approximately US$19.5 million, also includes RAHCO's sales, design and service operation in Chile. The company will, from the effective date of 1 April 2007, trade under the name of FLSmidth RAHCO Inc. RAHCO designs, manufactures and services bulk handling systems for the mining, aggregate and bulk solids industries, including mobile conveyors, radial stackers, portable conveyors, fixed/overland conveyors and at-the-face mining conveyors. The at-the-face mining solutions supplied by RAHCO, ranging in capacity from 200 - 10,000 tph and in lengths from 25 - 700 meters, represent viable and economic alternatives to traditional mining methods. The acquisition of RAHCO combined with the recent acquisition of KOCH Transporttechnik positions FFE Minerals as a global leader in material handling solutions for the minerals industries, with the ability to offer large scale energy efficient mobile crushing and conveying equipment used in mining operations. The sales of RAHCO are expected to surpass US$20 million in 2007 and will have a minimal effect on the FLSmidth Group's earnings in 2007, after consideration of IAS purchase accounting impacts. "The expansion of the Minerals operation of FLSmidth has been identified as a strategic objective for our company. The acquisition of the materials handling business of RAHCO is one more step along the way. The combination of RAHCO, a respected mobile conveying technology provider, with the FFE Minerals group, presents opportunities to leverage the RAHCO technology through the worldwide footprint of FFE Minerals including penetration into the growing oil sands markets." says, Group CEO Jørgen Huno Rasmussen, FLSmidth. ------------- Please address any questions regarding this announcement to Group Chief Executive Officer Jørgen Huno Rasmussen, FLSmidth & Co. A/S at +45 36 18 18 00. Yours faithfully Torben Seemann Hansen Corporate Public Relations


 

BERLIN, GERMANY -- (MARKET WIRE) -- March 30, 2007 -- Bombardier Transportation announced today that it has been awarded a seven-year contract valued at 63 million euros ($84 million US) by the South Florida Regional Transportation Authority (SFRTA) to provide maintenance services for SFRTA's fleet of commuter rail vehicles. The agreement includes one option for a three-year extension. Should that option be exercised, the contract value could reach up to 91 million euros ($122 million US). Bombardier's mandate under the agreement is to design and implement a comprehensive life-cycle maintenance program for SFRTA's commuter rail fleet, which includes locomotives, self-propelled passenger rail vehicles and Bombardier BiLevel passenger coaches. Specific responsibilities include preventive and corrective maintenance, scheduled vehicle and component overhauls, materials provisioning and handling, and implementation of a new Maintenance Management Information System. SFRTA's Tri-Rail commuter service operates along a 72-mile corridor from Miami to West Palm Beach on the east coast of southern Florida. The Tri-Rail service currently runs 40 trains per day with expectations for additional trains later this year. Formal transition of the maintenance operation to Bombardier is scheduled for July 1, 2007. "We are very pleased that another transit authority has selected Bombardier to keep its rail assets in top working condition," said Mike Hardt, Vice President for Bombardier Transportation's rail services business in North America. "Our focus is to continue growing Bombardier's business presence in the North American rail services market, and this contract indicates that we are moving in the right direction." Bombardier is the world's leading supplier of rail services, maintaining more than 8,000 vehicles internationally. Bombardier's services portfolio supports the entire life cycle of passenger rail vehicles and equipment, including fleet operations and maintenance, vehicle and component overhaul services, and materials solutions. In North America, Bombardier maintains commuter rail fleets in Los Angeles, San Diego, Toronto and Ottawa. It is involved in combined fleet operations and maintenance contracts for rail systems in Boston and southern New Jersey. Bombardier also provides a range of operations and maintenance services for fully automated transit systems and people movers in 12 U.S. cities. Note to editors: Useful company background facts and contact details follow. Background facts and figures Bombardier ORBITA In September 2006, Bombardier launched ORBITA, a major technical advancement in management of rail maintenance. ORBITA allows Control Center-based system experts to analyze data, liaise with maintenance depots and cross-reference information from Bombardier's extensive global fleet database to establish patterns of equipment performance. This enables Bombardier to diagnose and identify potential equipment issues before they occur, allowing quick and knowledgeable response to in-service faults. About Bombardier Transportation Bombardier Transportation has its global headquarters in Berlin, Germany with a presence in over 60 countries. It has an installed base of over 100,000 vehicles worldwide. The Group offers the broadest product portfolio and is recognized as the leader in the global rail sector. About Bombardier A world-leading manufacturer of innovative transportation solutions, from regional aircraft and business jets to rail transportation equipment, systems and services, Bombardier Inc. is a global corporation headquartered in Canada. Its revenues for the fiscal year ended Jan. 31, 2007, were $14.8 billion US, and its shares are traded on the Toronto Stock Exchange (BBD). News and information are available at www.bombardier.com. Bombardier, ORBITA and BiLevel are trademarks of Bombardier Inc. or its subsidiaries. Contacts: Americas David Slack: + 1-450-441-3190 Germany, Austria Birgit Stallmann: + 49 30 986 07 1136 Switzerland Fiona Flannery: +41 44 318 29 91 Central and Eastern Europe, Russia Natalia Kourakina-Lattner: + 49 30 986 07 1137 UK, Ireland, Nordic Countries, Australia, New Zealand, other countries Neil Harvey: + 44 1332 2664703 Benelux Anne Froger: + 33 6 07 78 95 38 France Jean-Pierre Hulot: +33 1 41 34 08 45 Spain, Portugal, Italy, Greece, Turkey, India Luis Ramos: + 35 1 919 693 728


 

Prosafe has today published the electronic version of its annual report for 2006 on the company's website www.prosafe.com with a direct link from the website's front page. The annual report's theme is "Strength in numbers", reflecting that the company has the expertise, capacity and financial resources to consolidate and fortify its leading positions, and is well equipped for implementing its plans for continued success in the time to come. The printed copy of the annual report, together with the notice of the annual general meeting, will be distributed to registered shareholders from 19 April. Other stakeholders may use the order from online http://ar2006.prosafe.com/category.php?categoryID=281 in order to request a hard copy of the report free of charge. Prosafe is the world's leading owner and operator of semi-submersible service rigs and a major owner and operator of floating production and storage vessels outside the North Sea. Operating profit reached USD 150 million in 2006. The company operates globally, employs approx. 1 000 people and is headquartered in Stavanger, Norway. Prosafe is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com. Stavanger, 30 March 2007 Prosafe SE


 

Studsvik has acquired the German nuclear consulting and engineering company Dr. Fary. The company employs five consultants and had a turnover 2006 of 650 k¤. Dr. Fary was established in 1990 and adds expertise to Studsvik within licensing, nuclear safety, emergency and technical documentation. Lifetime extension and decommissioning projects will increase demand in Germany for consulting and engineering services in general, but more specifically for safety-related services. Dr. Fary GmbH & Co KG, located in Kiel, is a small consulting company with long experience of servicing the nuclear power plants in Germany with safety related consulting. Studsvik's German-based operations are active in the two Strategic Business Areas, Decommissioning and Service and Maintenance, offering a wide range of services including consulting and engineering services. The operations of Dr. Fary GmbH & Co KG will be integrated into Studsvik's German operations as of April 1, 2007. For further information, please contact: Magnus Groth, CEO, +46 155 22 10 86, +46 709 67 70 86 Ulf Kannengiesser, Geschäftsführer, +49 7231 586 95 11, +49 173 345 94 31 Facts about Studsvik Studsvik is a leading service supplier to the international nuclear industry. The company has almost a half century's experience of nuclear technology and radiological services. Studsvik addresses a market in strong growth with specialized services in four Strategic Business Areas: Waste Treatment, Decommissioning, Operating Efficiency and Service and Maintenance. Studsvik has 1,200 employees in 7 countries and the company's shares are listed on the Nordic Stock Exchange, Stockholm, MidCap.


 

Ahlstrom Corporation STOCK EXCHANGE RELEASE 30.3.2007 at 15.15 Ahlstrom Corporation's Annual General Meeting of Shareholders (AGM) was held today March 30, 2007 at 1:00 p.m. Resolution on the distribution of profits The AGM resolved to distribute a dividend of EUR 1,00 per share for the fiscal year that ended on December 31, 2006 in accordance with the proposal of the Board of Directors. The dividend record date is April 4, 2007 and the pay date April 13, 2007. In addition, the AGM resolved to reserve EUR 70,000 to be used for the public good at the discretion of the Board of Directors. Approval of the Financial Statements and Consolidated Financial Statements The AGM approved the financial statements and consolidated financial statements and discharged the members of the Board of Directors and the CEO from liability for the financial period January 1-December 31, 2006. Remuneration and election of the Board of Directors The AGM confirmed the number of Board members unchanged at seven. Sebastian Bondestam, Jan Inborr, Urban Jansson, Bertel Paulig, Peter Seligson and Willem F. Zetteler were re-elected as members of the Board of Directors and Thomas Ahlström was elected as a new member as proposed by the Nomination Committee of Board. The term of the Board of Directors will expire at the close of the next Annual General Meeting. It was decided that the Chairman of the Board of Directors will receive a remuneration of EUR 5,400 per month. For the members of the Board of Directors, the remuneration was decided to be EUR 2,700 per month. In addition, the remuneration for attendance at the meetings of the permanent Board committees was decided to be EUR 1,150 per meeting. Travel expenses are reimbursed in accordance with Ahlstrom's travel policy. Remuneration and election of the auditor KPMG Oy Ab was re-elected as Ahlstrom's auditor as proposed by the Audit Committee. KPMG Oy Ab has designated Authorized Public Accountant Sixten Nyman as auditor in charge. The auditor's remuneration will be paid according to invoicing. Authorization to repurchase Ahlstrom shares The AGM authorized the Board of Directors to repurchase Ahlstrom shares as proposed by the Board of Directors, taking into account the limitations set forth in the Companies' Act. The maximum number of shares to be repurchased is 4,500,000, corresponding to less than 10% of all issued Company shares. The authorization will be valid for 18 months from the close of the Annual General Meeting but will expire at the close of the next Annual General Meeting, at the latest. The shares may be repurchased only through public trading at the prevailing market price by using unrestricted shareholders' equity. Authorization to distribute Ahlstrom shares held by the Company The AGM authorized the Board of Directors to resolve to distribute a maximum of 4,500,000 own shares held by the Company as proposed by the Board of Directors. The Board of Directors is authorized to decide to whom and in which order the shares will be distributed. The Board of Directors may decide on the distribution of own shares otherwise than in proportion to the existing pre-emptive right of shareholders to purchase the Company's own shares. The shares may be used as compensation in acquisitions and in other arrangements as well as to implement the Company's share-based incentive plans in the manner and to the extent decided by the Board of Directors. The Board of Directors has also the right to decide on the distribution of the shares in public trading for the purpose of financing possible acquisitions. The authorization will be valid for 18 months from the close of the Annual General Meeting but will expire at the close of the next Annual General Meeting, at the latest. Amendments to the Articles of Association The Annual General Meeting resolved to amend the Articles of Association in accordance with the proposal by the Board of Directors. Decisions taken by the Board of Directors After the AGM, the organization meeting of the Board of Directors elected Peter Seligson as Chairman and Urban Jansson as Vice Chairman of the Board. The Board of Directors also appointed the members of the permanent committees. The members of the Audit Committee are Bertel Paulig (Chairman), Thomas Ahlström and Willem F. Zetteler. The members of the Compensation Committee are Peter Seligson (Chairman), Jan Inborr and Urban Jansson. Ahlstrom Corporation Jukka Moisio, President & CEO For further information, please contact: Jukka Moisio, President & CEO, tel. +358 10 888 4700 Gustav Adlercreutz, Senior Vice President, Administration, General Counsel, tel +358 10 888 4727 Distribution: Helsinki Stock Exchange Main media www.ahlstrom.com Ahlstrom in brief Ahlstrom is a global leader in the development, manufacture and marketing of high performance fiber-based materials. Nonwovens and specialty papers, made by Ahlstrom, are used in a large variety of everyday products, e.g. in filters, wipes, flooring, labels, and tapes. The company has a strong market position in several business areas in which it operates, built upon the company's unique fiber expertise and innovative approach. Ahlstrom's 5,700 employees serve customers via sales offices and production facilities in more than 20 countries on six continents. In 2006, Ahlstrom's net sales amounted to EUR 1.6 billion. Ahlstrom's share is listed on the Helsinki Stock Exchange. The company website is www.ahlstrom.com.


 

Dividend The Annual General Meeting today approved a dividend of SEK 6.00 per share for the fiscal year. The record date for the right to receive dividends is 3 April 2007 and payment through VPC is expected to take place on 10 April 2007. Election of Board members Board members Fredrik Cappelen, Stefan Dahlbo, Bodil Eriksson, Hans Larsson, Wilhelm Laurén, Harald Mix and Fredrik Palmstierna were re-elected. Lotta Stalin, President of Kuusakoski Sverige AB, and Thore Ohlsson, President of Elimexo AB, were elected as new Board members. Ingrid Osmundsen and Thomas Nilsson declined re-election. Election of Chairman The Meeting elected Hans Larsson as Chairman of the Board of Directors. Election of auditors Accounting firm KPMG, with Helene Willberg as Auditor in Charge, was appointed the company's auditor. Split and amendment to the Articles of Association in connection therewith The Annual General Meeting decided on a split to the effect that every share be split into three shares. The date of execution of the share split with VPC AB shall be such day as presented separately and shall occur after registration with the Swedish Companies Registration Office. As a result of the share split, it was also decided that the Articles of Association be amended, implying that the limits for the maximum and minimum number of shares are amended to be not less than 135,000,000 and not more than 540,000,000. Performance-related employee share option scheme The Annual General Meeting decided to continue with the three-year employee share option scheme that was introduced in 2005. This means that for 2007, approximately 150 senior executives in the Nobia Group will be allotted a total of a maximum of 1,830,000 employee share options free of charge. The number of options that may be exercised is determined by the average increase in earnings per share over the three-year period 2007-2009. Each employee share option entitles subscription for one share in Nobia. Authorisation regarding buy-back of treasury shares The Annual General Meeting decided to authorise the Board of Directors to acquire and sell treasury shares during the period until the next Annual General Meeting on the basis of the conditions presented in more detail in the complete decision. A detailed description of the split, the employee share option scheme and the authorisation regarding the buy-back of treasury shares and other decisions made at the AGM are available on the company's website in Swedish only. Presentation by the President The presentation given by President and CEO Fredrik Cappelen in Swedish at the Annual General Meeting is available for viewing at Nobia's website, www.nobia.se. Nobia AB 29 March 2007 For further information, contact: Hans Larsson, Chairman of the Board, telephone +46 8 679 92 04, mobile +46 70 592 92 55 Nobia är Europe's leading kitchen company. The Group works with strong brands in many European countries. Sales are generated mainly through specialised kitchen studios, both wholly owned and franchised, in addition to business-to-business customers such as construction companies and builders' merchants. The Group has approximately 8,000 employees and net sales of approximately SEK 16 billion. Nobia is found in the Consumer Discretionary sector of the Large Cap segment of the Nordic List.


 

DNO ASA ("DNO") today files its first ASR under the new Oslo Stock Exchange regulations related to disclosure of hydrocarbon reserves. During the presentation the given to the market on 14.02.2007, DNO reported preliminary P50 reserves and resources as of 31.12.06 of 151 million barrels oil equivalents. The total remaining P50 reserves for DNO as of 31.12.2006 are now estimated to 79,7 million barrels of oil equivalents. These volumes correspond to class 1-3. In addition, 48,8 million barrels are estimated as contingent resources in class 4-5. Resources under evaluation (class 7) are estimated to 22,5 million barrels of oil equivalents. The ASR report does not include Class 7 resources. In summary, the estimate for total P50 reserves and resources for DNO as of 31.12.2006 is 151 million barrels of oil equivalents, as previously communicated. (P50 figures) Reserves (class 1-3), mill. boe 79,7 Contingent resources (class 4-5), mill. boe 48,8 Total reported in ASR report, mill boe 128,5 Resources (class 7), mill. boe 22,5 Total reserves and resources, mill. boe 151,0 DNO ASA 30 March 2007 Contacts: Media: Helge Eide, MD DNO ASA Telephone: +47 23 23 84 80 Ketil Jørgensen, Crux Communication Telephone +47 930 36 866 (Norway) Ben Willey, Buchanan Communications Telephone: +44 207 466 5000 (UK) Investor Relations: Haakon Sandborg, CFO DNO ASA Telephone: +47 23 23 84 80 Robert Arnott, Advisor (UK) Telephone +44 207 839 7764


 

30 March 2007 - Russian police came to the Aker Kvaerner Engineering & Technology representation office in Moscow to inquire about a complaint from a former Russian business partner regarding Aker Kvaerner Engineering & Technology's acquisition of 56 percent ownership in Astrakhan Korabel. The inquiry concerns Aker Kvaerner Engineering & Technology's acquisition of shares from the Finnish company RR Offshore Oy. "The acquisition was conducted in accordance with Aker Kvaerner's contractual rights under credit facility and pledge agreements with RR Offshore Oy and in accordance with all relevant laws and regulations," says Martinus Brandal, President & CEO, Aker Kvaerner. There were 14 employees working in the office when the police started investigation, of them 11 Russian citizens and three Norwegians. Aker Kvaerner is a reputed international project, engineering and technology company in the oil and gas industry. As a publicly listed company, Aker Kvaerner manages its assets responsibly. "The North Caspian Sea is an important market for Aker Kvaerner and we are already delivering projects in this market. We are confident about the continued development of this region and we intend to strengthen our presence there," says Martinus Brandal. ENDS For further information, please contact: Media: Torbjørn S. Andersen, SVP Group Communications, Aker Kvaerner. Tel: +47 67 51 30 36, Mob: +47 928 85 542 AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

Hafslunds`s Annual Report for 2006 in English is attached in PDF format. The PDF version of the annual report can also be found on www.hafslund.no. Hafslund ASA Oslo, 30 March 2007


 

Statoil (OSE:STL, NYSE:STO) is today, 30 March, publishing the online editions of its annual report and accounts and sustainability report for 2006. These documents are available on the group's web site at http://www.statoil.com/ir. At the same time an e-mail will be sent to shareholders who have opted to receive the reports electronically. Printed copies of the annual report and accounts and the sustainability report will be available from 16 April for distribution to all other shareholders registered in the Norwegian Registry of Securities. Other interested parties can use the order form online at www.statoil.com/order Further information from: Investor relations Lars Troen Sørensen, senior vice president for investor relations, + 47 90 64 91 44 (mobile), +47 51 99 77 90 (office) Geir Bjørnstad, vice president for investor relations USA: +1 (203) 978 69 50 (mobile) Press Ola Morten Aanestad, vice president for media relations, +47 48 08 02 12 (mobile) +47 51 99 13 77 (office) Disclaimer: This press release does not constitute an offer to exchange or sell or an offer to exchange or buy any securities. An offer of securities in the United States pursuant to a business combination transaction will only be made through a prospectus which is part of an effective registration statement filed with the US Securities and Exchange Commission. Hydro shareholders who are US persons or are located in the United States are advised to read the registration statement when and if it is declared effective by the US Securities and Exchange Commission because it will contain important information relating to the proposed transaction. You will be able to inspect and copy the registration statement relating to the proposed transaction and documents incorporated by reference at the SEC's Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Statoil's SEC filings are also available to the public at the SEC's web site at http://www.sec.gov. In addition Statoil will make the effective registration statement available for free to Hydro shareholders in the United States.


 

CORPORATE RESPONSIBILITY 2007 Presentation: "Sense and Sustainability: The Limits and Reach of Corporate Responsibility" Carlo Donati, Nestlé Executive Vice President, Chairman and CEO Nestlé Waters Chatham House, London, March 26 You can access the MP3, transcript and related presentation slides in the section Presentations > Corporate Responsibility of our website: http://www.ir.nestle.com/News_Events/Presentations/Group_Presentations/Corporate_Responsibility --- End of Message --- Nestlé S.A. Avenue Nestlé 55 Vevey WKN: 887208; ISIN: CH0012056047; Index: SLCI, SMI, SPI, SMIEXP; Listed: Main Market in SWX Swiss Exchange;


 

For Immediate Release 30 March 2007 Intellego Holdings plc ("Intellego" or "the Company") Directors' shareholdings On 29 March 2007 the board of Intellego approved the grant of, in aggregate, 4,500,000 unapproved options. Andy Green, Managing Director, received 1,000,000 options, Ranjit Roy-Choudhuri, Finance Director, received 2,500,000 options, Michael Couzens, Chairman received 500,000 options and Angus Forrest, Non-Executive Director, 500,000 at an exercise price of 2.0p (the market price close of 29 March 2007 being 1.625p) and the options are exercisable three years from date of grant until the tenth anniversary of the date of grant. The grant of options is a related party transaction under the AIM Rules and as all the directors are involved in the transaction as related parties, Beaumont Cornish Limited, the Company's nominated adviser, considers that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned. There had been no options granted prior to this award. Enquiries Ranjit Roy-Choudhuri, Finance Director Tel: 0870 428 1250 Roland Cornish, Beaumont Cornish Limited Tel: 020 7628 3396 ---END OF MESSAGE---


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are set to open marginally lower Friday, in line with weaker European indexes. "Looking at the Dow Jones (Industrial Average), we are looking toward the 12,400 level on the upside to cap any rallies over the next couple of days, while on the downside we are still looking at 12,250 that has been underpinning the market since the middle of last week," says Geoff Langham of CMC Markets. On the economic front, investors will closely watch Chicago PMI numbers due at 1345 GMT, Langham said. CMC Markets is calling the Dow Jones Industrial Average to open down 20 at 12,330, the Nasdaq 100 5 points lower at 1768 and the S&P 500 down 2 at 1420.5. EUROPEAN MARKETS: European stocks are flat to lower, with losses from Vodafone Group weighing down the telecoms sector and a rise in oil prices affecting sentiment. In London, the FTSE 100 index is down 0.4% at 6295.50, weighed down by Vodafone. The company effectively warned that future year profits in the U.K. would come under pressure, sending its share price down 3.1%. In Frankfurt, the DAX 30 index little changed at 6902.80. Confirmation that Citigroup is interested in acquiring a German operation sent bank stocks up. In Paris, the CAC 40 is down 0.2% at 5621. Bunds and gilts are marginally higher in light trade, unmoved by euro-zone CPI data. The June bund future is up 0.04 at 115.1 and the June gilt future is down at 107.87. In the currency markets, the dollar is a little higher in Europe, helped by end-month currency flows but still capped by concerns over the continued tensions between Iran and the U.K. At 1025 GMT, the dollar was down at Y118, the euro was unchanged at $1.3320 and the pound was down at $1.9580. =========================== TOP STORIES: MAN GROUP CONFIRMS BROKERAGE UNIT WILL IPO: Man Group PLC (EMG.LN) said it will make an initial public offering on the New York Stock Exchange of Man Financial, its brokerage division, in a long-anticipated move that will leave the hedge-fund group to focus on its investment management business. (By Margot Patrick) ALLIANCE BOOTS GETS NEW BID FROM PESSINA, KKR: Health and beauty retailer Alliance Boots PLC (AB.LN) said it has received a revised takeover offer from its executive deputy chairman Stefano Pessina, backed by private equity group Kohlberg Kravis Roberts & Co, at 40 pence per share more than its original bid. (By Anita Likus) IBERIA APPROACHED BY TPG CAPITAL WITH EUR3.41B BID: Spanish airline Iberia Lineas Aereas de Espana SA (IBLA.MC) said it has received a EUR3.41 billion non-binding offer from U.S. private equity firm TPG Capital LLP. (By Jonathan House and Jason Sinclair) UCB SHARES FALL 5% AFTER CREDIT SUISSE TARGET PRICE CUT: Shares in Belgian drug company UCB SA (UCB.BT) slumped more than 5% early after a painful week of target price reductions and negative broker notes, following a delay to the launch of one of its most promising new pipeline drugs, Cimzia. (By Carolyn Henson) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: The dollar is likely to come under growing selling pressure as evidence of a slowdown in the U.S. economy fuels expectations that a Federal Reserve interest rate cut is in the pipeline. (By Nicholas Hastings) =CHARTING EUROPE: The Australian dollar remains bullish and targets its 10-year, 3-month high at US$0.8106, reached Monday, provided Mondays US$0.8030 low and minor support holds. (By Axel Rudolph) =FOCUS: Germanys economic recovery is broadening and accelerating, but much of that resurgence is washing right by eastern German communities where jobs remain scarce. (By Andrea Thomas) =ASSET CLASS: Its said that by the time corporate management starts to talk about the risks of recession, its already started. (By Alen Mattich) =========================== STILL TO COME COUNTRY PERIOD ET/GMT 0830/1230 US Feb Personal Income 0830/1230 US Feb Personal Spending 0830/1230 US Phila Fed Pres Plosser speaks before a Community Affairs Research Conference in Washington 0945/1345 US Mar Chicago PMI 1000/1400 US Jan Construction Spending 1000/1400 US Mar Reuters/Univ Mich Index, final 1030/1630 US Fed Chmn Bernanke speaks on the Community Reinvestment Act at the Community Affairs Research Conference in Washington =========================== OTHER NEWS: Consumer-price inflation in the euro zone nudged up to 1.9% year-on-year in March from 1.8% in February, broadly in line with the European Central Banks target of price stability, preliminary data from the European Unions statistics office showed. (Data Snap by Natasha Brereton) Vodafone Group PLC (VOD) disclosed weaker-than-expected margins in the U.K. as it outlined plans to try and raise revenues and cut costs in both the U.K. and Germany. (By Daniel Thomas) Resolution PLC (RSL.LN) shares tumbled more than 5% after the U.K. firm said that preliminary talks about a possible offer for the company had ended. (By Victoria Howley) Goldman Sachs Group Inc.s (GS) private equity arm is sizing up a bid for Kingfisher PLC (KGF.LN) this year, as the DIY retailer said it had slashed its debt and revalued its property assets, reports The Times of London. Volkswagen AG (VOW.XE) is still in talks with the Malaysian government on the possibility of a production cooperation with local automaker Proton Holdings Bhd. (5304.KU), the German firm said. (By Carolyn Lim) The U.K.s consumer protection body said it has formally requested that the more powerful Competition Commission investigate BAA Ltd.s dominance of the airports market. (By Rod Stone) U.K. pub group Enterprise Inns PLC (ETI.LN) is weighing up the advantages of converting its property assets into a Real Estate Investment Trust, or REIT, but is under no pressure to do so, Chief Executive Ted Tuppen said. (By Michael Carolan) European investment bank UBS AG (UBS) led investment banking revenues in the first quarter of the year in the whole of the Asia-Pacific region, thanks to transactions in Australia and India, according to data provider Dealogic. (By Nisha Gopalan) The U.K.s aviation industry regulator formally signalled that charges at Londons Heathrow and Gatwick airports will rise, and laid out measures to penalize operator BAA Ltd. if service levels arent met. (By Rod Stone) Europes drug regulator said its restricting the use of Sanofi-Aventis S.A.s (SNY) antibiotic Ketek, following a similar move by the U.S. Food and Drug Administration last month. (By Elena Berton) U.K. consumer confidence was unchanged from the previous month in March, although consumers were less willing to make big purchases, a survey published by GfK NOP showed. (By Paul Hannon) The rate of unemployment in the 13 countries that share the euro fell again in February, a development that is likely to boost consumer confidence. (Data Snap by Paul Hannon) Businesses and consumers in the 13 countries that share the euro became more confident about their prospects during March despite a further hike in interest rates. (Data Snap by Paul Hannon) German retail sales recovered in February, gaining broadly in line with expectations from the previous month due to increased purchases of durable goods and other non-food items, preliminary data from the Federal Statistics Office showed. (Data Snap by Roman Kessler) -By Vaughn Mckenzie-Landell, Dow Jones Newswires; +44 20 7842 9273; vaughn.mckenzie-landell@dowjones.com


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-----------------------------------------------+-------------------| | Company dealt in | Wilson Bowden Plc | |-----------------------------------------------+-------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-----------------------------------------------+-------------------| | Date of dealing | 29th March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 0 | | | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 1,870 | 2,145p | 2,145p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 30th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

The appointment of Synne Syrrist and Hilde Nakstad to the board of directors of Wavefield Inseis ASA is effective as of today, 30 March 2007. The new Board of Directors of Wavefield Inseis ASA hereafter consists of: Anders Farestveit (chairman), Dag-Erik Rasmussen, Jan Bertil Gateman, Hilde Nakstad and Synne Syrrist. Dated: 30 March 2007 Wavefield Inseis ASA For further information contact: Atle Jacobsen, CEO, Wavefield Inseis ASA Tel: +47 56 11 48 00 Email: atle.jacobsen@wavefield-inseis.com Or Erik Hokholt, CFO, Wavefield Inseis ASA Tel: +47 67 82 84 00 Email: erik.hokholt@wavefield-inseis.com About Wavefield Inseis ASA Wavefield Inseis is a Norwegian company providing a range of proprietary and non-exclusive multi- client marine geophysical services using highly specified vessels and the latest seismic equipment. From its main offices in Oslo and Bergen, Norway, Wavefield Inseis has a global reach, with activities in the Americas, Europe, Africa, the Middle East and Asia. The company was founded by a number of the most experienced people in the geophysical industry in order to provide a high quality range of services aimed at increasing the exploration success of its clients and to assist them in maximising production from their existing reservoirs. Wavefield Inseis` range of proprietary and non-exclusive Multi-client services includes long offset 2D, high capacity 3D, 4D, Multi-azimuth and Wide-azimuth data acquired with highly specified vessels and the latest seismic equipment. The company is also a full service permanent 4D acquisition provider and will, through a number of strategic alliances, bring new technologies to market to further accelerate and de-risk the replenishment of its clients` reserves. www.wavefield-inseis.com


 

(Oslo, 30 March 2007) As of today the companies in the Statkraft Group have a new look and a joint visual profile. The modernisation marks the beginning of a process of closer collaboration between Statkraft and the Group companies Trondheim Energi and Skagerak Energi. This will strengthen the Group's vision of being a European leader within environment-friendly energy. The Statkraft Group covers the entire value chain, from the innovation and development of new energy, through power and heat production, distribution grid operations, trading on the major power exchanges, sales to industrial, corporate and private customers to trading in environmental products such as carbon quotas, green certificates and certified renewable energy. The majority of the Statkraft Group's customer-based activities are performed by the subsidiaries Trondheim Energi and Skagerak Energi. A uniform corporate identity will help Statkraft focus on the Group's 600,000 electricity, grid and district heating customers. Trondheim Energiverk is also changing its name to Trondheim Energi today. "A joint visual profile will bind the three companies' activities together more closely. It will raise our outward visibility and external profile and support the development of a strong common corporate culture. We are proud to project the image of a modern group that is also ready to deliver the energy solutions of the future," remarked President and CEO Bård Mikkelsen. European position The new look will be donned by 2,000 employees, 158 hydropower plants in Norway, Sweden and Finland, 3 wind farms in Norway, 1 gas power plant under construction in Germany as well as offices in 8 European countries. A total of 750 vehicles and 2000 signboards will be given a new appearance. "The Statkraft Group has taken responsibility for the natural resources we manage for more than a century, and this is a legacy we will take with us in our industrial initiatives in Norway and the rest of Europe. We are an environment-friendly ground-breaker in the European power market, and are also helping to meet climate challenges on a commercial footing. Our visual profile will support this position. The Statkraft Group's main focus is environment-friendly energy production, and we will be one of the first players to start using new, renewable energy sources," commented Mikkelsen. Increased visibility During the spring, the Statkraft Group will also step up its initiatives to raise awareness levels of the Group among the general public, primarily by means of an information and marketing campaign. "Statkraft is a company that many people have heard of, but a company that few people know well. Despite this, we are Europe's second largest producer of renewable energy. This is something we intend to leverage, not least in relation to the Group's 600,000 customers," remarked Mikkelsen. Statkraft is a leading player in Europe within renewable energy. The company produces hydropower, wind power and district heating, and builds gas power plants while focusing on innovation with a clear ambition to deliver the energy solutions of the future. Statkraft is a major player on Europe's power exchanges. In Norway the company supplies electricity and heat to around 600,000 customers through its shareholdings in other companies. In 2006 Statkraft recorded gross revenues of more than NOK 16 billion and a profit after tax of NOK 6.3 billion and employed more than 2000 staff in Norway, Sweden, Finland, Germany, the Netherlands, the United Kingdom, Bulgaria and Serbia. The world needs pure energy. Statkraft works to deliver this every day. For further information, please contact: EVP Ragnvald Nærø, tel.: +47 24 06 71 00 / 900 80 303 Spokesperson Knut Fjerdingstad, tel: +47 24 06 71 61/ +47 901 86 310


 

Jena, March 30, 2007; CyBio AG, Jena (German Stock Exchange: General Standard, ISIN-Number DE0005412308) achieved a turnover of 15.46 Mio. Euro, an increase of 8.2 % over prior year (14.29 Mio. Euro). Annual Group Profit closed at 0.5 Mio. Euro (previous year 1.0 Mio. Euro). The Group Profit before interest and taxes (EBIT) increased to 0.2 Mio. Euro (py 0.1 Mio. Euro). The result of operation has largely been influenced by non-recurring cost incurred in connection with the acquisition of accelab GmbH and advanced cost to build up additional production and service capacity. The operation result of CyBio AG stand alone was 0.8 Mio. Euro (py 1.2 Mio. Euro). The Group net equity of 10.3 Mio. Euro remained unchanged compared to the previous year. The Balance sheet total increased by 2.7 Mio. Euro to 17.8 Mio. Euro in conjunction with the acquisition of accelab GmbH. This growth was manly borne by our sales area in Northern America with a growth rate of 18 % to 7.02 Mio. Euro (py 5.92 Mio. Euro). In Europe sales amounted to 7.68 Mio. Euro (py 7.50 Mio. Euro) a growth of 2.4 %. Sales in Asia declined slightly. Related to sales regions, sales was split up as follows: Germany 21.6 %, Europe without Germany 28.1 %, Northern America 45.4 % an Asia 4.9 %. About half of total sales is generated by our instrument business; the other half is contributed by sales from Service, Contract Development work, Customised Solutions and Consumables business. Our Customised Solution activities performed over average. Due to the tie up of funds by the acquisition of accelab GmbH at midyear the Group had available liquid funds at year end of 3.3 Mio. Euro (py 7.2 Mio. Euro). Affected by high sales volume in the fourth quarter a large part of the cash intake will occur not until the first Quarter 2007. Total accounts receivable balance was 3.9 Mio. Euro after 4.3 Mio. Euro the year before. In October of the fiscal year the batch production for the product Epic® for the technology company Coning had begun. In autumn the cooperation with Coning had been widened by a long term service agreement which contains in its scope the world wide installation and service of the equipment. In contract development we continue the successful cooperation in this device project. In our own development projects of the current year the work on a detection device stands in the foreground. In fiscal year 2007 we will further expand our sales organisation. Special importance will be attached to the expansion of our Japan customer base. In the second quarter of 2007 CyBio will set up its own sales subsidiary in Japan with branch experienced employees. The already existing broad customer base for our equipment and the significant growth potential in Asia has prompted us to put a focal point of distribution and service activities there. After we have successfully implemented the diversification concept in the last years and we expect in the current business year significant growth of sales in all product groups. The contract development with Coring Inc. and CLONDIAG Chip Technologies GmbH has already been launched into the production phase. The sales volume of customized solutions will double by the portion added from accelab. In our instrument business we also expect significant growth rates. In business year 2007 we will exceed the sales volume of 20 Mio. Euro which will lead to a strongly improved operational result. The testified Financial Statement of 2006 as part of our Annual Report is available today on our web site www.cybio-ag.com . Contact: CyBio AG Franziska Haase-Metz Göschwitzer Str. 40 07745 Jena Germany Phone +49 3641 / 351 401 Fax. +49 3641 / 351 409 Email: info@cybio-ag.com --- End of Message --- CyBio AG Göschwitzer Straße 40 Jena WKN: 541230; ISIN: DE0005412308; Index: CDAX; Listed: General Standard in Frankfurter Wertpapierbörse, Geregelter Markt in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

SOLTEQ PLC STOCK EXCHANGE BULLETIN 30.3.2007 Trading with the new shares together with the old shares will begin on April 2, 2007. SOLTEQ PLC Hannu Ahola Managing Director For further information, please contact: Managing Director Hannu Ahola, Tel +358 20 1444 211 or +358 40 8444 211, e-mail hannu.ahola@solteq.com Antti Kärkkäinen, CFO Tel +358 20 1444 393 or +358 40 8444 393, e-mail antti.karkkainen@solteq.com Distribution: Helsinki Stock Exchange Key media


 

- Consolidated sales boosted by 23% to ¤24.9 million - Group EBIT increased by 21% to ¤2.3 million - Group annual net profit increased by 38% to ¤2.9 million - Earnings per share at ¤0.30 - Solid balance sheet structure with a high liquidity (¤10.7 million) - Further growth planned (Cologne, 30 March 2007) - Splendid Medien AG, Cologne, generated 23% growth in consolidated sales in fiscal 2006, reaching ¤24.9 million (prior year: ¤20.3 million). Group earnings before interest and tax (EBIT) also posted significant growth of 21%, from ¤1.9 million in 2005 to ¤2.3 million in 2006. The EBIT margin stands at 9.2%. The Group even succeeded in boosting its annual net profit by 38% to ¤2.9 million (2005: ¤2.1 million). The earnings per share amount to ¤0.30 (prior year: ¤0.22). Hence the company has posted figures that exceed the previous year's figures by far. The most important business division was Home Entertainment with a 77% share in the total sales revenues. The Post-production division came second with a 13% share in sales before the Licence Trade division with a 10% share in sales. The Group likewise succeeded in sharply increasing its earnings before interest, taxes, depreciation and amortization (EBITDA) from ¤4.9 million to ¤7.4 million. The Group's earnings before tax (EBT) reached ¤2.0 million (2005: ¤1.9 million). The earnings situation in 2006 was largely influenced by the good performance in all segments. At ¤19.1 million, the Home Entertainment business division achieved a 22% growth in sales compared to the previous year (2005: ¤15.6 million). The Post-production division also succeeded in continuing the positive trend in recent years by posting sales growth to ¤3.2 million (2005: ¤2.7 million). The Licence Trade division boosted sales by 25% to ¤2.5 million (2005: ¤2.0 million). The Company's equity stood at ¤15.3 million at the balance sheet date (2005: ¤12.3 million). The liquid funds amounted to ¤10.7 million (prior year: ¤7.7 million). The Group invested ¤7.6 million in the film library in the past fiscal year (prior year: ¤3.3 million). High investments are also planned for fiscal 2007. The Splendid Group is expecting further growth in sales in the fiscal year 2007, coupled with an increase in the operating profit before tax. The 2006 Annual Report will be available for downloading from 30 March 2007 on the homepage of www.splendidmedien.com. For further information please contact: Splendid Medien AG Karin Opgenoorth Alsdorfer Str. 3 50933 Cologne Germany Tel.: +49 (0)221-95 42 32 99 Fax: +49 (0)221-95 42 32 613 karin.opgenoorth@splendid-medien.com --- End of Message --- splendid medien AG Alsdorfer Strasse 3 Köln WKN: 727950; ISIN: DE0007279507; Index: CDAX, CLASSIC All Share, Prime All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse;


 

Landspítali háskólasjúkrahús (LSH) undirritaði á dögunum samning við TM Software um uppsetningu og innleiðingu á verslunar- og kassakerfislausn TM Software - Maritech fyrir móttökustaði slysa (bráða)- og göngudeilda vegna komugjalda sjúklinga LSH, segir í frétt frá félaginu.Kassakerfið tengist Sögu frá TM Software og Ris sem er þegar í notkun hjá LSH, og flytur upplýsingar um gjöld sjúklinga í kassakerfið.


 

Tölvubankinn kynnti nýlega nýja hugbúnaðarlausn fyrir stjórnendur fyrirtækja og sveitarfélaga sem kallast BizVision, að því er fram kemur í frétt frá fyrirtækinu. Í þessu nýja kerfi er komin ný upplýsingasýn sem veitir einfalda yfirsýn yfir allan fjárhag, starfsmannahald, laun, viðskipti og sölu. Meðal lykilþátta í kerfinu er fullkomið áætlunarkerfi fyrir fjárhagsbókhald, launabókhald og sölukerfi.


 

Flugleiðahótel hafa undirritað samning við Skýrr um uppfærslu og innleiðingu á viðskiptalausnum Microsoft Dynamics NAV og hótelbókunarkerfinu Cenium. Kerfin verða innleidd á 21 Flugleiðahóteli ásamt miðlægri bókunarskrifstofu hótelanna, segir í frétt frá Skýrr.


 

This repeats an item filed at 0500 GMT) DJIA 12348.75 +48.39 +0.39% Nasdaq 2417.88 +0.78 +0.03% S&P 500 1422.53 +5.30 +0.37% FTSE 100 6324.20 +57.00 +0.91% Xetra DAX 6897.08 +80.19 +1.18% CAC40 5631.53 +78.84 +1.42% Above are closing prices Nikkei 225 17297.89 +33.95 +0.20% Hang Seng 19763.30 -58.48 -0.30% S&P/ASX 200 5972.00 +26.30 +0.40% Taiwan Index 7852.63 +4.30 +0.10% S.Korea Kospi 1451.61 +0.66 +0.10% Dow Future 12429.00 +13.00 +0.10% NASDAQ Future 1789.00 +1.00 +0.10% S&P Future 1433.00 +1.50 +0.10% Above are as of 0450 GMT USD/JPY 117.87-90 -0.08 Range 118.19 - 117.49 EUR/USD 1.3345-48 +0.09 Range 1.3344 - 1.3320 AUD/USD 0.8073-77 +0.15% Range 0.8081 - 0.8059 GBP/USD 1.9638-40 +0.10% Range 1.9657 - 1.9618 USD/CHF 1.2158-61 -0.12% Range 1.2186 - 1.2158 Above are as of 0450 GMT vs NY close USD/JPY Vol Option Contract 8.98%/9.22% EUR/USD Vol Option Contract 5.80%/6.10% AUD/USD Vol Option Contract 7.62%/7.88% GBP/USD Vol Option Contract 6.12%/6.37% USD/CHF Vol Option Contract 6.99%/7.21% Above are 1-Mo prices as of 0420 GMT 2Y Tsy 99 27/32 N/A 4.58% +5.1 5Y Tsy 100 13/32 -6/32 4.53% +4.3 10Y Tsy 99 28/32 -5/32 4.64% +2.0 10Y JGB 1.6550% +0.0100 Closing Treasury prices vs prior NY close; JGB as of 0450 GMT Asian Spot Gold $662.25 +$1.25 +0.2% Comex Gold $662.20 +$0.70 +0.1% Brent Crude Oil $68.63 +$0.75 +1.1% Above are as of 0400 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European shares may open slightly higher, while government debt remains under light pressure. The euro is steady against the dollar in a tight range, and Iran tension is lifting gold and oil. STOCKS: Confidence in the European economy is likely to underpin modest gains in stocks at the opening Friday. Spreadbetting firm Cantor Index is calling the FTSE up 3 at 6327, the DAX up 4 at 6901, the CAC up 3 at 5634, and the Eurostoxx up 2 at 4113. Strong economic data are one reason Europe is HSBCs most favored equity region in the world, notes Robert Parkes, an equity strategist at the bank. Europe has the only overweight rating in HSBCs regional equity coverage. "We are generally positive on equities overall as profitability continues to be strong and valuations still look too low given those levels of profitability," said Parkes. U.S. stock futures are slightly higher after a late comeback in volatile trading Thursday as investors weighed fears about mounting tension in Iran against news that U.S. economic growth at the end of last year was stronger than initially estimated. The U.S. Commerce Departments final measure of fourth-quarter gross domestic product showed growth of 2.5%, up from an earlier estimate of 2.2%. That could help quell concerns the economy is slowing too quickly. "The market is at a pivotal point," said Scott Fullman, director of investment strategy for Israel A. Englander & Co. It "has become more volatile, and more sensitive, to news items." In corporate news, U.S. Steel Inc. announced it will acquire tube maker Lone Star Technologies Inc. for $2.1 billion, which represents a 39% premium. In Asia, Japan led markets higher in line with Wall Streets rebound, but dealers looked for late profit-taking to crimp gains as the Japan fiscal year ends. In Australia, broad-based gains lifted the market, led by media sector shares after the government said media ownership deregulation would be introduced next week. FOREX: The euro is holding steady in a very narrow range against the dollar. The "euro-dollar continues to show ... greater sensitivity to fluctuations in the outlook for Fed policy," noted Daniel Katzive, currency strategist at UBS. "With continued neutral-to-hawkish guidance from the Fed offsetting indications of weakness in the housing market and manufacturing sector, Fed expectations remain contained and so has euro-dollar," he said. Dealers talk of good-sized euro bids at $1.3315-1.3325 and strong offers at $1.3345-1.3350. The dollar has support at around Y117.40-117.50, backed by importers waiting with buy orders. The euro is pegged to be in a range of Y156.70-157.20 for now. BONDS: European government bond prices are still under pressure, after closing lower Thursday as strong data and inflation concerns in the U.S., the U.K. and the euro zone continue to weigh on the market. Looking ahead to Friday, U.K. markets will focus on the consumer with the release of the GfK March consumer confidence report at 0930 GMT. HSBC says that in recent months households have become more concerned about their personal finances, which is probably a reflection of higher interest rates. For bund traders the flash euro-zone HICP inflation report, due at 0900 GMT, is the highlight of Friday mornings session, with year-on-year inflation likely to pick up to 1.9% in March, HSBC said. This would be the seventh consecutive month inflation remained within the ECBs target for price stability of below, but close to 2%, a feat which hasnt been achieved since early 2000. U.S. Treasury prices are slightly lower in Asia Friday, having ended lower Thursday, with investors more pessimistic about a possible ease in interest rates following recent discouraging words from the Federal Reserve and after stronger economic growth data. The governments lackluster auction of $13 billion in five-year notes also lent a negative tone to the Treasurys market. "People are still trying to digest where the Fed stands to some extent," said Kevin Flanagan, executive director and fixed income strategist at Morgan Stanley in New York. The latest data and Federal Reserve remarks "confirm the viewpoint that the Fed is not going to do anything," said Richard Gilhooly, senior fixed income strategist at BNP Paribas in New York, "and that the economy is healthy." Richmond Federal Reserve Bank President Jeffrey Lacker said Thursday he expects the risks of a slowing economy to ease later in the year, but there are risks that current inflation expectations will become "entrenched" without a significant drop in inflation. Regarding the recent spate of mortgage delinquencies in the subprime market, particularly the market for adjustable-rate subprime loans, Lacker said he didnt see broader risks for the economy. Investors now eagerly await Fridays key inflation data, personal consumption expenditures, which is closely monitored by the Fed for signs of inflation pressures. Market consensus was "starting to move toward the idea we could get an upside surprise," Credit Suisses Lantz said, with whispers in the bond market of a more pronounced rise. In Japan, government bond JGB players are likely trying to keep the 10-year yield around the 1.7% level ahead of two 10-year JGB auctions next week, says ABN Amro chief bond strategist Tatsuo Ichikawa. The 10-years price was slightly lower Friday. Falling energy costs and cellphone fees caused Japans consumer prices to drop for the first time in 10 months in February, further weakening the Bank of Japans case for raising interest rates in the near future. ENERGY: Oil prices kept soaring Friday as a standoff between Britain and Iran was taken to the United Nations and a jittery market worried that oil exports could be affected by the crisis. After settling at a six-month high a day earlier, light, sweet crude futures rose another 43 cents to $66.46 a barrel Asian electronic trading on the New York Mercantile Exchange. "The market is very much factoring in a worst-case scenario," said Mark Pervan, a commodities analyst at Daiwa Securities in Melbourne. "Other fundamentals have been pushed to the side." Traders are not saying they believe war with Iran is likely, but in an environment of high demand and falling domestic supplies, they maintain that the effects of a large-scale conflict on the energy markets could be huge. METALS: Spot gold is slightly higher as gains in crude oil prices and firmer base metals buoy gold sentiment, said a Hong Kong-based trader. Spot gold was last at $662.25/oz, up $1.25 on the NY close. The trader adds the upward trend in crude is stoking inflation concerns, and this is likely to induce safe-haven buying in the near term. LME copper is facing resistance at $6,850 and so is likely to retreat to $6,600-$6,700/ton in the short term before buying interest revives, said a commodities trader in Hong Kong. Copper is "looking a little tired" after two days of narrow range-trade and a pullback to its 14-day moving average of $6,630 should refresh the market and entice dip-buyers. LME 3-month copper was up $45 on the London PM kerb in thin volume at $6,800, in picking up support from steadiness in other base metals, the trader said.


 

Stock exchange release 30 March 2007 at 11 a.m. At Incap Corporation's Annual General Meeting to be held on Tuesday, 3 April 2007 at 2 p.m. will be dealt, besides the matters mentioned in the Notice of Annual General Meeting published on 14 March 2007, also the following proposal, which has been delivered to the Board of Directors: Incap Corporation's shareholders whose aggregate proportion of the voting rights and share capital is 43% have proposed that the number of members of the Board of Directors to be confirmed at 5 and that Jukka Harju, Juha-Pekka Kallunki, Kalevi Laurila, Susanna Miekk-oja and Sakari Nikkanen be elected to seats on the Board of Directors. The proposed persons have given their consent to stand for election. INCAP CORPORATION Board of Directors Juhani Hanninen President and CEO For additional information, please contact: Juhani Hanninen, President and CEO, tel. +358 50 556 7199 Anne Sointu, Chief Financial Officer, tel. +358 40 347 2059 Hannele Pöllä, Director, Communications and Investor Relations, tel. +358 40 504 8296 DISTRIBUTION Helsinki Stock Exchange Principal media ANNEX Profile of the candidates for election to the Board of Directors Jukka Harju M.Sc. (Eng.), M.Sc. (Econ.), born 1956. Jukka Harju is a Partner of Boier Capital Ltd. Previously he has among others served as Chief Operating Officer and Executive Vice President at Elektrobit Corporation, as Managing Director at Tellabs Ltd. and in various positions at Nokia Telecommunications Ltd. (present Nokia Networks). Jukka Harju has multifaceted experience in international business management and development, and his core competence areas include among others business transactions. Jukka Harju is a board member at Efore Plc. and Elektrobit Corporation. Juha-Pekka Kallunki Professor, D.Sc.(Econ.), born 1969. Juha-Pekka Kallunki has been a member of the Board of Directors of Incap since 2005. He acts as professor of financial accounting at the University of Oulu, Faculty of Economics and Business. He has published several management books and dozens of international papers in accounting and finance. Juha-Pekka Kallunki has been a member of several corporate boards. Kalevi Laurila B.Sc. (Eng.), Executive MBA, born 1947. Kalevi Laurila has been a member of the Board of Directors of Incap since 2002. Previously he was CEO of JMC Tools Oy and Turveruukki Oy as well as a director with Rautaruukki Oyj. He is a member of several other corporate boards. Susanna Miekk-oja M.Sc. (Econ.), born 1950. Susanna Miekk-oja serves as Director at Sampo Fund Management Ltd. She has 30 years of experience in versatile expert and executive positions at Sampo Group and its predecessors Postipankki and Leonia. Susanna Miekk-oja has extensive knowledge in securities market and in international financing and insurance businesses. She has gained international expertise especially in Asia and Eastern Europe. She has held a number of corporate board positions. Sakari Nikkanen Licentiate in Technology, born 1952. Sakari Nikkanen was appointed to the Board of Directors of Incap Corporation in 2004. He has occupied various positions with Nokia Networks and with the PI-Group. At present, Sakari Nikkanen is a management consultant with Sanik Consulting Oy. He is also a member of several other corporate boards.


 

As part of Odfjell's continued fleet renewal process, two older ships have been sold. OWL Trader (12 450 dwt./built 1982) was delivered to her new owners 28 March 2007. We have also entered into an agreement to sell Bow Lady (32 225 dwt./built 1978) and expected time of delivery to new owners is medio April. These transactions give a total gain of about USD 3 million for the Odfjell group, which will be accounted for in the second quarter of 2007. Press contact: Anne-Kristine Øen, Information Manager, ph. +47 5527 4548 or +47 957 71549, E-mail: anne.kristine.oen@odfjell.com Additional information about Odfjell is available at: www.odfjell.com


 

Affibody Holding AB, a biotech company that has developed a late-stage pipeline of oncology products for molecular imaging and targeted therapy, issues new shares amounting to SEK 200 million. Affibody's mission is to provide the medical community with previously not available information for timely cancer diagnosis and appropriate individualized treatment regimes. The issuance of new shares gives Affibody a capital infusion of approximately SEK 107 million through a private placement with new and existing investors. At the same time, loans from shareholders totaling SEK 93 million are set off against new shares. Among the new investors, which invested in total SEK 57 million, are the Third Swedish National Pension Fund, Kaupthing Bank, Lage Jonason, Stena Sessan and Ingvar Kamprad. The net proceeds from the private placement will be used for the clinical development program for a product intended for the diagnosing of an aggressive form of breast cancer. The market potential for the product is exceeding one billion Euros per year. The product is expected to be commercially launched in 2009. "The research within the cancer area is heading towards more specific diagnostic methods and individualized treatment regimes. Affibody has a unique position within these areas, as our targeting molecules can be efficiently used for the identification and treatment of certain cancer forms", says Ulf Boberg, CEO of Affibody. The key components of Affibody's proprietary technology platform are the Affibody® molecules, unique and highly specific affinity ligands that can be designed to bind to any target protein. Based on its proprietary technology, Affibody has developed a unique pipeline of oncology products. Affibody has also entered a number of commercial collaborations where the company develops Affibody® molecules for use in the partners' applications. Among the collaboration partners in molecular imaging is GE Healthcare. After the issuance of new shares, Affibody's five main owners besides the founders are: HealthCap, Investor, Schroder Ventures Life Sciences, Life Equity Sweden and the Third Swedish National Pension Fund. Lage Jonason AB acted as financial advisor for the private placement. For further information, please contact: Ulf Boberg, Chief Executive Officer +46 8 598 838 10, ulf.boberg@affibody.com Erika Johnson, Chief Financial Officer +46 8 598 838 16, erika.johnson@affibody.com About Affibody Affibody is a biotech company that has developed a late-stage pipeline of oncology products for molecular imaging and targeted therapy. Affibody's mission is to provide the medical community with previously not available information for timely cancer diagnosis and appropriate individualized treatment regimes. The key components of Affibody's proprietary technology platform are unique and highly specific affinity ligands: Affibody® molecules. These small robust protein molecules are easy to produce and can be designed to bind to any target protein. The Affibody molecules are ideal for molecular imaging. Importantly, the same Affibody® molecule can, with a cytotoxic payload, be used for targeted therapeutics. Affibody's vision is to be a leading player in the emerging field of molecular imaging and targeted therapeutics. The company's lead product for molecular imaging is targeting HER2, a key receptor on e.g. certain breast cancer tumors, and is expected to be commercially launched in 2009. Affibody® molecules specific for other oncology targets are in development and will provide a steady stream of new molecular imaging products and subsequently, targeted therapeutic products. Affibody also develops Affibody® molecules within commercial collaborations for various applications. Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute in Stockholm. Investors in Affibody Holding AB include HealthCap, Schroder Ventures Life Sciences and Investor. Affibody is based in Stockholm, Sweden and has 50 employees. Further information is found on: www.affibody.com Statements in this press release that are not strictly historical may be forward-looking and include risks and uncertainties. Therefore, though based on Affibody's current expectations, it should be duly noted that a variety of factors could cause actual results and experiences to differ materially from what is herein expressed. Risks and uncertainties include, but are not limited to, risks associated with the management of growth and international operations (including effects of currency fluctuations), variability of operating results, unforeseen changes in the diagnostic and pharmaceutical markets, market competition, rapid or unexpected changes in technologies, fluctuations in product demand, difficulties to successfully develop, adapt, produce or commercialize products, the ability to identify and develop new products and to differentiate products from those of competitors, as well as various legal hazards.


 

On March 29th 2007, the Board of Directors approved the financial statements for 2006, compared to the preliminary result presented in the q4 report there are no changes in the profit for the year. For further information please contact: Kristian Haneberg, CFO; Simrad Optronics ASA (+47) 90 59 99 16. E-mail: kh@simrad-optronics.no


 

On 28 March 2007, Handelsbanken became a member of the London Stock Exchange, one of the world's largest stock exchanges. Some 350 players from 50 countries trade on the London Stock Exchange, which is one of the oldest stock exchanges. Mikael Ericson, head of Handelsbanken Capital Markets, states, "The membership enables us to improve our offerings to customers, as we have direct access to Europe's financial centre. This represents a further step in our strategy to build the leading Nordic investment bank." For further information, please contact: Mikael Ericson, Head, Handelsbanken Capital Markets Phone: +46 8 701 43 56, email: mier03@handelsbanken.se Erik Wikström, Head of Communication, Handelsbanken Capital Markets Phone: +46 8 701 12 70, email: erwi03@handelsbanken.se Handelsbanken Capital Markets is Handelsbanken's investment bank. It is responsible for Handelsbanken's transactions in the fixed income, foreign exchange and stock markets, including macroeconomic, equity, credit and financial research, corporate finance, debt capital markets and structured products. Some 900 staff on three continents specialise in financial solutions for Nordic requirements. Handelsbanken Capital Markets is an integral part of Handelsbanken, which has over 600 branches, operations in 20 countries, total assets of SEK 1,790 billion and an operating profit for 2006 of SEK 17.2 billion. The Bank has over 10,000 employees.


 

Artumas Group Inc. is pleased to report on the successful closing of the Private Placement announced on 29 March 2007, for gross proceeds of USD 35 million (215 million NOK). The Offering was significantly over-subscribed. The Offering comprised of 3,308,000 shares priced at 65,00 NOK (5.45% discount to closing price on 29 March 2007) in a combination of new shares and existing shares, equal to 15.7% of the existing number of outstanding shares in the company. The Offering consisted of 2,108,000 shares issued from Treasury, and 1,200,000 shares borrowed from members of Artumas' management, without any compensation. The offering was subscribed by Norwegian and International institutional investors. EMP Africa Fund II PCC, of Washington, DC participated in the Offering. EMP Africa is a private equity fund manager targeting Africa infrastructure investments with a regionally diversified portfolio that spans numerous sectors such as telecoms, oil & gas, agribusiness, power & water and transportation. Net proceeds of the offering will be used to finance working capital and the ongoing exploration and seismic programs of the Company's Mnazi Bay Concession. ABG Sundal Collier ASA, the Lead Manager and First Securities, the Co-lead Manager, will undertake to file a prospectus with the Oslo Børs whereby the borrowed shares will be returned to management upon the issuance of shares under the prospectus. ------------------------------------------------------------------------------ Artumas Group Inc. is an international energy producer focused on monetizing its hydrocarbon reserves in the Rovuma Delta Basin in Tanzania and Mozambique. By exploring, developing, producing and commercializing known petroleum systems, Artumas is poised to deliver a sustainable rate of return for its stakeholders while creating social and economic opportunities for the people of Eastern Africa. Artumas' common shares trade on the Oslo Stock Exchange under the symbol AGI. FORWARD LOOKING STATEMENTS This news release may contain forward-looking statements including expectations of future production, cash flow and earnings. These statements are based on current expectations that involve a number of risks and uncertainties, which could cause actual results to differ from those anticipated. These risks include, but are not limited to: the risks associated with the oil and gas industry (e.g. operational risks in development, exploration and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to production, costs and expenses, and health, safety and environmental risks), commodity price, price and exchange rate fluctuation and uncertainties resulting from potential delays or changes in plans with respect to exploration or development projects or capital expenditures. This news release is not for dissemination in the United States or to any United States news services. The common shares of Artumas have not and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold in the United States or to any U.S. person except in certain transactions exempt from the registration requirements of the U.S. Securities Act and applicable state securities laws. NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WARNING Oslo Bors has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


 

Focus on early detection of colorectal cancer - New Strategy aims at fastest route to market and commercialization * Financials in line with latest expectations: - Full year revenue EUR 3.5 million, EBIT at EUR -15.8 million - Operational costs EUR 21.2 million - Liquidity of EUR 17.3 million as of December 31 2006 - Dedicated project evaluating all strategic and tactical financing options started in Q4-2006 * Strategy and organization realigned with focus on key value drivers and fastest route to market * Positive clinical data from colorectal and prostate cancer screening programs * Roche Diagnostics ended partnership despite positive clinical data - all rights reverted to Epigenomics * Qiagen launched EpiTect ® Bisulfite Kit for research use * Affymetrix became strategic diagnostics platform partner and shareholder * Seven new biomarker R&D collaborations * New CEO Geert Nygaard joined early 2007 to succeed founder Alex Olek Berlin, Germany and Seattle, WA, USA, March 30, 2007 - Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, today reported its financial results for the fiscal year ending December 31, 2006, and presented its strategy realignment aiming at the fastest route to commercialization. Strategy Realignment Under the lead of Epigenomics' new CEO, Geert Walther Nygaard, Epigenomics has realigned its strategy and operational focus. The company has decided to further streamline its product development pipeline in an attempt to pursue the fastest possible route to market for Epigenomics' lead products. Accordingly, Epigenomics aims at establishing multiple non-exclusive partnerships for its screening products to ensure a faster route to market and broader market penetration. "Epigenomics' main focus is to turn the impressive development work that it has done in both core businesses, screening and specialty diagnostics, into products. I am convinced that Epigenomics' DNA methylation technology is ideally positioned to fill the large unmet need in early cancer diagnosis, probably one of the most attractive market segments in diagnostics today," commented Geert Walther Nygaard, CEO of Epigenomics. "We are now focusing all our strength, expertise and resources on progressing our lead product for colorectal cancer screening and identifying new diagnostics industry partners for the broad commercialization of our pipeline of screening products." Financial Review 2006 Epigenomics' full year 2006 revenue was EUR 3.5 million, a decrease compared to fiscal year 2005 of EUR 9.6 million. This development was mainly due to a one-time multi-million Euro milestone payment in Q4 of 2005 under the Roche Diagnostics partnership, the termination of the Roche Diagnostics agreement, as well as lower than expected new business collaborations. Throughout 2006, Epigenomics continued its strong commitment to building and maintaining a leadership position in DNA methylation-based products, science and technology. A total of EUR 8.7 million in research and development (R&D) expenditures was spent versus EUR 8.1 million for fiscal 2005. This reflects a resource shift towards Epigenomics' prostate cancer classification program and the development of a proprietary diagnostics platform for tissue testing. Marketing and business development costs increased to EUR 2.7 million compared to EUR 1.5 million in 2005. The increase was driven by a build out of a dedicated marketing function, significant market research for our most advanced products, and a strengthening of our business development and licensing team. General and administrative expenses of EUR 4.1 million were slightly above the EUR 3.8 million in 2005. Earnings before interest and taxes (EBIT) totaled EUR -15.8 million in 2006, a drop from previous year's EUR -10.2 million. Net loss increased from EUR 8.8 million in 2005 to EUR 15.4 million in 2006. The increase in the Company's net loss is driven primarily by lower revenue in 2006 as operating costs were tightly controlled. Epigenomics' total operating expenses in 2006 of EUR 21.2 million were similar to 2005 operating costs of EUR 21.3 million. Net loss per share was EUR 0.92 in 2006 compared to a EUR 0.54 net loss per share in 2005. As of December 31, 2006, liquid assets including marketable securities totaled EUR 17.3 million compared with EUR 32.7 million at the end of 2005. The number of outstanding shares as of December 31, 2006 was 16,916,125. Operational Review 2006 The past year has been challenging for Epigenomics but 2006 has also been a year of outstanding clinical and product development progress as the company worked towards the launch of its diagnostics products. Epigenomics' lead product, a blood-based test for the early detection of colorectal cancer, has been validated in several large clinical studies. With the identification of an additional biomarker and improvement of the assay procedure, Epigenomics has been able to significantly improve the product, which now detects two-thirds of all colorectal cancers patients from a simple blood draw - compared to half of the cancer patients a year ago. In Epigenomics' prostate cancer program, the company demonstrated reliable and accurate detection of cancer using urine samples. Despite these excellent results and the progress made in 2006, Epigenomics' partner of more than four years, Roche Diagnostics, decided to end the collaboration in December 2006. Since then, all worldwide rights and ownership of the data, licenses and products have returned to Epigenomics. Epigenomics' tissue-based prostate cancer molecular classification test was successfully transferred onto the IVD platform of our partner, Affymetrix. In the summer of 2006, Epigenomics and Affymetrix entered into a strategic partnership under the "Powered by Affymetrix"(TM) program granting Epigenomics access to Affymetrix's entire installed instrument base. Combined with the Qiagen partnership for sample preparation Epigenomics now has secured access to all modules required for a molecular diagnostics platform using DNA methylation-based diagnostics. Regarding the Clinical Solutions business, Epigenomics signed seven new biomarker R&D collaboration agreements in 2006. Partnerships include follow-on deals with AstraZeneca and Philip Morris as well as several new collaborations with Johnson & Johnson, Centocor and three undisclosed partners among leading pharma and biotech industry companies. Epigenomics' leading DNA methylation technologies and strong IP portfolio of more than 200 filed patent families was further strengthened bringing the total number of patents granted to 61. As part of the Qiagen and Affymetrix partnerships, several key patent families have successfully been out-licensed to leaders in their respective fields. After the resignation of founder and former CEO Alexander Olek, the management team decided to focus on key value drivers of the business. As a consequence, Epigenomics underwent a corporate restructuring in October 2006, resulting in a streamlined organization with a clear emphasis on later stage clinical research and development programs in oncology, and a reduction of 33 management and staff positions in Berlin. Since then Epigenomics' Executive Board has been strengthened with significant operational and commercial diagnostics industry expertise. Moreover, on February 1, 2007 Geert Walther Nygaard, former Managing Director of Abbott Germany, joined the Epigenomics team as the new Chief Executive Officer. Future Outlook Under the lead of Epigenomics' new CEO, Geert Walther Nygaard, Epigenomics will focus on the execution of its key corporate objectives. The main 2007 corporate priority is to prepare the colorectal cancer screening program and make certain that the adapted assay procedure is suitable and ready for routine clinical and reference laboratories. Epigenomics' goal is to establish a reference lab partnership in the second half of 2007. The first blood based colorectal cancer test is expected to be launched via a reference lab in 2008 as a centralized testing service. Following the termination of the cooperation with Roche Diagnostics Epigenomics now holds all worldwide rights and ownership of the data, licenses and products. This has opened the way for leveraging Epigenomics' attractive cancer screening pipeline in multiple non-exclusive partnerships with diagnostics industry players. Discussions with suitable partners are ongoing. The commercialization strategy for the company's in vitro diagnostic (IVD) kits targeted for mass markets in cancer screening has thus been changed. Epigenomics' aim is to have multiple non-exclusive partnerships rather than a single, exclusive worldwide R&D and commercialization partnership. This is to ensure broader market penetration, a faster route to market and sales ramp for Epigenomics' screening products on several diagnostic platforms, which the company believes can be accomplished based on the sales and marketing efforts of several IVD players. The company expects to sign the first of these non-exclusive partnerships by the end of 2007 followed by additional deals in 2008 and beyond. Epigenomics anticipates 2007 revenue to be similar to 2006 revenue. 2007 revenue will depend on current R&D collaborations, as well as the new partnerships previously outlined. EBIT for the fiscal year 2007 is also expected to be similar to 2006 figures. Net cash burn from operations is expected to be significantly lower than 2006 based on expected deals with certain up-front components. The company expects a net cash consumption of approximately EUR 11 to 12 million in 2007 to execute on the revised strategy. During 2007, Epigenomics expects to strengthen its financial position and is currently evaluating all options. Timing, structure as well as size will depend on the nature of the strategic business deals the company anticipates closing during 2007. Further Information Epigenomics will host an analyst meeting and press conference today at 10 am CET at DZ Bank, Platz der Republik, 60265 Frankfurt am Main to present the fiscal year 2006 results and provide guidance for 2007. Epigenomics' management will also host a conference call at 3 pm CET. The dial-in numbers for the conference call are: Dial-in number (within Germany.): +49 6958 999 0804 Dial-in number (outside Germany): +1 480 293 1744 Participants are kindly requested to dial in 10 minutes prior to the start of the call. A recording of the conference call will be provided on Epigenomics' website subsequently (http://www.epigenomics.com/en/down_loads/corporate_material/). The presentation accompanying the meeting and the conference call will be available for download on the Epigenomics website: English: http://www.epigenomics.com/en/down_loads/corporate_material/ German: http://www.epigenomics.com/de/downloads_/firmeninformation/ Also available for download is the Company's Annual Report 2006: Englisch: http://www.epigenomics.com/en/investor_relations/Financial_Information/ German: http://www.epigenomics.com/en/investor_relations/Financial_Information/?lang=1 About Epigenomics AG Epigenomics is a molecular diagnostics company with a focus on the development of novel products for cancer. Using DNA methylation biomarkers, Epigenomics' tests can potentially diagnose disease at an early stage and help guide physicians to select an appropriate therapy. Epigenomics' defined business strategy covers two complementary core business areas: In cooperation with industry partners, the company develops diagnostic screening tests for the early detection of cancer, mass-market products with huge potentials. Based on easily obtainable body fluid samples (e.g. blood and urine), these tests are aimed at finding cancer at an early stage before symptoms occur. Epigenomics' product pipeline contains an extensively validated biomarker panel for the early detection of colorectal cancer in blood plasma, and further proprietary DNA methylation biomarkers at various stages of development for prostate, and lung cancer detection in body fluids. Epigenomics aims at giving patients and doctors early access to these biomarkers through reference laboratory testing services. For development and global commercialization as in vitro diagnostic tests kits, Epigenomics pursues a non-exclusive partnering strategy with diagnostics industry players. As a second core business area, Epigenomics develops specialty diagnostics for individuals at high risk for cancer and cancer patients. These tests include surveillance applications of our colorectal cancer biomarkers and a tissue-based prognostic cancer molecular classification test for prostate cancer patients. Our tissue-based prostate cancer application is developed in strategic partnerships with Qiagen (pre-analytics) and Affymetrix (diagnostic device platform). The biomarkers for cancer specialty diagnostic applications will be made available through testing services in centralized reference laboratories. Epigenomics retains the flexibility to decide on further commercialization as in vitro diagnostic test kits in Europe and eventually the US midterm. Pharma, diagnostics and biotech partners can access Epigenomics' portfolio of proprietary DNA methylation technologies and biomarkers protected by more than 200 patent families through Biomarker Services, IVD Development Collaborations, and Licensing. The company is headquartered in Berlin, Germany, and has a wholly owned subsidiary in Seattle, WA, USA. For more information, please visit Epigenomics' website at www.epigenomics.com. ### Disclaimer This communication expressly or implicitly contains certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.


 

Vaisala Oyj stock exchange release 30.3.2007 at 9:00 M.Sc., eMBA Ari Meskanen (43 years) has been appointed as Vaisala Chief Technology Officer and member of the Management Group starting May 1st, 2007. As Chief Technology Officer, Ari Meskanen will be responsible for the management of Vaisala's common technology platforms and sensor technologies, mapping new technology developments and trends, as well as research and development partnerships. Ari Meskanen has been with Vaisala from 1998, working in various positions within the Vaisala Solutions and Vaisala Measurement Systems divisions. His current role is Business Unit Manager, Vaisala Soundings. In his new role, Ari Meskanen will report to CEO Kjell Forsén. As a member of the Vaisala Management Group and the person in charge of Vaisala's technological development, Ari Meskanen is a successor to Director Jussi Mykkänen, who will concentrate on Vaisala's mergers and acquisitions activities. The Vaisala Group is a successful international technology company that develops and manufactures electronic measurement products and solutions and related services. Application areas include meteorology, environmental sciences, traffic and industry. The Vaisala Group employs over 1,000 professionals. In 2006, Vaisala achieved net sales of EUR 220.8 million. Vaisala operates and serves its customers globally. In 2006, operations outside Finland accounted for 97% of net sales. Parent company Vaisala Oyj, domicile in Finland, is listed on the Helsinki Exchanges in Finland. Further information: CEO Kjell Forsén, tel. +358 9 8949 2202 or +358 400 757948 Distribution: Helsinki Stock Exchange Finnish news agency Major media


 

* Dynamic revenue and earnings growth in 2006 * Strong international demand for biodiesel plants * Outlook: EBIT margin of more than 10 per cent expected (Graz, 30. March 2007) The Austrian company BDI - BioDiesel International AG set revenue and earnings records in the past fiscal year. The company increased its revenues by 500.3 per cent over the previous year to EUR 87.8 million. Earnings before interest and tax (EBIT) went up from EUR 0.4 million to EUR 14.0 million in the same period. The EBIT margin increased to 15.9 per cent in the 2006 fiscal year from 2.8 per cent in the previous year. This means that the 2006 fiscal year was the most profitable in BDI's corporate history so far. Thanks to the fast growth in the 2006 fiscal year, BDI succeeded in improving its strong position on the market as well as its status as technology leader with multi-feedstock plants. Two multi-feedstock plants and one single-feedstock plant with a total capacity of more than 175 000 tonnes per year were brought into operation last year. Wilhelm Hammer, CEO of BDI - BioDiesel International AG: "Our total orders on hand at the end of the year amounted to EUR 99.5 million, which is a record level. Due to the favourable raw material prices for animal fats and waste edible oil, demand for multi-feedstock plants from BDI remains high. The trend with single-feedstock plants is towards larger plants. We have succeeded, for example, in obtaining orders to build two single-feedstock plants in Spain with a capacity of 200 000 tonnes per year each." Outlook: strong international demand for BDI biodiesel plants In addition to the orders that have already been obtained, BDI is currently holding worldwide negotiations about orders with a potential volume of far more than EUR 150 million in total. Renewable energy sources are becoming increasingly popular not only in Europe but also in other parts of the world. The International Energy Agency (IEA) is working on the assumption that the proportion of total global fuel consumption in road transport accounted for by biofuels will increase almost sevenfold between 2004 and 2030. It is expecting the highest growth rates to be achieved primarily in the USA, Europe and the emerging countries in Asia. In view of this, the company is optimistic about the future. An EBIT margin of more than 10 per cent is anticipated in 2007. Further information is available at www.bdi-biodiesel.com. About BDI - BioDiesel International AG BDI - BioDiesel is one of the world's leading suppliers of complete biodiesel production plants. The services the company provides include plant planning, construction and start-up and subsequent after-sales service. BDI - BioDiesel has had in-depth experience with the production of biodiesel and owns an extensive patent portfolio that has resulted from its in-house research and development activities. The company considers itself to be among the leading international technology suppliers on the market for the production of multi-feedstock plants that can manufacture biodiesel on the basis of different raw materials, such as vegetable oils, waste edible oils and animal fats. BDI - BioDiesel International AG currently has more than 100 employees. The BDI - BioDiesel International AG shares (ISIN AT0000A02177) are listed in the Prime Standard/Regulated Market. Press contact: Kirchhoff Consult AG Dr Kay Baden Tel. +49 40 60 91 86 39 baden@kirchhoff.de --- End of Message --- BDI - BioDiesel International AG Parkring 18 Grambach/Graz Austria WKN: A0LAXT; ISIN: AT0000A02177; Index: Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse;


 

OctoPlus N.V. ("OctoPlus" or "the Company") (Euronext: OCTO), the drug delivery and development company, announces today the publication of its Annual Report 2006. The Annual Report is available on the Company's website, www.octoplus.nl. Hard copies of the report can be requested by sending an e-mail to IR@octoplus.nl. For further information, please contact: Rianne Roukema, Corporate Communications, +31 71 524 4044. About OctoPlus OctoPlus N.V. is a product-oriented biopharmaceutical company committed to the development of improved pharmaceutical products that are based on its proprietary drug delivery technologies and have fewer side effects, improved patient convenience and a better efficacy/safety balance than existing therapies. Rather than seeking to discover novel drug candidates through early stage research activities, OctoPlus focuses on the development of long-acting, controlled release versions of known protein therapeutics and other drugs. OctoPlus is also a leading provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industry, with a focus on difficult to formulate active pharmaceutical ingredients in injectable formulations. The earnings and expertise that OctoPlus derives from rendering formulation and manufacturing services help to support its own drug development programs. OctoPlus is listed on Euronext Amsterdam under the symbol OCTO. For more information about OctoPlus, please visit our website www.octoplus.nl. This document may contain certain forward-looking statements relating to the business, financial performance and results of OctoPlus N.V. and the industry in which it operates. These statements are based on OctoPlus N.V.'s current plans, estimates and projections, as well as its expectations of external conditions and events. In particular the words "expect", "anticipate", "predict", "estimate", "project", "plan", "may", "should", "would", "will", "intend", "believe" and similar expressions are intended to identify forward-looking statements. We caution investors that a number of important factors, and the inherent risks and uncertainties that such statements involve, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements. In the event of any inconsistency between an English version and a Dutch version of this document, the English version will prevail over the Dutch version.


 

Ahlstrom Corporation STOCK EXCHANGE RELEASE 30.3.2007 at 8.15 Ahlstrom, a global leader in high performance fiber-based materials, today announced that it has signed an agreement to acquire the consumer wipes business of Fiberweb plc. Following the acquisition, Ahlstrom will become the third largest producer of nonwoven roll goods globally. The acquisition price is approximately EUR 65 million. The acquired business includes four plants, two of which are located in Italy, one in Spain and one in the USA. In 2006, the net sales of the acquired business amounted to EUR 110 million and it employed approximately 400 people. Ahlstrom anticipates closing the deal within the second quarter of 2007 subject to antitrust clearances. Further, relevant trade unions will be informed accordingly. Fiberweb is one of the leading suppliers of high performance specialty nonwoven fabrics globally. The wiping fabrics currently produced by Fiberweb's consumer wipes business are used mainly in personal care, baby care and household wipe applications. Following the deal, Ahlstrom will be the leading wiping fabrics producer in the world with manufacturing sites in Europe and in the USA. Furthermore, Ahlstrom announced in 2006 that it will expand its nonwovens production in South America by investing in a new wiping fabrics production line in Brazil. The new line will be operational in early 2008. "We have been very consistent in implementing our global growth strategy. In addition to this deal, our investments in organic growth as well as the acquisition of Orlandi's spunlace nonwovens business, announced in February 2007, will position Ahlstrom as the third largest supplier of nonwoven materials in the world. Strong market presence further improves our ability to serve our customers globally", says Jukka Moisio, President and CEO of Ahlstrom Corporation. "This acquisition further strengthens Ahlstrom's unique fiber expertise and its versatile technology base. Fiberweb's leading pulp-containing wipes technology allows Ahlstrom to introduce additional properties, such as enhanced softness and increased strength, to its wiping fabrics. This capability combined with Ahlstrom's and Orlandi's pulp-containing technologies positions Ahlstrom the leading supplier of pulp-containing wipes products", comments Claudio Ermondi, Senior Vice President, Nonwovens. The market for wiping fabrics is estimated to grow at a rate of 7% annually, and even higher growth rates are anticipated in the emerging markets. For further information, please contact: Jukka Moisio, President and CEO, Ahlstrom Corporation, tel. +358 10 888 4700 Claudio Ermondi, Senior Vice President, Nonwovens, tel. +39 011 9260 232 Distribution: Helsinki Stock Exchange Main media www.ahlstrom.com Ahlstrom in brief Ahlstrom is a global leader in the development, manufacture and marketing of high performance fiber-based materials. Nonwovens and specialty papers, made by Ahlstrom, are used in a large variety of everyday products, e.g. in filters, wipes, flooring, labels, and tapes. The company has a strong market position in several of the business areas in which it operates, built upon the company's unique fiber expertise and innovative approach. Ahlstrom's 5,700 employees serve customers via sales offices and production facilities in more than 20 countries on six continents. In 2006, Ahlstrom's net sales amounted to EUR 1.6 billion. Ahlstrom's share is listed on the Helsinki Stock change. The company website is www.ahlstrom.com.


 

Unilabs has announced that Günter Konrad will leave his position as Chief Operating Officer - Swiss Operations, on 31 March 2007. Mr Konrad, who joined the group in 1994 and has held the position since December 2001, is leaving to explore new challenges. Responsibility for Swiss Operations will now lie with three regional directors: Tiziana Meregalli (Italian-speaking Switzerland), Monica Mendez (French-speaking Switzerland) and Matthias Kuratli (German-speaking Switzerland). The three directors are joining the Swiss management committee and will report directly to Edgard Zwirn, Executive Chairman. This new structure will enable the regional directors to work more closely with their respective regional customers. About Unilabs The Unilabs Group (SWX: ULB) is the European leader of clinical testing laboratories. With over 50 laboratories and over 1500 employees operating in 6 countries, Unilabs tests over 3.5 million samples per year using more than 1500 different tests. Unilabs' clinical testing services are used by over 60 public and private hospitals in France, Spain and Switzerland. Unilabs has been listed on the SWX Swiss Stock Exchange since 1997. Edgard Zwirn, Executive Chairman, is at your disposal for any further query (tel. +4122 909 77 77). Our press releases are also available on the Internet at our web site www.unilabs.com --- End of Message --- Unilabs SA C.P. 2559 Genève 1 WKN: 906648; ISIN: CH0012561640; Index: SPI, SSCI, SBIOM, SLIFE, SPIEX; Listed: Main Market in SWX Swiss Exchange;


 

Wiesbaden/Munich, 29 March 2007 - The technology group The Linde Group has signed a definitive agreement to sell its packaged gases business with retail stores in the United States to the industrial gases company Airgas Inc. at an enterprise value of 310 million US dollars. Linde will retain certain packaged gases accounts related to its independent distributors, including acetylene production sites and filling plants. The business to be divested had sales of 346 million US dollars and EBITDA of around 36 million US dollars in the financial year 2006, with a workforce of approximately 1,400. By this transaction Linde optimizes its portfolio focusing on customer segments in the US with a higher content of application technology. The closing of the transaction is subject to regulatory approval and customary conditions. The Linde Group is a world leading industrial gases and engineering company with more than 51,000 employees working in around 70 countries worldwide. Following the acquisition of The BOC Group the company has gases and engineering sales of approximately 12 billion euro. The strategy of The Linde Group is geared towards earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. For more information, please see The Linde Group online at http://www.linde.com For further information: Press Uwe Wolfinger Telephone: +49.89.35757-1320 Investor Relations Thomas Eisenlohr Telephone: +49.89.35757-1330 --- End of Message --- Linde AG Abraham-Lincoln-Str. 21 Wiesbaden Germany WKN: 648300; ISIN: DE0006483001; Index: CDAX, DAX, HDAX, Prime All Share; Listed: Amtlicher Markt in Hanseatische Wertpapierbörse zu Hamburg, Prime Standard in Frankfurter Wertpapierbörse, Amtlicher Markt in Frankfurter Wertpapierbörse, Amtlicher Markt in Bayerische Börse München, Amtlicher Markt in Börse Berlin Bremen, Amtlicher Markt in Börse Düsseldorf, Amtlicher Markt in Börse Stuttgart, Freiverkehr in Niedersächsische Börse zu Hannover;


 

CHEVY CHASE, MD -- (MARKET WIRE) -- March 29, 2007 -- The Ritz-Carlton, Tokyo, a 248-room hotel in the city's tallest skyscraper, welcomes its first guests on March 30, 2007. With a strategic location in the new Tokyo Midtown Development in Roppongi, the hotel begins on the 45th floor and offers many notable features including Japan's most expensive Presidential Suite, available for $20,000 per night, and an authentic 200-year-old Japanese teahouse. Owned by Mitsui Fudosan, The Ritz-Carlton, Tokyo is the second site in Japan for the award-winning hotel company, which also manages a property in Osaka. "We have been interested in adding a Tokyo location for a number of years, and believe there could be no better place for a Ritz-Carlton than in this exciting Tokyo Midtown Development. The hotel will be in the heart of the city's most vibrant commercial and residential complex," said Simon F. Cooper, president and chief operating officer, The Ritz-Carlton Hotel Company, L.L.C. Designed by renowned interior decorator Frank Nicholson, The Ritz-Carlton, Tokyo will reflect classic European inspiration fused with contemporary accents, including four bold and colorful works by American painter Sam Francis, a favorite of Japanese art collectors. Throughout the hotel, windows will overlook the dramatic cityscapes below and provide scenic glimpses of snow-capped Mt. Fuji in the distance. Guestrooms will be the most spacious in Tokyo at 559 square feet (52 square meters) and provide every comfort and convenience, along with luxury in-room amenities. Guests can select accommodations on The Ritz-Carlton Club, accessible only by elevator key and providing a range of exclusive privileges including dedicated, multi-lingual concierge service, round the clock food and beverage offerings, and an extra measure of privacy and security. A selection of restaurant and lounge choices will allow guests of The Ritz-Carlton, Tokyo to dine or entertain in places either relaxed or formal. From extensive types of sushi, tempura and Teppanyaki in "Hinokizaka" -- where the 200-year-old Japanese teahouse is available for private dining -- to the sophisticated ambience of "Forty Five," where Asian and French inspired cuisine is on the menu, the dining experience will be as memorable as the setting. Meeting space, totaling 6,372 square feet (560 square meters) at The Ritz-Carlton, Tokyo, is extensive and able to accommodate groups from board room gatherings to large social events and is the perfect venue for the traditional and elaborate Japanese weddings. A large 21,527-square foot (2,000 square meters) ESPA spa and fitness center will be available at The Ritz-Carlton, Tokyo to provide state-of-the-art workout equipment, as well as a range of therapies, treatments, and wellness programs. Introductory rates at The Ritz-Carlton, Tokyo; Deluxe Room: $467 Club Deluxe: $647 Suite: Executive Suite: $856 Millennia Suite: $1,027 Tower Suite: $1,198 Japanese Carlton Suite: $1,198 The Ritz-Carlton Suite: $1,541 Rates exclude 10% service charge and accommodation tax. The Ritz-Carlton Hotel Company, L.L.C. of Chevy Chase, Md currently operates 63 hotels in the Americas, Europe, Asia, The Middle East, and Africa. Over 35 projects are under development around the globe with future openings including Moscow, Tokyo, Dublin, Beijing and Dallas. The Ritz-Carlton is the only service company to have twice earned the prestigious Malcolm Baldrige National Quality Award, which recognized outstanding customer service. For more information, contact The Ritz-Carlton toll free reservations line at 1 (800) 241-3333, visit the company web site at www.ritzcarlton.com, or consult a travel professional. Contact: Vivian Deuschl Corporate Vice President, Public Relations 4445 Willard Avenue, Suite 800 Chevy Chase, Md. 20815 Tel: (703) 941-6225 Fax: (703) 941-7492 Cell: (202) 255-5786 Email: vivian.deuschl@ritzcarlton.com


 

Corio has completed the issuance of USD 980 million of the USD 1,210 million (EUR 920 million) of senior unsecured notes through a private placement to 33 institutional investors. Closing of the remaining USD 230 million is due to take place in May 2007. The proceeds will be used to refinance parts of the existing debt and to finance projects currently in the pipeline. The transaction is in line with Corio's internal guideline to finance between 1/3 and 2/3 of its debt at fixed rates and to aim for an average financing term of more than 5 years.


 

COPENHAGEN: Denmark-based investment bank Saxo Bank is pleased to announce the election of former Burger King and Smirnoff vodka CEO Dennis Malamatinas to its board of directors. Dennis Malamatinas comes to Saxo Bank after an extensive executive career at the helm of some of the world's most recognized consumer brands. From 1997-2000 he served as global CEO of fast-food chain Burger King. From 1991-1995 he was president and CEO of the Pierre Smirnoff Company, the world's largest vodka and spirits maker. He is now officially the fifth member of Saxo Bank's board of directors, which, in addition to chairman Henrik Thufason and vice-chairman Florian Wendelstadt, includes John Korsø Jensen and the former global head of Citibank's foreign exchange division, Julian Simmonds. Commenting on his election to the board, Mr. Malamatinas said: "I'm very pleased to come aboard Saxo Bank's board of directors, and look forward to the opportunity to follow developments within the company at first hand. I've been a keen observer of Saxo Bank's adaptable business model, and I believe its impressive growth rates bode well for its future. I'm excited to be part of this development and to contribute to the bank's continued success." Malamatinas has also served on the boards of directors of global news agency Reuters and Priceline. "Dennis Malamatinas is one of the absolute stars of the international business firmament, and welcoming a member with his extensive knowledge and experience will vitally bolster our now five-member board," said Saxo Bank co-founder and CEO Kim Fournais. "Given our ambitions on the international capital markets, it is of inestimable value to us to welcome a professional of this caliber, one who can help us to realize our increasingly global strategy." The cosmopolitan Malamatinas has lived in eight countries, speaks five languages, and is currently based in London.


 

Leiden, The Netherlands, March 29, 2007. Biotech company Pharming Group NV ("Pharming" or "the Company") (Euronext: PHARM) today announced adjustments in its Board of Management (BOM), as well as key appointments in the area of commercial development. The Board of Management now consists of Dr. Francis Pinto (Chief Executive Officer), Dr. Rein Strijker (Chief Commercial Officer) and Dr. Bruno Giannettti (Chief Operating Officer). Dr. Francis Pinto is Chairman of the BOM and has the primary responsibility for the long term strategy of the Company. Dr. Rein Strijker is responsible for all commercial, financial and investor relation activities. Dr. Bruno Giannetti is responsible for all operational activities, including clinical development, R&D, regulatory and manufacturing. Pharming has appointed Mr. Samir Singh to a new position of President, US Operations focusing on business development and operational activities in the US. Dr. Frank Pieper will continue to focus on technology and intellectual property matters, but has decided to leave Pharming as of October 1, 2007 to pursue other activities in the area of biotechnology. The Company has secured his continued support after this date in certain relevant areas. The Company has further strengthened its commercial development team with the appointments of Mr. Richard Onyett and Dr. Tolleiv Trimborn. Mr. Onyett previously was Commercial Director at KuDOS Pharmaceuticals Ltd and responsible for all corporate and business development and marketing activities within the company. Prior to KuDOS, he was Senior Vice President Business Development and Marketing at Epidauros Biotechnologie AG and Senior Vice President, Corporate Development at Anthra Pharmaceuticals, Inc. Dr. Trimborn is the former Director Commercial Development of DNage. Prior to DNage, he was an associate at Life Sciences Partners and has a PhD in Molecular Biology from the Erasmus University of Rotterdam and a post-doctoral training at Stanford University in California. Dr. Francis Pinto, Chief Executive Officer, commented: "Pharming is moving into a growth era which requires a strategic focus on commercial development. I am very pleased with the strengthening of our commercial development team and am hopeful that the experience and expertise of Richard and Tolleiv, as well as the other members, will bring additional opportunities for the Company. We are very grateful to Frank who has been instrumental in developing Pharming's science and technology to produce our innovative therapeutic products. We respect his decision to pursue new opportunities and thank him for his contributions to the Company. We would also like to acknowledge the important role played by Samir in the turnaround of the Company during his tenure as member of the BOM. We are excited that he will now focus on the development of our business in the US, which likely represents the largest future market opportunity for Pharming." Background on Pharming Group NV Pharming Group NV is developing innovative products for the treatment of genetic disorders, ageing diseases, specialty products for surgical indications, intermediates for various applications and nutritional products. Pharming has two products in late stage development - Rhucin® (recombinant human C1 inhibitor) for hereditary angioedema (MAA under review by EMEA) and human lactoferrin for use in food products (GRAS notification under review by US FDA). The advanced technologies of the Company include innovative platforms for the production of protein therapeutics and technology and processes for the purification and formulation of these products, as well as technologies in the field of tissue repair (via its collaboration with NovaThera) and DNA repair (via its acquisition of DNage). Additional information is available on the Pharming website, http://www.pharming.com and on http://www.dnage.nl. This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements. The press release also appears in Dutch. In the event of any inconsistency, the English version will prevail over the Dutch version. Contact: Carina Hamaker Rein Strijker Investor Voice Pharming Group NV T: +31 (0)6 537 499 59 T: +31 (0)71 52 47 431 T: +31 (0)71 52 47 431


 

Addtech AB signed an agreement on 29 March 2007 for the acquisition of all shares in Metric Industrial Oy, Metric Industrial A/S, Metric Industrial AB and Metric Industrial AS. The seller is Metric Industrial Holding BV, which in turn is owned by the Dutch investment firm PION Holding BV. The four Metric Industrial companies sell components and systems in the field of industrial automation, as well as testing and measurement systems in Finland, Denmark, Sweden and Norway. Annual sales amount to EUR 16 million and the Group has over 30 employees. Finland is currently the biggest market, with good growth potential in all four markets. In the field of industrial automation, the companies sell components such as sensors, vision systems, industrial computers, industrial ethernet and built-in power management for OEM enterprises and system integrators in basic industries in the Nordic region. In the field of testing and measurement the firms sell testing systems and electronic instruments for installation, verification and monitoring of fiber optic communication networks. In several cases the suppliers are world leaders in their often very narrow product areas. The acquisition is an important addition to the Addtech Group's sales of niche and critical components intended for demanding customers in Nordic industry. The acquisition strengthens the Addtech Group's presence in Finland and Denmark in particular, while providing growth opportunities in the other Nordic markets. Metric Industrial will be managed as an independent unit in the Components business area. The acquisition is expected to have a marginally positive impact on Addtech's earnings per share during the upcoming financial year, which begins on 1 April 2007. Closing took place on 29 March 2007. Stockholm 29 March 2007 Addtech AB For more information please contact Roger Bergqvist, Managing director Addtech AB, +46 8 470 49 04 Addtech is a technology trading group that develops and sells hi-tech components and systems to industrial companies and the service industry in selected niche areas. The Group has an annual turnover of about SEK 3.6 billion and around 1,300 employees. Its customers are mainly manufacturing companies in the engineering, vehicle, telecoms and electronics industries and laboratories in the fields of health care and research in the Nordic region. Addtech provides its customers with technological and financial added value. Addtech is listed on OMX Nordic Exchange.


 

Renewable Energy Resources has acquired 22.1% in Romag and, at this point, is the largest shareholder in the company. Renewable Energy Resources, which is owned by Atorka Group, specialises in investments in renewable energy. Among Renewable Energy Resources' other assets are Jarðboranir, a geothermal energy leader specialising high-temperature geothermal energy in Iceland, and Enex (a 16% holding), which focuses on development projects in the geothermal heat sector. Renewable Energy Resources has purchased Atorka's entire holding in Romag, as well as an additional 3,200,000 shares. The company therefore owns 10,083,299 shares in Romag, or a 22.1% stake. The acquisitions were financed with cash and borrowed funds, and the total purchase price is just over ISK 2.4 billion. Romag is a global leader in the manufacture of specialised photovoltaic glass, which utilises daylight for the production of electricity. The market for such innovative solutions is rapidly growing, as is evidenced by the fact that Romag's turnover from this production grew by 300% last year. Magnús Jónsson, CEO of Atorka: "With this acquisition, Renewable Energy Resources has become a leading investor in Romag, and it will support the company in its future growth endeavours. This investment is Renewable Energy Resources' first move in the solar energy sector. The market for renewable energy has grown substantially in recent years, and we see further growth coming as a by-product of greater awareness and greater emphasis on the use of renewable energy." For further information, contact Magnús Jónsson, CEO of Atorka (tel. +354 840 6240).


 

FL Group is pleased to announce Refresco's acquisition of Sun Beverages Company N.V. (SBC), a major soft drinks producer based in France, the Netherlands and Belgium. This is Refresco's third acquisition in two months and, following strong organic growth, means Refresco has almost doubled in size since acquired by the FL Group-led consortium. Refresco was acquired in April 2006 with a key strategy of making complementary acquisitions in both new and existing markets. FL Group, already an investor in the beverage sector, and the consortium investors have supported management pursuing this shared strategy and helped them to pursue a number of targets over the last 9 months. This backing has now led to the three acquisitions being announced in February and March. Key figures: * Refresco closed 2005 with revenues of ¤600 million just prior to its acquisition by FL Group * Kentpol added exposure to Poland, a high growth market and additional revenues of ¤40 million * Histogram added around ¤30 million of revenues and was a key entry into the UK market, one of the largest in Europe for soft drinks * The SBC acquisition is a landmark transaction as it adds substantial scale to Refresco, already the second largest juice producer in Europe, and is a complementary mineral water and soft drinks producer. In 2006 Sunco generated revenues of ¤235 million * After the recent acquisitions Refresco revenues exceed ¤ 1 billion The backing of Refresco highlights FL Group's strength and willingness to support strong management teams in driving through their strategic vision, particularly through a buy and build strategy. The flexible approach to investing allows FL Group to move quickly to support acquisitions and, by investing directly from its balance sheet, it can be more flexible on the timing of those acquisitions. Hannes Smárason, CEO of FL Group commented: "The Refresco story is an excellent example of what both Refresco and FL Group are all about: ambitious targets, strategic vision and a clear focus. We believe that these are key drivers for success in delivering growth both now and in the future." Kaupthing Bank arranged the debt financing and acted as M&A adviser on all three of these Refresco acquisitions. Notes to editors: About FL Group: FL Group is a unique international investment company which operates primarily in two areas. The company's private equity and strategic investment unit focuses on investments in public and private companies seeking to increase value through an active approach, and the company's proprietary trading unit is a hedge fund-like operation focused on maximising profits from a portfolio of listed securities and currencies. FL Group is a flexible investor and does not restrict investments to certain sectors or geographical areas. The company has its head office in Reykjavik, Iceland but is also located in London and Copenhagen. Its current market capitalization is approximately ¤2.6 billion with total assets of ¤2.9 billion. FL Group is listed on the OMX Nordic Exchange in Reykjavik (OMX: FL). The FL Group-led investment consortium, which acquired a majority stake in Refresco Holding in June 2006 also comprises of Kaupthing Principal Investments and Vífilfell. About Refresco: The Refresco Group is a major European manufacturer of beverages. Formed in 1999 from the demerger of Menken Drinks B.V. and Refresco de Sur Europa S.A. from the Dutch dairy group Campina, the Group now has a total of 14 production sites across the Netherlands, Germany, France, Spain, Finland, Poland and the United Kingdom. In 2006 the Refresco Group had a total of 1,250 employees and realised a turnover of ¤ 660 million. The focus of the group is on the fruit juices and soft drinks market, mainly for the production of private labels for its retail clients as well as production under fancy labels and co-packing for A-brand partners. The Group is owned by a consortium of Icelandic investors of which FL Group is the lead investor. The management of the Refresco Group holds a significant minority interest. About Sun Beverages Company N.V. (SBC): SBC is an important European beverage company whose principal operating companies include: * Eaux Minérales de Saint-Alban-les-Eaux S.A. in Saint-Alban-les-Eaux, France * Sunco N.V. in Ninove, Belgium * Frisdranken Industrie Winters B.V. in Maarheeze, The Netherlands The group turnover of SBC was ¤235 million in 2006, operating with 490 employees. SBC is presently majority owned by Bencis Capital Partners together with a minority interest of the management. The main activities of the SBC Group are the production of soft drinks and mineral water in PET bottles and cans. The company manufactures for major international companies. Next to that, its focus is on private label production for major European retailers and co-packing for other beverage marketers. About Histogram: Histogram is a Durham-based soft drinks business, manufacturing juice and juice drinks. It was formed in February 2001 through a Management Buyout from the previous owners Coca-Cola. Histogram has a turnover of ¤30 million on a basis comparable to Refresco and has 68 employees. A minority of the shares of Histogram will remain in the hands of the existing shareholder. Over the last three years, Histogram has invested heavily in new capacity and capability to deliver its promise of premium quality, highly efficient and flexible manufacturing of soft drinks. It now offers an unrivalled range of carton packaging systems encompassing singleserve and multi-serve formats. Histogram's focus has been on co-packing for A-brands. About Kentpol: Kentpol, a Polish soft drinks and mineral water company, operates from Kety and Slemien. The company produces carbonated drinks, soft drinks in PET bottles as well as mineral water of a high quality from their own source. Products are mainly produced under a private label for the Polish market. The turnover of Kentpol is ¤34 million. Kentpol will continue to produce under its own name and will be part of the new entity "Refresco Poland". For more information, please contact: FL Group: Mr. Adam Shaw Tel. +44 (0)20 7518 8094 www.flgroup.is Brunswick Group LLP Anita Scott, Nigel Prideaux, Leonora Pou Tel. 020 7404 5959 Refresco Holding B.V.: Mr. Hans Roelofs, CEO Tel. +31 (0)78 6321313 www.refrescoholding.com Sun Beverages Company N.V.: Mr. Dennis Jones Tel. +32 (0)54 319595


 

Awilco Offshore has today been awarded two long term drilling contracts for two semi submersible drilling rigs by Norsk Hydro Produksjon AS on behalf of the license partners for the Troll Production License. The minimum contract length for each rig is 5 years plus options. Within May 28, 2007, Hydro has the opportunity to increase the firm contract length to 8 years per rig. The total contract value for the 5 year period is approximately USD 1.37 billion, plus mobilisation cost. If the firm contract length is increased to 8 years per rig, the total contract value will increase to USD 2.10 billion, plus mobilisation cost. The above contract values include additional rig modifications to be provided to Hydro. The first contract is to commence mid 2009 and is for the rig WilInnovator, under construction at Yantai Raffles Shipyard in China, with scheduled delivery by end 2008. The second contract is to commence mid 2010 and is for the rig WilPromoter with scheduled delivery in the fourth quarter 2009. Awilco Offshore is pleased to have Hydro and the Troll Production License partners as our customers and regard this contract award as recognition of our capabilities as a drilling contractor. It is also a recognition of our modern and highly efficient rig design specifically designed according to Norwegian regulations to meet the harsh requirements in the North Sea. Oslo, 29 March 2007 For further information, please contact: Sigurd E. Thorvildsen, Chairman (+ 47 977 42121) Henrik Fougner, Managing Director (+47 906 88608) Petter H. Tomren, President Semi Submersibles (+47 932 19215) Awilco Offshore has invested in eight jack-up drilling rigs (of which six are under construction), three semi submersible drilling rigs under construction and two accommodation units in operation. The company also holds one option for the construction of one further semi submersible drilling rig.


 

` FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |-----------------------------------------------+-------------------| | Company dealt in | Wilson Bowden Plc | |-----------------------------------------------+-------------------| | Class of relevant security to which the | 10p Ordinary | | dealings being disclosed relate (Note 2) | | |-----------------------------------------------+-------------------| | Date of dealing | 28 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (2) Derivatives (other than | 1,305,000 | 1.3793 | | | | options) | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | Total | 1,305,000 | 1.3793 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per unit | | name, | (Note 6) | (Note 7) | (Note 5) | | e.g. CFD | | | | |----------+------------+--------------------------+----------------| | | | | | | CFD | SHORT | 70,000 | 2133.5748 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 29th March 2007 | |-------------------------------------------------+-----------------| | Contact name | James Feast | |-------------------------------------------------+-----------------| | Telephone number | 0207 469 1901 | |-------------------------------------------------+-----------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |-------------------------------------------------+-----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Company Teams With Regionally-Established Distributor IP Vista to Help Drive Sales KING OF PRUSSIA, Pa.and AALBORG, Denmark, March 29, 2007 (PRIME NEWSWIRE) -- Neoware, Inc. (Nasdaq:NWRE), a leading supplier of thin client software and devices, and IPVista, a leading Danish distributor, today announced a new distributor partnership to capitalize on the rapidly growing thin client segment of the PC market in Denmark. Today's announcement reflects Neoware's drive to further expand its global presence and meet the demands of rapidly growing markets with its thin client technology. Neoware has appointed IPVista as its primary distributor for the Danish market. With Neoware's support, IPVista will market, stock and sell Neoware products for resellers, VARS and thin client customers throughout the country. IPVista will create a dedicated team of Neoware sales specialists who will provide sales, marketing, and logistics support to Neoware customers in the region. IPVista, a LOGIX Company, is a specialised distributor focusing on software products and services, including Internet security and virtualisation products, as well as Citrix(r) products and server-based computing technology. In addition to Neoware, IPVista also distributes Citrix, McAfee, Aurema, and Thinprint products. "IPVista is delighted to engage in a partnership with Neoware," said Steen Ejstrup, director of IPVista. "Their product portfolio aligns directly with our focus as a Network and Security distributor, and our strong market presence with Citrix makes Neoware an ideal partner for us. We believe the terminal services market in Denmark has only scratched the surface in terms of usage and we expect to see a strong growth in the future." "Neoware is pleased to have partnered with IPVista, providing a relationship that expands our presence in the Danish market," said Peter Bolton, executive vice president, Neoware, Inc. "IPVista is well-established in the Danish market, and has specific expertise in IT security solutions so we feel thin client technology will be a very good fit with their customers." Neoware thin clients and software enable enterprises to improve the security, manageability, and reliability of their desktops, while reducing both up-front and ongoing costs. Because Neoware thin clients can be secured, and because applications run on central servers, Neoware thin clients can be made virtually immune from standard PC viruses and other security threats, significantly improving information security, reliability and backup/recovery operations. Using Neoware management software, which can be integrated with industry-standard PC management tools such as Microsoft SMS, IBM Tivoli, or Altiris, a system administrator can manage tens of thousands of Neoware thin clients without travelling from desk to desk, lowering administrative costs. About Neoware Neoware, Inc. (Nasdaq:NWRE) provides enterprises throughout the world with thin client computing devices, software that turns PCs into thin clients, and services that adapt thin client technology to virtually any enterprise computing environment. Neoware's software powers, manages and secures thin client devices and traditional personal computers, enabling them to run Windows(r) and Web applications across a network, stream operating systems on demand, and connect to mainframes, mid-range, UNIX and Linux systems. Headquartered in King of Prussia, PA, USA, Neoware has offices in Australia, Austria, China, France, Germany, and the United Kingdom. Neoware's products are available worldwide from select, knowledgeable resellers, as well as via its partnerships with IBM, Lenovo, NEC, and ClearCube. Neoware can be reached by email at marketing_ne@neoware.com. About IPVista IPVista A/S, a Network and Security distributor, is the leading Citrix and McAfee distributor in Denmark. With a strong focus on sales and marketing enablement, IPVista plays a vital role in identifying and driving business through and together with its resellers. Combined with a deep technical knowledge, represented in both consulting and educational services, IPVista acts as a trusted advisor and is known to engage heavily in building markets for vendors. IPVista is a part of the LOGIX group, one of the largest Value Add distributors in Europe. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding: the expansion of our global presence; our distributor partnership with IPVista; the rapidly growing thin client segment of the PC market in Denmark; our expanded presence in the Danish market; and future sales to IPVista's customers. Factors that could cause actual results to differ materially from those predicted in such forward-looking statement include: our ability to maintain our relationship with IPVista; rapid technological changes in the industry; our success in implementing our product development initiatives; our timely development and customers' acceptance of our products, including IPVista's customers; increased competition; adverse changes in customer order patterns; our continued dependence on enterprise customers; our inability to manage our expanded organization; adverse changes in general economic conditions in the U.S. and internationally; risks associated with foreign operations; and political and economic uncertainties associated with current world events. These and other risks are detailed from time to time in Neoware's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our annual report on Form 10-K for the year ended June 30, 2006 and our quarterly reports on Form 10-Q for the quarters ended September 30, 2006 and December 31, 2006. Neoware is a trademark of Neoware, Inc. All other names, products and services are trademarks or registered trademarks of their respective holders. CONTACT: Neoware, Northern Europe Pippa White +44 (0)1908 267 111 pippa.white@neoware.com IPVista, Denmark Steen Ejstrup +45 70 254 502 steen.ejstrup@ipvista.dk


 

MORGAN STANLEY'S HOLDING IN TALENTUM FALLEN BELOW 5 PER CENT This is a notice under the Securities Market Act of Finland, Chapter 2 Section 10. Morgan Stanley Limited has notified Talentum Oyj today that its holdings of the voting rights and share capital in Talentum Oyj have fallen below one twentieth (1/20) as a result of a share transaction concluded on 28 March 2007, and now represent 4.56%. 1. Name of the company in which holdings have been acquired Talentum Oyj 2. Date of change in holdings 28 March 2007 3. Exact proportion of voting rights and share capital in Talentum Oyj Number of shares: 2,018,680 Proportion of share capital: 4.56% Proportion of voting rights: 4.56% 4. Shareholder's complete name Morgan Stanley & Co International Limited Further information: Lasse Rosengren, General Counsel, tel. +358 40 342 4204


 

Norse Energy Corp, in Partnership with Petrobras (Operator) and Queiroz Galvão Oleo e Gas S.A., is pleased to present the following Manati (MNT) flow test from well no. 5. Well MNT - 5 which is equipped with a gravel packer, performed the production tests with results of approximately 1.5MMm3/day, with a 76/64" choke. With full choke the well should be able to produce 2,5MM3/ day. There was no indication of sand production during the tests, confirming that the gravel works as forecasted. Contact info Anders Kapstad CFO NORSE ENERGY CORP ASA Strandveien 50, P.O Box 262, 1326 Lysaker, Norway Tlf.: +47 67 51 61 12 Telefax: +47 67 51 61 11 Mobil: +47 91 81 74 42 www.norseenergycorp.com


 

Stora Enso Oyj News Release March 29, 2007 at 13.00 GMT HELSINKI, Finland - Stora Enso (NYSE:SEO) today announced that Jukka Härmälä addresses shareholders after 18 years as CEO. Jukka Härmälä at the AGM: "In 2006 profits rose as newsprint, uncoated fine paper and wood product prices increased, and we benefited from our internal profit improvement programmes. Profit 2007 and the Asset Performance Review (APR) are concluded ahead of schedule, but the returns are unsatisfactory as increases in energy costs last year and wood costs this year have eaten away a good lot of the benefits," says CEO Jukka Härmälä. "I would like to take this opportunity to thank all personnel, shareholders and the Board of Directors for very stimulating and rewarding years in the industry, and to wish all of you the very best in the future," he concludes. Stora Enso changes its strategic focus from growth to profitability ROCE target remains 13%. Jouko Karvinen at the AGM: Stora Enso has accelerated its portfolio and strategy review. The key element in the new strategy is that the company will change its focus from growth to profitability. The ROCE target remains 13%. "We have to make choices and focus on businesses that can earn double-digit returns on capital employed by allocating our resources to them," says new CEO Jouko Karvinen at today's Stora Enso Annual General Meeting. The management of the company is not planning to initiate a new, specific profit improvement programme. Instead, the new CEO and his team will lead the company on an intensified improvement path. Decisions will be communicated when they have been made instead of announcing single multi-year plans. "The good news is that the overall global economic situation is relatively healthy. However, that makes the distance to the 13% return on capital target over the cycle that much greater, so we have no time to lose," Karvinen continues. "A reality for Stora Enso and the European forest products industry is the worsening shortage of wood supply resulting from announced higher Russian export duties, the increasing use of wood fibre as biofuel, and the rising environmental pressures to limit the procurement of wood raw material. As we have announced today, we have agreed not to buy wood from Metsähallitus from disputed areas in northern Finland for now, but there is no way we can produce pulp or sawn goods without sufficient wood supply. Some production curtailments are expected at Enocell Pulp Mill (part of Packaging Boards) in the second quarter of 2007 due to shortage of raw material. We are fast-tracking efforts to find alternative sources of wood - in parallel with initiatives to solve the issues of Russian duties and critical stakeholder dialogue will continue," Karvinen concludes. For further information, please contact: Jukka Härmälä, CEO, tel. +358 2046 21404 Jouko Karvinen, CEO, tel. +358 2046 21404 Tim Laatsch, SVP, Communications, Stora Enso North America, tel. 715 422 4023 www.storaenso.com www.storaenso.com/investors Photos of Jouko Karvinen are available at http://bmt.storaenso.com/storaensolink.jsp?imageid=070329 Please copy the link into your web browser.


 

ZEELAND, MI -- (MARKET WIRE) -- March 29, 2007 -- Gentex Corporation (NASDAQ: GNTX), the leading supplier of automatic-dimming rearview mirrors to the worldwide automotive industry, has announced that it is shipping interior auto-dimming mirrors for the all-new Toyota Auris. The Auris is a family hatchback designed for the European market. Gentex auto-dimming mirrors automatically darken to reduce glare from the headlamps of vehicles approaching from the rear. The brighter the glare, the darker the mirrors become, making nighttime driving safer. The 2007 Auris hatchback offers an interior auto-dimming mirror as standard equipment on the T Spirit trim level. "The Auris will appeal to young families and older customers as well. This dual demographic will expose Gentex products to a large and more diverse European market," said Gentex Senior Vice President Enoch Jen. Founded in 1974, Gentex Corporation (NASDAQ: GNTX) is an international company that provides high-quality products to the worldwide automotive industry and North American fire protection market. Based in Zeeland, Michigan, the Company develops, manufactures and markets interior and exterior automatic-dimming automotive rearview mirrors that utilize proprietary electrochromic technology to dim in proportion to the amount of headlight glare from trailing vehicle headlamps. Many of the mirrors are sold with advanced electronic features, and approximately 96 percent of the Company's revenues are derived from the sales of auto-dimming mirrors to nearly every major automaker in the world. FINANCIAL MEDIA AND INVESTOR CONTACT: Connie Hamblin 616/772-1800 GENERAL MEDIA CONTACT: Craig Piersma 616/772-1800 EXCHANGE: NASDAQ Global Select Market SYMBOL: GNTX WEBSITE: www.gentex.com SOURCE: Gentex


 

KESKO CORPORATION STOCK EXCHANGE RELEASE 29.03.2007 AT 15.15 Kesko Corporation's year 2003 scheme stock options under the symbol 2003F, approved at the Annual General Meeting of 31 March 2003, will be included on the main list of the Helsinki Stock Exchange for public trading as from 2 April 2007. The total number of year 2003 stock options under the symbol 2003F (trading symbol: KESBVEW303; ISIN code: FI0009609333) is 600,000. Each stock option entitles its holder to subscribe for one (1) new Kesko Corporation B share during 1 April 2007 to 30 April 2010 at a subscription price that corresponds to the trade volume weighted average price of a Kesko Corporation B share on the Helsinki Stock Exchange during the period 1 to 30 April 2005 (EUR 19.08), with a deduction of the amount of dividends decided after the period for the determination of the subscription price has begun but before share subscription, on the record date of each dividend distribution. Currently the subscription price of a share subscribed for with a 2003F stock option is EUR 16.48. Kesko Corporation's Annual General Meeting held on 31 March 2003 decided to gratuitously issue a total of 1,800,000 stock options to the management of the Kesko Group as well as to a wholly-owned subsidiary of Kesko Corporation. The options were marked with symbols 2003D, 2003E and 2003F in units of 600,000 options each. A deviation was made from the shareholders' pre-emptive right to subscription since the stock options form a part of the incentive and commitment programme for the management. The stock options have been included in the book-entry securities system. A total of 600,000 new Kesko Corporation B shares can be subscribed for with the 2003F stock options. The company share capital can increase by EUR 1,200,000 at the maximum as a result of subscriptions made with the 2003F stock options. At present, the total number of Kesko Corporation shares is 97,543,113, of which 31,737,007 are A shares and 65,806,106 are B shares. Each A share entitles the holder to ten (10) votes and each B share to one (1) vote. Kesko Corporation's share capital is currently EUR 195,086,226. The dividend right and other shareholder rights carried by shares subscribed for with stock options take effect after the share capital increase has been entered in the Trade Register. On 23 February 2005, Financial Supervision granted the company a permission to be exempted from the obligation to publish a prospectus in connection with applying for listing stock options on the main list of the Helsinki Stock Exchange and offering new Kesko Corporation B shares subscribed for with stock options and applying for their listing on the main list of the Helsinki Stock Exchange. The shares can be subscribed at the offices of Nordea Bank Finland Plc. Further information is available from Corporate Counsel Jarkko Karjalainen, telephone +358 1053 22602. Kesko Corporation The whole stock exchange release is published at www.kesko.fi. You can download the release in pdf format from the link below. Harri Utoslahti Communications Manager DISTRIBUTION Helsinki Stock Exchange Main news media


 

CEO Brings Track Record of Leading Companies to Profitable Growth and Market Leadership NEW YORK, NY -- (MARKET WIRE) -- March 29, 2007 -- Muze Inc., a worldwide leader in B2B digital commerce solutions used to connect people to art, education, and entertainment, today announced that former Onyx Software Chairman and CEO Janice P. Anderson has been named chief executive officer of Muze Inc. Anderson is an experienced business leader, strategist, and entrepreneur with an impressive track record in technology marketing and global operations. Her extensive career includes executive management positions in communications, web-based solutions and enterprise software, with Onyx Software, Lucent Technologies, and AT&T Corporation, as well as with two technology startups. "Janice has a successful history of delivering profitable revenue growth through new business models, targeted go-to-market strategies and strategic acquisitions," said Muze Inc., Chairman Bill Stensrud. "She is an exceptional leader with the right mix of original thinking, problem solving abilities, leadership skills, and energy to help Muze capitalize on the growing opportunities in the digital media marketplace." "Over the last year, Muze has reinvented itself as a single source for the provisioning of digital content for retailers, wireless services providers and online companies who want to offer entertainment, art, and music to their customers," said Anderson, adding, "Muze has all of the essential ingredients for a tremendous outcome of growth, market leadership, and value creation. I'm very excited to be a part of this organization at this stage in its evolution." Ms. Anderson has a BA in Commerce from the University of Toronto and an MBA in Finance and Strategy from York University. The arrival of Ms. Anderson as CEO will enable Bill Stensrud, who had been interim CEO and remains chairman of Muze Inc., to focus 100% of his time on a strategic industry initiative that will partner Muze with the top-tier organizations in content, consumer electronics, and retail. Muze, along with these industry partners, are creating a technology standard that will drive the next generation of rich media distribution. About Muze Inc. Established in 1991, Muze provides digital media management technology and media information to a vast array of markets and verticals, ranging from in-store and online retail, portals, community sites, auction sites, consumer electronics, and mobile devices. Nearly 900 companies worldwide now rely on Muze's rich entertainment content and digital media platform to support both physical and digital retail commerce. Clients include Yahoo!, eBay, O2 Germany, Best Buy, Overstock, Pricegrabber, Packet Video, Hot Topic, Amazon, Play.com, RealNetworks, BurnLounge, CNET, and many others. Muze has offices in New York City, Seattle and London. To learn more about Muze, please visit www.muze.com and www.muzeeurope.com. Muze U.S. Press Contact David Z Orban (212) 824-0349 dorban@muze.com Muze Europe Press Contact Doug Marshall +44 (0)20 7566 8216 dmarshall@muzeeurope.com


 

Press release 29 March 2007 at 2.30 p.m. Incap has signed a new agreement with Onninen Teletekno regarding deliveries of sheet-metal parts and mechanical assemblies for telecommunications and professional electronics. The contract covers manufacturing of different kinds of parts and entities, among others cross-connect racks, at Incap's factory in Helsinki. Onninen Teletekno is a subsidiary of Onninen Oy and it employs 120 persons. Onninen Teletekno was created when Onninen Oy and Teletekno Oy merged in the beginning of 2007. Onninen Oy is one of the leading companies offering material services in the Baltic and Scandinavian markets. Onninen Teletekno provides complete solutions and services in telecommunications to corporate customers. Company's products include telecommunications networks, measuring and testing devices as well as cabling systems for properties. Teletekno Oy has been Incap's customer for some years already, and the agreement signed by the companies will reinforce their cooperation and enables expansion of the partnership in future. "We are seeking growth by acquiring new customers but also by strengthening our role as partner of our existing customers. We are very pleased to be able to deepen our cooperation with Onninen Teletekno, which is a provider of demanding total solutions for telecommunications sector. During the past few years we have invested strongly in increasing capacity of Helsinki factory and purchased modern machinery there in order to serve our customers even better and more flexibly", tells Petri Saari, Vice President Sales and Marketing at Incap. "The merger with Onninen has increased our sales channels and we now have even better possibilities to increase our business. With the support of our skilful partners such as Incap we are able to focus in servicing our own customers by offering complete solutions", says Rolf Salenius, Sales Director of Onninen Teletekno. INCAP CORPORATION Further information: Petri Saari, Vice President, Sales and Marketing, tel. +358 40 777 5769 Hannele Pöllä, Director, Communications and IR, tel. +358 40 504 8296 DISTRIBUTION Helsinki Stock Exchange Principal media INCAP IN BRIEF Incap Corporation is a fast-growing electronics contract manufacturer whose comprehensive service covers the entire product life cycle from design and manufacture to repair and maintenance services. The company's main customer sectors are leading equipment suppliers in telecommunications, electrical power technology, the automation and process industries as well as measurement technology, safety electronics and health care. The Incap Group's revenue in 2006 amounted to EUR 89 million and the company currently employs approx. 540 persons. Incap's share is listed on the Helsinki Stock Exchange and it is a component of the Nordic Small Cap list within the information technology sector. For additional information, please visit www.incap.fi


 

(Lysaker, 29. mars 2007): The facility management company NEAS has signed an agreement with Pitney Bowes Norge AS to take over distribution, warehousing and assembly of Pitney Bowes' office and incidental furniture in Oslo, Akershus and Buskerud, with an option to extend the agreement to Hedmark , Oppland and Hordaland. The agreement is worth around NOK 21 million over three years, with the possibility of an additional NOK 10 million if the agreement is extended. NEAS, whose workforce numbers more than 300 people, is divided into two business areas: Consulting and Operations. The agreement with Pitney Bowes Norge will provide a further boost to the Operations area. Integrated with earlier business area from Totalreform, NEAS Operations will be the leading partner in Norway in regard to handling office furniture. As part of the agreement, 4-5 of Pitney Bowes' employees will transfer to the NEAS organisation. "The agreement confirms the strong outsourcing trend and high level of activity we have seen for some time, and which we communicated to the market in connection with our recent flotation," says NEAS CEO Tor Rønhovde. "Pitney Bowes has offices in Oslo, Gjøvik, Tynset, Hamar and Bergen, as well as a nationwide distributor network. Their business footprint corresponds very well with NEAS's own geographical representation, a fact which we believe will provide enhanced business opportunities." The duration of the agreement is three years, starting June 2007. The Norwegian facility management market is still in an early growth phase. At the start of the year NEAS was responsible for the management and operation of around 4.3 million m2, divided between some 1,500 properties. Among its customers are well-known companies such as Telenor, Norway Post, Aberdeen Property Investors and ICA. For further information: Tor Rønhovde, CEO, tel. 6740 1000 Bjørn Forwald, Director Operations, tel. 6740 1000 or www.neas.no NEAS in brief NEAS is Norway's leading facility management company. Headquartered in Lysaker, just outside Oslo, NEAS has offices in Bergen, Trondheim, Stavanger, Kristiansand, Sarpsborg, Gjøvik and Grenland. NEAS generated gross revenues of approx. NOK 260 million in 2006 and had around 270 employees. Pitney Bowes in brief Pitney Bowes Norge AS is a wholly owned subsidiary of US-based Pitney Bowes Inc. (NYSE: PBI). This international group has 32,000 employees and total revenues of USD 5.5 billion. Pitney Bowes Norge has 216 employees and generated revenues of NOK 440 million in 2006.


 

Drill Programs to Upgrade Near-Surface Resources, Expand Down-Dip Resources TORONTO, ONTARIO -- (MARKET WIRE) -- March 29, 2007 -- Pele Mountain Resources Inc. (TSX VENTURE: GEM) ("Pele" or the "Company") today announced the continued advancement of technical, economic, and environmental scoping studies at its 100-percent owned Elliot Lake Uranium project in Northern Ontario. The focus of the ongoing studies is to establish the basis for economically viable, safe and environmentally compliant mining and processing facilities at Elliot Lake. In January, Scott Wilson Roscoe Postle Associates Inc. ("Scott Wilson RPA") released a NI 43-101 compliant Technical Report (the "Report") estimating that the deposit contains 30.05 million tonnes grading 0.05-percent U3O8, for a total inferred resource of 33.05-million pounds U3O8, and an additional potential mineral deposit of 25 to 30 million tonnes at grades ranging from 0.04 to 0.05 percent U3O81. Scott Wilson RPA is collaborating with experienced professionals from a wide range of disciplines to complete the assessments recommended in its Report. Pele President and CEO Al Shefsky stated, "As detailed below, we are achieving outstanding progress on multiple fronts at Elliot Lake. Our positive results to-date, along with our belief in the long-term sustainability of a robust uranium market, continue to increase our confidence that the near-term development of a world-class uranium mine and processing facility is a realistic objective." The ongoing scoping studies are focused on determining the optimal mining and processing methods for the deposit while establishing an effective environmental management plan. The project is advancing systematically and on schedule according to the recommendations set out in the Report. Pele is pleased to report the following updates and milestones in the areas of resource estimation, mine planning, processing methods, and environmental management. Resource Estimation - The initial 22-hole drill program has been completed with the drill core logged, sawed, and sent to SGS Minerals Services for analysis of uranium and rare earth elements ("REE"). Assay results are expected next month. - 20 of the 22 holes were located within a near-surface area measuring 600 by 800 metres and will enable the upgrade of "inferred" mineral resources within this area to the "indicated" category. Six of these holes were originally scheduled as part of the stage two pre-feasibility study, however they have been completed earlier in the schedule to facilitate the more detailed resource estimate. - An additional drill program is planned in a previously drill-tested area now categorized as a "potential mineral deposit" that, if successful, will enable the upgrade of significant portions to the "inferred" category, adding to Pele's current NI 43-101 compliant U3O8 resource total of 33 million pounds. - Down-hole radiometric surveys have been completed in current drill holes with the objective to provide high resolution spectra that can be converted to provide equivalent uranium and thorium content. Correlations between thorium and REE have been established from the core analyses and the radiomentric surveys are expected to also provide a relatively quick, and cost effective method to estimate the REE content. Furthermore, a previously drilled AXT-size hole was successfully re-entered with a "dummy-probe" indicating that many of the historic holes can also be surveyed. Mine Planning - Preliminary geotechnical assessments on drill cores are complete and have demonstrated that the rock mass quality of the deposit and its host rocks is good to excellent and sufficient to support room-and-pillar mining methods. - The deposit outcrops for approximately 6 kilometres and dips to the northwest at approximately 20 degrees, with the highest concentrations of uranium occurring at the base of the "Main Conglomerate Bed". A reduction in mining height from approximately 2.4 metres (as stated in the Technical Report) is now considered likely in order to optimize grade and operating costs. - Additional in-fill holes are planned to further outline relatively higher-grade, near-surface zones for mining early in the project life. Processing Methods - Samples have been sent to the Inco Innovation Center at Memorial University in Saint John's Newfoundland, for mineralogical assessment using its Mineral Liberation Analyzer with results expected by June. This testing will provide information on the mineralogical associations and distribution of both uranium and rare earth oxides. - Upon receipt of the assay results from the current 22 drill holes, additional core samples from the Main Conglomerate Bed will be shipped to SGS Lakefield Research Limited for use in uranium and REE leaching recovery tests that are expected to be completed this summer. - Processing methods now under consideration include conventional milling and underground leaching, both of which proved to be effective in former operations at Elliot Lake. Other options are also being evaluated. Environmental Management - Consultation has been initiated with the Serpent River First Nation and the City of Elliot Lake to foster open and constructive dialogue regarding the project in the interest of preserving the natural balance in this culturally significant and beautiful area of Northern Ontario. - "Best Practices" for environmental management are being implemented for the exploration programs and are being established for the development stages of the project. - Environmental and permitting aspects for various processing options are under review and preparation for an environmental baseline survey is scheduled to commence this summer. The "Qualified Person" under NI 43-101 for Scott Wilson RPA's Technical Report is Lawrence Cochrane, P.Eng. This press release has been reviewed and approved by Robert MacGregor, P.Eng., a Qualified Person under NI 43-101. About Pele Mountain Resources Pele Mountain Resources is focused on the advancement of its 100-percent owned Elliot Lake uranium and rare earth elements project in Northern Ontario. The Elliot Lake project hosts a NI 43-101 compliant mineral resource of 33 million pounds of U3O8 with very good potential to increase the mineral resources on the property, according to a Technical Report authored by Scott Wilson Roscoe Postle Associates Inc. The Elliot Lake mining camp was once known as "the uranium capital of the world" and has produced more than 270 million pounds of U3O8 from stratigraphically-bound deposits that demonstrate remarkable consistency over extensive areas. The uranium market is currently experiencing a strong upward price trend due to uncertain supply and increasing global demand. Pele also holds a diverse portfolio of gold, diamond, and base metal projects located across Northern Ontario, including the Highland project where drilling has outlined several high-grade, narrow-vein gold zones within an historic mining camp. Through project generation and mineral discovery, Pele provides shareholders with exposure and leverage to the increasing global demand for natural resources. Pele stock trades on the TSX Venture Exchange under the symbol "GEM". 1. The potential quantity and grade of the potential mineral deposit are conceptual in nature and there has been insufficient exploration to define a mineral resource and it is uncertain if further exploration will result in the targets being delineated as a mineral resource. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe Pele's future plans, objectives or goals, including words to the effect that Pele or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Contacts: Pele Mountain Resources Inc. Al Shefsky President (416) 368-7224 Website: www.pelemountain.com


 

Today the Board of Directors (the "Board") of Prosafe SE (the "Company" or "Prosafe") has proposed to adopt a new dividend policy which will yield substantially higher dividend payments. The Board will propose a divided plan which should yield total payments of at least NOK 5 per share in 2007 and 2008, followed by a dividend pay-out ratio of approximately 75% of net profits. The new dividend policy will not affect the Company's annual investment capacity, which currently is around USD 800 million. Strong business and cash flow Recent and ongoing developments in the rig market have allowed for substantial value uplift in Prosafe's accommodation rig business. Prosafe is the global market leader, owning 12 such units. An optimal mix between long-term and spot contracts allows Prosafe to benefit from increasing day rates. Further, the FPSO market is witnessing rapid growth with high bidding activity. Prosafe is well positioned as one of the leading suppliers and operators of high quality FPSOs with a strong competitive edge based on in-house technology and project experience. The Company has engineering capacity and access to hulls and shipyards to take on multiple new projects and deliver them on time and within budget. Prosafe is actively pursuing several new FPSO projects with expected awards within three to twelve months. Improved dividend policy In line with Prosafe's stated policy to return capital to shareholders without compromising future growth opportunities, the Board has concluded that these developments should be immediately reflected in the capital return policy of Prosafe. The Board has earlier proposed a dividend of NOK 1.25 to be paid in 2007. In addition, the Board has today proposed to distribute a special dividend of NOK 3.75 to be approved by an Extraordinary General Meeting following the Company's relocation to Cyprus where there is no withholding tax on dividend payment. The Board has also proposed to increase the target dividend pay-out ratio from the currently stated policy of 30-50% to approximately 75%. The new pay-out ratio will be effective from fiscal year 2007, however, with a proposed minimum of NOK 5 per share payable in 2008. The proposed total dividend of NOK 5 per share payable in 2007 would imply a dividend yield of 5.4% based on a closing price of NOK 93.10 per share as of March 28th. The dividend payments will be subject to approval of shareholders of the Company at the respective General Meetings. The new dividend policy will give increased predictability, and will allow Prosafe shareholders to directly benefit from the positive momentum in Prosafe's existing FPSO and accommodation rig operations, while still allowing for strong value creating growth. Growth Prosafe remains committed to continue its strong FPSO growth. With more than 350 employees in Singapore, mainly within engineering disciplines, and with proprietary mooring and swivel technology, the company is strongly positioned in the upper segment of the FPSO market where barriers of entry remain high. The company will target to increase annual investments into new FPSOs to around USD 800 million. Prosafe will be able to fund such a growth rate, combined with the revised dividend policy, on the back of its current strong balance sheet and high cashflow from existing FPSO contracts and firm and expected cash flow from its existing accommodation units. Prosafe is the world's leading owner and operator of semi-submersible service rigs and a major owner and operator of floating production and storage vessels outside the North Sea. Operating profit reached USD 150 million in 2006. The company operates globally, employs approx. 1 000 people and is headquartered in Stavanger, Norway. Prosafe is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com. Stavanger, 29 March 2007 For further information please contact: Arne Austreid, President and CEO Phone no: +47 900 77 334 Bjørn Henriksen, Exec. Vice President and CFO Phone: +47 902 52 480


 

AMERICAN MARKETS OUTLOOK: U.S. stocks are expected to open higher Thursday, following gains in European markets, says Geoff Langham of CMC Markets. "Economic data will influence the markets today, with GDP figures and jobless claims (at 1230 GMT)," Langham says. On the corporate front, CDC, Texas Industries, Family Dollar, Red Hat and Solectron are due to report earnings. CMC Markets is calling the Dow Jones Industrial Average to open up 50 points at 12,350, the Nasdaq 100 6 points higher at 1776 and the S&P 500 up 6 points at 1423.3. EUROPEAN MARKETS: European stocks are higher around midday, with a pullback in crude oil prices boosting sentiment. In London, the FTSE 100 index is up 0.6% at 6305 on a raft of positive corporate earnings. Compass and Tate & Lyle led the advance after posting better-than-expected trading updates. In Frankfurt, the DAX 30 index is up 0.8% at 6868, on improved performance on most Asian markets and a stabilization of oil prices, a trader said. In Paris the CAC 40 is up 0.8% at 5597. Bunds and gilts are lower, weighed down by stronger-than-forecast economic data. Euro-zone March retail PMI rose to 53.4 from 49.8 in February, pushing June bunds lower, while a rise in U.K. February consumer lending saw gilts tick down. The June bund future is down 0.29 at 115.01 and the June gilt future down 0.29 at 107.9. In the currency markets, Fed Chairman Ben Bernankes confirmation of an inflation bias has given the dollar only limited support in Europe as investors remain concerned about U.S. economic growth. At 1025 GMT, the dollar was up at Y117.5, the euro was up at $1.3340 and the pound was up at $1.9640. =========================== TOP STORIES: ENDESA: ENEL NOT LEGALLY ALLOWED BOARD REPRESENTATION: Italys Enel SpA (EN) is not legally allowed to have board representation at Spanish electricity company Endesa SA (ELE), Endesa Chairman Manuel Pizarro said. (By David Roman and Jonathan House) 3I TO RETURN GBP800M TO HLDRS ON STRONG EXITS: U.K.-based private equity company 3i Group PLC (III.LN) said it plans to return a further GBP800 million to shareholders because of significant gains from realizations, or assets sold, refinanced or listed. (By Marietta Cauchi) KINGFISHER FY PRETAX PFT -11%, BUT UK MKT STABLE: Kingfisher (KGF.LN), Europes biggest home improvement retailer by sales, posted a 11% fall in full-year pretax preitems profit, hurt by difficult trading conditions in the U.K., but gave an upbeat outlook for the sector saying the U.K. market has stabilized. (By Anita Likus) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: Geopolitical risk could start to feature as a key element in currency markets for the first time since 2003. (By Nicholas Hastings) =CHARTING EUROPE: ICE May Brent crude futures made a new 2007 high at $69.00 per barrel this week as forecast in Mondays column. The break out of Wednesdays $66.67 to $65.19 per barrel inside day should determine the short-term trend for the days to come though. (By Axel Rudolph) =========================== STILL TO COME COUNTRY PERIOD ET/GMT 0830/1230 US Richmond Fed Pres Lacker speaks on financing community development at the Community Affairs Research Conference in Washington 0830/1230 US 4Q GDP, final 0830/1230 US 4Q Corp Profits, final 0830/1230 US Mar 24 Jobless Claims 1000/1400 US Mar 17 DJ-BTMU Business Barometer 1000/1400 US Feb Conference Board Help-Wanted Index 1000/1400 US Fed Vice Chmn Kohn testifies before the House Financial Services Committee on industrial loan companies 1030/1430 US Mar 23 US Energy Dept Natural Gas Stocks 1100/1500 US Mar Kansas City Fed Mfg Index 1200/1600 US Minneapolis Fed Pres Stern speaks at a global investment forum in Dayton, Ohio 1230/1630 US BoC Gov Dodge speaks on economic policy priorities across America in New York 1630/2030 US Money Supply =========================== OTHER NEWS: The London Stock Exchange Group PLC (LSE.LN) said in an update that trading has been strong, with electronic volumes rising an average 56% on SETS and new issue values up 58%. (By Henry Teitelbaum) Tate & Lyle PLC (TATE.LN) said that its full-year trading performance has continued in line with market expectations, with news on the possible sale of its European starch unit expected in the coming weeks. (By Michael Carolan) Swiss drugmaker Roche Holding AG (RHHBY) said it received permission from the European Commission to sell its cancer drug Avastin for the treatment of breast cancer. (By Anita Greil) Caterer Compass Group PLC (CPG.LN) said that trading in the first five months of its fiscal year has been ahead of expectations, with these positive trends expected to continue into the rest of the year. (By Michael Carolan) ICAP PLC (IAP.LN) said trading volumes surged toward the end of its fiscal year on volatile markets, and that full-year profit would be in line with analyst estimates. (By Henry Teitelbaum) Defense and services contractor VT Group PLC (VTG.LN) said current trading is in line with management expectations and that talks to form a shipbuilding joint venture with BAE Systems PLC (BA.LN) are making good progress. (By Elena Berton) U.K. retailers sales volumes surged ahead in March to the highest balance since December 2004, boosted by sales of do-it-yourself and household goods, according to a survey by the Confederation of British Industry. (Data Snap by Ilona Billington) U.K. real estate investment trusts Liberty International PLC (LII.LN) and Great Portland Estates PLC (GPOR.LN) said that they have formed a GBP460 million joint venture to own, manage and develop properties in central London. (By Molly Dover) Homeserve PLC (HSV.LN), the home emergency service company, said that pretax profit for the year to Mar. 31 would be "in line with expectations." (By Molly Dover) Retail and mail-order group KarstadtQuelle AG (KAR.XE) said it swung to a net profit in 2006 after the disposal of its real estate assets. (By Archibald Preuschat And Roman Kessler) DSG International PLC (DSITY) said it has uncovered fraud at its warehouse in Paris, France, saying that several warehouse staff and external individuals have been arrested. (By Elena Berton) U.K. consumers appetite for secured debt returned in February, despite the Bank of Englands surprise January rate hike, as a lack of properties available to purchase ensured would-be house buyers paid a premium for suitable homes. (Data Snap by Ilona Billington) Output from the dominant services sector grew only slightly in January, indicating that the U.K. economy started 2007 more sluggishly than it ended 2006. (Data Snap by Paul Hannon) Unemployment in Germany continued to fall at a faster pace than expected in March as the economic upswing lead to higher demand for workers, data released Thursday by the German labor agency showed. (By Klaus Brune and Christine Popp) Skandinaviska Enskilda Banken (SEB-A.SK) is keeping an eye on European banking-sector consolidation, but for now remains focused on making itself more profitable to enhance its future possibilities, the banks two top officials told Dow Jones Newswires. (By Jenny Clevstrom)


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-------------------------------------------------+-----------------| | Company dealt in | Corus Group plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-------------------------------------------------+-----------------| | Date of dealing | 28th March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 361 | 606p | 606p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 1,823 | 606p | 606p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 29th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Corus Group Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Aker Yards ASA has today on 29 March 2006 held its Annual General Meeting. The minutes of the meeting are attached, in Norwegian and an English office translation. The Annual General Meting approved the Board's proposed distribution of dividend for 2006 of NOK 18 per share (before share split). Dividend will be distributed to the company's shareholders as at the end of 29 March 2007. Consequently, the shares will be traded ex dividend as from Friday 30 March 2007. The Board was given authorization to increase the company's share capital through new share subscription(s). The share capital can be increased by up to NOK 100 000 000, equivalent to 22 % of existing share capital. The Board was given authorization to acquire company shares with an aggregate par value of NOK 45 million. Two board members have resigned from their positions, and as from 30 March 2007 the Board of Directors consists of: Svein Sivertsen Ole Melberg Rebekka Glasser Herlofsen Martinus Brandal Carola Teir-Lehtinen Arne Otte Rogne Karl Johan Breivik Terje Nerås A separate release will be published as soon as the Board has elected its chairman and vice-chairman. The election committee now consists of: Gerhard Heiberg, Chairman Yngve Hågensen Kjeld Rimberg The Annual General Meeting concluded some changes to the Articles of Association to reflect the new number of shares following the share split. Please see a separate release regarding share split. The minutes of the meeting are attached, in Norwegian and an English office translation. For further information, Tore Langballe, SVP Corporate Communications and IR, Aker Yards ASA, +47 24 13 00 00


 

Okmetic Oyj's Annual General Meeting, which was held on 29 March 2007, adopted the Financial Statements for 2006 and discharged the members of the Board of Directors and the President from personal liability. No dividends will be distributed for the financial year 2006. Moreover, the Annual General Meeting approved of the Board of Directors' proposal regarding the Board's rights to increase share capital and the proposed amendments to the Articles of Association. Adoption of the Financial Statements The Annual General Meeting adopted the Financial Statements of Okmetic Oyj for 2006, including the Consolidated Financial Statements. Discharge from liability The Annual General Meeting discharged the members of the Board of Directors and the President from personal liability regarding the financial year 2006. Dividends The Annual General Meeting decided that no dividends shall be distributed for the financial year 2006. Members and Chairman of the Board of Directors It was decided that there would be five members on the Company's Board of Directors. The following persons were re-elected as members of the Board of Directors until the end of the next Annual General Meeting: Mikko J. Aro, Karri Kaitue, Esa Lager, Pekka Paasikivi and Pekka Salmi. The Board of Directors elected Mikko J. Aro as its Chairman and Karri Kaitue as its Vice Chairman in its organisation meeting held immediately after the Annual General Meeting. The Annual General Meeting confirmed the annual fees to the members of the Board of Directors as follows: Chairman 34,800 euro, Vice Chairman 26,100 euro, and other board members 17,400 euro. Auditors PricewaterhouseCoopers Oy, Authorised Public Accountants, were appointed as auditors. Markku Marjomaa, Authorised Public Accountant was appointed as the principal auditor. The fees for the auditor are paid according to invoice. Increasing the share capital The Annual General Meeting accepted the proposal of the Board of Directors for granting the board the authorisation to increase the share capital (Appendix 1). Amendment of the Articles of Association The Annual General Meeting accepted the proposal of the Board of Directors for amending the Articles of Association (Appendix 2). President's review at the Annual General Meeting President Antti Rasilo's review is available on the Company's website at www.okmetic.com under Presentation Materials in the Investor Information section. OKMETIC OYJ Antti Rasilo President For further information, please contact: President Antti Rasilo, Okmetic Oyj, Tel. +358 9 5028 0232, email: antti.rasilo@okmetic.com Senior Vice President, Finance Esko Sipilä, Okmetic Oyj, Tel. +358 9 5028 0286, email: esko.sipila@okmetic.com The entire release including appendices is available via the link below:


 

Highlights of 2006: * EUR 66.6 million in cash and cash equivalents as of December 31, 2006 * Increase in revenues to EUR 13.1 million from EUR 9.6 million in 2005 * Anticipated filing of FDA and EMEA marketing authorization applications for Icatibant in HAE in third quarter 2007 Berlin, March 29, 2007 - Jerini AG (FSE:JI4) reported financial results for fiscal year ended December 31, 2006 at a press conference today in Frankfurt. "We made significant progress in Icatibant's clinical development for the subcutaneous treatment of hereditary angioedema (HAE). Based on the outcome of our two Phase III clinical trials, we plan to complete US and European regulatory submissions in the third quarter of this year and anticipate product launch in 2008," said Jens Schneider-Mergener, CEO of Jerini. Financial Review for Fiscal Year 2006 Under International Financial Reporting Standards (IFRS), revenues in 2006 increased by 36 percent to EUR 13.1 million from EUR 9.6 million in 2005, due to revenues generated from collaboration agreements with US-based pharmaceutical companies Alcon Research Ltd., Baxter AG, and Kos Pharmaceuticals, Inc. (now Abbott), along with higher revenues in its peptide services unit (JPT Peptide Technologies). Research and development expenses increased as planned to EUR 23.2 million (EUR 18.9 million in 2005), largely attributable to expenses from the Phase III clinical trials for hereditary angioedema (HAE). The loss from operations (EBIT) of EUR 25.1 million (compared to EUR 19.8 million in 2005) was in line with the company's forecast. The net loss increased to EUR 22.9 million (compared to EUR 15.3 million in 2005) as expected. Net cash burn (calculated as cash used in operating activities plus cash for investment in property and equipment) amounted to EUR 30.4 million in 2006, compared to EUR 7.0 million in 2005. As of December 31, 2006, cash and cash equivalents amounted to EUR 66.6 million (December 31, 2005: EUR 96.5 million). "Our solid cash position provides us with the means to achieve our goal of launching Icatibant in Europe with our own sales and marketing teams. In preparation, we have increased our employee headcount by approximately 25 percent this year to 140, mainly in the sales and marketing areas," said Berndt Modig, Jerini CFO. Outlook Based on Icatibant's HAE clinical trial progress to date and the positive development of its other drug candidates, Jerini intends to concentrate in the future on developing of its own drug candidates. For 2007, the company forecasts a rise in operating expenses. Higher research and development expenses are anticipated as a result of the further development of Icatibant in at least one other indication, along with the start of clinical trials of JSM 6427, Jerini's integrin antagonist for the treatment of age-related macular degeneration (AMD). The development of Jerini's AMD program along with other ophthalmology compounds will be carried out by the company's newly established wholly-owned US subsidiary, Jerini Ophthalmic, Inc. Further expansion in the sales area for the planned market launch of Icatibant in 2008 will also add expenses in 2007. As a result, an overall increase in losses from operations is to be expected in 2007. About Jerini AG Jerini is a pharmaceutical company based in Berlin, Germany, focusing on the discovery, development, and commercialization of novel peptide-based drugs. The company pursues disease indications that have limited or no treatment options and has built a drug pipeline composed of its own programs, as well as others in collaboration with established partners. In September 2006, Jerini reported Phase III clinical results of Icatibant in the subcutaneous treatment of hereditary angioedema. Based on its technology platform, Jerini has also established several in-house development programs, which address indications within the therapeutic areas of ophthalmology, oncology, and inflammatory disease. ISIN: DE0006787476 For questions, please contact: Stacy Wiedenmann Director Investor Relations & Corporate Communications Jerini AG Invalidenstr. 130 10115 Berlin T + 49 - 30 - 97893 - 285 X + 49 - 30 - 97893 - 105 wiedenmann@jerini.com


 

2006 financial year: (Holzminden/Frankfurt) Symrise AG, one of the world's leading suppliers of fragrances and flavorings, generated record sales and earnings in the 2006 financial year and improved its profitability again too. Symrise is expecting a further increase in sales and earnings in the current financial year. Symrise increased sales substantially by 7.0 per cent in 2006, from EUR 1 148.9 million to EUR 1 229.4 million and thus recorded higher growth than the market average. The high increase in sales in 2006 was attributable to a very large extent to the successful implementation of the strategic realignment. Gerold Linzbach, Chairman of the Management Board of Symrise AG: "With the strong growth achieved in the 2006 financial year, Symrise enjoyed the benefits of the comprehensive restructuring exercise and technological product innovations in the previous years. We reached our ambitious targets in every respect and grew considerably faster than the market. This dynamic development has continued in the initial weeks of the current financial year too. We are therefore confident about the rest of the year." Many leading international companies in the consumer goods industry have made Symrise one of their core suppliers. This success is mainly due to the systematic implementation of our strategy in the research, marketing and organizational fields. Products that have an additional benefit above and beyond the flavor or fragrance - the so-called "and" products - have been given particularly high priority here. EBITDA adjusted to eliminate non-recurring factors increased to a disproportionately larger extent than sales, from EUR 193.1 million to EUR 243.2 million in 2006. The adjusted EBITDA margin went up from 16.8 per cent to 19.8 per cent as a result. The non-recurring factors include expenses in connection with the IPO and the restructuring program. The outcome was a net loss for the year after taxes of EUR 89.9 million. Substantial reduction in debt Group debt was reduced emphatically with the help of the gross proceeds of the IPO of EUR 652 million. The equity ratio improved to 30.5 per cent as a result. Interest payments will decrease considerably in future thanks to this too. Developments in the Flavor & Nutrition Division Sales in the Flavor & Nutrition Division in 2006 increased strongly by 7.5 per cent to EUR 582.0 million. The adjusted EBITDA developed accordingly and went up from EUR 105.7 million in 2005 to EUR 130.3 million in 2006. The strategic focus was on the marketing launch of the "Taste for Life(TM)" program: Taste for Life(TM) flavors aim to make good taste even healthier in future. The sugar, salt and fat content of food products can, for example, be reduced considerably with the help of these flavors - keeping the same authentic taste. The new business with such innovations - the "and" products that give customers an additional benefit - was one of the growth drivers in the Flavor & Nutrition Division. In addition to this, the strategy of growing primarily with the major customers as well as maintaining and continuing to expand Symrise's core list positions has already paid off. We succeeded in recording disproportionately fast growth with global food and beverage manufacturers. Symrise achieved above-average growth rates in the emerging markets. Sales in South America increased by 15.0 per cent, for example. Developments in the Scent & Care Division Sales in the Scent & Care Division in 2006 increased by 6.5 per cent to EUR 647.4 million. The adjusted EBITDA improved far better, climbing 29.2 per cent from EUR 87.4 million to EUR 112.9 million in 2006. This means that Symrise grew faster than the market in this division. Active cosmetic ingredients, UV filters, special aroma chemicals and sensates as well as fine fragrances recorded double-digit growth rates. Symrise benefitted from successful market launches in the luxury perfume field with such exclusive names as Donna Karan (Red Delicious), Jil Sander (Jil Sander Style) or Givenchy (Amarige Mariage). The Scent & Care Division recorded above-average growth in the emerging markets of China (+ 18.6%), Brazil (+ 25.0%) and India (+ 8.2%) in particular. Sales in the EAME region (Europe, Africa and the Middle East) improved by 5.2 per cent. Positive outlook Following an intensive phase of strategic realignment, Symrise is excellently positioned to continue growing profitably. We are concentrating on the development of innovative products and the improvement of our services. It is our objective to achieve faster, primarily organic growth than the market. We are also planning to make selective strategic acquisitions to improve our know-how. All in all, average sales growth of about 5 per cent p.a. is planned for the two-year period from 2007 to 2008. The adjusted EBITDA margin is to increase from 19.8 per cent in 2006 to substantially more than 20 per cent in this context. The company also intends to pay a dividend of the standard size for the industry for the first time in 2008 for the 2007 financial year, depending on the development of the business. About Symrise: Symrise is a global supplier of fragrances, flavors and raw materials and active ingredients for the perfume, cosmetics and food industries. With sales of ¤1.23 bn in 2006, the company is among the top four in the international flavors and fragrances market. Headquartered in Holzminden, Germany, the company maintains a total of 31 locations in Europe, the United States, the Asia Pacific region, as well as in South America. With over 50 registered patents each year, Symrise is one of the most innovative manufacturers on the market. Our products are used by perfume, cosmetics and food manufacturers and are essential features of everyday life today. Combining consumer insights and technology, Symrise focus on the development of innovative trend and lifestyle products with a specific additional benefit for the consumer. Symrise - Always inspiring more. www.symrise.com Press inquiries: Katja Derow, red roses communications, Tel.: +49 40 46 96 770-10, Email k.derow@redroses-pr.com Dr. Kay Baden, Kirchhoff Consult AG, Tel.: 040-609 186 39, Email baden@kirchhoff.de --- End of Message --- Symrise AG Mühlenfeldstraße 1 Holzminden Germany WKN: SYM999; ISIN: DE000SYM9999; Index: MDAX, TecDAX; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Prime Standard in Frankfurter Wertpapierbörse;


 

The Central Bank of Iceland left its repurchase agreement rate unchanged Thursday at 14.25%, as expected.Sedlabanki also left rates unchanged at its last monetary policy meeting Feb. 8, but surprised market watchers with a 25 basis point hike Dec. 21.The central bank makes its next rate decision May 16.


 

Zug/Munich, 29 March 2007 - Global Life Science Ventures (GLSV) today announced that it has co-led a $22.6 million Series E financing round in Coapt Systems, Inc., a company based in Palo Alto, California that is developing bioabsorbable implants for use in aesthetic surgery. The round, led by Easton Capital, also included existing investors Alta Partners, Asset Management Company, Canaan Partners, Boston Millennia Partners, and Foundation Medical Partners. Coapt Systems, founded in 2000, has developed an innovative range of implantable soft tissue fixation devices under the EndotineÔ name for use in facial plastic surgery. It has already built up a market presence in 38 countries, including 2'300 plastic surgeons in the USA, and generated good revenue growth. The company's rich pipeline also includes long-lasting dermatological fillers, currently in late-stage clinical development and to be used as a complement to the fixation devices, as well as an implantable and absorbable hand tendon repair device. The new financing round will support Coapt's launch of the dermal filler product range and the in-licensing of additional aesthetic products, which will allow the company to capitalize on its market presence and global distribution network in the high-growth worldwide aesthetic market, already valued at $25 billion. Stephen J. McCormack, PhD, Partner at GLSV, commented, "Coapt Systems has rapidly built up a broad pipeline of products with solid patent protection addressing unmet needs in the very large aesthetic surgery market. The strong management team, headed by Kenneth Anstey, has a wealth of experience in medical devices, with several successful exits, and we see excellent perspectives to generate attractive returns in the near future. GLSV has once again joined forces with international syndicate partners to capitalize on an exciting investment opportunity." Dr. Stephen J. McCormack will become a member of the Board of Directors of Coapt Systems. Kenneth Anstey, CEO of Coapt, commented, "We are pleased to welcome on board such experienced life science investors as GLSV and Easton to support the future development of the Company. Having a European investor will bring much value to Coapt as we begin to expand outside of the United States." Hans A. Küpper, PhD, Partner at GLSV, added, "This investment fits very well within our portfolio of innovative companies and is consistent with GLSV's strategy of maintaining a balance in developmental stage and field of indication." About Global Life Science Ventures: GLSV is a leading, independent venture capital fund focusing exclusively on the life sciences. With offices in Germany and Switzerland, GLSV is dedicated to supporting early-stage companies originating from universities, scientific institutions or industry, but also invests in selected later-stage companies, including buy-outs. The group currently advises and manages funds totalling more than ¤200 million. GLSV has financed 32 innovative life science companies, twelve of which have completed an exit through IPO, trade sale or M&A. GLSV has built up a broadly diversified portfolio of companies in pharmaceuticals, diagnostics, medical devices, and biotechnology. Global Life Science Ventures Industry-born team - Proven track record - Global perspective Germany Switzerland GLSV GmbH GLSV AG Von-der-Tann-Str. 3 Postplatz 1, P.O. 626 D - 80539 München CH - 6301 Zug Tel. +49 (0)89 288 151 0 Tel. +41 (0)41 727 19 40 Fax +49 (0)89 288 151 30 Fax +41 (0)41 727 19 45 www.glsv-vc.com mailbox@glsv-vc.com For additional information, please contact: Rochat & Partners Christophe Lamps or Jonathan Leighton Tel. +41 22 718 37 46 Fax +41 22 786 54 58 E-mail: clamps@rochat-pr.ch jleighton@rochat-pr.ch


 

3G Smartphone can download and play tracks from range of Internet music stores Espoo, Finland - Today, Nokia revealed the Nokia 5700 XpressMusic, an accessible 3G smartphone augmented by a dedicated audio chip for enhanced music performance. The Nokia 5700 XpressMusic features an iconic twist design that easily switches between four modes at the flick of the wrist - music player, 2 Megapixel camera, video call and smartphone. Combining the benefits of a music-oriented, multipurpose device featuring 3G dataspeeds, the Nokia 5700 XpressMusic is expected to retail for an estimated EUR 350 before taxes and subsidies during the second quarter of 2007. "The Nokia 5700 XpressMusic adds a new twist to the mobile music experience with compatibility for tracks purchased from many Internet music stores," says Heikki Norta, Senior Vice President, Mobile Phones, Nokia. "In addition the Nokia 5700 XpressMusic features a dedicated audio chip for improved music performance which consumers can further enhance by selecting from an ever increasing line of compatible audio enhancements." Using an optional 2GB MicroSD card, the Nokia 5700 XpressMusic supports up to 1500 tracks that can be enjoyed using Bluetooth stereo headphones, with their own favorite 3.5mm plug-equipped headphones and the included headset adaptor or through built-in stereo loudspeakers. Loading songs onto the Nokia 5700 XpressMusic is fast and easy as consumers can choose from a broad range of supported digital formats, including WMA, MP3, AAC, as well as eAAC+ and MP4. When purchasing music online, shoppers again have the luxury of choice as they can select from a range of Internet music stores, also those utilizing Windows Media Player Digital Rights management (WMDRM). The optimized music player in the Nokia 5700 XpressMusic supports album art, playlists, plus a 5-band equalizer and audio visualizations. 3G and video are part of the package More than a music-only device, the Nokia 5700 XpressMusic brings videos to life on a vibrant color screen supporting up to 16 million colors for exceptional video playback. With 3G high-speed data connectivity, the Nokia 5700 XpressMusic makes browsing, downloading and streaming multimedia content much more convenient and faster than before. A video call feature and the built-in 2 Megapixel camera make it easy to share moments with friends and family. The Nokia 5700 XpressMusic is based on the world's leading S60 software running on Symbian OS. S60 enables consumers to personalize their device with a wide choice of compatible applications that can be downloaded to the Nokia 5700 XpressMusic, including games, navigation, entertainment, productivity and creativity. About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. Media Enquiries: Nokia, Mobile Phones Communications Tel. +358 7180 60992 Nokia Communications Tel. +358 7180 34900 Email: press.office@nokia.com www.nokia.com --- End of Message --- NOKIA P.O. Box 226<br>FIN-00045 NOKIA GROUP Espoo WKN: 870737; ISIN: FI0009000681; Index: DJ STOXX Large 200, DJ STOXX 50; Listed: Nordic list (Large Cap) in THE HELSINKI STOCK EXCHANGE;


 

Tämä on arvopaperimarkkinalain 2 luvun 10 pykälän mukainen ilmoitus. Morgan Stanley & Co International Limited on ilmoittanut Talentum Oyj:lle, että sen osuus yhtiön äänimäärästä ja osakepääomasta on ylittänyt yhden kahdeskymmenesosan (1/20) kaupalla, joka tehtiin 26.3.2007, ja on nyt 5,58 %. 1. Kohdeyhtiö Talentum Oyj 2. Ajankohta, jolloin omistus on muuttunut 26.3.2007 3. Osuus Talentum Oyj:n äänimäärästä ja osakepääomasta Osakkeita 2.468.680 kpl Osuus osakepääomasta 5,58 % Osuus äänimäärästä 5,58 % 4. Osakkeenomistajan täydellinen nimi Morgan Stanley & Co International Limited Lisätiedot Lakiasiainjohtaja Lasse Rosengren, puhelin 040 342 4204


 

(Oslo, 29 March 2007) Statkraft and its partner, Catamount Energy Corporation, have been given a licence to build Blaengwen Wind Farm in Wales in the UK. This is Statkraft's first wind power licence outside Norway. The wind farm could be ready within two years. "With our first licence for wind power in the UK, we have reached a milestone. This demonstrates that Statkraft is also ready to develop renewable energy production outside Norway. All that now remains is to invite tenders and make the decision to invest," says Executive Vice President Ingelise Arntsen. In operation in two years' time Blaengwen Wind Farm is planned for a range of hills north of the town of Carmarthen in South Wales. The wind farm will be about 20 km inland of the west coast of Wales. The licence will allow for wind turbines up to 110.5 metres high, measured from the ground to the highest point of the wind turbine. The wind farm will consist of 10 wind turbines and a licence has been granted for a total generating capacity of up to 30 MW. The wind farm could be ready within two years. Investing heavily in the UK The project has been developed by Force 9 Energy in partnership with Catamount Cymru Cyf (CCC), who will be the owners of Blaengwen Wind Farm. Statkraft and the American Catamount Energy Corporation each own half of CCC. The companies are working together on a number of wind power projects on the mainland of Great Britain and have also applied for licences for a further three wind farms. In addition, Statkraft is part owner in five other projects in the British Isles, but with other partners. "There are two fundamental reasons for us investing so heavily in wind power in the UK. There are good wind conditions here and also the best financial incentive schemes in Northern Europe today," says Arntsen. Statkraft has three large wind farms in Norway, on Smøla and Hitra and in Kjøllefjord. Wind power is renewable energy and this form of power production does not emit any polluting discharges to the soil, air or water. Statkraft is Europe's second largest company within renewable energy. We produce hydropower and wind power, and we focus on innovation with a clear ambition to deliver the energy solutions for the future. We are a major operator on the European energy markets with special expertise within physical and financial power trading. In Norway we own shares in companies that supply electricity to more than 600,000 customers. In 2006, we had a turnover of more than NOK 16 billion and a total balance sheet of more than NOK 96 billion. More than 2000 employees in Norway, Sweden, Finland, Germany, the Netherlands, the UK, Bulgaria and Serbia create value every day. Together we strive to be a European leader in environment-friendly energy. For further information: EVP Ragnvald Nærø, tel.: +47 24 06 71 00/ +47 900 80 303 Managing Director, Statkraft UK Ltd., Morten Henriksen, tel.: +44 79 39 53 23 20 www.statkraft.com


 

KYOTO, Japan, March 29, 2007 (PRIME NEWSWIRE) -- Nidec Corporation (NYSE:NJ) today announced the launch of a new corporate statement codifying the core values Nidec adheres to and seeks to share with its stakeholders. The new statement, "All for dreams," will be implemented across the entire Nidec group companies from April 1, 2007 onward. "I want every Nidec Group employee to experience the pleasure of a dream come true through work," says Shigemori Nagamori, president of Nidec Corporation. "Dreams shape a company, raise it, and in adversity toughen it up. Dreams give us strength to address innovative challenges. We hope our undertakings will also contribute to your dream come true somehow. That is when Nidec's corporate value truly shines through." The corporate statement, "All for dreams," is the product of months of research by Nidec employees and brand-building experts to create a message that best exemplifies the company's present and future. The Nidec Corporation logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1734 CONTACT: Nidec Corporation Hiroshi Toriba, Senior General Manager, Investor Relations +81-75-935-6140 HIROSHI_TORIBA@notes.nidec.co.jp


 

* Strong growth in revenues and earnings * Success through innovation, global presence and process optimization * Higher dividend for 2006 - sound stock performance * Profitable growth forecast for 2007 and 2008 Lübeck, March 29, 2007 - Drägerwerk AG, Lübeck, has continued its success story for the sixth consecutive year. At today's annual accounts press conference, Dräger's Executive Board presented the 2006 financial statements, which were completed four weeks earlier than last year. The audited results are in line with the preliminary figures published at the end of February. Order intake was up 10 percent to EUR 1,865.0 million and revenues increased by 10.5 percent to EUR 1,801.3 million. New records were also set by EBIT (before non-recurring expenses) (EUR 148.2 million; 2005: EUR 128.2 million) and net profit (EUR 73.9 million; 2005: EUR 59.6 million). Group overview 2006 (audited figures) +-------------------------------------------------------------------+ | | 2006 | 2005 | Change | | | | | | |--------------------------+---------------+---------------+--------| | Order intake | ¤1,865.0 | ¤1,695.9 | 10.0% | | | million | million | | |--------------------------+---------------+---------------+--------| | Revenues | ¤1,801.3 | ¤1,630.8 | 10.5% | | Percentage generated | million | million | | | abroad | 78.7% | 77.8% | | |--------------------------+---------------+---------------+--------| | EBIT (before | ¤148.2 | ¤128.2 | 15.6% | | non-recurring expenses) | million | million | | |--------------------------+---------------+---------------+--------| | EBIT margin | 8.2% | 7.9% | | |--------------------------+---------------+---------------+--------| | Net profit | ¤73.9 million | ¤59.6 million | 24.0% | |--------------------------+---------------+---------------+--------| | Net profit after | ¤43.6 million | ¤36.9 million | 18.4% | | minority interests | | | | |--------------------------+---------------+---------------+--------| | Earnings per preferred | ¤3.47 | ¤2.93 | 18.4% | | share after minority | | | | | interests | | | | |--------------------------+---------------+---------------+--------| | Capital employed | ¤910.8 | ¤885.4 | 2.9% | | | million | million | | |--------------------------+---------------+---------------+--------| | ROCE (return on capital | 16.3% | 14.5% | | | employed) | | | | |--------------------------+---------------+---------------+--------| | Equity ratio | 33.0% | 32.7% | | |--------------------------+---------------+---------------+--------| | Dividend per common | ¤0.49 | ¤0.44 | 11.4% | | share* | ¤0.55 | ¤0.50 | 10.0% | | Dividend per preferred | | | | | share* | | | | |--------------------------+---------------+---------------+--------| | Headcount as of December | 9,949 | 9,687 | 2.7% | | 31 | | | | +-------------------------------------------------------------------+ *As proposed by the Executive and Supervisory Boards Assets, equity and liabilities +-------------------------------------------------------------------+ | | 2006 | 2005 | Change | | | | | | |--------------------+------------------+------------------+--------| | Total assets | ¤1,636.3 million | ¤1,536.2 million | 6.5% | |--------------------+------------------+------------------+--------| | Equity | ¤540.0 million | ¤502.8 million | 7.4% | |--------------------+------------------+------------------+--------| | Equity ratio | 33,0 % | 32,7 % | | |--------------------+------------------+------------------+--------| | Capital employed | ¤910.8 million | ¤885.4 million | 2.9% | | | | | | |--------------------+------------------+------------------+--------| | Net financial debt | ¤254.5 million | ¤255.8 million | - 0.5% | +-------------------------------------------------------------------+ Chairman of Drägerwerk AG's Executive Board Stefan Dräger attributes the Group's sound performance in fiscal year 2006 to a number of successful projects as well as comprehensive measures that have been consistently pursued over the last few years. Successful product innovations, the ongoing optimization of global business processes and the expansion of its international sales and service network have improved Dräger's competitiveness and efficiency as a global medical and safety technology group. As a result, the Group is growing faster than the market. Business performance of Dräger Medical and Dräger Safety +-------------------------------------------------------------------+ | | 2006 | 2005 | Change | | | | | | |-------------------------+----------------+---------------+--------| | Dräger Medical | | | | | Order intake | ¤1,275.1 | ¤1,156.4 | 10.3% | | Revenues | million | million | 12.0% | | | ¤1,239.2 | ¤1,106.4 | | | | million | million | | |-------------------------+----------------+---------------+--------| | EBIT (before | ¤112.7 million | ¤100.7 | 11.9% | | non-recurring expenses) | | million | | |-------------------------+----------------+---------------+--------| | EBIT margin | 9.1% | 9.1% | | |-------------------------+----------------+---------------+--------| | ROCE | 17.2% | 16.1% | | |-------------------------+----------------+---------------+--------| | Headcount as of | 6,051 | 5,856 | 3.3% | | December 31 | | | | |-------------------------+----------------+---------------+--------| | Dräger Safety | | | | | Order intake | ¤611.8 million | ¤573.2 | 6.7% | | Revenues | ¤589.1 million | million | 5.6% | | | | ¤557.8 | | | | | million | | |-------------------------+----------------+---------------+--------| | EBIT (before | ¤54.9 million | ¤47.2 million | 16.3% | | non-recurring expenses) | | | | |-------------------------+----------------+---------------+--------| | EBIT margin | 9.3% | 8.5% | | |-------------------------+----------------+---------------+--------| | ROCE | 25.7% | 24.7% | | |-------------------------+----------------+---------------+--------| | Headcount as of | 3,683 | 3,620 | 1.7% | | December 31 | | | | +-------------------------------------------------------------------+ Dräger Medical In fiscal year 2006, the Dräger Medical subgroup's revenues rose by 12 percent to EUR 1,239.2 million (prior year: EUR 1,106.4 million). Strong revenue growth was achieved in the Americas (up 20.1 percent) as well as in Europe excluding Germany (up 14.6 percent), where Italy, Spain and the UK made a particular contribution. Although high cost pressure on acute point of care ("APOC") customers in Germany caused this market to stagnate, the sales organization enjoyed impressive growth of 5.7 percent. Only in the Asia/Pacific region did temporary and local circumstances not allow growth. Dräger Medical's order intake was also pleasing, up 10.3 percent. Dräger's internationalization efforts have reaped significant rewards in this respect, with around 79 percent of overall business now being generated abroad. EBIT (before non-recurring expenses) increased by 11.9 percent to EUR 112.7 million (prior year: EUR 100.7 million). At 9.1 percent, the EBIT margin was unchanged on the prior year. Dräger Safety In fiscal year 2006, the Dräger Safety subgroup's revenues rose by 5.6 percent to EUR 589.1 million (prior year: EUR 557.8 million), thus outperforming the market. At 1.3 percent, revenue growth in Germany was also pleasing, despite an stagnating market. Order intake, up by a total of 6.7 percent to EUR 611.8 million, developed differently across the regions. In the Americas and the Asia/Pacific region, for example, orders increased by 0.2 and 7.6 percent, respectively. In Europe (excluding Germany), order intake was up by 13.2 percent; in Germany, a slight dip of 1.6 percent was recorded. EBIT increased by 16.3 percent to EUR 54.9 million (prior year: EUR 47.2 million), producing an EBIT margin of 9.3 percent (prior year: 8.5 percent). Headcount up 2.7 percent - increased added value through research and development (R&D) and sales and marketing As of December 31, 2006, headcount at the Dräger Group had increased by 262 from 9,687 in the prior year to 9,949. At 55 percent, the portion of employees based abroad remained the same. In 2006, Dräger created added value of EUR 754.7 million, a 7.1 percent increase on the prior year. The largest portion of this added value, EUR 594.7 million (78.8 percent), was attributable to Dräger employees (2005: EUR 570.1 million; 80.9 percent). Added value per employee (annual average) amounted to EUR 77 thousand, a 5.5 percent increase on the prior year (2005: EUR 73 thousand). By contrast, personnel expenses per employee only increased by 1.7 percent to EUR 60 thousand (2005: EUR 59 thousand). The share in added value of just over EUR 594.7 million, broken down by function, highlights the knowledge and customer-oriented focus of the Company. Some EUR 300 million of the personnel expenses incurred was attributable to research and development and sales and marketing employees. A further EUR 228 million was attributable to production and service employees, around 40 percent of whom serve customers on site as service engineers or equipment assemblers. Research and development at high level In fiscal year 2006, research and development expenses amounted to EUR 118.0 million, which equals 6.6 percent of revenues (2005: EUR 108.3 million or 6.6 percent). In the fiscal year, 74 patent applications and 2 utility models were filed with the German Patent and Trademark Office. Overall, 896 people were employed in the Dräger Group's research and development departments in 2006. Added value through higher dividend and sound stock performance The Executive and Supervisory Boards of Drägerwerk AG will propose an increase in dividends to EUR 0.49 per common share (prior year: EUR 0.44) and EUR 0.55 per preferred share (prior year: EUR 0.50) and submit this proposal for resolution at the annual shareholders' meeting on May 11, 2006. Dräger's sound business performance was also rewarded by the stock market. Since the beginning of 2006, the preferred stock price has risen by around 50 percent. Dräger stock is now trading at over EUR 67 (opening price as of March 28, 2007). Outlook - further growth expected The Dräger Group has entered the new fiscal year with confidence and aims to continue its top and bottom-line success in 2007 and 2008. Both subgroups, Dräger Medical and Dräger Safety, want to continue expanding their global presence, particularly in Asia and the Americas. The Group also wants to stave off the competition by increasing productivity. A key project for Dräger Medical is the implementation of the platform strategy for its product portfolio. Dräger Safety sees its potential in the further expansion of the two strategic business fields Dräger Safety Solutions and Compliance. The new Compliance business field is mainly engaged in core business, selling industrial respiratory protection equipment via dealers. The Q1/2007 figures will be published on May 8, 2007. This press release contains forward-looking statements regarding the development of the Dräger Group. No assurance can be given as to the content of these statements as they are based on assumptions and estimates that entail certain risks and uncertainties. Contact Corporate Communications: Dr. Welf Böttcher, Drägerwerk AG, Tel. 0451-882-2201, welf.boettcher@draeger.com Investor Relations: Vanina Herbst, Drägerwerk AG, Tel. 0451-882-2685, vanina.herbst@draeger.com --- End of Message --- Drägerwerk AG Moislinger Allee 53-55 Lübeck Germany WKN: 555063; ISIN: DE0005550636; Index: TecDAX, CDAX, HDAX, MIDCAP, Prime All Share, TECH All Share; Listed: Geregelter Markt in Börse Berlin Bremen, Geregelter Markt in Börse Düsseldorf, Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Geregelter Markt in Hanseatische Wertpapierbörse zu Hamburg, Geregelter Markt in Niedersächsische Börse zu Hannover, Geregelter Markt in Bayerische Börse München, Freiverkehr in Börse Stuttgart;


 

The Annual General Meeting of shareholders in Teligent AB (publ) was held Wednesday, 28 March 2007. The board members Lars-Erik Nilsson, Anders Björkman, Olle Isberg and Bengt Jörgensen had declined re-elction. The following individuals were elected to the new Board of Directors: Jan Rynning (Chairman), Elisabet Annell, Per Axelsson, Tomas Franzén, Sverker Hannervall and Ulf Lindstén. Öhrlings PricewaterhouseCoopers AB, with Anders Lundin as responsible for the audit, were elected auditors of the company. For further information, please contact: Tomas Duffy, CEO & President Teligent AB Tel. +46-(0)8 410 172 76 tomas.duffy@teligent.se Jan Bengtsson, CFO Teligent AB Tel. +46-(0)8 410 172 52 jan.bengtsson@teligent.se


 

Oslo (2007-03-29): Yara published today its complete 2006 Annual Accounts with notes. The accounts are available on Yara's website http://www.yara.com/en/investor_relations/financial_reports/index.html Contact Torgeir Kvidal, Investor Relations Telephone (+47) 24 15 72 95 Cellular (+47) 91 339 832 E-mail torgeir.kvidal@yara.com Hamed Brodersen, Media Relations Cellular (+47) 40 468 110 E-mail hamed.mozaffari.brodersen@yara.com Yara International ASA is a leading chemical company that converts energy and nitrogen from the air into essential products for farmers and industrial customers. As the number one global supplier of mineral fertilizers and agronomic solutions, we help provide food for a growing world population. Our industrial product portfolio includes environmental protection agents that safeguard air and water purity and preserve food quality. Yara's global workforce of 6800 employees represents great diversity and talent enabling Yara to remain a leading performer in its industry. www.yara.com


 

Lindab, provider of ventilation and construction systems, is expanding into Russia. A manufacturing unit for the Ventilation business area is now open for business in the St Petersburg region. In order to meet the increased demand from the Russian market, Lindab's operations are being boosted with local manufacturing. The St Petersburg unit is Lindab's first step in local manufacturing in Russia. The Profile business area will follow suit with a production unit for Building Systems to be ready during the second quarter of 2008. "Local production has many advantages compared to importing products from Lindab's other European factories, says Lindab's Business Area Manager for Ventilation, Hannu Paitula. "Being present locally is also a prerequisite to forging customer relations and obtaining the strong position that we strive for" The location of the new manufacturing unit, approximately 30 km northwest of St Petersburg and close to the new ring road, provides quick access to other growth areas, including Moscow. The organisation is under development but 30 employees have already been recruited. The ventilation market in Russia is growing rapidly at a rate of 10 - 15 % annually. "We want to be part of this development phase and believe that we have a lot to offer, thanks to our experience from the demanding Nordic market," says CEO Kjell Åkesson. "We provide energy-efficient systems that generate a comfortable indoor climate both in summer and winter. The large number of international companies now setting up in St Petersburg and other parts of Russia leads to increasing demands on the construction quality, including ventilation, which is good news for us." Ends Contacts: LINDAB Kjell Åkesson, CEO Email: kjell.akesson@lindab.com Tel. +46 (0)431 850 00 Hannu Paitula, Business Area Manager - Ventilation Mobile: +41 797392388 Anders Persson, HR & IR director Mobile: +46 705185129 About Lindab: Lindab is an international group that develops, manufactures and markets sheet metal products and system solutions for the construction sector. The two business areas, Profile and Ventilation offer complete solutions for construction systems and indoor climate, as well as individual construction and ventilation components for all types of buildings. Lindab is listed on the Stockholm Stock Exchange, Nordic Mid Cap under the ticker "LIAB". The Lindab group has approximately 4,900 employees in 29 countries and generated sales of SEK 7,609 million in 2006. Its head office is located in Grevie near Bastad in southwestern Sweden. For more information visit www.lindab.com


 

Hamburg, Germany | Oxford, UK - Evotec AG (Frankfurt Stock Exchange: EVT) today reported financial results for the year ended 31 December 2006. Total Group revenues increased by 6% to ¤84.7m and net income improved to ¤-32.5m (2005: ¤-33.6m). Following the divestment of Evotec Technologies GmbH to PerkinElmer effective 1 January 2007, this release focuses on the financials of the two continuing business segments of Evotec only, Services Division and Pharmaceuticals Division (defined as 'continuing business' or 'the Group'). The financials of the discontinued segment of Evotec Technologies (ET) are reported in Evotec's Annual Report 2006. The gain from the divestment will be reported in the Q1 2007 financial statements. Evotec Group revenues of the continuing business increased by 5% to ¤67.4m (2005: ¤64.1m). The Services Division contributed growth of 5% to ¤64.3m (2005: ¤61.0m) due mainly to strong performances from the manufacturing and formulation services and a milestone payment. This is particularly satisfying because the increased focus on results-based collaborations with downstream elements means that the Company is foregoing some short-term revenues (lower direct R&D funding in exchange for later milestones and potentially royalties). The revenues of the Pharmaceuticals Division are predominantly a result of the ongoing collaboration with Takeda, and at ¤3.2m, are in line with those achieved in 2005 (2005: ¤3.2m). The net loss of the continuing business increased to ¤36.3m (2005: ¤31.2m), the operating loss to ¤36.8m (2005: ¤33.0m). The vast majority thereof arises from the Pharmaceuticals Division reflecting Evotec's focused investments in its proprietary research programmes. Total R&D expenses increased markedly to ¤30.3m (2005: ¤9.3m) mainly due to the commencement and support of various clinical trials including the two Phase II studies with EVT 201. This higher R&D spend as well as higher SG&A costs as a result of the transaction costs related to the divestment of ET and costs for a strategic and operational business review by an external consulting firm were not fully offset by improved gross profit, lower other operating costs and significantly lower amortisation and impairment in 2006. In total, impairment charges and regular amortisation amounted to ¤9.2m in 2006, compared to ¤27.1m in 2005. The majority of the large 2005 amount was related to the acquisition of ENS. In 2006, as a result of the Company's regular impairment review, a non-cash intangible asset impairment charge of ¤6.6m and a non-cash tangible asset unimpairment benefit of ¤0.6m were recognised. The operating profit before amortisation and impairment of the Services Division improved by 69% to ¤2.5m (2005: ¤1.5m), underlining its solid operational performance. 2006 Highlights: * CNS pipeline approaching significant value inflection point for insomnia candidate EVT 201 * Second Phase I/II study confirmed positive findings of the previous study * Two Phase II patient studies started in the US with results expected in Q3 2007 * Successful completion of Phase I studies with Alzheimer/Pain candidate EVT 101 * Reset focus on EVT 302 for smoking cessation after discontinuation of Phase I of EVT 301 * Milestone payments received from Takeda and Boehringer Ingelheim * Signed global alliance with Roche to jointly discover novel drugs * Evotec Technologies sold to PerkinElmer for ¤23m, sharpening Evotec's focus on its core business "We are proud to report a very successful financial year 2006. We overachieved on our revenue target of 0% to 5% growth and met all other financial guidance given for the Group in March 2006. In line with the Company's strategy and projections, we significantly ramped up our R&D activities in the Pharmaceuticals Division and continued to manage our services business for profitability and cash generation, with positive operating income before amortisation and impairment charges at ¤2.5m", said Jörn Aldag, President & CEO of Evotec AG. "Amongst the most significant highlights in 2006 was the progress of our insomnia drug candidate EVT 201 for which Phase II data will be reported this year. This is an important value inflection point in the development of any drug. Through the divestment of ET and a capital increase in April 2006, we have increased our liquidity substantially to ¤79m at the end of 2006 which is a very solid position to expand and further develop our pipeline." Strong cash position and balance sheet structure Cash and cash equivalents at the end of December 2006 increased to ¤78.7m (end of December 2005: ¤52.2m) due mainly to the divestment of Evotec Technologies and the capital increase in April 2006. Evotec's strong equity ratio reduced only temporarily to 67% (2005: 80%) due to accounting of the prepayment received from the divestment of this business. Outlook The pharmaceutical industry is facing significant challenges. High revenues historically enjoyed by companies from blockbuster drug sales are increasingly in jeopardy due to expiring patents, whilst at the same time the costs of developing a new drug have increased dramatically. The industry is responding to these pressures with cost reductions, for example by outsourcing individual elements of traditional discovery, and with pipeline building to offset revenue losses from generic competition. Pharmaceutical companies are increasingly turning to the biotechnology industry as a prime source of new products or drug candidates - either by in-licensing or acquisitions. However, in-licensing opportunities - even at early stages of development - have become increasingly scarce and licensing competition has driven up prices of drug candidates in early clinical or late preclinical development. Companies supplying these candidates, such as Evotec, hence could benefit significantly. Evotec therefore believes that pharmaceutical companies will increase levels of outsourcing and will focus more on early stage external sources of innovation. Academic institutes, often at the forefront of medical basic research, lack the robust downstream capabilities to translate their assets into value for the pharmaceutical industry. Evotec expects to benefit from this trend by playing the role of catalyst in a powerful network connecting the pharmaceutical industry and academic research, and providing drug candidates to pharmaceutical companies at various stages of development. Financial guidance On this basis Evotec continues to invest in R&D. The level of spending in its clinical development programmes is increasing as Evotec advances more drug candidates into the clinic. The Company is also ramping up its internal discovery efforts to support its results-based collaborations and organic pipeline growth to capture the increasing value of early stage projects. Evotec's Group operating result for 2007 is therefore expected to decline slightly compared to 2006. With successful out-licensing of clinical candidates and the ability to achieve milestones from collaborations, profitability could significantly improve in 2008 and/or 2009. As these revenues are subject to successful research and development activities, both results-based deals and clinical out-licensing are likely to lead to more revenue volatility in the mid-term. In 2007, Group revenues are expected to reach ¤65m to ¤70m, depending on the contribution from success-based milestone payments in the Services Division. In January 2007, the sales and order book for 2007, excluding milestones, totalled approximately ¤28m (2006: ¤27m). In the absence of any changes in financing, Evotec's liquidity position to a large degree will move in line with the operating result before amortisation or impairment. Liquidity at the end of 2007 is targeted to exceed ¤40m. Webcast / Conference Call Evotec is going to broadcast today's analyst and press conference in Frankfurt starting at 10.00 am CET (09.00 am GMT) live on the internet. The presentation will be held in English. To join the audio webcast and to access the presentation slides you will find a link on our home page www.evotec.com shortly before the event. For those who prefer to listen to the presentation via phone, please dial: From Europe: +49.(0)69.5007 1308 (Germany) +44.(0)20.7806 1956 (UK) From the US: +1.718.354 1389 The on-demand version of the webcast will be available on our website: www.evotec.com - Investors - Webcasts. Key figures of consolidated statements of operations according to IFRS Evotec AG and Subsidiaries - Continuing Business - Euro in thousands except share data and per share data +-------------------------------------------------------------------+ | | 2006 | 2005 | Change | | | | | in % | |--------------------------------+------------+------------+--------| | | | | | |--------------------------------+------------+------------+--------| | Revenues | 67,354 | 64,115 | 5.1 | |--------------------------------+------------+------------+--------| | Gross margin | 34.1% | 33.0% | - | |--------------------------------+------------+------------+--------| | | | | | |--------------------------------+------------+------------+--------| | - Research and development | 30,307 | 9,304 | 225.7 | | expenses | | | | |--------------------------------+------------+------------+--------| | - Selling, general and | 18,576 | 15,540 | 19.5 | | administrative expenses | | | | |--------------------------------+------------+------------+--------| | - Amortisation of intangible | 9,223 | 27,086 | (65.9) | | assets and impairment | | | | |--------------------------------+------------+------------+--------| | - Other operating expenses | 1,607 | 2,163 | (25.7) | |--------------------------------+------------+------------+--------| | Operating result | (36,762) | (32,965) | (11.5) | |--------------------------------+------------+------------+--------| | | | | | |--------------------------------+------------+------------+--------| | Net loss continuing operations | (36,296) | (31,212) | 16.3 | |--------------------------------+------------+------------+--------| | Net income (loss) discontinued | 3,828 | (2,371) | 261.5 | | operations | | | | |--------------------------------+------------+------------+--------| | Net loss total | (32,468) | (33,583) | (3.3) | |--------------------------------+------------+------------+--------| | | | | | |--------------------------------+------------+------------+--------| | Weighted average shares | 66,355,593 | 51,987,921 | | | outstanding | | | | |--------------------------------+------------+------------+--------| | Net loss per share | (0.55) | (0.60) | | +-------------------------------------------------------------------+ Key figures of consolidated balance sheets according to IFRS Evotec AG and Subsidiaries - Continuing Business - Euro in thousands +-------------------------------------------------------------------+ | | 31 Dec 06 | 31 Dec 05 | Change in % | |-----------------------------+-----------+-----------+-------------| | | | | | |-----------------------------+-----------+-----------+-------------| | Cash and cash equivalents | 78,723 | 52,185 | 50.9 | |-----------------------------+-----------+-----------+-------------| | Net working capital* | (10,606) | (6,769) | (56.7) | |-----------------------------+-----------+-----------+-------------| | Current and non-current | | | | | portion of loans and | 11,906 | 12,635 | (5.8) | | finance lease obligations | | | | |-----------------------------+-----------+-----------+-------------| | Stockholders' equity** | 137,176 | 148,669 | (7.7) | |-----------------------------+-----------+-----------+-------------| | | | | | |-----------------------------+-----------+-----------+-------------| | Total assets** | 205,526 | 186,111 | 10.4 | +-------------------------------------------------------------------+ *Excluding early payments received for Evotec Technologies **Including assets held for sale Contact: Anne Hennecke, Senior Vice President, Investor Relations & Corporate Communications, Evotec AG, Phone: +49.(0)40.56081-286, anne.hennecke@evotec.com --- End of Message --- Evotec AG Schnackenburgallee 114 Hamburg Germany WKN: 566480; ISIN: DE0005664809 ; Index: Prime All Share, CDAX, HDAX, MIDCAP, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Interim report for the Second Quarter of financial year 2006/2007 Second Quarter (December 2006 - February 2007) * KappAhl's net sales for the period amounted to MSEK 1,088 (1,026), an increase of 6.0 percent. * Operating profit amounted to MSEK 117 (88), an increase of 33 percent. This has been positively affected by non-recurring items of MSEK 13. * The gross margin was 57.7 percent (57.4) and the operating margin was 10.8 percent (8.6). * Profit after taxes amounted to MSEK 338 (19), which is equivalent to SEK 4.50 (0.25) per share. This has been positively affected by a tax revenue of MSEK 270. * Cash flow from operating activities totalled MSEK 104 (120). CEO comments on KappAhl's second quarter results The quarter showed continued increased sales of KappAhl's fashions. Previously we have reported that, as of this financial year, we will be focusing upon sales growth while maintaining our margins. The development of the quarter is a clear consequence of this strategy. We are above all glad for a highly successful first part to the quarter. We are also exceptionally proud of the continued improvement in profits, in which we have gone from a good position to an even better one. This is the consequence of continued sales successes and a disciplined cost development. In summary, KappAhl is continuing with its strategy of constant improvements and we now present the 18th consecutive quarter of improved profits. Christian W. Jansson President and CEO For further information, please contact Christian W. Jansson, President and CEO Tel. +46 (0)70 995 02 01 Håkan Westin, CFO Tel. +46 (0)70 471 56 64 KappAhl is a leading Nordic fashion chain with approximately 270 stores in Sweden, Norway, Finland and Poland. We design, market and sell clothes for the entire family but focus in particular on women between 30 and 50 years of age, shopping for the whole family. KappAhl's head office and distribution centre, which handles the distribution of goods to all stores, is located in Mölndal, just outside Gothenburg. KappAhl employs approximately 3,700 individuals, more than 90 percent of whom are women. During the financial year 2005/2006, KappAhl had sales of SEK 4.2 billion, with an operating profit of MSEK 530. KappAhl shares are listed on the Stockholm Stock Exchange. Further information about the company is available on www.kappahl.com and financial information is available on www.kappahl.com/ir. The full report with tables can be downloaded from the following link:


 

- Strategic focus on asset management, brokerage and corporate finance - SFBC investigation from December 2006 closed - Dividend increase from CHF 2.00 to CHF 5.00 per registered share proposed Bellevue Group AG generated a profit from continuing operations of CHF 101.1 million in 2006, an increase of 82.1% over the comparable year-ago figure of CHF 55.5 million. Net profit from discontinued operations amounted to CHF 22.8 million (CHF 8.3 million in the previous year), resulting in total profit of CHF 123.8 million before minorities and a net profit of CHF 120.1 million attributable to Bellevue Group shareholders. Group profit from continuing operations excluding non-recurring other income amounted to CHF 61.8 million, an increase of 37.8% over the comparable previous-year figure of CHF 44.9 million. The Board of Directors will propose an increase in the dividend per registered share from CHF 2 to CHF 5 at the annual general meeting on May 11, 2007. Bellevue Group AG is now focused on the business areas of asset management, brokerage and corporate finance. A comparison with the prior year is further complicated by the fact that in the 2005 fiscal year Bank am Bellevue AG and Bellevue Asset Management AG were consolidated for only the final quarter of the year. Bellevue Group's total operating income for 2006 amounted to CHF 151.0 million (CHF 87.1 million in the previous year). Fee and commission income was the largest source of income. Net fees and commissions increased from CHF 57.5 million to CHF 106.8 million, of which fees and commissions for brokerage and corporate finance services accounted for CHF 63.7 million, up from CHF 36.1 million in 2005. The second-largest component of commission income was asset management fees, which advanced 77.6% to CHF 20.7 million. Performance fees in the asset management business contributed CHF 16.9 million to overall net fee and commission income (CHF 5.5 million in 2005). As a consequence of the Group's operational realignment, net interest income fell from CHF 9.0 million in 2005 to CHF 2.4 million in 2006 and trading income declined from CHF 10.0 million to CHF 2.5 million. "Other income" amounted to CHF 39.2 million (previous year: CHF 10.6 million). This item consisted of CHF 17.4 million in gains on the sale of financial assets and proceeds of CHF 20.7 million on the sale of the 52.5% interest in Swissfirst Bank (Liechtenstein) AG. Total operating expenses increased by 30.1% to CHF 31.4 million in 2006 (previous year: CHF 24.1 million). The cost/income ratio declined from 31.5% to 28.1%. Depreciation of tangible fixed assets and intangible assets plus impairments, provisions and losses added up to CHF 8.2 million (CHF 2.3 million in the previous year). Assets under management at year-end totalled CHF 6,771 million compared to CHF 10,914 million in the previous year. The change consists of net new money of CHF 65 million and the deconsolidation of CHF 2,076 million in assets following the sale of the private banking activities in Liechtenstein and Basel and another CHF 2,237 million due to the divestment of the private banking activities (Swissfirst Bank AG) in Zurich and Zug as of 2007. Shareholders' equity of the Bellevue Group amounted to CHF 394.2 million at the end of December 2006 (+25% from CHF 315.5 million at year-end 2005). Proceeds from the sale of Swissfirst Bank AG are not yet reflected in this figure. Return on equity in 2006 based on consolidated profit attributable to Bellevue Group shareholders (CHF 120.1 million) was 33.8% (2005: 28%). The past year was dominated by Bellevue Group's strategic reorientation. All private banking activities were sold off last year in three separate transactions: On November 8, 2006 Swissfirst Bank (Liechtenstein) AG was sold to a group of shareholders headed by its Board Chairman, on December 8, 2006 the private banking operations in Basel were sold to Adler Bank, and January 3, 2007 marked the closing date of the sale of Swissfirst Bank AG, with operations in Zurich and Zug, to Bank Pasche S.A. The withdrawal from private banking will be reported separately as discontinued business operations in the 2006 accounts and will no longer be consolidated. This will have a material impact on the 2006 financial statements of Bellevue Group under IFRS. Financial calendar: Results for the first quarter of 2007 April 20, 2007 Annual General Meeting 2007 May 11, 2007 For further information please contact: Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht Anja Stubenrauch, Tel. +41 (44) 267 67 00, as@bellevue.ch Income Statement 2006 2005 Continued business CHF 1'000 CHF 1'000 Net interest income Interest and discount income 2'598 10'756 Dividend income 3'221 2'183 Interest expenses -3'425 -3'970 Subtotal: Net interest income 2'394 8'969 Net commission and service fee income Commission income from lending activities 0 33 Commission income from securities and investment business 105'806 55'385 Commission income from other services 1'765 2'446 Commission expenses -753 -373 Subtotal: Net commission and service fee income 106'818 57'491 Net trading income Securities trading 1'722 7'537 Foreign exchange trading 794 2'496 Subtotal: Net trading income 2'516 10'033 Other ordinary income Real estate income 0 112 Income from associated companies 20'710 0 Income from sale of financial investments 17'351 8'744 Other ordinary expenses -11 -1'473 Other ordinary income 1'172 3'265 Subtotal: Other ordinary income 39'222 10'648 NET OPERATING INCOME 150'950 87'141 Operating expenses Personnel expenses -19'841 -13'756 Other operating expenses -11'512 -10'350 Depreciation and amortization on fixed assets -320 -265 Depreciation and amortization on intangible fixed assets -7'011 -2'131 Valuation adjustments, provisions and losses -831 78 TOTAL operating expenses -39'515 -26'424 Result of continued business before taxes 111'435 60'717 Taxes -10'367 -5'203 Result of continued business after taxes 101'068 55'514 Discountinued Business Result of discountinued business before taxes 28'863 9'158 Taxes -6'086 -838 Net result of discountinued business 22'777 8'320 Group net profit 123'845 63'834 Attribuable to: Shareholders of Bellevue Group AG 120'046 59'719 Minorities 3'799 4'115 Earnings per share of continued business 9.68 5.44 Earnings per share of discontinued business 1.86 0.58 Diluted earnings per share of continued business 9.63 5.40 Diluted earnings per share of discontinued business 1.85 0.58 Balance Sheet 31.12.2006 31.12.2005 CHF 1'000 CHF 1'000 Assets Cash 112'316 317'267 Due from banks 245'927 485'687 Due from customers 32'494 371'940 Securities trading portfolios 19'920 80'287 Derivative financial instruments 2'516 43'371 Financial investments 186'340 196'223 Associated participations 0 1'383 Fixed assets 285 22'292 Intangible fixed assets 72'999 79'558 Goodwill 160'289 160'289 Prepaid expenses and accrued income 1'292 2'941 Current tax assets 459 18'450 Other assets 1'885 5'066 Discountinued assets 444'366 0 Total assets 1'281'088 1'784'754 Total liabilities and shareholders' equity Due to banks 5'269 92'830 Due to costumers 303'687 910'779 Derivative financial instruments and other trading liabilities 148'352 189'242 Debt issued 0 150'000 Deferred income 9'909 29'076 Other liabilities 21'836 43'619 Current tax liabilities 6'864 5'539 Deferred tax liabilities 14'795 18'939 Provisions 2'301 7'062 Discountinued liabilities 373'826 0 Total liabilities 886'839 1'447'086 Share capital 1'050 1'050 Treasury shares 3'609 1'351 Capital reserve 27'250 27'250 Retained earnings 362'340 285'888 Equity attribuable to shareholders of Bellevue Group AG 394'249 315'539 Minority interests 0 22'129 Total equity 394'249 337'668 Total liabilities and shareholders' equity 1'281'088 1'784'754 Segment Reporting 1.1. - Private Asset Investment Banking Corporate Items Total 31.12.2006 Banking Management CHF 1'000 CHF 1'000 CHF 1'000 CHF 1'000 CHF 1'000 Net operating 71'443 38'362 216'811 income 68'112 38'894 Operating -31'983 -16'908 -6'314 -66'074 expenses -10'869 Services from/to other 187 3'570 0 business -4'182 425 units, net Gross operating 31'947 28'450 54'722 35'618 150'737 profit Depreciation, valuation adjustments, -3'084 -2'681 -4'674 0 -10'439 provisions and losses Taxes -10'192 904 -16'453 -6'086 -1'079 Minority -3'799 interests -3'425 -374 0 0 Profit after 39'856 36'522 120'046 taxes 19'352 24'316 Total assets 444'366 396'242 426'909 1'281'088 13'571 Total 373'826 342'778 168'019 886'839 liabilities 2'216 Total 743 870 investments 116 11 0 Assets under 2'237 mn 4'039 mn 2'732 mn 0 mn 9'008 mn Management The Private Banking represents the discountined business. 1.1. - 31.12.2005 CHF 1'000 CHF 1'000 CHF 1'000 CHF 1'000 CHF 1'000 Net operating 62'514 3'521 118'103 income 30'963 21'105 Operating -17'560 -17'362 -164 -41'666 expenses -6'580 Gross operating 13'403 14'525 45'152 3'357 76'437 profit Depreciation, valuation adjustments, -4'244 -214 -2'116 12 -6'562 provisions and losses Taxes -2'772 -1'318 -6'041 -838 -1'113 Minority -4'115 interests -2'565 -1'545 -5 0 Profit after 40'259 2'051 59'719 taxes 5'756 11'653 Total assets 474'181 1'222'560 11'221 1'784'754 76'792 Total 424'804 896'093 18'672 1'447'086 liabilities 107'517 Total 153'562 241'521 investments 241 87'718 0 Assets under 2'849 mn 4'906 mn 3'085 mn 74 mn 10'914 Management mn --- End of Message --- Bellevue Group AG Seestrasse 16, Postfach Küsnacht/Zürich Switzerland WKN: A0LG3Z; ISIN: CH0028422100; Index: SPI, SPIEX, SSCI; ;


 

Please, find enclosed the press release issued, today, by RHJ International announcing Leonhard Fisher to join as Co-Chief Executive Officer. RHJ International (Euronext: RHJI) is a diversified holding company focused on creating long-term value for its shareholders by acquiring and operating businesses in attractive industries in Japan and elsewhere. For further information visit www.rhji.com . Arnaud Denis Investor Relations Director RHJ International Tel. +32 2 643 60 13 http://www.rhji.com


 

TORONTO, ONTARIO -- (MARKET WIRE) -- March 28, 2007 -- Nortel(1) Networks Corporation (TSX: NT)(NYSE: NT) (the "Company") today announced the closing of the previously announced offering of US$1.15 billion aggregate principal amount of senior unsecured convertible notes (the "Notes") to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and in Canada to qualified institutional buyers that are also accredited investors pursuant to applicable Canadian private placement exemptions. As previously announced, the Notes issued by the Company consist of US$575 million principal amount of Senior Convertible Notes due 2012 (the "2012 Notes") and US$575 million of Senior Convertible Notes due 2014 (the "2014 Notes"), which principal amounts include Notes issued pursuant to the exercise in full of the over- allotment options granted to the initial purchasers. The 2012 Notes pay interest semi-annually at a rate per annum of 1.75% and the 2014 Notes pay interest semi-annually at a rate per annum of 2.125%. The Notes are fully and unconditionally guaranteed by the Company's principal direct operating subsidiary, Nortel Networks Limited, and initially guaranteed by the Company's indirect subsidiary, Nortel Networks Inc. The Notes are senior unsecured obligations and will rank pari passu with all other senior obligations of the Company. The 2012 Notes and 2014 Notes are each convertible into common shares of the Company at any time based on an initial conversion rate of 31.25 common shares per $1,000 principal amount of Notes (which is equal to an initial conversion price of $32.00 per common share), in each case subject to adjustment in certain events. The Company expects that the net proceeds from the sale of the Notes will be approximately US$1.125 billion and plans to use these net proceeds to redeem on or about September 1, 2007 at par a corresponding amount of its US$1.8 billion outstanding principal amount of 4.25% Convertible Notes due 2008. Pending this redemption, the Company plans to invest the net proceeds in money market instruments. The Notes and related guarantees and any common shares issuable upon conversion of the Notes have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold unless so registered except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable securities laws in other jurisdictions. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes and related guarantees or common shares issuable upon conversion of the Notes nor shall there be any sale of the Notes and related guarantees or common shares issuable upon conversion of the Notes in any jurisdiction in which such offer, solicitation or sale is unlawful. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act. (1) Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks.


 

The DSM Annual General Meeting of Shareholders on 28 March 2007 passed a resolution to declare a dividend for 2006 of EUR 1.00 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.33 per ordinary share having been paid on 11 August 2006, the final dividend for 2006 will amount to EUR 0.67 per ordinary share. This final dividend will be payable to shareholders on the number of ordinary DSM shares held by them on 29 March 2007 at close of business. This final dividend of EUR 0.67 will be paid out entirely in cash, after deduction of 15% dividend tax, and will be made payable from 27 April 2007. The ex-dividend date on Eurolist by Euronext Amsterdam will be 30 March 2007. The record date is 3 April 2007. Holders of registered shares listed in the register of shares kept by ANT will be informed by ANT about the payment to which they are entitled. Holders of bearer shares held in a securities account will receive the final dividend through their bank or broker in whose custody the shares are held on 29 March 2007. The dividend will be made payable to them through the intermediary of ABN AMRO Bank N.V. in Amsterdam (Netherlands). ABN AMRO Bank N.V. is offering all DSM shareholders the option to participate in the dividend reinvestment plan (DRIP). For further information on the programme see the Investors website at www.dsm.com. DSM DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over ¤8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com. For more information: DSM Corporate Communications DSM Investor Relations Elvira Luykx Dries Ausems tel. +31 (0) 45 tel. +31 (0) 45 5782864 5782035 fax +31 (0) 45 5782595 fax +31 (0) 45 e-mail 5740680 investor.relations@dsm.com e-mail media.relations@dsm.com


 

At SEB's Annual General Meeting (AGM) this Wednesday the board members Annika Falkengren, Penny Hughes, Urban Jansson, Tuve Johannesson, Hans-Joachim Körber, Jesper Ovesen, Carl Wilhelm Ros, Jacob Wallenberg and Marcus Wallenberg were re-elected. Steven Kaempfer was elected new member of the Board. The AGM re-elected Marcus Wallenberg as the Chairman of the Board. At the statutory Board Meeting following the AGM, Jacob Wallenberg and Tuve Johannesson were elected Deputy Chairmen. It was resolved that Directors' fees were unchanged at SEK 8.07m to be distributed by SEK 2.6m (2.6) to the Chairman of the Board, SEK 3.67m (3.67) to the other Directors elected by the AGM with SEK 530,000 each to the Deputy Chairmen and SEK 435,000 each to other board members. For committee work, the AGM resolved a total fee of SEK 1.8m split between SEK 460,000 to the Chairman and SEK 290,000 to other member of the Risk & Capital Committee and SEK 350,000 each to the Chairmen and SEK 175,000 each to other members of the Audit & Compliance Committee and the Remuneration & HR Committee. No fee for committee work is distributed to the Chairman of the Board and employees of the Bank. The dividend was approved at SEK 6.00 per share (4.75), with a record date of 2 April, 2007. The AGM approved the Board's proposal for principles for remuneration to the President and the other members of the Group Executive Committee as well as a new share-based long-term incentive programme for 2007. The programme, which is based on performance shares, has the same structure and conditions as the 2006 programme. In the Chairman's presentation of these two proposals, he stressed the importance of having a competitive total compensation encompassing base salary, short-term incentive compensation, long-term incentive program as well as pension and benefits. In 2006 short-term incentive compensation amounted to around 20 per cent of the total staff costs in SEB. The AGM also decided on the acquisition and sale of own shares in accordance with the Board's proposal. The decisions of the AGM can be read in full at www.sebgroup.com. At the Board Meeting it was also, within the mandate from the AGM, decided to sell 2,600,000 of the bank's holdings of own A-shares. The sale is taking place as a result of the review of the hedging arrangement of SEB Group's long-term incentive program. It was furthermore decided to mandate the Risk & Capital Committee of the Board to decide on further acquisitions and sales of own shares according to the AGM mandate. The sale, which starts shortly, will be transacted at the Stockholm Exchange within the "spread", and transactions will be reported through the Stockholm Exchange in accordance with existing regulations. In addition, SEB's web site (www.sebgroup.com) will be regularly updated. The total amount of shares in SEB is 687 156 631, of which 663 004 123 Class A shares and 24 152 508 Class C shares. On March 26, SEB had 7 483 033 Class A shares as hedging arrangement of the long-term incentive program. The SEB Group is a North European financial group for 400,000 corporate customers and institutions, and 5 million private customers. SEB has local presence in the Nordic and Baltic countries, Germany, Poland, the Ukraine and Russia and has a global presence through its international network in another 10 countries. On 31 December 2006, the Group's total assets amounted to SEK 1,934bn while its assets under management totalled SEK 1,262bn. The Group has about 20,000 employees. Read more about SEB at www.sebgroup.com. ___________________________________ For further information, please contact: Ulf Grunnesjö, Head of Investor Relations, +46 8 763 85 01, +47 70 763 85 01 Elisabet Linge Bergman, acting Press Officer, +46 8 763 88 04, +47 70 604 40 96


 

Today, the General Meeting of Shareholders appointed Mr Stephan B. Tanda as Member of the Managing Board of DSM as of 1 May 2007. Stephan Tanda (41) was born in Innsbruck, Austria. He studied mechanical and plastics engineering at the University of Leoben, Austria, and Business Administration at the Wharton Business School of the University of Pennsylvania, USA. Stephan Tanda started his career in 1991 with DuPont in Switzerland. From 1993 he had several responsibilities with DuPont in the USA and Luxembourg. In 2000 he became President of Protein Technologies International, Inc. and later President and CEO of The Solae Company (USA). The Solae Company is a Joint Venture between DuPont and Bunge in the area of food innovation and food ingredient manufacturing. Since 2004 Stephan Tanda was President and CEO of Freudenberg Nonwovens, Weinheim (Germany) and Durham (USA). DSM DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa and the Americas. More information on DSM can be found at www.dsm.com. More information: DSM Corporate Communications DSM Investor Relations Elvira Luykx Dries Ausems tel. +31 (0) 45 tel. +31 (0) 45 5782864 5782035 fax +31 (0) 45 5782595 fax +31 (0) 45 e-mail 5740680 investor.relations@dsm.com e-mail media.relations@dsm.com


 

Latest Release Integrates Next Generation Technology for Security Scanning, Patch Management and Network Auditing Within a Single Solution LONDON -- (MARKET WIRE) -- 03/28/07 -- GFI Software, an international developer of network security, content security and messaging software, announced today the release of GFI LANguard Network Security Scanner (N.S.S.) 8, the latest version of its award-winning solution that addresses the three pillars of vulnerability management: security scanning, patch management and network auditing in one integrated solution. GFI LANguard N.S.S. 8 is an essential, cost-effective solution for businesses to safeguard their systems and networks from hacker attacks and security breaches. GFI LANguard N.S.S. 8 scans the entire network for over 15,000 vulnerabilities, identifies all possible security issues and provides administrators with the tools they need to detect, assess, report and remediate any threats before hackers do. Having to deal with problems related to vulnerability issues, patch management and network auditing separately, at times using multiple products, is a major concern for administrators. Not only do they have to install, learn to use and manage multiple solutions but their time is mostly spent trying to understand where the problems are instead of actually addressing the threats that may be present. Using a single console with extensive reporting functionality, GFI LANguard N.S.S.'s integrated solution helps administrators address these issues faster and more effectively. What's new in GFI LANguard N.S.S. 8? The latest version of GFI LANguard N.S.S. has over 2,000 new vulnerability checks -- using SANS top 20 and Open Vulnerabilities Assessment Language (OVAL) security definitions -- over and above the vulnerabilities which are discovered through its inbuilt vulnerability assessment functionality. OVAL is an international information security community standard that is backed by the U.S. Department of Homeland Security, and this is the first time that this technology is being made available to small and medium businesses (SMBs) as OVAL is mainly offered in enterprise level solutions. The latest version of GFI LANguard N.S.S. responds to a number of specific customer requests over the past year, according to Andre Muscat, Director, Network Security Products, GFI. "We listened to feedback and are thrilled to present an updated product that will undoubtedly be well-received by our customers," said Andre. "Together with the technology advancements implemented such as support for OVAL and the SANS top 20, this latest version combines years of user experience and vulnerability management technology into one modestly priced solution." Apart from more extensive vulnerability scanning capabilities, GFI LANguard N.S.S. also has a performance enhanced scanning engine, additional patch management functionality and a highly intuitive graphical threat level indicator. The latest version has received a variety of patch management improvements including added support to rollback Microsoft patches as well as technology to automatically download new Microsoft security patches when made available. It also supports scanning for vulnerabilities on Windows Vista-based systems. As part of the launch, GFI LANguard N.S.S. 8 also includes a ReportPack add-on with over 30 customizable reports, which automatically generate graphical IT and management-level reports based on data collected during security scans. About GFI GFI is a leading software developer that provides a single source for network administrators to address their network security, content security and messaging needs. With award-winning technology, an aggressive pricing strategy and a strong focus on small-to-medium sized businesses, GFI is able to satisfy the need for business continuity and productivity encountered by organizations on a global scale. Founded in 1992, GFI has offices in Malta, London, Raleigh, Hong Kong, Adelaide, Hamburg and Cyprus which support more than 160,000 installations worldwide. GFI is a channel-focused company with over 10,000 partners throughout the world. GFI is also a Microsoft Gold Certified Partner. More information about GFI can be found at http://www.gfi.com. All product and company names herein may be trademarks of their respective owners. For more information: Please email David Kelleher davidk@gfi.com GFI Software Ltd Malta: Tel: +356 21382418 Fax: +356 21382419 URL: www.gfi.com


 

LAS VEGAS, March 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Pharmaplaz, Ltd., a private Irish healthcare company, announced today they have a collaboration to develop and commercialize SP-01A, an "oral" HIV entry inhibitor that has demonstrated safety and efficacy in Phase II human clinical trials. Under the terms of the agreement, Samaritan is to receive $10 million upfront in two tranches. The first funding of $1.4 million was received by Samaritan, and a remaining $8.6 million is payable on September 16, 2007. Pharmaplaz will be responsible for clinical development, clinical trial costs and manufacturing. Upon successful commercialization, Samaritan and Pharmaplaz will co-market SP-01A and will share 50-50 in its revenue royalty stream. Samaritan, in looking at costly Phase III clinical trials, decided to partner its lead HIV drug SP-01A to allow Samaritan's resources to be allocated to the development of numerous late-stage preclinical programs, with the objective of achieving FDA investigational new drug (IND) status for several drugs. Samaritan intends to focus its efforts on developing and commercializing its promising blockbuster drugs in order to maximize valuations with potential partnering deals. Samaritan's current plans include moving its Alzheimer's drug SP-233 forward so it can advance its IND application to commence a Phase I clinical trial; and to move ahead with late-stage preclinical trials for its acute-care cardiovascular disease drug, SP-1000 and its "oral" Hepatitis C drug, SP-10. Dr. Greeson, CEO of Samaritan Pharmaceuticals stated, "Samaritan and Pharmaplaz have had a working relationship for five years now. They have a proven track record in pharmaceutical research, drug development, regulatory affairs, and clinical trial manufacturing. Through the years, we have grown to respect and trust them. We believe this is going to be an excellent partnering relationship and anticipate doing great things together to make SP-01A a viable affordable drug for suffering HIV patients." Michael J. Macken, CEO of Pharmaplaz Ltd., commented, "Ireland has a huge commitment to the global fight against HIV. Ireland is also a major supporter of former President Bill Clinton's work to fight HIV. Our Taoiseach (Prime Minister) Bertie Ahern, while visiting our facility in Ireland, heard about our relationship with Samaritan and the development of SP-01A and commented, he hoped an Irish company would be part of finding a real and affordable cure for HIV/AIDS in sub-Saharan Africa. At Pharmaplaz, we believe this agreement lays the foundation for that." About SP-01A SP-01A is a viral replication inhibitor that acts in a dose-dependent manner by reducing the levels of the rate-limiting enzyme HMG-CoA reductase mRNA, leading to decreased intracellular cholesterol and corticosteroid biosynthesis. In a Phase I/II Proof of Concept Study, SP01A was associated with reductions in HIV-1 viral load in patients with measurable HIV-1 in a dose dependent manner. In the high dose group, mean HIV-1 viral load reduction of 1.34 log10 copies/ml was observed; 100% of the patients achieved HIV-1 viral loads below the limit of detection and a greater than 1.0 log reduction was observed in 80% of the patients by Week 8. This level of reduction in viral load is clinically relevant, particularly since patients continued on background antiretroviral therapy throughout the clinical trial. About Pharmaplaz Pharmaplaz is a fully integrated pharmaceutical company located in Athlone, Ireland. Pharmaplaz develops patented pharmaceutical technologies and products for our partners, providing access to revenue streams that are exempt from taxation on a worldwide basis -- a benefit enjoyed by all Irish-based high-technology companies. Our dynamic approach to customer requirements ensures success in all areas including initial research, process development, clinical trials, regulatory submissions and product manufacturing. Pharmaplaz Web site: www.pharmaplaz.com. Samaritan Pharmaceuticals: "We LIV....to Save Lives." Samaritan is a small-cap BioPharma, driven to commercialize its innovative therapeutics for AIDS, Alzheimer's, Cancer and Cardiovascular disease. In addition, Samaritan has acquired the marketing and sales rights to sell nine approved revenue generating products in niche overlooked territories. Look at www.samaritanpharma.com. Please register on Website so we can notify you of upcoming conference calls, and current news. http://www.samaritanpharma.com/html/videos.html The Samaritan Pharmaceuticals Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2670 Disclaimer The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Website. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K/A filed November 2, 2006. The company undertakes no duty to update forward-looking statements. CONTACT: Samaritan Pharmaceuticals, Inc. Richard Brown (702) 735-7001 rbrown@SamaritanPharma.com


 

Santhera Pharmaceuticals (SWX:SANN), a Swiss specialty pharmaceutical company with a focus on neuromuscular diseases, announced today that it has appointed Dr Cesare Mondadori to the position of Senior Vice President Research. As Head of Research, he will oversee all research activities and have responsibility for the Company's preclinical programs reporting directly to Dr Thomas Meier, Chief Scientific Officer of Santhera. "Cesare is a distinguished pharmaceutical research manager with a track record in basic research, drug discovery and preclinical drug development, particularly in the CNS area. He brings to Santhera almost 30 years of experience both in big pharmaceutical and biotech companies. His background, ranging from target discovery and assay development to in vivo pharmacology, preclinical development as well as preparation of clinical studies, will be of great value in further enhancing Santhera's preclinical organization," said Dr Thomas Meier, Chief Scientific Officer of Santhera. "It is with great pleasure that we welcome Cesare to Santhera and I am confident that he will make a significant contribution to advancing our preclinical programs in neuromuscular diseases." Dr Mondadori joins Santhera from Neuro3d, Mulhouse, France, where he was Chief Scientific Officer with responsibility for all aspects of drug discovery and development of this CNS company. Prior to this position, Dr Mondadori was Head of CNS research at Aventis (1999 to 2000) and before at Hoechst Marion Russell and Marion Merrell Dow respectively (1996 to 1999) with focus on target discovery, assay development, target validation and screening in several CNS indications. In this role he was a member of the drug innovation and approval teams as well as the scientific review committees. Dr Mondadori began his scientific career at Ciba-Geigy, Basel, Switzerland in 1978 as a research scientist in psychopharmacology. From 1981 to 1982 he was associate professor at the Department of Psychology of the University of Toronto, Canada. Dr Mondadori holds a PhD in neurosciences from the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. * * * About Santhera Santhera Pharmaceuticals (SWX:SANN) is a Swiss specialty pharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of severe neuromuscular diseases. Santhera's vision is to become a leading specialty pharmaceutical company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy. Santhera currently has four clinical-stage development programs, three of which are investigating its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's Hereditary Optic Neuropathy (LHON). The fourth clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease (DPD) in cooperation with Juvantia, the compound's owner. The most advanced program, SNT-MC17 in FRDA, is currently prepared for filing for Marketing Authorization Approval (MAA) in Europe and in Phase III clinical development in the US while the other clinical programs are in Phase II. For further information, please visit www.santhera.com. For Further Information, Contact Santhera Pharmaceuticals Thomas Meier Thomas Staffelbach Chief Scientific Officer VP Public & Investor Relations phone: +41 (0)61 906 89 87 phone: +41 (0)61 906 89 47 thomas.meier@santhera.com thomas.staffelbach@santhera.com Media Contacts: Citigate Dewe Rogerson David Dible Valerie Auffray phone: +44 207 638 95 71 phone: +44 207 638 95 71 david.dible@citigatedr.co.uk valerie.auffray@citigatedr.co.uk Disclaimer/Forward-looking Statements This news release is not and under no circumstances is to be construed as a solicitation, offer, or recommendation, to buy or sell securities issued by Santhera. Santhera makes no representation (either express or implied) that the information and opinions expressed in this news release are accurate, complete or up to date. Santhera disclaims, without limitation, all liability for any loss or damage of any kind, including any direct, indirect or consequential damages, which might be incurred in connection with the information contained in this news release. Forward-looking statements and other information contained in this release involve risks and uncertainties. Such statements reflect the current views, intentions and estimates of the Company. They are based on assumptions that may be inaccurate. Results could differ materially from those anticipated. Certain of these forward-looking statements can be identified by the use of forward-looking terminology such as "believe", "expect", "may", "are expected to", "will", "will continue", "should", "would be", "seek" or "anticipate" or by discussions of strategy, plans or intentions. Furthermore, the Company does not assume any obligation to update these forward-looking statements. --- End of Message --- Santhera Pharmaceuticals Holding AG Hammerstrasse 47 Liestal Switzerland WKN: A0LCUK; ISIN: CH0027148649; Index: SPI, SPIEX, SSCI; Listed: Main Market in SWX Swiss Exchange;


 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer PayPoint plc 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (i) 3. Name of person discharging managerial responsibilities Mark Astbury 4. State whether notification relates to a person connected with a person discharging managerial responsibilities named in 3 and identify the connected person Yes. The connected person is the RITCP Subtrust 004, a trust in relation to which Mark Astbury was beneficiary of the 54,111 shares disposed of under this transaction. 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest As per 4 above 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares Ordinary 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them Forest Nominees Limited 8 State the nature of the transaction Disposal of shares 9. Number of shares, debentures or financial instruments relating to shares acquired n/a 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) n/a 11. Number of shares, debentures or financial instruments relating to shares disposed 22 March 2007 2,631 23 March 2007 51,480 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 0.08% 13. Price per share or value of transaction 700 pence 14. Date and place of transaction 22 March 2007, London 23 March 2007, London 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 50,949 16. Date issuer informed of transaction 27 March 2007 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17 Date of grant n/a 18. Period during which or date on which it can be exercised n/a 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved (class and number) n/a 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise n/a 22. Total number of shares or debentures over which options held following notification n/a 23. Any additional information n/a 24. Name of contact and telephone number for queries Susan Court, +44(0)1707 600300 Name and signature of duly authorised officer of issuer responsible for making notification Susan Court Date of notification 28 March 2007 END ---END OF MESSAGE---


 

Notification of Substantial Shareholding Pursuant to the obligation placed on us by LR6.6.7 of the Listing Rules, we advise that on 27th March 2007 the Company received notification that Deutsche Bank AG and its subsidiary companies no longer have a notifiable interest in the Company's issued share capital. Tom Corcoran Company Secretary 27 March 2007 ---END OF MESSAGE---


 

The Annual General Meeting of Shareholders in Tomra Systems ASA will be held at the company's offices in Drengsrudhagen 2, Asker, Norway on Tuesday 17 April 2007 at 6:30 p.m. Registration starts at 6:00 p.m. Please see attached invitation with enclosures to the Annual General Meeting. A pdf-version of the 2006 Annual Report is enclosed in this announcement and will also be available on TOMRA's web page (under the Investor Relation pages on www.tomra.com), on Oslo Børs (www.newsweb.no) and on Hugin Online (www.huginonline.no). The printed version will be mailed to shareholders today. If you have questions, please contact CFO Espen Gundersen at +47 97 68 73 01. Asker, 28 March 2007 Tomra Systems ASA


 

` FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Scottish Power Plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 42p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 27 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------------+---------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------------+------------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (2) Derivatives (other than | 16,160,000 | 1.0850 | | | | options) | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (3) Options and agreements | | | | | | to purchase/sell | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | Total | 16,160,000 | 1.0850 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | | | | | | CFD | LONG | 250,000 | 799.3196 | | CFD | LONG | 400,000 | 799.3683 | | CFD | LONG | 250,000 | 801.0004 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 28th March 2007 | |-------------------------------------------------+-----------------| | Contact name | James Feast | |-------------------------------------------------+-----------------| | Telephone number | 0207 469 1901 | |-------------------------------------------------+-----------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |-------------------------------------------------+-----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

NORGANI HOTELS ASA - APPROVED ANNUAL ACCOUNTS The Board of Directors did on the 28th of March approve the final and audited accounts for 2006. The Ordinary General Assembly will be held on 27th of April 2007. The Board of Directors will propose to the General Assembly a dividend of NOK 4.00 per share. The share will be quoted ex dividend on the 30th of April 2007. The Board of Directors will also propose to the General Assembly that the Board of Directors is granted an authority to increase the share capital with an amount up to NOK 98 350 000, corresponding to approximately 10 % of the current share capital. For further information, please contact Mats Sterner, CFO Mob: +46 70 690 2009 About Norgani With a portfolio of more than 70 hotels in the Nordic region, Norgani Hotels is Europe's fifth largest hotel property investor. Through size and specialization Norgani has a knowledge of and insight in the hotel industry, creating a unique platform for development of hotel properties and business in cooperation with operators and brands. The share is listed on the Oslo Stock Exchange. www.norgani.no


 

In advance of Investment AB Kinnevik's (publ) Annual General Meeting on 10 May 2007, Kinnevik's Nomination Committee has decided to propose that Vigo Carlund, Wilhelm Klingspor, Erik Mitteregger, Stig Nordin and Cristina Stenbeck be re-elected as members of the Board of Directors. The Nomination Committee has also decided to propose that Allen Sangines Krause be elected as a new Board member. The Nomination Committee proposes Cristina Stenbeck be elected Chairman of the Board of Directors. Allen Sangines Krause is Managing Director at Goldman Sachs International in London. He currently sits on the firm's Commitments Committee with responsibility for approving all transactions and monitoring commercial and reputational risks to the firm. He has been with Goldman Sachs since 1993, based in both London and New York and has significant investment banking and senior leadership experience from emerging markets such as Latin America, Russia and other CIS countries. Mr Sangines Krause has a Ph.D. in Economics from Harvard University and a degree in Economics from Instituto Tecnologico Autonomo de Mexico. He is a Member of the Council of the Graduate School of Arts and Sciences, Harvard University. The Chairman of the Nomination Committee, Cristina Stenbeck, commented: "On behalf of the Nomination Committee I want to express my gratitude for the work that Mr Pehr G Gyllenhammar has done as Chairman over the last 3 years. Mr Gyllenhammar joined the Board after the merger between Invik and Kinnevik and has made signifycant contributions to the work of the Board of the new Investment AB Kinnevik." "I would also like to give my special thanks to Mr Edvard von Horn for the last 15 years that he has served on both of the Investment AB Kinnevik and Industriförvaltnings AB Kinnevik Boards. He has participated in the beginnings, the growth and the positive changes that these companies have experienced over the years. It is the intention that Edvard shall continue as Chairman of Mellersta Sveriges Lantbruks AB and as a director of the Board of Korsnäs AB." The Nomination Committee will also submit a proposal for the remuneration for the Board of Directors and the auditor as well as a proposal on the Chairman of the Annual General Meeting of 2007 that will be presented to the 2007 Annual General Meeting for approval. The complete proposals of the Nomination Committee along with a report of the work of the Nomination Committee will be available on the Company's website. The Nomination Committee is comprised of Cristina Stenbeck on behalf Emesco AB and other shareholders, Mats Guldbrand on behalf of AMF Pension, Wilhelm Klingspor on behalf of the Klingspor family, Mats Lagerqvist on behalf of Swedbank Robur Fonder and Tomas Nicolin on behalf of Alecta, who together represent more than 50% of the voting rights in Kinnevik. For further information, please visit www.kinnevik.se or contact: Henrik Persson, Investor Relations +46 (0) 8 562 000 87 Investment AB Kinnevik's objective is to increase shareholder value, primarily through net asset value growth. The Parent Company manages a portfolio of long-term investments in a number of listed companies such as Tele2, Modern Times Group MTG, Millicom International Cellular, Metro International, Transcom WorldWide and Invik & Co. Kinnevik plays an active role on the Boards of its listed holdings. The Company's subsidiaries are principally active in cartonboard and paper production through Korsnäs, and farming through Mellersta Sveriges Lantbruk. Investment AB Kinnevik's class A and class B shares are listed on the Stockholm Stock Exchange's Nordic list for large-cap companies within the financial and real estate sector. The ticker codes are KINV A and KINV B.


 

- Final figures for 2006: Sales over EUR 300 million for the first time, consolidated earnings up from previous year Hamburg, 28 March 2007. The wine trading group Hawesko Holding AG (HAW GR, HAWG.DE, DE0006042708) will raise its regular dividend for the past 2006 fiscal year to EUR 0.85 per share (previous year, adjusted for the 2-for-1 share split: EUR 0.70; plus a non-recurring bonus of EUR 0.30 per share). At its meeting today, the supervisory board of the company approved the corresponding dividend proposal of the management board, on which the annual general meeting will vote on 18 June 2007. The proposed increase in the ordinary dividend corresponds to a rise of 21%. The bonus dividend from the previous year was based on a non-recurring large reduction in tax expenditure resulting from a profit and loss transfer agreement between the subsidiary Jacques' Wein-Depot and the parent company. For fiscal year 2006 a total of EUR 7.5 million will be paid out to the shareholders (previous year including bonus: EUR 8.8 million). Furthermore, the supervisory board discussed and ratified the annual and consolidated group financial statements for fiscal year 2006; the parent company's annual financial statements were approved. As already reported, Group sales in 2006 rose by 5.4% to EUR 302.6 million (previous year: EUR 287.0 million). The Group's operating result (EBIT) was slightly higher than originally reported based on preliminary figures, amounting to EUR 18.6 million (previous year: EUR 18.9 million). Consolidated earnings after taxes and minority interests rose to EUR 10.8 million in 2006 (previous year: EUR 10.7 million). This corresponds to a profit per share of EUR 1.23 (previous year, comparable: EUR 1.22). The consolidated balance sheet total amounted to EUR 171.9 million (previous year: EUR 162.6 million). The free cash flow (cash flow from ongoing business activities minus investments and interest paid out) in 2006 amounted to EUR 5.6 million (previous year: EUR 17.1 million). The management board will give a detailed presentation of the results of fiscal year 2006 as well as the outlook for fiscal year 2007 on 9 May 2007 at the balance sheet press conference of Hawesko Holding AG. Hawesko Holding AG is a leading supplier of premium wines and champagnes. In fiscal year 2006 the Group achieved sales of EUR 303 million through its three sales channels - specialist wine retail (Jacques' Wein-Depot), wholesale (Wein Wolf and CWD Champagner und Wein Distributionsgesellschaft) and mail order (in particular Hanseatisches Wein- und Sekt-Kontor). The Group employs 551 people. The shares of Hawesko Holding AG are listed on the Hanseatic Stock Exchange in Hamburg as well as in the prime standard segment of the Frankfurt Stock Exchange. # # # Publisher: Hawesko Holding AG Postfach 20 15 52 20205 Hamburg, Germany Web site: http://www.hawesko.com (Company information) http://www.hawesko.de (Online shop) http://www.jacques.de (Information Jacques' Wein-Depot) Press/Media: Vera Maria Bau,VMB Public Relations Phone: +49 (0)228 44 96 240 Fax: +49 (0)228 8 44 96 E-mail: vmb-pr@t-online.de Investor Relations: Thomas Hutchinson, Hawesko Holding AG Phone: +49 (0)40 30 39 21 00 Fax: +49(0)40 30 39 21 05 E-mail: ir@hawesko.com --- End of Message --- HAWESKO Holding AG Postfach 201552 Hamburg WKN: 604270; ISIN: DE0006042708; Index: CDAX, Prime All Share, SDAX, CLASSIC All Share, GEX; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Amtlicher Markt in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

At the Annual General Meeting of Shareholders (AGM) held this afternoon, DSM announced that the company is withdrawing its proposal to introduce a loyalty dividend program. DSM is now considering other ways of achieving the program's objective. Briefly put, this objective is to reinforce the company's relationship with its shareholders and ensure better and more direct communication. This morning, the Enterprise Section of the Amsterdam Court of Appeals ruled that DSM would not be allowed to put the proposal to the AGM because, according to the Enterprise Section, the proposal was in violation of the principle of equality. Peter Elverding, chairman of DSM's Managing Board: "Contrary to our expectations, the Enterprise Section of the Amsterdam Court of Appeals has not allowed us to put the proposal to our shareholders. The Enterprise Section is of the opinion that the proposed loyalty dividend program is in violation of the principle of equality. We are therefore withdrawing the proposal. Over the past few months many of our shareholders have indicated that they support our aim of communicating with them in more direct ways. We will therefore continue to pursue this aim." A number of shareholders have already had their shares registered. DSM will inform them as soon as possible about the new situation. The company will do its utmost to mitigate any inconveniences that may arise. DSM DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over ¤8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com. For more information: DSM Corporate Communications DSM Investor Relations Nelleke Barning Dries Ausems tel. +31 (0) 45 tel. +31 (0) 45 5782864 5782017 fax +31 (0) 45 5782595 fax +31 (0) 45 e-mail 5740680 investor.relations@dsm.com e-mail media.relations@dsm.com


 

Merck & Co., Inc. and H. Lundbeck A/S announced today the discontinuation of the joint development program for gaboxadol, an investigational new medicine for the treatment of insomnia currently in phase III development. Data from recently completed clinical studies suggest that the overall clinical profile for gaboxadol in insomnia does not support further development. As a result of this new information, Merck and Lundbeck will not file a new drug application for gaboxadol for the treatment of insomnia with the U.S. Food and Drug Administration, or other regulatory agencies worldwide, and are terminating ongoing clinical studies. "The termination of our joint insomnia development program with Lundbeck is clearly disappointing," said Dr. Peter S. Kim, president of Merck Research Laboratories. "Lundbeck has been a valued partner for the past three years, and our collaboration has benefited from the strong relationship between the companies. Although Merck will not be continuing with the clinical development program for gaboxadol for the treatment of insomnia, we remain committed to our neuroscience and sleep disorders research program, one of nine priority disease areas for research and product development. As part of that commitment, we also welcome the opportunity to engage in other joint development efforts with Lundbeck in the future." "When developing new and innovative medicines there are always risks of failure, particularly for broad-based therapeutics which often carry a higher threshold for demonstrating value to physicians, and ultimately to patients," said Senior Vice President Anders Gersel Pedersen, head of development at Lundbeck. "It is clearly disappointing, but we will continue to develop new and innovative medicines to treat unmet medical needs and to seek strong and productive partnerships like the one we have experienced with Merck to maximize these efforts." Merck forward-looking statement This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2006, and in its periodic reports on Form 10-Q and Form 8-K, which the Company incorporates by reference. H. Lundbeck A/S forward-looking statement The content of this release will have no influence on the Lundbeck Group's financial guidance for 2007. The company expects a profit from operations of more than DKK 2.5 billion and an EBIT margin of 25 pct. for 2007. Teleconference Lundbeck will host a conference call today at 3:30 PM (CET, Copenhagen time) for analysts and investors. To participate in the conference call, please call one of the following call-in numbers and quote the password: UK: +44 (0) 20 7162 0125 US: +1 334 323 6203 Password: Lundbeck A replay will be available one hour after the teleconference and will be accessible for 48 hours. Please call one of the following call-in numbers and quote the access code: UK: +44 (0) 20 7031 4064 US: +1 954 334 0342 Access code: 744716 The live call and replay will also be available at: www.lundbeck.com/investor/Reportsandpresentations/Teleconference/default.asp Merck contacts Investor Contacts: Media Contacts: Graeme Bell Amy Rose Merck & Co., Inc. Merck & Co., Inc. +1 (908) 423-5185 +1 (908) 423-6537 Pam Eisele Merck & Co., Inc. +1 (267) 305-7896 Lundbeck contacts Steen Juul Jensen Vice President +45 36 43 30 06 Investors: Media: Mads Bjerregaard Pedersen Caroline Broge Investor Relations Officer Media Relations Manager +45 36 43 41 04 +45 36 43 26 38 Jacob Tolstrup Investor Relations Manager, North America +1 201 350 0187 Stock Exchange Release No 263 - 28 March 2007 About Merck & Co., Inc. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com. About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com


 

Advanced Optical and Wireless Backhaul Technologies Increase Network Capacity and Decrease Operator Costs SEOUL, KOREA -- (MARKET WIRE) -- March 28, 2007 -- LG-Nortel - the LG Electronics and Nortel(1) (TSX: NT)(NYSE: NT) joint venture - is helping SK Telecom deliver new wireless services such as wireless Internet, 3D gaming, digital home services and telematics. The LG-Nortel solution handles increased volumes of high-speed wireless traffic while significantly improving network cost-effectiveness, scalability and reliability. The solution supports wireless backhaul - the communications traffic between the cell towers and the network. The new, high-performance Metro Ethernet wireless backhaul infrastructure is already in service, and will support the optimization of over 7,000 wireless base stations nationwide, once fully deployed. The rollout enhances SK Telecom's position as Korea's largest wireless communications operator as the take up of new next-generation wireless services takes off throughout Korea. According to SK Telecom, by upgrading the existing wireless backhaul network to this next-generation Metro Ethernet solution, the company can easily and cost-effectively deliver high-speed wireless broadband services and reduce current and future wireless backhaul expenses by up to 40 percent. SK Telecom chose LG-Nortel for this large-scale investment in the future because of the company's leadership in delivering both wireless and optical solutions. SK Telecom's satisfaction with the 10G optical backbone from Nortel that has carried its advanced multimedia services for the past several years was also a key factor in that decision. The new infrastructure supports SK Telecom's existing 2G, 3G and next-generation wireless services, including current wireless multimedia offerings like multimedia messaging, satellite DMB (digital multimedia broadcasting) and WiBro. "SK Telecom's enhanced wireless capabilities lay the foundation for their customers to enjoy next-generation services, such as mobile video and streaming media. LG-Nortel's wireless backhaul solution builds on Nortel's experience and reputation, gained through meeting the needs of over 40 of the world's largest mobile operators in recent years," said Peter MacKinnon, chairman, LG-Nortel. "Leveraging both this global expertise and our ability to provide solutions that are flexible, cost-efficient and scalable is critical to LG-Nortel's increasingly important role in the rapidly evolving next-generation wireless communications environment." The components of the LG-Nortel Metro Ethernet backhaul solution for SK Telecom are the Nortel Optical Multiservice Edge (OME) 6110 and 6130 multiservice access products as well as the OME 6500 next-generation multiservice convergence platform - both part of Nortel's IP/Ethernet-centric Metro Ethernet Networks Mobile Backhaul Solutions portfolio. The small and compact OME 6110/6130 devices are used to provide the cell site concentration before the wireless traffic is transported over SONET/SDH, CWDM or Ethernet to the OME 6500 for aggregation and grooming into an efficient and scalable core. About LG-Nortel LG-Nortel is a joint venture of LG Electronics and Nortel. Established in 2005, LG-Nortel provides leading edge telecommunications equipment and network solutions, spanning wired and wireless technologies, to service provider and enterprise customers in Korea and around the world. LG-Nortel is also actively developing next generation solutions for global markets, with over 1,000 skilled R&D engineers currently focused on wireless broadband technology evolution and the development of powerful new product lines. For more information on LG-Nortel, visit www.lg-nortel.com. About Nortel Nortel is a recognized leader in delivering communications capabilities that make the promise of Business Made Simple a reality for our customers. Our next-generation technologies, for both service provider and enterprise networks, support multimedia and business-critical applications. Nortel's technologies are designed to help eliminate today's barriers to efficiency, speed and performance by simplifying networks and connecting people to the information they need, when they need it. Nortel does business in more than 150 countries around the world. For more information, visit Nortel on the Web at www.nortel.com. For the latest Nortel news, visit www.nortel.com/news. Certain statements in this press release may contain words such as "could", "expects", "may", "anticipates", "believes", "intends", "estimates", "targets", "envisions", "seeks" and other similar language and are considered forward-looking statements or information under applicable securities legislation. These statements are based on Nortel's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which Nortel operates. These statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and the actual outcome may be materially different. Further, actual results or events could differ materially from those contemplated in forward-looking statements as a result of the following (i) risks and uncertainties relating to Nortel's restatements and related matters including: Nortel's most recent restatement and two previous restatements of its financial statements and related events; the negative impact on Nortel and NNL of their most recent restatement and delay in filing their financial statements and related periodic reports; legal judgments, fines, penalties or settlements, or any substantial regulatory fines or other penalties or sanctions, related to the ongoing regulatory and criminal investigations of Nortel in the U.S. and Canada; any significant pending civil litigation actions not encompassed by Nortel's proposed class action settlement; any substantial cash payment and/or significant dilution of Nortel's existing equity positions resulting from the approval of its proposed class action settlement; any unsuccessful remediation of Nortel's material weaknesses in internal control over financial reporting resulting in an inability to report Nortel's results of operations and financial condition accurately and in a timely manner; the time required to implement Nortel's remedial measures; Nortel's inability to access, in its current form, its shelf registration filed with the United States Securities and Exchange Commission (SEC), and Nortel's below investment grade credit rating and any further adverse effect on its credit rating due to Nortel's restatements of its financial statements; any adverse affect on Nortel's business and market price of its publicly traded securities arising from continuing negative publicity related to Nortel's restatements; Nortel's potential inability to attract or retain the personnel necessary to achieve its business objectives; any breach by Nortel of the continued listing requirements of the NYSE or TSX causing the NYSE and/or the TSX to commence suspension or delisting procedures; (ii) risks and uncertainties relating to Nortel's business including: yearly and quarterly fluctuations of Nortel's operating results; reduced demand and pricing pressures for its products due to global economic conditions, significant competition, competitive pricing practice, cautious capital spending by customers, increased industry consolidation, rapidly changing technologies, evolving industry standards, frequent new product introductions and short product life cycles, and other trends and industry characteristics affecting the telecommunications industry; the sufficiency of recently announced restructuring actions, including the potential for higher actual costs to be incurred in connection with these restructuring actions compared to the estimated costs of such actions and the ability to achieve the targeted cost savings and reductions of Nortel's unfunded pension liability deficit; any material and adverse affects on Nortel's performance if its expectations regarding market demand for particular products prove to be wrong or because of certain barriers in its efforts to expand internationally; any reduction in Nortel's operating results and any related volatility in the market price of its publicly traded securities arising from any decline in its gross margin, or fluctuations in foreign currency exchange rates; any negative developments associated with Nortel's supply contract and contract manufacturing agreements including as a result of using a sole supplier for key optical networking solutions components, and any defects or errors in Nortel's current or planned products; any negative impact to Nortel of its failure to achieve its business transformation objective; additional valuation allowances for all or a portion of its deferred tax assets; Nortel's failure to protect its intellectual property rights, or any adverse judgments or settlements arising out of disputes regarding intellectual property; changes in regulation of the Internet and/or other aspects of the industry; Nortel's failure to successfully operate or integrate its strategic acquisitions, or failure to consummate or succeed with its strategic alliances; any negative effect of Nortel's failure to evolve adequately its financial and managerial control and reporting systems and processes, manage and grow its business, or create an effective risk management strategy; and (iii) risks and uncertainties relating to Nortel's liquidity, financing arrangements and capital including: the impact of Nortel's most recent restatement and two previous restatements of its financial statements; any inability of Nortel to manage cash flow fluctuations to fund working capital requirements or achieve its business objectives in a timely manner or obtain additional sources of funding; high levels of debt, limitations on Nortel capitalizing on business opportunities because of support facility covenants, or on obtaining additional secured debt pursuant to the provisions of indentures governing certain of Nortel's public debt issues and the provisions of its support facility; any increase of restricted cash requirements for Nortel if it is unable to secure alternative support for obligations arising from certain normal course business activities, or any inability of Nortel's subsidiaries to provide it with sufficient funding; any negative effect to Nortel of the need to make larger defined benefit plans contributions in the future or exposure to customer credit risks or inability of customers to fulfill payment obligations under customer financing arrangements; any negative impact on Nortel's ability to make future acquisitions, raise capital, issue debt and retain employees arising from stock price volatility and further declines in the market price of Nortel's publicly traded securities, or the share consolidation resulting in a lower total market capitalization or adverse effect on the liquidity of Nortel's common shares. For additional information with respect to certain of these and other factors, see Nortel's Annual Report on Form10-K/A, Quarterly Reports on Form 10-Q and other securities filings with the SEC. Unless otherwise required by applicable securities laws, Nortel disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (1)Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks. (1)LG-Nortel and the LG-Nortel logo are trademarks of LG-Nortel. Contacts: Nortel Bohyun Kim +82 2 2005 2128 Email: kimvo@LG-NORTEL.com Nortel Jamie Moody (972) 684-7167 Email: moodyjam@nortel.com Nortel Hyun Chul Ahn +82 2 2005 2127 Email: hcan@LG-NORTEL.com Website: www.nortel.com


 

New Converged Office Innovations Benefit Service Providers and Businesses Alike ORLANDO, FLORIDA -- (MARKET WIRE) -- March 28, 2007 -- Nortel(1) (TSX: NT)(NYSE: NT) and Microsoft Corp. are expanding their efforts to drive the widespread adoption of unified communications among businesses around the world. Building on their existing Innovative Communications Alliance (ICA), the companies plan to offer solutions that will enable service providers to deliver comprehensive unified communications services to small and medium business (SMBs) and enterprises. Nortel and Microsoft's alliance will allow carriers to host unified business communication and collaboration services for their business customers, including e-mail, instant messaging, VoIP, click-to-call, video conferencing and other multimedia services. This will enable carriers to derive greater value from their existing network investments and resources, while allowing SMBs and enterprises to benefit from unified communications without bearing the burden of purchasing, installing and managing additional network infrastructure. Nortel announced the companies' new carrier-hosted converged office solution in Orlando at Inform 2007, Nortel's carrier user group conference that is attended by more than 300 global carrier customers. "We are experiencing a dynamic restructuring of the communication landscape, transforming it from disparate computing and infrastructure networks to an integrated communication experience," said Tom Valovic, IDC's program director for VOIP Infrastructure. "New and collaborative business models involving both IT and telecom suppliers will be a major element in this transformation going forward. The Nortel-Microsoft alliance and its extension into the carrier space is an excellent example of a market response targeting new business opportunities presented by this changing landscape." "As one of the world's leading providers to both carriers and enterprises, Nortel is uniquely positioned to identify and address challenges that cross the boundary between public and private networks," said Richard Lowe, president, Carrier Networks, Nortel. "With these carrier solutions we can deliver feature-rich unified communications to small and medium-sized enterprises through the carrier partners that host their voice services today. Together Nortel and Microsoft are eliminating challenges that SMBs face when sourcing professional grade communications, by stripping the burden of complexity from the enterprise back office." Building on their existing Innovative Communications Alliance, Nortel will integrate its Communication Server 2000 (CS 2000) softswitch with the Microsoft® Solution for Hosted Messaging and Collaboration, which incorporates hosted versions of Microsoft's familiar, world-class enterprise products Microsoft Exchange, Microsoft Office Live Communications Server and Windows® SharePoint® Services. In addition, Nortel will provide a full range of convergence integration services from the Nortel Global Services portfolio that can accelerate and expedite all stages of a unified communications deployment to unify disparate modes of communication into a seamless model integrating business processes at the applications level. The companies intend to begin field trials the second half of 2007 with general availability planned by the end of the year. The integrated solutions will enable service providers to offer subscribers combined telephony, e-mail, collaboration, presence, instant messaging and desktop services. With these hosted communications solutions offerings, service providers will be able to equip SMB and enterprise workers with advanced tools such as click- to-call, as well as traditional voice communications and in/outbound dialing from their Microsoft Office Communicator desktop client. In addition, workers will be able to place and receive calls and access their calendars and contacts from their PC or desktop telephone whether they are sitting at their desk, working from their home office or from their hotel rooms while traveling. "In the anywhere, anytime world we live in, business users want easy access to all of their communications tools, regardless of location, type of device or time of day," said Michael O'Hara, general manager, Communications Sector, Microsoft. "Microsoft and Nortel, working with service providers around the globe, are making it easier than ever for businesses of all sizes to get the rich communications services they want, wherever they want, whenever they want them." Nortel's Global Services portfolio is focused on smoothing the transition to a secure, optimally converged network environment. Nortel's services lifecycle approach is focused on easing the transition to a secure, optimally converged network environment by mitigating technology and network complexity and optimizing performance throughout the lifecycle of the network. About Nortel Nortel is a recognized leader in delivering communications capabilities that make the promise of Business Made Simple a reality for our customers. Our next-generation technologies, for both service provider and enterprise networks, support multimedia and business-critical applications. Nortel's technologies are designed to help eliminate today's barriers to efficiency, speed and performance by simplifying networks and connecting people to the information they need, when they need it. Nortel does business in more than 150 countries around the world. For more information, visit Nortel on the Web at www.nortel.com. For the latest Nortel news, visit www.nortel.com/news. Certain statements in this press release may contain words such as "could", "expects", "may", "anticipates", "believes", "intends", "estimates", "targets", "envisions", "seeks" and other similar language and are considered forward-looking statements or information under applicable securities legislation. These statements are based on Nortel's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which Nortel operates. These statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and the actual outcome may be materially different. Further, actual results or events could differ materially from those contemplated in forward-looking statements as a result of the following (i) risks and uncertainties relating to Nortel's restatements and related matters including: Nortel's most recent restatement and two previous restatements of its financial statements and related events; the negative impact on Nortel and NNL of their most recent restatement and delay in filing their financial statements and related periodic reports; legal judgments, fines, penalties or settlements, or any substantial regulatory fines or other penalties or sanctions, related to the ongoing regulatory and criminal investigations of Nortel in the U.S. and Canada; any significant pending civil litigation actions not encompassed by Nortel's proposed class action settlement; any substantial cash payment and/or significant dilution of Nortel's existing equity positions resulting from the approval of its proposed class action settlement; any unsuccessful remediation of Nortel's material weaknesses in internal control over financial reporting resulting in an inability to report Nortel's results of operations and financial condition accurately and in a timely manner; the time required to implement Nortel's remedial measures; Nortel's inability to access, in its current form, its shelf registration filed with the United States Securities and Exchange Commission (SEC), and Nortel's below investment grade credit rating and any further adverse effect on its credit rating due to Nortel's restatements of its financial statements; any adverse affect on Nortel's business and market price of its publicly traded securities arising from continuing negative publicity related to Nortel's restatements; Nortel's potential inability to attract or retain the personnel necessary to achieve its business objectives; any breach by Nortel of the continued listing requirements of the NYSE or TSX causing the NYSE and/or the TSX to commence suspension or delisting procedures; (ii) risks and uncertainties relating to Nortel's business including: yearly and quarterly fluctuations of Nortel's operating results; reduced demand and pricing pressures for its products due to global economic conditions, significant competition, competitive pricing practice, cautious capital spending by customers, increased industry consolidation, rapidly changing technologies, evolving industry standards, frequent new product introductions and short product life cycles, and other trends and industry characteristics affecting the telecommunications industry; the sufficiency of recently announced restructuring actions, including the potential for higher actual costs to be incurred in connection with these restructuring actions compared to the estimated costs of such actions and the ability to achieve the targeted cost savings and reductions of Nortel's unfunded pension liability deficit; any material and adverse affects on Nortel's performance if its expectations regarding market demand for particular products prove to be wrong or because of certain barriers in its efforts to expand internationally; any reduction in Nortel's operating results and any related volatility in the market price of its publicly traded securities arising from any decline in its gross margin, or fluctuations in foreign currency exchange rates; any negative developments associated with Nortel's supply contract and contract manufacturing agreements including as a result of using a sole supplier for key optical networking solutions components, and any defects or errors in Nortel's current or planned products; any negative impact to Nortel of its failure to achieve its business transformation objective; additional valuation allowances for all or a portion of its deferred tax assets; Nortel's failure to protect its intellectual property rights, or any adverse judgments or settlements arising out of disputes regarding intellectual property; changes in regulation of the Internet and/or other aspects of the industry; Nortel's failure to successfully operate or integrate its strategic acquisitions, or failure to consummate or succeed with its strategic alliances; any negative effect of Nortel's failure to evolve adequately its financial and managerial control and reporting systems and processes, manage and grow its business, or create an effective risk management strategy; and (iii) risks and uncertainties relating to Nortel's liquidity, financing arrangements and capital including: the impact of Nortel's most recent restatement and two previous restatements of its financial statements; any inability of Nortel to manage cash flow fluctuations to fund working capital requirements or achieve its business objectives in a timely manner or obtain additional sources of funding; high levels of debt, limitations on Nortel capitalizing on business opportunities because of support facility covenants, or on obtaining additional secured debt pursuant to the provisions of indentures governing certain of Nortel's public debt issues and the provisions of its support facility; any increase of restricted cash requirements for Nortel if it is unable to secure alternative support for obligations arising from certain normal course business activities, or any inability of Nortel's subsidiaries to provide it with sufficient funding; any negative effect to Nortel of the need to make larger defined benefit plans contributions in the future or exposure to customer credit risks or inability of customers to fulfill payment obligations under customer financing arrangements; any negative impact on Nortel's ability to make future acquisitions, raise capital, issue debt and retain employees arising from stock price volatility and further declines in the market price of Nortel's publicly traded securities, or the share consolidation resulting in a lower total market capitalization or adverse effect on the liquidity of Nortel's common shares. For additional information with respect to certain of these and other factors, see Nortel's Annual Report on Form10-K/A, Quarterly Reports on Form 10-Q and other securities filings with the SEC. Unless otherwise required by applicable securities laws, Nortel disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (1)Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks. Contacts: Nortel Jamie Moody (972) 684-7167 Email: moodyjam@nortel.com Nortel Greta Brown +44 1628 432968 Email: gretab@nortel.com Website: www.nortel.com Melissa Lane (781) 782-5755 Email: melissa_lane@lpp.com


 

ZEELAND, MI -- (MARKET WIRE) -- March 28, 2007 -- Gentex Corporation (NASDAQ: GNTX), the leading supplier of automatic-dimming rearview mirrors to the worldwide automotive industry, has announced that it is shipping auto-dimming mirrors with advanced electronic features for the 2007 X3 and X5, BMW's premier sport activity vehicles. The BMW X5, sold in Europe and other select regions, now includes Gentex's SmartBeam® High-Beam Headlamp Assist Technology as a stand-alone feature, or as part of a "premium lighting" package. SmartBeam uses a miniature camera-on-a-chip combined with algorithmic decision making to automatically turn a vehicle's high-beams on and off according to surrounding traffic conditions. The system is designed to maximize a vehicle's forward lighting and to eliminate the repetitive and sometimes burdensome task of turning the high beams on and off. BMW refers to SmartBeam as High-Beam Assist, or the German translation, Fernlichtassistent. In North America, the new 2007 X5 adds Johnson Controls' HomeLink® Wireless Control System to the list of available mirror-based options. HomeLink consists of three buttons conveniently located on the face of the mirror that can be programmed to operate garage doors, estate gates, security systems, home lighting and other radio-frequency-controlled devices. The North American version of the X3, which has offered a base Gentex interior auto-dimming mirror as part of an option package since 2004, has added a digital compass feature to the mirror. The availability of driver- and passenger-side exterior auto-dimming mirrors is another feature upgrade. The three-mirror system can be purchased as part of a premium package. "The X5 is the latest in a long list of BMW vehicles to offer the proprietary SmartBeam feature that further enhances driver safety, comfort and convenience," said Gentex Senior Vice President Enoch Jen. "BMW continues to see the value of Gentex products on its vehicle line-up as evidenced by their increased availability in North America and countries around the world where BMWs are sold." Founded in 1974, Gentex Corporation (NASDAQ: GNTX) is an international company that provides high-quality products to the worldwide automotive industry and North American fire protection market. Based in Zeeland, Michigan, the Company develops, manufactures and markets interior and exterior automatic-dimming automotive rearview mirrors that utilize proprietary electrochromic technology to dim in proportion to the amount of headlight glare from trailing vehicle headlamps. Many of the mirrors are sold with advanced electronic features, and more than 96 percent of the Company's revenues are derived from the sale of auto-dimming mirrors to nearly every major automaker in the world. FINANCIAL MEDIA AND INVESTOR CONTACT: Connie Hamblin 616/772-1800 GENERAL MEDIA CONTACT: Craig Piersma 616/772-1800 WEBSITE: www.gentex.com SOURCE: Gentex


 

28 March 2007 - BP Norge AS has awarded Aker Kvaerner a service contract for provision of personnel and equipment for well intervention services for the Ula, Valhall, Hod, Tambar and Skarv fields on the Norwegian Continental Shelf. The contract is for a firm period of five years plus a two year optional period. The estimated contract value for the initial five years is NOK 175 million. The scope of work comprises mechanical wireline services, wireline tractor services and cased hole logging services. The work will be undertaken by the Aker Kvaerner subsidiary, Aker Kvaerner Well Service in Stavanger. Since the Ula field came onstream in 1986, Aker Kvaerner Well Service has provided well intervention services to BP. "The award of this contract offer the possibility for Aker Kvaerner to continue its good cooperation and working relationship with BP. Together we have built a strong and confident team within slickline, data acquisition and wireline tractor services. This new, long-term contract gives us the possibility to jointly develop and implement new intervention technologies to further enhance safety and increase operational efficiency", says Ole Petter Thomesen, president of Aker Kvaerner Well Service. ENDS For further information, please contact: Media: Siw Anett Enerud, Communication Manager, Aker Kvaerner Products & Technologies. Tel: +47 22 94 71 92 Mob: +47 951 93 415 Ole Petter Thomesen, President Aker Kvaerner Well Service. Mob.: 982 96 990 Investor relations: Lasse Torkildsen, Vice President, Aker Kvaerner, Group Comms. Tel: +47 67 51 30 39 Suppliers: For further information about sourcing and potential subcontracts for this project, please contact Bjørn E. Klepsvik, tel.: +47 22 94 51 63 Career opportunities: Visit http://www.akerkvaerner.com/Internet/CareerCentre AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. Aker Kvaerner Well Service is Aker Kvaerner's Centre of Excellence for Well Intervention technology. The company is a principle supplier of Wireline, Tractor and Cased Hole Logging Services to the technology oriented North Sea oil and gas industry. Aker Kvaerner Well Service is experienced in the management and execution of integrated well service contracts. Aker Kvaerner Well Service specialises in mechanical wireline operations and data acquisition for all cable sizes. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

(Norway) Danish TOPNORDIC AS - part of the Ementor Group, one of the leading IT infrastructure products and services suppliers in the Nordic region - has entered into an agreement to acquire dmsave AS. dmsave is a market leader within Remote Backup in Denmark and the company has offices in Århus and Copenhagen. With Remote Backup a client is installed on the customer's server, who via a WAN/internet connection performs periodic backup of all, or parts of, the customer's data. This means that if a customer server goes down, lost data can be completely restored on a new server, which in turn is delivered to the customer. This provides increased security, minimum down-time, secure data storage and frees up resources in the customer's IT department. TOPNORDIC's acquisition of dmsave will further develop and support existing hosting-business in Denmark, and create a more defined profile in the market. The strengthening and focusing of services enable TOPNORDIC to hoste also the largest companies in the country. Additionally, the acquisition opens up for an expansion of the services side of the business through and increased customer base, and for a further improvement in the quality of services delivered. Until today dmsave has been owned 50% by IBM and 50% by ITS Finans ApS, which primarily consists of the dmsave management group. The cost of the acquisition is not disclosed. "dmsave is a perfect match for TOPNORDIC. We are expanding our outsourcing department with the correct key competences, through a highly skilled and recognised partner," said Director Jan Elbæk, TOPNORDIC. The six year old business provides the most secure and flexible backup solutions in the market, and in 2005 Computerworld voted dmsave the most competent in its field. "I am looking forward to the cooperation, as the combination of dmsave's skills and TOPNORDIC's market position will be both strong and convincing," said Director Poul Bærentsen, TOPNORDIC. For more information, please contact: Jan Elbæk, Director TOPNORDIC AS Mobile +45 30 18 70 44 Rune Falstad, CFO Ementor ASA. Mobile +47 906 14 482 About Ementor The Ementor Group is the leading provider of IT infrastructure products and services in the Nordic region. The Group has approximately 3 100 employees and is strategically located in the 48 most important cities in Norway, Denmark, Sweden, Finland and Lativa and an annual revenue of approximately NOK 13 bn. The Ementor Group uses the Topnordic, Atea and Ementor brand in its business and is listed on the Oslo Stock Exchange. www.ementor.com --- End of Message --- Ementor Group PB. 6472 Etterstad Oslo Norway WKN: 884578 ; ISIN: NO0004822503; ;


 

Please find attached presentations by the Executive Management Team in Aker Yards held at the company's Capital Markets Day 28 March 2007. ENDS For further information, please contact: Aker Yards ASA: Tore Langballe, Senior Vice President, Communications & IR, phone +47 90 77 78 41 Elise Heidenreich, Investor Relations Manager & Analyst, phone +47 95 14 11 47 Kristin M. Johansen, Communications Manager, phone +47 45 41 11 04 Aker Yards ASA is an international shipbuilding group focusing on sophisticated vessels. The Group has a strong position both in terms of innovation, product range, technology, experience and capacity. The product range includes cruise vessels & ferries, merchant vessels, offshore & specialized vessels. Aker Yards comprises 17 yards in Brazil, Finland, France, Germany, Norway, Romania and Ukraine. Aker Yards has approximately 20,000 employees. www.akeryards.com


 

Funds managed by Sector Omega ASA, Anfar Invest AS, Geo Innova AS, Zaragossa Invest AS, Three M AS, Richard William Donoghue, Peter Hooper, Leyline AS, Jalani AS and Økonomi og Regnskapsbistand AS, have in total sold 36,843,449 shares through a private placement of secondary shares in Wavefield Inseis ASA (the "Selling Shareholders"). All the shares were sold at a price of NOK 44 per share. For further details regarding the secondary sale of shares in the private placement, please refer to the company's stock exchange announcement regarding the completion of the private placement dated 28 March 2007. Following completion of the sale of 36,843,449 shares in the private placement, each of the Selling Shareholders own shares as set forth below: Speculare 2 has sold 22,733,000 shares and now owns 0 shares in Wavefield Inseis ASA. Speculare 2 is an investment fund that is under the management of Sector Omega ASA. Ole-Jacob Storvik (Board member) is an employee of Sector Omega ASA. Sector Maritime has sold 2,867,000 shares and now owns 7,487,500 shares, equal to 5.84 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Sector Maritime is an investment fund that is under the management of Sector Omega ASA. Sector Cognimetrica has sold 4,400,000 shares and now owns 4,906,500 shares, equal to 3.83 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Sector Cognimetrica is an investment fund that is under the management of Sector Omega ASA. Anfar Invest AS, a company controlled by Anders Farestveit (Chairman of the board of directors), has sold 2,800,000 shares and now owns 8,431,000 shares, equal to 6.58 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Geo Innova AS, a company controlled by Jan Bertil Gateman (Director and Senior Vice President Multi-Client projects), has sold 1,750,000 shares and now owns 5,137,000 shares, equal to 4.01 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Zaragossa Invest AS, a company in which Erik Hokholt (CFO) is a minority shareholder, has sold 908,700 shares and now owns 2,120,300 shares, equal to 1.65 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Three M AS, a company controlled by Atle Jacobsen (CEO), has sold 246,333 shares and now owns 492,667 shares, equal to 0.38 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Richard William Donoghue (Director and Vice President Marketing and Sales) has sold 246,333 shares and now owns 492,667 shares, equal to 0.38 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Peter Hooper (Vice President Operations) has sold 246,333 shares and now owns 492,667 shares, equal to 0.38 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Leyline AS, a company controlled by Mike Hodge (QHSE Manager), has sold 184,750 shares and now owns 554,250 shares, equal to 0.43 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Jalani AS, a company controlled by Jan Åge Langeland (Vice President Technical), has sold 246,000 shares and now owns 492,000 shares, equal to 0.38 per cent of the outstanding shares and votes in Wavefield Inseis ASA. Økonomi og Regnskapsbistand AS, a company controlled by Erik Hokholt (CFO), has sold 215,000 shares and now owns 466,000 shares, equal to 0.36 per cent of the outstanding shares and votes in Wavefield Inseis ASA. For purpose of this Notification an outstanding share balance of 128,164,636 shares in Wavefield Inseis ASA was used to calculate the percentages. Dated: 28 March 2007


 

BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 28 March, 2007 The Annual General Meeting of Biotie Therapies Corp. was held on 28 March 2007. The General Meeting of Shareholders adopted the income statement and balance sheet including the consolidated income statement and balance sheet for the financial year 1 January 2006-31 December 2006. The General Meeting of Shareholders resolved pursuant to the proposal of the Board of Directors that the loss of the financial year, EUR 8,021,000, shall be transferred to the company's equity. The General Meeting of Shareholders discharged the members of the Board of Directors and the President and CEO from liability concerning the financial year from 1 January-31 December 2006. The number of the members of the Board of Directors was resolved to be four. Juha Jouhki, Pauli Marttila, Riku Rautsola and Piet Serrure were re-elected as the members of the Board of Directors. Janne Rajalahti, Authorized Public Accountant, and PricewaterhouseCoopers Oy, Authorized Public Accountants, were elected as auditors of Biotie Therapies Corp. At the organization meeting of the Board of Directors, convened immediately after the Annual General Meeting, Juha Jouhki was elected as the Chairman of the Board of Directors and Pauli Marttila as the deputy chairman. The General Meeting resolved pursuant to the proposal of the Board of Directors to amend the Articles of Association to better correspond to the Finnish Companies Act entered into force on 1 September 2006. The Meeting resolved on the following amendments: a) Removal of regulations concerning the amount and range of the share capital (Article 4). b) Removal of the statement regarding the tasks of the Board of Directors in the management of the company and the statement that a quorum requires the attendance of either the Chairman or the Vice Chairman (Article 5). c) Removal of the description of the President and CEO's function (Article 6). d) The right to sign for the company was changed to the right of representation as set forth in the Finnish Companies Act currently in force and removal of the statement how the Board of Directors may grant rights to sign for the company. It is noted that the Company is represented by the Chairman of the Board of Directors and the Managing Director, each alone, and two members of the Board of Directors together (Article 7). e) Section which concerns the presentation of the financial statements at the Annual General Meeting of Shareholders was amended so that the financial statements containing the consolidated financial statements and the annual report, which no longer is a part of the financial statements, will be presented at the meeting (Article 12). f) The wording of the section concerning the adoption of the financial statements was amended so that according to it the General Meeting of Shareholders shall adopt the financial statements and the consolidated financial statements instead of the previous income statement and balance sheet and the consolidated income statement and balance sheet (Article 12). The General Meeting resolved pursuant to the proposal of the Board of Directors to amend the terms and conditions of the company's convertible capital loan of 2004. Further, the General Meeting resolved to amend the terms and conditions of the 2004 and 2006 option programmes. The references in terms of both the convertible capital loan and option programmes to terms and practices under the former Finnish Companies Act, which after the amendment of the Act and the Company's Articles of Association no longer are necessary, will be removed. Further, the reference to measures to be taken pursuant to option rights in the reduction of the share capital was amended to correspond to the Finnish Companies Act in force. Furthermore, the terms and conditions were amended so that the subscription price of the shares both according to the terms and conditions of the convertible capital loan and the options may be recognised in the invested free equity fund in its entirety. The General Meeting authorised the Board of Directors to make other corresponding amendments to the terms and conditions of the convertible capital loan and option programmes without changing the number of shares to be subscribed for pursuant to the convertible capital loans or option rights or any other material terms and conditions. The General Meeting authorised the Board of Directors to resolve on the issuance of the maximum of 18,000,000 new shares in one or several instalments in a share issue or on the issuance of options or other special rights to the shares. The authorisation entitles the Board of Directors to deviate from the shareholders' pre-emptive subscription right. The authorisation is effective until 30 June 2008. PRESIDENT AND CEO'S REVIEW Timo Veromaa, President and CEO, discussed the company's operations, results and future in his review. The presentation is available on the Company's homepage at www.biotie.com. Turku, 28 March 2007 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Timo Veromaa, President and CEO, Biotie Therapies Corp. tel. +358 2 274 8901, e-mail: timo.veromaa@biotie.com www.biotie.com Distribution: Helsinki Stock Exchange Main Media


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------+--------------------------| | Company dealt in | Barratt Developments Plc | |----------------------------------------+--------------------------| | Class of relevant security to which | Ordinary Shares | | the dealings being disclosed relate | | | (Note 1) | | |----------------------------------------+--------------------------| | Date of dealing | 27th March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price paid | | securities | (Note 3) | (Note 3) | | purchased | | | |--------------------------+--------------------+-------------------| | 11,599 | 1,147.60p | 1,132.40p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |------------------------+---------------------+--------------------| | 9,379 | 1,149.60p | 1,133.80p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 28th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Robeco is to enter the Egyptian market as a strategic partner of Obelisk by means of a convertible loan. Obelisk Portfolio and Investment Fund Management SAE, an asset manager established in Cairo, was founded earlier this year by Dr. Sameh el-Torgoman, former chairman of the Egyptian stock exchange and Ahmed Khedr, portfolio manager and former CEO of Obelisk Securities in partnership with New York based Baron Group Holdings led by Ahmed Fattouh. Robeco will have the right to convert the loan into a stake of up to 49% in the new company. Obelisk will focus on active asset management in Egypt and the Middle East using managed accounts and investment funds. Robeco will launch a Luxembourg-based MENA (Middle East North Africa) equity fund, for which Obelisk will act as adviser. By financing this startup asset manager Robeco continues to promote its 'seed in emerging markets' strategy of being present in emerging markets with high expected growth. This strategy is currently focused on the Middle East, India and China. Egypt is the third Middle-Eastern country where Robeco is active. Robeco's distribution activities in the Middle East are carried out from the Bahrain office. Last year Robeco entered into a strategic alliance with Rana Investment Company in Saudi Arabia, which aims to jointly develop investment products for the Saudi market. Robeco has been active in these regions as an investor for a very long time, for example, through the Robeco Emerging Markets Equities fund. About Robeco Robeco provides discretionary asset-management products and services, as well as a complete range of mutual funds to a large number of institutional and retail clients worldwide. Robeco's product range encompasses fixed-income and equity investments, as well as balanced accounts, money-market funds and alternative investments. Robeco distributes its funds for the retail market directly, and through other financial institutions. Several of its mutual funds, including the flagship Robeco N.V., are listed on major European stock exchanges such as Amsterdam, Paris, Frankfurt and London. Robeco services its clients not only from its head office in Rotterdam but also from its European offices in Belgium, France, Germany, Spain and Switzerland. In the United States, Robeco has offices in New York, Boston, Greenbrae, Los Angeles, Honolulu and Toledo (Harbor Capital Advisors). Robeco also has an office in Bahrain and an office in Japan. Robeco is the center for asset management within the Rabobank Group and has full operational independence. The combination of the highest credit ratings from the major international rating agencies and the highest Sustainability Cluster Score within the banking sector reflects the high added value Rabobank has always offered its investors, members, clients and employees. Ronald Florisson, Robeco Corporate Communications Office: +31 - 10 - 224 28 10 Mobile: +31 - 653 - 831 586 E-mail: ronald.florisson@robeco.com


 

In accordance with a decision to change the Company's registered name, taken at the Extra General Meeting of Shareholders in Bergman & Beving AB held 22 February 2007, the Swedish Companies Registration Office (Bolagsverket) registered the change in the Articles of Association on Tuesday, 27 March. Accordingly, Bergman & Beving AB (publ) will change its name to B&B TOOLS AB (publ) as from today, 28 March 2007. "The motive for the name-change is to create a more distinct kinship between the business in TOOLS, the industrial reseller chain operated by Bergman & Beving, and the publicly traded parent company," says Stefan Wigren, President & CEO of B&B TOOLS. "The Board of Directors is of the opinion that the relationship between B&B TOOLS and TOOLS, over time, will create positive values for customers, shareholders as well as employees." Stockholm, 28 March 2007 B&B TOOLS AB (publ) For further information, contact: Stefan Wigren, President & CEO, B&B TOOLS AB, telephone +46 8 660 10 30 B&B TOOLS provides the industrial and construction sectors in Northern Europe with tools, industrial consumables and industrial components, and related services. The Group has annual revenues of approximately SEK 7.3 billion and approximately 2,600 employees.


 

* Plans for around 200 Fred Butler® areas across Europe by 2011 * Investment of 50 million euros * Several thousand jobs to be created across Europe * Eco-friendly cleaning process awarded Blue Angel certification Munich, 28 March 2007. The Linde Group is to roll out its Fred Butler® brand across Europe - offering dry-cleaning services based on an eco-friendly process that uses carbon dioxide. "Fred Butler is a prime example of the many applications for industrial gases," says Professor Dr Wolfgang Reitzle, chief executive officer of Linde AG, "We are committed to developing this business model, investing around 50 million euros in outlets and cleaning facilities by 2011. Through Fred Butler, we will make a sustainable contribution to protecting the earth's climate - and to creating new jobs." Over the next five years, Fred Butler® aims to establish thousands of new jobs across Europe. These plans were announced today at a press conference in Munich by CEO Andreas Klensch. The franchising company is currently opening shops in Munich, kick-starting a Europe-wide roll-out of the brand. At the press conference, the company was also awarded Blue Angel environmental certification by Matthias Machnig, State Secretary of the Federal German Ministry for the Environment, Nature Conservation and Nuclear Safety. The Fred Butler® cleaning method uses recycled carbon dioxide. As a result, it is not only more environmentally friendly, but is also far gentler on clothes than conventional dry-cleaning techniques. Plans for 200 areas across Europe by 2011 Following a highly successful market trial in Frankfurt, Fred Butler® has now opened two outlets in Munich (in Wasserburger Landstrasse and Rosenheimer Strasse) and a central cleaning facility in nearby Feldkirchen. "This year, we will set up a further nine cleaning facilities - so-called areas - in major German economic centers. Six of these will be run by franchisees" says Klensch. The company is planning to create 33 more areas Europe-wide in 2008. And it aims to establish 50 per year between 2009 and 2011. That will take the total to almost 200, providing jobs for several thousand people. The Fred Butler® principle The Fred Butler® cleaning technique is based on recycled carbon dioxide: no toxic chemicals or high-speed spin cycles are required. This prevents skin irritation and, according to a study carried out within the scope of the EU Life initiative, makes clothes last 30 to 40 percent longer. Moreover, the process is suitable for items that, until now, could not be dry-cleaned - such as leather or extremely soiled industrial work clothing. In addition, Fred Butler® offers innovative added-value services: including setting up collection points at companies such as banks, insurance firms, publishing houses, etc. - and cleaning and returning clothes within 48 hours. Fred Butler® is a brand of Cleaning Enterprises GmbH, a wholly-owned subsidiary of leading industrial gases and engineering company, the Linde Group. Cleaning Enterprises GmbH is headquartered in Pullach, near Munich, Germany and employs around 100 people. The Linde Group is a world leading industrial gases and engineering company with more than 51,000 employees working in around 70 countries worldwide. Following the acquisition of The BOC Group the company has gases and engineering sales of approximately 12 billion euro. The strategy of The Linde Group is geared towards earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. For more information, please see The Linde Group online at http://www.linde.com For additional information: Cleaning Enterprises GmbH Frauke Kollmorgen Tel.: +49 (0)89 7446-1621 Frauke.Kollmorgen@fred-butler.de The Linde Group Stefan Metz Tel.: +49 (0)89 35757-1322 Stefan.Metz@linde.com --- End of Message --- Linde AG Abraham-Lincoln-Str. 21 Wiesbaden Germany WKN: 648300; ISIN: DE0006483001; Index: CDAX, DAX, HDAX, Prime All Share; Listed: Amtlicher Markt in Hanseatische Wertpapierbörse zu Hamburg, Prime Standard in Frankfurter Wertpapierbörse, Amtlicher Markt in Frankfurter Wertpapierbörse, Amtlicher Markt in Bayerische Börse München, Amtlicher Markt in Börse Berlin Bremen, Amtlicher Markt in Börse Düsseldorf, Amtlicher Markt in Börse Stuttgart, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Ericsson (NASDAQ:ERIC) will provide IMS (IP Multimedia Subsystem) to leading Polish operator Telekomunikacja Polska (TP), paving the way for the latest multimedia communication services for consumers and enterprises alike. Under a frame agreement, the first for IMS in Poland, Ericsson will integrate the solution into TP's network and provide support and maintenance until the end of the year. With Ericsson IMS, Telekomunikacja Polska will be able to deliver enriched multimedia services, such as multimedia telephony, presence, instant messaging and IP centrex services, via either fixed or mobile broadband access. IMS is an important step towards fixed-mobile convergence. The international standards-based technology is highly scalable, takes care of connection control, and ensures service quality, and network and service security. IMS also allows network operators and service providers to implement new revenue-generating multimedia services quickly and cost effectively. Lars E. Svensson, President of Ericsson Poland, says: "Broadband access to the internet is one of the strategic paths of telecommunication development both for suppliers and operators. We are pleased to be a partner to Telekomunikacja Polska and work with it to provide cutting-edge solutions for its customers." Ericsson leads the IMS market with 36 IMS system contracts for commercial launch and 70 additional trials distributed around the world. Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +4687196992 E-mail: press.relations@ericsson.com About Telekomunikacja Polska (TP) Telekomunikacja Polska is a leading fixed-line operator in Poland and the core company of the TP Group, the largest telecommunications group in central Europe. The TP Group is the only operator in the country to be active in both fixed and mobile telephony as well as internet markets, with 10.3 million fixed-line subscribers and 11.7 million mobile customers (third-quarter 2006). It is also part of the France Telecom Group. About IMS Ericsson IMS is an end-to-end solution that gives operators immediate revenue opportunities when evolving to all-IP operations. It enables seamless access to a wide range of new multimedia services across both fixed and mobile networks. Ericsson's IP Multimedia Subsystem (IMS) includes a converged IMS core infrastructure, as well as application servers and service enablers for common functions that can be reused for multiple fixed and mobile applications.


 

Amsterdam, The Netherlands and London, UK - The Supervisory Board of Jetix Europe N.V. (AMEX: JETIX; Reuters: JETIX.AS; Bloomberg: JETIX.NA), is pleased to announce that it has extended the contract of Paul Taylor, Chief Executive Officer of Jetix Europe N.V. for a further two years effective from October 1st 2007. Mr. Taylor has been Chief Executive Officer of Jetix Europe since October 2004. He reports to the Supervisory Board of Jetix Europe and is responsible for leading the continued growth of all businesses within Jetix Europe including the 15 channels which reach more than 48 million households in 58 countries, and the Company's Programme Distribution, Online and Consumer Products businesses. -Ends- For further information please contact: Press: Investors: Jenny Burbage Peter Brimacombe Tel: +44 (0) 208 222 5910 Tel: + 44 (0) 20 8 222 5959 E Mail: jenny.burbage@jetix.net E mail: peter.brimacombe@jetix.net The press release can be downloaded from the following link:


 

Det Norske Oljeselskap AS, a wholly owned subsidiary of DNO ASA ("DNO") has entered into a NOK 300 million loan agreement with the Bank of Scotland. The loan facility will provide pre-funding of state tax refunds related to DNO's Norwegian Continental Shelf ("NCS") exploration expenditures. DNO has expanded its position in Norway substantially over the past few years and it is now one of the company's core areas. The Company holds a diversified portfolio of 22 licenses on the NCS. DNO's primary focus is smart exploration, cost effective development and high margin production, where oil prospects are the current priority of the Company. DNO has a strong commitment as an active player at NCS and the Company is planning to participate in 7 exploration wells in 2007, of which 3 are as Operator. In order to diversify and expand its debt funding options, DNO is pleased to announce the signing of a new NOK 300 million bank loan facility, which will support its extensive NCS exploration program. The new loan facility will be used to finance the tax refund value for exploration expenses incurred by DNO on the NCS. The competitive terms and conditions of the loan facility make this type of financing an attractive supplement to other debt financing alternatives. DNO also views the new loan facility as an opportunity to further strengthen its relationship with the Bank of Scotland, one of the leading European energy banks. Managing Director Helge Eide comments: "DNO is pleased with the new loan facility which supports our exploration strategy for Norway. We are engaged in high exploration activity on the NCS, and the loan facility will further strengthen funding of our exploration investments". DNO ASA 28 March 2007 Contact: Media: Helge Eide, MD DNO ASA Telephone: +47 23 23 84 80 Ketil Jørgensen, Crux Communication Telephone +47 930 36 866 (Norway) Ben Willey, Buchanan Communications Telephone: +44 207 466 5000 (UK) Investor Relations: Haakon Sandborg, CFO DNO ASA Telephone: +47 23 23 84 80 Robert Arnott, Advisor (UK) Telephone +44 207 839 7764


 

DJIA 12397.29 -71.78 -0.58% Nasdaq 2437.43 -18.20 -0.74% S&P 500 1428.61 -8.89 -0.62% FTSE 100 6292.60 +0.70 +0.01% Xetra DAX 6858.34 +29.52 +0.43% CAC40 5587.06 +10.76 +0.19% Above are closing prices Nikkei 225 17173.82 -191.20 -1.10% Hang Seng 19462.74 -244.00 -1.20% S&P/ASX 200 5909.20 -43.10 -0.70% Taiwan Index 7777.14 -68.03 -0.87% S.Korea Kospi 1434.77 -18.46 -1.30% Dow Future 12432.00 -52.00 -0.40% NASDAQ Future 1800.25 -10.00 -0.60% S&P Future 1433.75 -6.75 -0.50% Above are as of 0450 GMT USD/JPY 117.22-25 -0.55% Range 117.99 - 117.36 EUR/USD 1.3351-54 +0.05% Range 1.3362 - 1.3345 AUD/USD 0.8056-59 -0.31% Range 0.8081 - 0.8064 GBP/USD 1.9640-43 -0.07% Range 1.9668 - 1.9649 USD/CHF 1.2105-08 -0.28% Range 1.2122 - 1.2108 Above are as of 0450 GMT vs NY close USD/JPY Vol Option Contract 8.30%/8.55% EUR/USD Vol Option Contract 5.80%/6.00% AUD/USD Vol Option Contract 7.78%/8.03% GBP/USD Vol Option Contract 6.20%/6.50% USD/CHF Vol Option Contract 6.95%/7.20% Above are 1-Mo prices as of 0430 GMT 2Y Tsy 100 9/32 -1/32 4.59% +1.2 5Y Tsy 100 17/32 -3/32 4.50% +1.9 10Y Tsy 100 3/32 -6/32 4.61% +2.3 10Y JGB 1.6600% +0.0250 Closing Treasury prices vs prior NY close; JGB as of 0450 GMT Asian Spot Gold $665.50 +$3.20 +0.5% Comex Gold $665.50 +$3.00 +0.5% Brent Crude Oil $65.43 +$0.83 +1.2% Above are as of 0400 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: Fears over escalating tensions with Iran and continued pessimism about the U.S. economic outlook are likely to hit European stock markets at the open. Government debt prices remains under light pressure, while gold, the favored safe haven at the moment, is higher, as is oil. The euro is steady against the dollar and lower against the yen. STOCKS: Investors face an uphill struggle at the open, with caution over the U.S. economy and concern about geopolitical events in the Persian Gulf likely to dent confidence. However, the energy sector may get a boost from the Gulf tensions that drove oil prices up Tuesday U.K. spreadbetting firm CMC Markets is calling the FTSE down 16 points at 6277, the DAX down 10 at 6848 and the CAC down 11 at 5576. Wall Street stumbled lower Tuesday as investors grew wary over economic data suggesting the nations weak housing market would seep into the broader economy and crimp consumer spending. A housing index released Tuesday by Standard & Poors showed that prices of single-family U.S. homes fell in January compared to a year ago, in their worst showing since January 2004. Also, Lennar, one of the nations largest homebuilders, said its first-quarter profit plummeted 73 percent and warned that it probably will miss its 2007 earnings guidance. The Conference Board said Tuesday that its March consumer confidence index fell to 107.2, the lowest level since November and a decline that was larger than Wall Street expected. The index was at 112.5 a month earlier, which had been its highest level in five-and-a-half years. "While the market remains on the cautious side, there was a nice little bounce since mid-March. Investors are just looking over their shoulders, wondering if the problems in the housing market and subprime market are going to spill over," said Edward Yardeni, president of Yardeni Research. "Theres enough softness in the economy that the Feds not going to raise rates," Yardeni said. "Its a delicate balancing act here - investors dont mind softness in the economy as long as its not a recession." On Wednesday, investors will be listening to testimony by Federal Reserve Chairman Ben Bernanke for clues about the economys direction, and reading the Commerce Departments report on orders of durable goods for February. Asian stocks were lower Wednesday, with exporters such as Samsung Electronics and Sony losing ground on renewed concerns over the growth outlook for the U.S. economy. Gains in energy prices helped lift resource-related shares such as Inpex Holdings. FOREX: The euro is little changed against the dollar, but could target resistance at around $1.3370 if the Bernanke softens recent statements by other Fed officials. The euro continues to draw support from hawkish European Central Bank commentary of late. On Wednesday the data focus is on German March consumer climate survey at 0610 GMT and eurozone February M3 at 0700 GMT. "Most indications are that activity in the euro zone remains fairly robust," said Daniel Katzive, currency strategist at UBS. But "with the ECB likely on hold at its next two meetings and unlikely to signal a June tightening until early May, markets are likely to be cautious about pricing too much more (tightening) into the curve in the very near term," he added. Yen investors are bidding Japans currency higher against the dollar and euro, on the theory that Bernanke will have to field questions about the subprime mortgage market. Any fresh concern there could revive talk of a rate cut ahead and validate the long-yen play. Support comes at Y117.20 for the dollar and Y156.50 for the euro. BONDS: European government bond prices may open mixed, after falling Tuesday on a mixture of weak technicals, above-forecast data and hawkish central bankers commentary pointing to higher interest rates. WestLB said the technical outlook for June bunds was negative. But investors who are nervous about Iran may opt to buy government debt paper for safety. Treasury prices are slightly higher in Asia after ending lower Tuesday on some hawkish talk from various Fed officials. Weak economic data failed to rescue the market because Fed officials stressed inflation risk over slower growth. The comments served to remind bond market participants that while the statement from the Fed meeting last week was seen as lowering the odds the central bank would raise rates again, its too soon to say that any easing in monetary policy looms. Investors will look to testimony on the economy from Bernanke set for Wednesday. Societe Generale bond analysts reckon Bernanke will stick closely to the Feds existing line and that hell continue to worry about the risks posed by inflation, even as he flags the risk the housing downturn poses to the economic outlook. They warn that bond investors might see what they want to see in Bernankes testimony and that could make it hard to predict what the market will do. But they did say, "given the mixed messages" from the Fed, "we fear the market will seize the occasion to continue recent trends, and so for the curve to steepen." They were referring to a widening in spreads between short- and long-dated Treasurys. In Japan, prices of Japans government bonds are lower ahead of Bernankes comments. But if Fridays Japan CPI comes in lower, with a drop of 0.1% predicted, yields could dip, dealers said. ENERGY: Benchmark crude oil futures held strong in Asian trading Wednesday, with sentiment still firmly anchored by supply jitters following speculation of a military confrontation between the U.S. and Iran in the Persian Gulf. The U.S. military denied reports that Iran fired a missile at a U.S. ship in the Gulf. The rumors of an attack had sent oil prices soaring. Concerns over security of supply have seemingly yet to filter into the physical oil markets, with traders - including an official at National Iranian Oil Co - noting relative calm, but the market remained on a hair trigger. "Despite the talk turning out to be a rumor, sentiment has become upbeat," said Ken Hasegawa at brokerage Himawari CX in Tokyo. Saudi oil minister Ali Naimi, in China for the signing of a joint venture refinery later this week, kept his silence on the issue as he touched down earlier in Beijing. May Nymex futures traded at $63.81 a barrel, up 88 cents in Asia. "If the crisis is not resolved quickly, we could see a rise in shipping and insurance rates if oil tankers become more hesitant to call on Iraqi oil-export terminals which nestle the Iranian border," noted Edward Meir, an analyst at Man Financial. METALS: Spot gold was last at $665.30/oz, after giving back half of a $6.00 jump after the close of New York trading, but still up around $3.00. The gain was fueled by worry over any military confrontation in the Persian Gulf involving Iran and the U.S. A trader said that the Iranian tension should outweigh central bank sales. LME 3-month copper was last $6,700/ton, up $20 from the late kerb close, after slumping 2.7% earlier when it posted new high for the year. Copper ultimately faltered at the lower end of $6,900-$7,000 primary resistance band. Standard Bank technical analysis said a break higher is unlikely, with "corrective weakness expected to come to the fore." Expectations for lower demand from China in April may also weigh. CALENDAR: Wednesday, March 28, 2007 GMT Expected Previous 0600 UK Mar Housing Review +0.7%MM +0.7%MM +9.3%YY +10.2%YY 0610 GER Mar Consumer Climate Survey 4.5 4.4 0730 UK 4Q GDP +0.8%QQ +0.7%QQ +3.0%YY +2.9%YY 0800 UK 4Q Current Account -GBP8.2B -GBP9.4B 0800 EU Feb ECB euro-zone M3 +9.8%YY +9.8%YY +9.8%YY +9.7%YY 0800 EU Feb Monetary developments in the euro area 0830 UK 4Q Balance of Payments 0830 UK 4Q National Accounts 1000 UK Feb House Price Index 1100 US Mar 23 MBA Refinancing Index -4.5% 1230 US Feb Durable Goods +3.5% -8.7% 1400 US Tsy Secy Paulson testifes before the House Appropriations Financial Services Subcommittee on the 2008 budget request 1430 US Fed Chmn Bernanke testifies before the Joint Economic Committee on Econ Outlook 1430 US Mar 23 US Energy Dept Crude Oil Stocks (in +1.1M +4.0M barrels) 1430 US Mar 23 US Energy Dept Distillate Stocks (in -0.8M -1.7M barrels) 1430 US Mar 23 US Energy Dept Gasoline Stocks (in -1.8M -3.4M barrels) 1900 US Tsy Secy Paulson testifies before the Senate Appropriations Committee on the 2008 budget request 2350 JPN Feb Current Survey of Commerce, prelim -0.8%YY 2350 JPN Mar Provisional Trade Statistics for 1st 10 days of Month N/A GER Mar CPI, prelim +0.2%MM +0.4%MM +1.8%YY +1.6%YY Autostrade (AUTO.MI): FY Earnings Average net profit (Factset Estimates, 11 analysts): EUR666.5M (EUR791.3M) Average operating profit: EUR1.62B (EUR1.53B) Note: Earnings in 2005 were inflated by EUR153 million one-off gains from asset sales. The increase in operating profit is reflecting higher toll revenue. But with the net earnings drop already well flagged at the nine-month stage, investors will be looking for comments on the future of Autostrades currently shelved plans to merge with Abertis (ABE.MC). Numbers due late Wednesday afternoon. Banca Popolare Italiana (BPI.MI): FY Earnings Average net profit (DJ, 4 analysts): EUR35M (EUR744M net loss) Average revenue: EUR1.51B (EUR1.26B) Note: Had to book hundreds of millions of euros worth of provisions linked to previous management operations. Analysts expect the bank to announce it will not pay an ordinary dividend as previously announced and to announce more provisions and write-downs ahead of its merger with Popolare Verona e Novara (BPVN.MI). Banco Popolare Verona e Novara (BPVN.MI): FY Earnings Average net profit (DJ, 6 analysts): EUR920M (EUR597M) Average operating income: EUR1.34B (EUR1.06B) Note: Expected to report a rise in full-year net profit, thanks to one-off gains and a higher net interest income. Eyes are on further merger details with Popolare Italiana such as a bancassurance partner and a future listing of the groups consumer credit operations. The bank is due to hold a conference call at 1630 GMT. Enel (EN): FY Earnings Average net profit (DJ, 12 analysts): EUR3.13B (EUR3.90B) Note: Enels 05 net profit was boosted by extraordinary gains. Analysts expect 06 dividend to rise to EUR0.49 a share versus EUR0.44 the year before. All eyes later Wednesday will be on the strategy presentation on details of its interest in Endesa (ELE), with some focus on the EUR400M charge Enel announced in February to cut costs. Hennes & Mauritz (HM-B.SK): 1Q Earnings Average pretax profit (FactSet, 4 analysts): SEK3.52B (SEK2.68B) Average sales: SEK16.99B (SEK15.07B) Average EBIT: SEK3.42B (SEK2.57B) Note: Improved operating margins and the favorable effect of the weak US dollar on H&M purchasing prices are seen supporting the rise. Eyes will be on February sales, outlook as well as gross and operating margins. Mediolanum (MED.MI): FY Earnings Average net profit (DJ, 4 analysts): EUR225M (EUR233M) Note: Net business value is seen +17% at EUR190 million from EUR162 million a year earlier. Analysts say eyes are on 06 embedded value and 07 outlook. A conference call is scheduled for 1630 GMT. Orco Property Group (5767.FR): FY Earnings Average consolidated net profit (DJ, 5 analysts): EUR88.1M (EUR54.5M) Average sales: EUR174.7M (EUR50.3M) Note: Analysts expect the majority of Orcos gains to come from a revaluation of its properties, adding that Orcos financial costs have risen sharply on the year due to an increase in debt used for some acquisitions. Raiffeisen International (RIBH.VI): 4Q Earnings Average net profit (Co, 13 analysts): EUR623M (EUR103.3M) Average net interest income: EUR488M (EUR361.1M) Average commission income: EUR252M (EUR175.2M) Note: Excluding a EUR486M gain from the sale of Raiffeisen Ukraine, net profit is seen +38% at EUR143M on currency appreciations in Central Europe and higher revenues in southeastern Europe. The trading result is seen -34% to EUR35M from EUR52.7M, due to a change in bookings of currency fees. Sal Oppenheim sees credit spreads widening and margin pressures rising and expects a conservative 2007 net profit outlook. Wimm-Bill-Dann (WBD): 4Q Earnings Average net profit (DJ, 6 analysts): $22.5M ($8.6M) Average revenue: $476.0M ($373.4M) Average EBITDA: $61.2M ($40.4M) Note: Analysts see the company continuing to reap the benefits of cost-cutting measures and higher selling prices, but warn that one-off charges in 3Q will negatively impact full-year numbers. Woolworths Group (WLW.LN): FY Earnings Average pretax profit and exceptional items (Co, 15 analysts): GBP21M (GBP57.7M) Note: The sharp profit fall is largely due to continued losses on the retail side, while the wholesale and publishing side is expected to perform strongly, according to analysts. "The core Retail business is loss-making and looks doomed, but management have done a good job of building up the wholesaling / publishing operations," says Pali Research analyst Nick Bubb. Analysts will focus on the results for wholesale and publishing. OTHER SCHEDULED EVENTS: AaB (AAB.KO): FY Earnings Aberdeen Asset Management (AAB.V): Trading Update AC Service (ACV.XE): FY Earnings Access Commerce (7424.FR): FY Earnings Acea (ACE.MI): FY Earnings Actielec Technologies (7665.FR): FY Earnings Akbank (AKBNK.IS): AGM Alliance Boots (AB.LN): Trading Update Alytaus Textile (10090.LH): AGM Amadeus Fire (AAD.XE): FY Earnings Amanda Capital (AMC1V.HE): AGM Arnoldo Mondadori Editore (MN.MI): FY Earnings ASML Holding (ASML): AGM AWD Holding (AWD.XE): FY Earnings Babcock International Group (BAB.LN): Trading Update Balda (BAD.XE): FY Earnings Banca Popolare di Intra (PIN.MI): FY Earnings Banca Popolare di Verona (BPVN.MI): FY Earnings Bechtle (BC8.XE): FY Earnings BioTie Therapies Corp (BTH1V.HE): AGM Bobst (BOBNN.EB): FY Earnings BRE Bank (BRE.WA): FY Earnings Brisa Auto-Estradas (BRI.LB): AGM Business et Decision (7895.FR): FY Earnings CDV Software Entertainment (OGG.XE): FY Earnings Cembre (CMB.MI): FY Earnings CeNeS Pharmaceuticals (CEN.LN): FY Earnings Cintra Concesiones de (CIN.MC): AGM Curanum (BHS.XE): FY Earnings D1 Oils (DOO.LN): FY Earnings Daily Mail & General Trust (DMGT.LN): Trading Update Deutsche Beteiligungs (DBA.XE): AGM DFDS (DFDS.KO): AGM Digital Bros (DIB.MI): 1H Earnings DSM (00982.AE): AGM Dyckerhoff (DYK.XE): FY Earnings Erg (ERG.MI): FY Earnings Evialis (5440.FR): FY Earnings Fidia (FDA.MI): FY Earnings First Calgary Petroleums (FPL.LN): FY Earnings FirstGroup (FGP.LN): Trading Update Fortum (FUM1V.HE): AGM Fraport (FRA.XE): FY Earnings Gabetti Holding (GAB.MI): FY Earnings Genesis Em Mkts Fund (GSS.LN): 1H Earnings Gunnebo (GUNN.SK): AGM Hal Trust (HAL.AE): FY Earnings Heritage Underwriting (HUA.LN): FY Earnings HES Beheer (35812.AE): FY Earnings Home Properties (HOPR.SK): AGM Iberdrola (IBE.MC): AGM Industrial and Financial (ifs-b.sk): AGM init innovation in traffic (IXX.XE): FY Earnings IQE (IQE.LN): FY Earnings Israel Chemicals (ICL.TV): FY Earnings Israel Corp (AMPL): FY Earnings IT Link (ITL.FR): FY Earnings J Sainsbury (SBRY.LN: Trading Update James Halstead (JHD.LN): 1H Earnings Jensen & Moller Invest (JMI.KO): FY Earnings Johnson Matthey (JMAT.LN): Trading Update Kardan (KARD.AE): FY Earnings Klovern (KLOV.SK): AGM Kobenhaven Lufthave (KBHL.KO): AGM Kontron (KBC.XE): FY Earnings Land of Leather Holdings (LAN.LN): 1H Earnings London Scottish Bank (LSB.LN): AGM Lonza Group (LONN.VX): AGM LPKF Laser & Electronics (LPK.XE): FY Earnings Marstons (MARS.LN): Trading Update MediGene (MDG.XE): FY Earnings Medion (MDN.XE): FY Earnings MTL Instruments Group (MTI.LN): FY Earnings OHB Technology (OHB.XE): FY Earnings Olav Thon Eiendomsselskap (OLT.OS): FY Earnings Outokumpu (OUT1V.HE): AGM Palfinger (PAL.VI): AGM Paragon (PGN.XE): FY Earnings Passat (3846.FR): FY Earnings Perlos (POS1V.HE): AGM Permedia (PMD.WA): FY Earnings Pescanova (PVA.MC): FY Earnings Pfleiderer Grajewo (GRJ.WA): FY Earnings Prevas (PREV-B.SK): AGM Prosodie (PRD.FR): FY Earnings Publigroupe (PUBN.EB): FY Earnings RM (RM.LN): Trading Update S&T System Integration & Tech (SNT.VI): FY Earnings Scana Industrier (SCI.OS): FY Earnings Silicon Sensor International (SGI.XX): FY Earnings Skandinaviska Enskilda Banken (SEB-A.SK): AGM Sol (SOL.MI): FY Earnings SolarWorld (SWV.XE): FY Earnings Synaxon (PCS.XE): FY Earnings Teligent (TGNT.SK): AGM Thielert Aktiengesellschaft (T3C.XE): FY Earnings Topps Tiles (TPT.LN): Trading Update Topsil Semiconductor Materials (TPSL.KO): AGM Totalbanken (TOTA.KO): AGM TrygVesta (TRYG.KO): AGM United Utilities (UU.LN): Trading Update Vacon (VAC1V.HE): AGM Valora (VALN.EB): FY Earnings Vislink (VSF.DB): FY Earnings VLT (VLT-B.SK): EGM VM Materiaux (VMMA.FR): FY Earnings Vossloh (VOS.XE): FY Earnings Wise Group (WISE.SK): AGM Zapf Creation (ZPF.XE): FY Earnings Zucchi (ZUC.MI): FY Earnings Alba (ABA.LN): 1H 2006 Ex-Dividend Date Alliance Trust (ATST.LN): Q4 2006 Ex-Dividend Date Alpha Pyrenees (ALPH.LN): FY 2006 Ex-Dividend Date Amlin (AML.LN): FY 2006 Ex-Dividend Date Amlin (AML.LN): Special ex-Dividend Date Arena Leisure (ARE.LN): FY 2006 Ex-Dividend Date Arriva (ARI.LN): FY 2006 Ex-Dividend Date Ashmore Group (ASHM.LN): 1H 2007 Ex-Dividend Date Asset Management Investment (AMN.LN): Special ex-Dividend Date Barratt Developments (BDEV.LN): 1H 2007 Ex-Dividend Date Benfield Group (BFD.LN): FY 2006 Ex-Dividend Date Bovis Homes Group (BVS.LN): FY 2006 Ex-Dividend Date British Sky Broadcasting Group (BSY.LN): 1H 2007 Ex-Dividend Date Capita Group (CPI.LN): FY 2006 Ex-Dividend Date Cattles (STT.LN): FY 2006 Ex-Dividend Date Chemring Group (CHG.LN): FY 2006 Ex-Dividend Date Churchill China (CHH.LN): FY 2006 Ex-Dividend Date Dr Hoenle (HNL.XE): FY 2006 Dividend Payment Date Dr Hoenle (HNL.XE): FY 2006 Ex-Dividend Date Edinburgh UK Tracker Trust (EUK.LN): FY 2006 Ex-Dividend Date F&C Commercial Property Trust (FCPT.LN): Q4 2006 Ex-Dividend Date Fabege - A Shares (FABG.SK): FY 2006 Ex-Dividend Date Finnlines (FLG1S.HE): FY 2006 Dividend Payment Date Finsbury Growth & Income Trust (FGT.LN): 1H 2007 Ex-Dividend Date Flying Brands (FBDU.LN): FY 2006 Ex-Dividend Date Helphire Group (HHR.LN): 1H 2007 Ex-Dividend Date Henderson High Income Trust (HHI.LN): Q4 2006 Ex-Dividend Date Holidaybreak (HBR.LN): FY 2006 Ex-Dividend Date Industrivarden - A Shares (INDU-A.SK): FY 2006 Ex-Dividend Date Invesco Perpetual Recovery (IPRT.LN): 1H 2007 Ex-Dividend Date Investor - A Shares (INVE-B.SK): FY 2006 Ex-Dividend Date Jardine Lloyd Thompson Group (JLT.LN): FY 2006 Ex-Dividend Date Kier Group (KIE.LN): 1H 2007 Ex-Dividend Date Lemminkainen (LEM1S.HE): FY 2006 Dividend Payment Date Manchester & London Investment (MNL.LN): 1H 2007 Ex-Dividend Date New Star Financial (NST.LN): Q1 2007 Ex-Dividend Date NWF Group (NWF.LN): 1H 2006 Ex-Dividend Date Ostasiatiske Kompagni: FY 2006 Ex-Dividend Date Ostasiatiske Kompagni: Special ex-Dividend Date Scottish & Newcastle (SCTN.LN): FY 2006 Ex-Dividend Date Sjaelso Gruppen (SJGR.KO): FY 2006 Ex-Dividend Date Smiths Group (SMIN.LN): 1H 2007 Ex-Dividend Date Standard Life (SL.LN): FY 2006 Ex-Dividend Date Talentum (TTM1V.HE): FY 2006 Ex-Dividend Date Thorntons (THT.LN): 1H 2007 Ex-Dividend Date UPM-Kymmene (UPM): FY 2006 Ex-Dividend Date UTV (UTV.LN): FY 2006 Ex-Dividend Date Wolseley (WOS.LN): 1H 2007 Ex-Dividend Date Yit-Yhtyma (YTY1V.HE): FY 2006 Dividend Payment Date (END) Dow Jones Newswires


 

LONDON (Dow Jones)--U.K. retailer Woolworths Group PLC (WLW.LN) Wednesday reported a 62% fall in full-year profit before tax and exceptional items, admitting that sales were "disappointing" despite a store refurbishment program. The main reason why the groups results were in line with analysts expectation of GBP21 million is because the retailer benefited from a change of accounting methodologies, which boosted profits by GBP9 million. Steve Davies an analyst at Numis Securities said: "This makes us pretty sceptical on the company." The company also benefitted from a slight change in accounting dates which meant that the year had 53 weeks. The U.K.-based general merchandise retailer and entertainment wholesaler said profit before tax, exceptional and some other items dropped in the year to Feb. 3 to GBP21.8 million from GBP57.7 million in 2005. However one analyst said that the company had delivered good news by maintaining the dividend at 1.34 pence a share. Davis of Numis noted that the companys share price had very little to do with the performance of the Group, but was being held up by bid speculation, especially hopes of a bid from the highly-acquisitive Icelandic group Baugur. Chief Executive Trevor Bish-Jones told reporters he is resisting any suggestion on spinning off parts of the groups saying "the structure of the group is the structure of the group." Sales from continuing operations rose 4% to GBP2.74 billion from GBP2.63 billion. Analysts say its main chain of around 800 high street stores is still under siege from larger rivals such as Tesco PLC (TSCO.LN) and Internet sales. Woolworths reported a 6.6% fall in like-for-like sales on the retail side, blaming fierce competition. On a continuing basis the retail side fell to a loss of GBP12.9 million from GBP17.1 million. The company said: "The key driver was not failure to control margins or costs but rather the underlying sales performance, which was worse than anticipated." Sales in Entertainment Wholesale and Publishing businesses, comprising of EUK, the entertainment distribution business and 2entertain were down marginally at GBP53.1 million from GBP56.4 million in 2005. CEO Bish-Jones said: "The retail environment is likely to remain challenging in the current year. The first seven weeks of the new financial year have begun positively, but it is early days and we will continue to manage the business tightly." Stephen East, finance director , said that analyst consensus for profit before tax and exceptional items for the financial year 2007 was at mid to high GBP20 million range. Reported pretax profit from continuing operations was GBP13.6 million against the previous years GBP41.3 million. Baugur, which owns many U.K. high street names such as toy store Hamleys, clothing stores Karen Millen and Oasis and supermarket chain Iceland, has been steadily building its stake in Woolworths. Now owning around 10%, but analysts have repeatedly said they dont see it going for a full takeover. Company Web site: http://www.woolworthsgroupplc.com -By Peppi Kiviniemi, Dow Jones Newswires, 44 20 7842 9496; peppi.kiviniemi@dowjones.com (END) Dow Jones Newswires


 

Orkla has the 27 March 2007 sold 1 194 335 shares in Renewable Energy Corporation ASA (REC) at a share price of NOK 140.33. After this transaction Orkla holds 196 425 000 shares in REC, which represents 39.75 % of the shares. The reason for the sale is that Orkla wishes to have a certain margin to the 40 % limit that triggers a mandatory offer. The reason for this notification is that Ole Enger and Roar Engeland (both Executive Vice President in Orkla) are members of the Board in REC. Contact: Rune Helland, Orkla Investor Relations - Tel: +47 2254 4411 Siv M. Skorpen Brekke, Orkla Investor Relations - Tel: +47 2254 4455


 

Martinsried/München - March 28, 2007. The biotech company MediGene AG (Frankfurt, Prime Standard: MDG) today submitted the Marketing Authorization Application (MAA) for Polyphenon® E Ointment for the treatment of genital warts to the regulatory authorities in Germany, Austria and Spain. The approval in these countries is supposed to be a reference for the submission of MAAs in further European countries. After the approval, MediGene is planning to market the Polyphenon® E Ointment together with the drug Oracea® against the skin disease Rosacea by its own sales force in selected European countries. In the US, the drug already received approval in October 2006. The US market launch by MediGene's partner Bradley Pharmaceuticals, Inc is scheduled for the second half of 2007 Dr. Peter Heinrich, Chief Executive Officer of MediGene AG, comments: "Once the approval process for Polyphenon® E Ointment in Europe is completed successfully, MediGene will possess several approved drugs. Currently, MediGene is establishing its own sales and marketing organisation in the field of dermatology. Following the expected launch of Oracea® in the second half of 2007, Polyphenon® E will be the second drug marketed by MediGene." About Polyphenon® E Ointment: The active substance in Polyphenon® E Ointment is a concentrate of catechines with a defined composition, extracted from green tea leaves. For the indication Genital Warts, MediGene estimates the peak sales potential of this drug to be more about 30 million EUR annually in Europe. About genital warts: Genital warts are one of the most common and fastest spreading venereal diseases worldwide. Genital warts are benign, but disfiguring and contagious skin tumors in the genital and anal area, which are mostly difficult to treat. Approximately 14 million people in North America and 15 million people in Europe are infected by human papilloma viruses (HPV type 6 or 11), which cause genital warts. This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of MediGene as of the date of this release. These forward-looking statements are no guarantees for future performance, and the forward-looking events discussed in this press release may not occur. MediGene disclaims any intent or obligation to update any of these forward-looking statements. MediGeneTM is a trademark of MediGene AG, Polyphenon® E is a trademark of Mitsui Norin. - Ends - MediGene AG is a publicly quoted (Frankfurt: Prime Standard: MDG) biotechnology company located in Martinsried/Munich, Germany, with subsidiaries in Oxford, UK and San Diego, USA. MediGene is the first German biotech company with a drug on the market. A second drug has been approved by the FDA. In addition, several drug candidates for the treatment of cancer and autoimmune diseases are currently in clinical development. MediGene also possesses innovative platform technologies. Contact MediGene AG Email: investor@medigene.com Fax:++49 - 89 - 85 65 - 2920 Julia Hofmann / Dr. Georg Dönges, Public Relations, Tel.: ++49 - 89 - 85 65 - 3317 Dr. Michael Nettersheim, Investor Relations, Tel.: ++49 - 89 - 85 65 - 2946 --- End of Message --- MediGene AG Lochhamer Strasse 11 Martinsried / München Germany WKN: 502090; ISIN: DE0005020903 ; Index: Prime All Share, CDAX, TECH All Share, HDAX, MIDCAP, TecDAX; Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Geregelter Markt in Frankfurter Wertpapierbörse;


 

The shareholders in NET INSIGHT AB (publ) are hereby summoned to the annual general meeting on 26 April 2007 at 10 a.m. at the company's offices, Västberga Allé 9, Hägersten, Stockholm Notification etc. Shareholders who wish to participate in the general meeting must firstly be included in the shareholders' register maintained by VPC AB as of Friday, 20 April 2007, and secondly notify the company of their participation in the annual general meeting no later than 4 p.m. on Friday, 20 April 2007. The notification shall be in writing to Net Insight AB, Attn: Lena Åberg, Box 42093, 126 14 Stockholm, via telephone: +46 8-685 04 00, via fax: +46 8-447 49 62 or via e-mail: info@netinsight.net. The notification should state the name, personal/corporate identity number, address, telephone number and shareholding and, when applicable, information about representatives, counsels and assistants. When applicable, complete authorization documents, such as registration certificates and powers of attorney for representatives and counsels, shall be appended the notification. Nominee shares Shareholders whose shares have been registered in the name of a bank or other trust department or with a private securities broker, must temporarily re-register their shares in their own names with VPC AB in order to be entitled to participate in the annual general meeting. Shareholders wishing such re-registration must inform their nominee of this well before Friday, 20 April 2007, when such re-registration must have been completed. Proxy etc. Shareholders represented by proxy shall issue dated and signed power of attorney for the proxy. If the power of attorney is issued on behalf of a legal entity, a certified copy of a registration certificate or a corresponding document shall be appended. The power of attorney and the registration certificate may not be older than one year. The power of attorney in original and, where applicable, the registration certificate, should be submitted to the company by mail at the address set forth above well in advance of the general meeting. Proposed agenda 1. Election of a chairman of the meeting. 2. Preparation and approval of the voting list. 3. Approval of the agenda. 4. Election of one or two persons to verify the minutes. 5. Determination as to whether the meeting has been duly convened. 6. Speech by the managing director. 7. Presentation of the annual accounts and the auditor's report, and the group annual accounts and the auditor's report on the group accounts. 8. Decision: (a) regarding the adoption of the income statement and the balance sheet, and of the consolidated income statement and the consolidated balance sheet; (b) regarding appropriation of the company's result according to the adopted balance sheet; (c) regarding discharge from liability for the members of the board of directors and the managing director. 9. Determination of the number of members and deputy members of the board of directors and number of auditors and deputy auditors. 10. Determination of the fees to the board of directors and the auditors. 11. Election of the members and deputy members of the board. 12. Election of the auditors. 13. Proposal for resolution regarding amendment of the articles of association. 14. Proposal for resolution regarding guidelines for remuneration and other terms of employment for the group management. 15. Proposal regarding the adoption of the employee stock option plan 2007/2011 and the issuance of warrants to subscribe for new shares, and approval of disposal of the warrants issued under the employee stock option plan. 16. Closing of the meeting. ___________________ Shareholders representing approximately 35 per cent of the votes of all shares in the company have announced that they at the annual general meeting will support the above resolutions as regards item 9-15. Annual accounts in accordance with item 7 above, proposal for resolution regarding amendment of the articles of association in accordance with item 13, proposal for resolution regarding guidelines for remuneration and other terms of employment for the group management in accordance with item 14 and proposal regarding the adoption of the employee stock option plan 2007/2011 in accordance with item 15 will as from Thursday, 12 April 2007, be held available at the company, address Västberga Allé 9, Hägersten, and be sent to shareholders that so request and inform the company of their postal address. Furthermore, the board of directors' proposal in accordance with item 15 will automatically be sent to all shareholders who have notified the company of their participation at the general meeting and thereby stated their postal address. Stockholm, March 2007 NET INSIGHT AB (publ) The board of directors The full Notice to attend the Annual General Meeting is available for download here or at www.netinsight.net


 

The Board of Directors of TradeDoubler today announces that William Cooper has been appointed as President and Chief Executive Officer of TradeDoubler AB (publ). William Cooper previously held a number of roles within senior management since joining the company at the beginning of 2000 when he assisted in the setting up of the UK organization. William has previously been Managing Director of the UK organization, Chief Marketing Officer, and most recently Chief Operating Officer of TradeDoubler Group. He has been on the Group Management Board since 2002. William succeeds Martin Henricson, who leaves the company from an operational capacity but remains on the Board of Directors. Commenting on his appointment William Cooper said, "I am delighted to have this opportunity to take TradeDoubler forward over the coming years. I believe with the knowledge and expertise we have throughout the organization, and in particular within the Group Management Board, we have a very exciting and strong future ahead of us as an independent listed company. We have an unrivalled pan European footprint and a market leading position in many of our products and services throughout the 18 European countries in which we operate. I hope that over time we can expand both our geographic footprint and our products and services in order to meet the requirements of our advertisers and publishers". Kjell Duveblad, Chairman of the Board, said, "We are pleased to announce this appointment. William has a deep knowledge of the company having joined it soon after its launch. We have a number of challenges and opportunities in front of us and his experience will be invaluable as we continue to expand the business over the coming years". For further information, please contact: Kjell Duveblad, Chairman of the Board +46 (0)703 33 54 20 William Cooper, CEO +44 207798 5804 +44 (771) 858 64 02 About TradeDoubler TradeDoubler is a Pan-European digital marketing company offering a range of performance-based marketing solutions. TradeDoubler's products and services provide companies with the tools and expertise to drive results online whether they are looking to generate sales or drive brand awareness. Headquartered in Sweden, the company boasts a unique European reach with local offices in 15 countries across Europe and a presence in a further three countries. With a breadth of expertise across multiple industry sectors and a network of more than 100,000 website publishers TradeDoubler helps deliver online results for over 1,000 advertisers across Europe including a mix of local and international companies such as Apple Store, Dell, Telia Sonera, eBay and Kelkoo. Please visit www.tradedoubler.com for further information.


 

MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) today announced that Astellas Pharma Inc. ("Astellas" Tokyo, Japan), Japan's second largest ethical pharmaceutical company, and MorphoSys AG have entered into a license agreement for the use of MorphoSys's HuCAL technology. Under the terms of the agreement, MorphoSys grants Astellas access to its HuCAL GOLD antibody library for use in its internal pharmaceutical drug discovery programs. In return, MorphoSys stands to receive an up-front payment and annual user fees during the life span of the agreement. During the term of the agreement, Astellas will have access to the MorphoSys HuCAL GOLD library at its research site in Tsukuba, Japan. Additionally, Astellas has the option to start antibody projects during the life time of the agreement. Under the optional collaboration component of the alliance, MorphoSys will utilize its HuCAL GOLD antibody library to generate novel HuCAL antibodies against targets provided by Astellas. Subsequently, Astellas will be responsible for preclinical and clinical development of these compounds, as well as the ensuing marketing of resulting products. For projects initiated under the collaboration, MorphoSys stands to receive research funding, plus licensing and milestone payments, as well as royalties on end-product sales. The agreement may have a duration of up to five years. "Today's deal adds another representative of Japan's leading pharmaceutical companies to MorphoSys's roster of partners and increases at the same time our market share among the 20 largest drug makers worldwide," commented Dr. Simon Moroney, Chief Executive Officer of MorphoSys. "This new therapeutic partnership with Astellas once again shows the potential for innovative technology such as our HuCAL GOLD antibody library in Japan - a market we set out to explore just some 24 months ago." For further information please contact: Dr. Claudia Gutjahr-Löser, Head of Corporate Communications, Tel: +49 (0) 89 / 899 27-122, gutjahr-loeser@morphosys.com or Mario Brkulj, Manager Public Relations, Tel: +49 (0) 89 / 899 27-454, brkulj@morphosys.com About Astellas: Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global pharmaceutical company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. For more information on Astellas Pharma Inc., please visit the company's website at http://www.astellas.com. About MorphoSys: MorphoSys develops and applies innovative technologies for the production of synthetic antibodies, which accelerate drug discovery and target characterization. Founded in 1992, the Company's proprietary Human Combinatorial Antibody Library (HuCAL) technology is used by researchers worldwide for human antibody generation. The Company currently has licensing agreements and/or research collaborations with Bayer-Schering (USA/Germany), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (USA), Centocor Inc. (USA), Daiichi Sankyo & Co., Ltd. (Japan), GPC Biotech AG (Germany), Hoffmann-La Roche AG (Switzerland), ImmunoGen Inc. (USA), Merck & Co., Inc. (USA), Novartis AG (Switzerland), Novoplant GmbH (Germany), OncoMed Pharmaceuticals, Inc. (USA), Pfizer Inc. (USA), ProChon Biotech Ltd. (Israel), Schering-Plough (USA), Shionogi & Co., Ltd. (Japan), Xoma Ltd. (USA) and others. Additionally, MorphoSys is active in the antibody research market through its AbD Serotec business unit. The business unit was founded in 2003 for the purpose of exploiting the MorphoSys non-therapeutic antibody markets. MorphoSys' activities in the research antibody segment were significantly strengthened through the acquisition of the U.K. and U.S.-based Biogenesis Group in January 2005 and Serotec Group in 2006. For further information please visit the corporate website at: http://www.morphosys.com/. HuCAL® and HuCAL GOLD® are registered trademarks of MorphoSys AG Statements included in this press release which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements" for purposes of the safe harbour provided by Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The company cautions readers that forward-looking statements, including without limitation those relating to the company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors that may affect future operations and business prospects include, but are not limited to, clinical and scientific results and developments concerning corporate collaborations and the company's proprietary rights and other factors described in the prospectus relating to the company's recent public offering.


 

Wärtsilä Corporation Stock Exchange Release 28.3.2007 at 08.00 am local time Wärtsilä Corporation announced a public offer to the minority shareholders of Wärtsilä India Ltd on 19 January 2007 to acquire 1,240,599 shares, or 10.3% of the share capital. The offer period expired on 23 March 2007. The delisting offer has been successful. Pursuant to the offer about 6.9% of the total shares will be acquired. This implies a consideration of approximately EUR 8.8 million. After the completion of the offer Wärtsilä Corporation will hold directly or indirectly 96.6% of Wärtsilä India shares. The actual delisting will take place in about 3 months subject to the required formalities. The remaining shareholders will be offered an exit facility at the same share price paid in the offer in accordance with the applicable delisting guidelines. Further information: Mr Markus Pietikäinen, Director, Corporate Development, Wärtsilä Corporation, tel. +358 10 709 5630. www.wartsila.com


 

LIMERICK, Ireland, March 27, 2007 (PRIME NEWSWIRE) -- Genesis Lease Limited (NYSE:GLS) announced that its Board of Directors today declared a dividend of $0.53 per outstanding Common Share for the period from the completion of its initial public offering on December 19, 2006 to March 31, 2007. The dividend is payable May 10, 2007 to shareholders of record as of the close of business on April 24, 2007. The dividend reflects a quarterly dividend of $0.47 per share, plus an incremental amount of $0.06 to reflect the slightly longer period. About Genesis Lease Limited Genesis Lease Limited is a global commercial aircraft leasing company that is headquartered in Limerick, Ireland. Genesis acquires and leases modern, operationally efficient passenger and cargo jet aircraft to a diverse group of airlines throughout the world. Genesis leverages the worldwide platform of GE Commercial Aviation Services Limited, or GECAS, to service its portfolio of leases, allowing management to focus on executing its growth strategy. Genesis' common shares, in the form of American Depositary Shares, are listed on the New York Stock Exchange under the symbol "GLS." CONTACT: Genesis Lease Limited Alan Jenkins, Chief Financial Officer +353-61-633-777 alan.jenkins@genesislease.com KCSA Worldwide Jeffrey Goldberger, Managing Partner (212) 896-1249 jgoldberger@kcsa.com


 

Ship Finance has posted a memo related to each cash dividend done in 2006. To access use the following link: http://www.shipfinance.no/IR/tax_treatment.shtml Oslo 27 March, 2007


 

I-D Media Berlin has realised a webcam which runs a livestream from Second Life to Internet websites. Second Life is a virtual world - a permanently developing 3-D environment which is completely created and enhanced by its residents. I-D Media, the service provider for digital interactive communication, developed an online webcam that can broadcast the action in the virtual world to any Internet website. Live events, product presentations, etc. can be followed by users on the home PC without having to log onto Second Life. In this way, enterprises can alert customers, multiplicators and employees to their Second Life activities via their websites, thus significantly expanding their reach. A statistics tool offers information on the number of visitors, the duration of their stay, their activities and much more. The webcam is available as a free service as well as paid service for e.g. company presentations or events. Further information is available at www.sl-foo.com. I-D Media developed the web service based on Second Life Open Source technology. The source code for the Second Life client technology was only released at the beginning of January, making it possible to develop applications for the virtual world. The web service was realised by Product Development at I-D Media, which has also developed www.DizKiz.de, for example - a Web 2.0 application (a so-called mashup) where videos from various platforms can be evaluated on the "hot or not" principle with "Diz" or "Kiz". Second Life (www.secondlife.com) has registered over four million users since October 2006. I-D Media also provides companies with consultation and supervision in setting up their own presence in Second Life as well as its integration in already existing communication channels. About I-D Media AG: Since its establishment in 1988, the company has developed into a provider of innovative marketing and technological solutions. The service offering consists of strategic marketing consulting, creative concept development & design and the production of integrated communication solutions, as well as their integration into existing system environments. In addition to its headquarters in Berlin, I-D Media also operates locations in Cologne and London. Its international clients include: BMW, CMA, Deutsche Telekom, JT International (Camel, Mild Seven, Salem, Winston), Ligne Roset, Nintendo, Premiere, Toshiba, wallpaper and Warsteiner. Contact Christiane Fleiter Corporate Communications I-D Media AG Ohlauer Strasse 43 10999 Berlin +49-(0)30 25947-132 christiane.fleiter@idmedia.com www.idmedia.com


 

Leiden, The Netherlands, March 27, 2007. Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) announced today that the Company's Annual General Meeting of Shareholders (AGM) will be held at the Pharming headquarters in Leiden on May 23, 2007 commencing at 15.00 pm CET. Pharming intends to publish a notice in the Financieele Dagblad and the Euronext Daily Official List (Officiële Prijscourant) of May 8, 2007. All documentation relating to the AGM will be available on Pharming's website as of that date. About Pharming Group NV Pharming Group NV is developing innovative products for the treatment of genetic disorders, ageing diseases, specialty products for surgical indications, intermediates for various applications and nutritional products. Pharming has two products in late stage development - Rhucin® (recombinant human C1 inhibitor) for hereditary angioedema (MAA under review by EMEA) and human lactoferrin for use in food products (GRAS notification under review by US FDA). The advanced technologies of the Company include innovative platforms for the production of protein therapeutics and technology and processes for the purification and formulation of these products, as well as technologies in the field of tissue repair (via its collaboration with NovaThera) and DNA repair (via its acquisition of DNage). Additional information is available on the Pharming website, http://www.pharming.com and on http://www.dnage.nl. This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements. The press release also appears in Dutch. In the event of any inconsistency, the English version will prevail over the Dutch version. Contact: Carina Hamaker (NL) Rein Strijker (NL) Investor Voice Pharming Group NV T: +31 (0)6 537 499 59 T: +31 (0)7 5247 431 T: +31 (0)71 52 47 431


 

27 March 2007 In accordance with Paragraph 6.6.14 of the Listing Rules of the Irish Stock Exchange and Paragraph 9.6.14 of the Listing Rules of the UK Listing Authority, the Company advises that Mr. Anthony Lowrie, a non-executive director of Kenmare, has been appointed to the board of Allied Gold Limited, a company listed on both the Australian Stock Exchange and the London Stock Exchange (AIM). Allied Gold's activities are focused on the development of the Simberi Oxide Gold Project located in the Tabar Islands of Papua New Guinea as well as exploration for gold and copper on the adjacent Tatau and Big Tabar Islands. Allied Gold also has gold and silver projects in Australia and Mexico respectively. For more information: Kenmare Resources plc Michael Carvill, Managing Director Tel: + 353 1 671 0411 Mob: + 353 87 674 0110 Conduit PR Ltd Leesa Peters Tel: + 44 (0) 207 429 6600 Mob: + 44 (0) 781 215 9885 Murray Consultants Ltd Elizabeth Headon Tel: + 353 1 498 0300 Mob: + 353 87 629 1453 www.kenmareresources.com ---END OF MESSAGE---


 

27 March 2007 - Qurius intends to issue 2 million additional B-shares of which 0.5 million B-shares will be used for earn out commitments relating to the acquisition of Faqtgroup Belgium (acquired in November 2005). It is intended to place the remaining 1.5 million B-shares with the large shareholder Parcom Ventures at an issue price of EUR 1.47 per share (5% discount with regard to the closing price on Friday 23 March 2007). We expect that negotiations with Parcom Ventures for this placement will be finalised shortly. The placement with Parcom Ventures will be used by Qurius for financing working capital of the recently acquired company ICM and for restructuring the balance sheet of Watermark Belgium. Together with the already issued 18.6 million B-shares as a result of the Watermark transaction in December 2006, the intended issue of an additional 2 million B-shares would lead to a total of 20.6 million B-shares and the total number of issued shares A and B of 76.6 million. Qurius has an obligation towards Parcom to convert all B-shares into listed A-shares in the second quarter of 2007. With this interim solution Qurius anticipates a structural financing solution for its acquisition strategy, on which the company will provide further information during the second quarter of 2007. Qurius N.V. Qurius provides architecture, realization and systems management of Microsoft technology based business and IT solutions, including infrastructures. Qurius has over 725 staff members; its headquarters are located in Zaltbommel, the Netherlands. Its offices in Belgium, Denmark, Germany, Italy, the Netherlands, Norway, Spain, Sweden and the United Kingdom serve over 1,700 clients. Qurius has been publicly listed on Euronext Amsterdam since 1998. On 18 December 2006, Qurius' shareholders authorized the merger with Watermark, which created Europe's largest Microsoft Dynamics partner. For further information, see www.qurius.com. Contact Qurius, Fred Hermans: telephone +31 (0)418 683 500 or fred.hermans@qurius.com. The press release can be downloaded from the following link:


 

Financial results for the fourth quarter and the fiscal year ended January 31, 2007 MONTREAL, QUEBEC -- (MARKET WIRE) -- March 27, 2007 -- Bombardier Inc.'s (TSX: BBD.A)(TSX: BBD.B) financial results for the fourth quarter and the fiscal year ended January 31, 2007, will be released Wednesday, March 28, 2007. Laurent Beaudoin, Chairman of the Board and Chief Executive Officer, Bombardier Inc.; Pierre Beaudoin, President and Chief Operating Officer, Bombardier Aerospace; Andre Navarri, President, Bombardier Transportation; and Pierre Alary, Senior Vice President and Chief Financial Officer, Bombardier Inc. will hold a conference call intended for investors and financial analysts to review the Corporation's financial results for the fourth quarter and the fiscal year ended January 31, 2007. DATE: Wednesday, March 28, 2007 TIME: 10:00 a.m., Montreal time A question period intended for the media will take place at the end of this same conference call. To participate, media representatives need simply identify themselves when they register for the call. This conference call will be broadcast live on the Internet at the following address: www.bombardier.com Media representatives wishing to listen in on the call will be able to do so by dialing one of the following conference call numbers: Integral version: 514-394-9321 or (without translation) 1-866-540-8119 (toll-free in North America) +2787-2790 (overseas calls) In English: 514-394-9319 or 1-866-240-8935 (toll-free in North America) +2492-4460 (overseas calls) In French: 514-394-9317 or 1-888-791-1369 (toll-free in North America) +4994-8960 (overseas calls) Contacts: Bombardier Inc. Shirley Chenier Senior Director, Investor Relations 514-861-9481 Bombardier Inc. Isabelle Rondeau Director, Communications 514-861-9481 www.bombardier.com


 

STOCK EXCHANGE RELEASE MARCH 27, 2007 TALENTUM'S ANNUAL GENERAL MEETING The Annual General Meeting of Talentum Oyj was held on March 27, 2007. 47.98 % of shares and voting rights were represented. The Annual General Meeting approved the financial statements for the financial year January 1 - December 31, 2006 and discharged the Board of Directors and the Managing Directors from liability. The Annual General Meeting approved to distribute a dividend of EUR 0.18 per share. The record day for payment is March 30, 2007 and the dividend will be paid on April 11, 2007. As members of the Board of Directors were re-elected Manne Airaksinen, Senior Advisor, Harri Kainulainen, Managing Director, Kai Mäkelä, Managing Director, Eero Lehti, Chairman of the Board, Tuomo Saarinen, M.Sc. (Eng.). Atte Palomäki, Communications Director, was elected as a new member. Tuomo Saarinen was re-elected as Chairman of the Board and Manne Airaksinen was re-elected as Deputy Chairman. Authorized Public Accountant firm PricewaterhouseCoopers Oy was re-elected as auditor, with Juha Wahlroos, APA, as the responsible auditor. The Annual General Meeting resolved the compensation of the Board of Directors as follows: Chairman of the Board EUR 4000/month, Deputy Chairman EUR 2500/month, Member EUR 2000/month. The Annual General meeting approved the amendments to the company's articles of association as proposed by the Board of Directors. The Board's proposal to the AGM was published as a stock exchange release on February 23, 2007 and the new Articles of Association is an appendix to this release. Authorization of the Board of Directors to decide on a Share Issue including the Conveyance of own Shares, and Issue of Special Rights The Annual General Meeting authorized the Board of Directors to decide on a share issue which may be either liable to charge or free of charge, including issuing of new shares and the conveyance of own shares possibly in the company's possession. The Annual General Meeting authorized the Board of Directors to decide on an issue of option rights and other special rights which entitle, against payment, to receive new shares or shares possibly in possession of the company. Based on the aforesaid authorizations by virtue of a share issue or issue of special rights, either in one or in several occasions, a maximum of 3,500,000 new shares may be issued and/or own shares possessed by the company may be conveyed, which corresponds to approximately eight per cent of the issued and outstanding shares of the company. The authorizations will remain in force until June 30, 2008. The authorizations do not exclude the right of the Board of Directors to also decide on a directed share issue and directed issue of special rights. Shareholders' pre-emptive subscription rights can be deviated from providing that there is a significant financial reason for the company to do so. Authorization of the Board of Directors to decide on Acquisition of own Shares The Annual General Meeting authorized the Board of Directors to decide on acquisition of its own shares. The shares can be acquired for the value decided by the Board of Directors which value is based on the fair value at the time of the acquisition formed to the shares in the public trading. Own shares may be only acquired with free equity. Based on the authorization, either in one or in several occasions, a maximum of 3,500,000 own shares, which correspond to approximately eight per cent of the issued and outstanding shares of the company, can be acquired. The authorization will remain in force until June 30, 2008. The Board of Directors is otherwise authorized to decide on all the conditions regarding the acquisition of own shares including the manner of acquisition of shares. The authorization does not exclude the right of the Board of Directors to also decide on a directed acquisition of own shares providing that there is a significant financial reason for the company to do so. FURTHER INFORMATION General Counsel Lasse Rosengren, tel. +358 40 342 4204 DISTRIBUTION Helsinki Stock Exchange Principal Media APPENDIX The new Articles of Association of Talentum Oyj


 

` FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Scottish Power Plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 42p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 26 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------------+---------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------------+------------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (2) Derivatives (other than | 15,260,000 | 1.0246 | | | | options) | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (3) Options and agreements | | | | | | to purchase/sell | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | Total | 15,260,000 | 1.0246 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | | | | | | CFD | LONG | 750,000 | 796.6401 | | CFD | LONG | 100,000 | 797.3252 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 27th March 2007 | |-------------------------------------------------+-----------------| | Contact name | James Feast | |-------------------------------------------------+-----------------| | Telephone number | 0207 469 1901 | |-------------------------------------------------+-----------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |-------------------------------------------------+-----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

NEW ORLEANS, LA -- (MARKET WIRE) -- March 27, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX) today announced the presentation of its Aggressive Reduction of Inflammation Stops Events (ARISE) Phase III clinical study of lead drug candidate, AGI-1067, at the American College of Cardiology's 56th Annual Scientific Session. While AGI-1067 did not show a difference from placebo in the composite primary endpoint, the study did achieve a number of other important predefined endpoints. These endpoints included a reduction in the composite of "hard" atherosclerotic clinical endpoints, composed of cardiovascular death, myocardial infarction (heart attack) and stroke, as well as improvement in the key diabetes parameters of new onset diabetes and glycemic control. "The highest bar in clinical research is to improve the prognosis of patients that are already receiving optimal care," said Marc A. Pfeffer, M.D., Ph.D., Professor of Medicine, Harvard Medical School; Cardiologist at Brigham and Women's Hospital and co-principal investigator for the ARISE trial. "Although the formal primary composite endpoint in ARISE was not met, we believe that the trial generated strong evidence that use of AGI-1067 will produce tangible clinical benefits for patients with coronary artery disease." ARISE study findings include: -- Secondary "hard" endpoint -- In a composite of "hard" atherosclerotic endpoints, composed of cardiovascular death, resuscitated cardiac arrest, myocardial infarction (heart attack) and stroke, AGI-1067 achieved a meaningful relative risk reduction of 19 percent (p=0.028). A subgroup analysis indicated that this result was consistent across important sub- populations such as: patients with and without diabetes, and men and women. Furthermore, this result was irrespective of whether patients' baseline cholesterol (LDL and HDL) levels were above or below target. -- Diabetes parameters -- Patients in ARISE taking AGI-1067 were 64 percent less likely to develop new onset diabetes (p < 0.0001). In patients with diabetes, AGI-1067 improved glycemic control as measured by reductions in HbA1c of 0.5 percent at 12 months (p < 0.0001). These patients had a mean baseline HbA1c of 7.2 percent. -- Safety and tolerability -- The most common side effect seen with AGI- 1067 was diarrhea-related; however, it did not frequently result in patient discontinuation (3.3 percent vs. 0.3 percent). There was a small increase in the number of patients with abnormal liver function tests as measured by changes in a combination of liver enzymes and bilirubin (0.2 percent vs. 0.1 percent). "We are pleased with the meaningful improvement of patient outcomes observed with AGI-1067 in ARISE, which should help to address the burden of cardiovascular risk that exists despite our effective contemporary treatments," said Jean-Claude Tardif, M.D., Director of Research; Professor of Medicine, Montreal Heart Institute, University of Montreal, and co-principal investigator of the ARISE trial. "The ARISE trial has shown that AGI-1067 demonstrated considerable efficacy in a number of important therapeutic areas, including heart disease and diabetes," said Rob Scott, M.D., Executive Vice President of Research and Development and Chief Medical Officer of AtheroGenics. "We look forward to our upcoming dialog with regulatory experts to discuss the next steps in the development program for AGI-1067." "We included a number of endpoints in ARISE to assess the impact of AGI-1067 on both cardiovascular disease and diabetes as there exists extensive scientific literature linking oxidative stress and inflammation to both of these therapeutic areas," said Russell M. Medford, M.D., Ph. D., President and Chief Executive Officer of AtheroGenics. "We are encouraged by the results of ARISE and look forward to continuing development of this important drug with the goal of improving patient care." About ARISE The ARISE trial is a Phase III, double-blind, placebo-controlled trial in 6,144 patients with recent acute coronary syndrome (ACS). The trial was conducted in 259 cardiac centers in the United States, United Kingdom, Canada and South Africa. The primary endpoint in the ARISE study was to compare the effect of AGI-1067 to placebo on the time to first incidence of a composite of major adverse cardiovascular events (MACE), specifically cardiovascular death, resuscitated cardiac arrest, myocardial infarction, stroke, need for coronary revascularization and admission to hospital for unstable angina. All patients in the study were well treated with the appropriate standard of care. About AtheroGenics AtheroGenics is focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. In addition to AGI-1067, the Company has another clinical-stage development program studying AGI-1096, a novel, oral agent in Phase I that is being developed for the prevention of organ transplant rejection in collaboration with Astellas. AtheroGenics also has preclinical programs in rheumatoid arthritis and asthma utilizing its proprietary vascular protectant® technology. For more information about AtheroGenics, please visit http://www.atherogenics.com. Disclosure Regarding Forward-Looking Statements This press release contains forward-looking statements that involve significant risks and uncertainties, including preliminary summary statements relating to the analysis of AtheroGenics' ARISE study for AGI-1067 and preliminary summary statements relating to the potential efficacy and safety profile of AGI-1067. These and other statements contained in this press release that relate to events or developments that we expect or anticipate will occur in the future are deemed to be forward-looking statements, and can be identified by words such as "believes," "intends," "expects" and similar expressions. Such statements are subject to certain factors, risks and uncertainties that may cause actual results, events and performances to differ materially from those referred to in such statements. AtheroGenics cautions investors not to place undue reliance on the forward-looking statements contained in this release. The preliminary results discussed in this release may not be confirmed upon full analysis of the detailed results of the ARISE study and additional information relating to the safety, efficacy or tolerability of AGI-1067, may be discovered upon further analysis of trial data. In addition, our forward-looking statements are subject to a number of factors that could cause actual outcomes to differ materially from those expressed or implied in our forward-looking statements, including that the Food and Drug Administration might not allow us to conduct further studies of the efficacy of AGI-1067 for the same or new endpoints, and, to the extent approved, additional clinical trial work may take a significant period of time to complete or require significant additional resources to complete, or that AstraZeneca could terminate its collaboration agreement with us based on the results of the clinical trial. We cannot ensure that AGI-1067 will ever be approved or be proven safe and effective for use in humans. These and other risks are discussed in AtheroGenics' Securities and Exchange Commission filings, including, but not limited to, the risks discussed in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006. The risk factors regarding AtheroGenics that are included under the caption "Risk Factors" in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006 are specifically incorporated by reference into this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. AtheroGenics, Inc. Mark P. Colonnese Chief Financial Officer 678-336-2511 investor@atherogenics.com Media Inquiries Jayme Maniatis/Dana Conti Schwartz Communications, Inc. 781-684-0770 or 508-971-4015 atherogenics@schwartz-pr.com Investor Inquiries Lilian Stern Stern Investor Relations, Inc. 212-362-1200 lilian@sternir.com SOURCE: AtheroGenics


 

"Four C's" reflect Nokia's strategy to connect millions of mobile workers ORLANDO, FL - March 27, 2007 - "Convergence" isn't just about technologies coming together. It's about a rapidly-consolidating playing field where companies "converge" to lead the future of business mobility. Nokia is poised to lead this convergence. At CTIA Wireless 2007 the company is showing how its business mobility products, solutions, ecosystem and strategy will benefit millions of mobile professionals in their work and personal lives and make it easier for IT managers to deploy and manage mobility solutions. The combination of the Nokia Intellisync mobileware platform and Nokia Eseries devices significantly increases potential for businesses to achieve new levels of productivity and competitive advantage. It also presents opportunities for operators, service providers and systems integrators to drive subscriber growth and technology adoption with the advent of new solutions and capabilities. "The mobile industry is clearly at a tipping point, in more ways than one," said Scott Cooper, vice president, Mobility Solutions, Enterprise Solutions, Nokia. "We are seeing a more strategic approach to mobility - a shift from the point solution implementations that we've encountered in the past three years, to a new, more comprehensive approach to mobility. Enterprise customers will enjoy the benefits of always-on, robust and secure mobility solutions, beyond mobile email delivered to the executive suite or traveling sales staff." The advantages of adopting Nokia's mobility solutions can be articulated in "Four C's": Connectivity, Cost-savings, Creativity, Culture Connectivity: Nokia can connect with more devices, on more platforms, using more operating systems and technologies, than any other mobility or technology vendor. - Nokia Intellisync Mobile Suite offers the most extensive device support in the industry, 100+ devices on five platforms: Symbian, WindowsMobile, Palm, UIQ, J2ME - Nokia Intellisync mobileware is a platform that extends well beyond email, delivering mobile connectivity to virtually any business application or data source - With a vast suite of products that grow with the customer's business, Nokia mobile solutions meet current and future mobility needs Cost-savings: Nokia solutions drive efficiency and security for businesses, translating to higher return on investment and improved worker productivity. - Common user interface makes training, scaling and troubleshooting easier - Compatibility with a variety of back-end solutions like MS Exchange, Lotus Domino, Novell GroupWise and other POP/IMAP corporate messaging platforms protects a company's existing email infrastructure - IP PBX-compatible mobile devices enable significant communications cost-savings to the enterprise by using VoIP in addition to cellular calling - Device management drives cost-savings and simplicity for IT managers, via traceability, security and over-the-air application installations - Consolidation of wireless, landline and data in ONE device simplifies support, drives scalability and realizes savings Creativity: Nokia simplifies the process of connecting people, empowering them to focus on collaboration to drive business success. - Enabling data retrieval and distribution across any network connection to any device - Allowing third-party developers to customize robust applications unique to individual companies due to the open standards platform - Enabling rich end-user features and "beyond email" capabilities offered by application and filesync Culture: Nokia products and solutions deliver on a future where everyone is connected. - Giving mobile workers the ability to manage work/life balance effectively - Allowing companies to foster environments of innovation, collaboration and productivity At CTIA, visitors to the Nokia stand (Hall B1 Booth #2537) can see demonstrations of the Nokia Intellisync Mobile Suite 8.0, the industry's most comprehensive platform for business mobility. Nokia Intellisync Mobile Suite 8.0 combines a comprehensive platform of wireless email, file synchronization and application synchronization, with the full security, asset collection, reporting, and control via fully integrated device management. Nokia will also be showcasing its business optimized Nokia Eseries devices, as well as software and enhancements at the show. Highlights include Nokia E62 and the anticipated second wave of Nokia Eseries business devices. In addition, featured offerings include other mobile application solutions such as business voice and VoIP over WLAN. About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. www.nokia.com. Media Enquiries: Nokia, Americas Communications Tel. +1 972 894 4573 Email: communication.corp@nokia.com Nokia, APAC Communications Tel. +65 6723 2323 Email: communications.apac@nokia.com Nokia Communications Tel. +358 7180 34900 Email: press.office@nokia.com www.nokia.com --- End of Message --- NOKIA P.O. Box 226<br>FIN-00045 NOKIA GROUP Espoo WKN: 870737; ISIN: FI0009000681; Index: DJ STOXX Large 200, DJ STOXX 50; Listed: Nordic list (Large Cap) in THE HELSINKI STOCK EXCHANGE;


 

Operator to Offer Mobile Broadband Service in Four Key Metropolitan Areas SANTO DOMINGO, DOMINICAN REPUBLIC -- (MARKET WIRE) -- March 27, 2007 -- Wind Telecom, a new network operator in the Dominican Republic, and Nortel(1) (TSX: NT)(NYSE: NT) have signed a Letter of Agreement expressing their firm commitment to deploy a wireless broadband network based on Nortel WiMAX technology. Wind Telecom intends to offer high-speed broadband services to urban and rural customers across the country. The network is expected to be commercially available in September 2007 in the initial launch cities of Santo Domingo, Santiago, Puerto Plata and Bavaro/Punta Cana, with other areas such as La Romana, projected for the near future. Nationwide coverage will be reached incrementally over the next few years. The award of the contract is subject to the execution of a final, legally binding agreement. Wind Telecom will use Nortel's MIMO-powered WiMAX innovations to deliver services such as VoIP, video-streaming and mobile broadband, which are expected to help bridge the digital divide in the Dominican Republic where broadband services have been limited. Subscribers will be able to benefit from the wealth of information and economic advantages such as e-commerce that are accessible through the use of advanced technologies. "Wind Telecom is striving to make affordable broadband services available to the mass market in the Dominican Republic, where the adoption of these services has been slow due to high prices, limited availability and insufficient competition. We will be a full service provider of voice, data, and video services," said Manuel Bonilla, CEO, Wind Telecom. "Nortel's WiMAX solution allows us to achieve the goal of affordable broadband for both business and individual consumers, without the complexities of building a wired network. This makes it especially well suited to historical cities like Santo Domingo where the inner-city is dense with buildings, as well as for sub-urban and rural services." "Wind Telecom firmly believes in the future of the Dominican Republic. The investment environment favors competition and innovation, allowing a greenfield operator with leading-edge disruptive technology to enter the market and become a prime competitor," said Jose Clase, chairman of the board of Wind Telecom. "Our company has the unique opportunity of significantly contributing to the development of the Dominican Republic while at the same time creating a prosperous telecom business." "With this end-to-end solution, Wind Telecom will become one of the first wireless broadband operators in the Dominican Republic to support fixed, portable, and mobile services," said Peter MacKinnon, general manager of WiMAX, Nortel. "With its high-bandwidth capabilities, minimal infrastructure requirements and one of the lowest costs per megabit in the industry, Nortel's WiMAX solution will help Wind Telecom position itself as a premium network operator." The network will be an end-to-end solution for Wind Telecom, including consumer devices, mobile WiMAX base stations, ASN gateway, business support system (BSS) and operational support system (OSS) platforms as well as professional services such as training. All proposed base stations will be operating in the 2.5GHz frequency band. As well as supplying the equipment, Nortel is to be responsible for the deployment, support and maintenance of Wind Telecom's entire network. Nortel's 4G WiMAX solution (standard 802.16e) delivers one of the highest performances in the smallest footprint with one of the most competitive costs per megabit in the industry. It is built on a foundation of OFDM-MIMO, a combination of innovative transmission and antenna technologies that maximizes spectrum to deliver the lightning-fast speeds and high bandwidth essential to high-quality mobile video and TV. About Wind Telecom, S.A. Wind Telecom is a company headquartered in Santo Domingo, Dominican Republic, and it is fully funded by a group of Dominican and international investors. The company will deploy broadband networks to complement and compete in the telecommunications market of the Dominican Republic, with the technological support of Nortel. Wind Telecom owns 200 Mhz of spectrum in the 2.5 Ghz band and therefore has the capability to deploy a nationwide WiMAX network and become a significant contributor to the Dominican telecommunications community. About Nortel Nortel is a recognized leader in delivering communications capabilities that make the promise of Business Made Simple a reality for our customers. Our next-generation technologies, for both service provider and enterprise networks, support multimedia and business-critical applications. Nortel's technologies are designed to help eliminate today's barriers to efficiency, speed and performance by simplifying networks and connecting people to the information they need, when they need it. Nortel does business in more than 150 countries around the world. For more information, visit Nortel on the Web at www.nortel.com. For the latest Nortel news, visit www.nortel.com/news. Certain statements in this press release may contain words such as "could", "expects", "may", "anticipates", "believes", "intends", "estimates", "targets", "envisions", "seeks" and other similar language and are considered forward-looking statements or information under applicable securities legislation. These statements are based on Nortel's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which Nortel operates. These statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and the actual outcome may be materially different. Further, actual results or events could differ materially from those contemplated in forward-looking statements as a result of the following (i) risks and uncertainties relating to Nortel's restatements and related matters including: Nortel's most recent restatement and two previous restatements of its financial statements and related events; the negative impact on Nortel and NNL of their most recent restatement and delay in filing their financial statements and related periodic reports; legal judgments, fines, penalties or settlements, or any substantial regulatory fines or other penalties or sanctions, related to the ongoing regulatory and criminal investigations of Nortel in the U.S. and Canada; any significant pending civil litigation actions not encompassed by Nortel's proposed class action settlement; any substantial cash payment and/or significant dilution of Nortel's existing equity positions resulting from the approval of its proposed class action settlement; any unsuccessful remediation of Nortel's material weaknesses in internal control over financial reporting resulting in an inability to report Nortel's results of operations and financial condition accurately and in a timely manner; the time required to implement Nortel's remedial measures; Nortel's inability to access, in its current form, its shelf registration filed with the United States Securities and Exchange Commission (SEC), and Nortel's below investment grade credit rating and any further adverse effect on its credit rating due to Nortel's restatements of its financial statements; any adverse affect on Nortel's business and market price of its publicly traded securities arising from continuing negative publicity related to Nortel's restatements; Nortel's potential inability to attract or retain the personnel necessary to achieve its business objectives; any breach by Nortel of the continued listing requirements of the NYSE or TSX causing the NYSE and/or the TSX to commence suspension or delisting procedures; (ii) risks and uncertainties relating to Nortel's business including: yearly and quarterly fluctuations of Nortel's operating results; reduced demand and pricing pressures for its products due to global economic conditions, significant competition, competitive pricing practice, cautious capital spending by customers, increased industry consolidation, rapidly changing technologies, evolving industry standards, frequent new product introductions and short product life cycles, and other trends and industry characteristics affecting the telecommunications industry; the sufficiency of recently announced restructuring actions, including the potential for higher actual costs to be incurred in connection with these restructuring actions compared to the estimated costs of such actions and the ability to achieve the targeted cost savings and reductions of Nortel's unfunded pension liability deficit; any material and adverse affects on Nortel's performance if its expectations regarding market demand for particular products prove to be wrong or because of certain barriers in its efforts to expand internationally; any reduction in Nortel's operating results and any related volatility in the market price of its publicly traded securities arising from any decline in its gross margin, or fluctuations in foreign currency exchange rates; any negative developments associated with Nortel's supply contract and contract manufacturing agreements including as a result of using a sole supplier for key optical networking solutions components, and any defects or errors in Nortel's current or planned products; any negative impact to Nortel of its failure to achieve its business transformation objective; additional valuation allowances for all or a portion of its deferred tax assets; Nortel's failure to protect its intellectual property rights, or any adverse judgments or settlements arising out of disputes regarding intellectual property; changes in regulation of the Internet and/or other aspects of the industry; Nortel's failure to successfully operate or integrate its strategic acquisitions, or failure to consummate or succeed with its strategic alliances; any negative effect of Nortel's failure to evolve adequately its financial and managerial control and reporting systems and processes, manage and grow its business, or create an effective risk management strategy; and (iii) risks and uncertainties relating to Nortel's liquidity, financing arrangements and capital including: the impact of Nortel's most recent restatement and two previous restatements of its financial statements; any inability of Nortel to manage cash flow fluctuations to fund working capital requirements or achieve its business objectives in a timely manner or obtain additional sources of funding; high levels of debt, limitations on Nortel capitalizing on business opportunities because of support facility covenants, or on obtaining additional secured debt pursuant to the provisions of indentures governing certain of Nortel's public debt issues and the provisions of its support facility; any increase of restricted cash requirements for Nortel if it is unable to secure alternative support for obligations arising from certain normal course business activities, or any inability of Nortel's subsidiaries to provide it with sufficient funding; any negative effect to Nortel of the need to make larger defined benefit plans contributions in the future or exposure to customer credit risks or inability of customers to fulfill payment obligations under customer financing arrangements; any negative impact on Nortel's ability to make future acquisitions, raise capital, issue debt and retain employees arising from stock price volatility and further declines in the market price of Nortel's publicly traded securities, or the share consolidation resulting in a lower total market capitalization or adverse effect on the liquidity of Nortel's common shares. For additional information with respect to certain of these and other factors, see Nortel's Annual Report on Form10-K/A, Quarterly Reports on Form 10-Q and other securities filings with the SEC. Unless otherwise required by applicable securities laws, Nortel disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (1)Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks. Contacts: Nortel Fabiana Coelho +55 11 5644-4334 Email: fcoelho@nortel.com Nortel Karen Monaghan (613) 763-1133 Email: kmonagha@nortel.com Website:www.nortel.com Wind Telecom Carlos Villamil (809) 508-3134


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- March 27, 2007 -- ROMARCO MINERALS INC. (TSX VENTURE: R) announces that it has divested of its 50% interest in the Cori Puncho Gold Project in Peru to its Joint Venture partner New Dimension Resources Ltd. (TSX VENTURE: NDR). Romarco will retain a 5% NSR on the project for as long as the project is held by New Dimension. In the event New Dimension enters into a Joint Venture with another party, Romarco has the ability to re-coup its initial investment by receiving 25% of any cash proceeds to New Dimension up to a maximum of US$100,000. Romarco has written-off the associated deferred costs of $389,662 as at December 31, 2006. Divesting of this interest allows Romarco to focus on its Pinos Gold Project in Mexico and its Nevada exploration projects. Pinos Drilling Update: Romarco has completed five holes to date and has assays pending. Hole PDDH-5 intersected an 8.5 meter wide vein and the drill hole ended in vein - see photos on Romarco's website (www.romarco.com). Four of the five drill holes have intersected vein or stockwork vein which confirms that the previously mined veins extended to at least 200 meters below the historic workings (which ended at approximately 100 m). Hole PDDH-2 intersecting a cross-cutting fault and missed the vein intersected in Hole PDDH-1 from the same location. Romarco is continuing to sample underground and outcropping veins on the project area - one in particular is the Penitas Vein (on Romarco's 100% property). The Penitas Vein is a 7.5 meter wide vein exposed at surface. Initial channel sample results returned an average of 6 g/t gold and 190 g/t silver. Pine Grove Drilling Update: Romarco has assay results pending on the first two reverse circulation holes drilled in the 2007 program. A core drilling rig is anticipated to be on the property in early May to complete the first phase of the 2007 program on the east side of the property. Romarco has plans to drill the Rockland Mine area in 2007 and is waiting on permits. Tommy Thompson is Romarco's Q.P. on the Pinos Project and Tom Kilbey is Romarco's Q.P. on the Pine Grove Project. Romarco Minerals is an advanced stage exploration company with 5 projects in Nevada and one gold district in Zacatecas, Mexico. ON BEHALF OF ROMARCO MINERALS INC. Diane R. Garrett, President and C.E.O. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release, which has been prepared by management. Contacts: Romarco Minerals Inc. Diane Garrett President and C.E.O. (830) 634-7489 Email: dgarrett@romarco.com Romarco Minerals Inc. Mr. Ralf Langner C.F.O. (604) 688-9271 (604) 688-9274 (FAX) Email: rlangner@romarco.co


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Unicorn Asset Management | | | Limited | |----------------------------------------+--------------------------| | Company dealt in | Compel Group plc | |----------------------------------------+--------------------------| | Class of relevant security to which | 5p Ordinary Shares | | the dealings being disclosed relate | | | (Note 2) | | |----------------------------------------+--------------------------| | Date of dealing | 26 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-----------------------------------------------------------------------------------+ | | Long | Short | | | | | |---------------+--------------------------+----------------------------------------| | |Number |Number | | | (%) | (%) | |---------------+--------------------------+----------------------------------------| |(1) Relevant |4,830,544 | | |securities |(14.23%) | | | | | | |---------------+--------------------------+----------------------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+--------------------------+----------------------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+--------------------------+----------------------------------------| |Total |4,830,544 | | | |(14.23%) | | +-----------------------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +--------------------------------------------------------------------------+ |Class of | Long | Short | |relevant | | | |security: | | | | | | | |---------------+----------------------------+-----------------------------| | |Number |Number | | | (%) | (%) | |---------------+----------------------------+-----------------------------| |(1) Relevant | | | |securities | | | | | | | |---------------+----------------------------+-----------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+----------------------------+-----------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+----------------------------+-----------------------------| |Total | | | | | | | +--------------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | Sale | 487,840 | 147.3p | | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short (Note | Number of securities | Price per | | name, | 6) | (Note 7) | unit (Note | | e.g. CFD | | | 5) | |----------+------------------+------------------------+------------| | | | | | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | Remaining holding in Compel Group plc is subject to a deed of | | irrevocable undertaking to accept e2e's offer of 149.3 pence per | | share. | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 27 March 2007 | |---------------------------------------------------+---------------| | Contact name | Sam Barton | |---------------------------------------------------+---------------| | Telephone number | 020 7253 0889 | |---------------------------------------------------+---------------| | If a connected EFM, name of offeree/offeror with | | | which connected | | |---------------------------------------------------+---------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

SAN JOSE, CA -- (MARKET WIRE) -- March 27, 2007 -- Cisco Systems, Inc. (NASDAQ: CSCO) today announced that its wholly owned subsidiary, Wonder Acquisition Corp., has commenced its tender offer for all outstanding shares of WebEx Communications, Inc. (NASDAQ: WEBX), at a price of $57.00 per share net to the seller in cash without interest, less brokerage fees and less any required withholding taxes. On March 15, 2007, Cisco and WebEx announced that they had signed a definitive merger agreement for Cisco to acquire WebEx. The Board of Directors of WebEx had previously unanimously approved the merger agreement and the transactions contemplated thereby, including the tender offer; declared that it is in the best interests of WebEx's stockholders for WebEx to enter into the merger agreement and the transactions contemplated thereby; declared that the tender offer is fair to WebEx's stockholders; and recommended that holders of shares of WebEx common stock accept the offer and tender their shares in the offer. The tender offer is subject to certain conditions set forth in the Offer to Purchase referenced below, including a minimum share tender condition, the expiration or termination of the Hart-Scott-Rodino waiting period, and the obtainment of applicable approvals under the antitrust, competition or merger control laws of other countries, and other customary conditions, as set forth in the merger agreement. Unless the tender offer is extended, the tender offer and any withdrawal rights to which WebEx's stockholders may be entitled will expire at 12:00 midnight, New York City time, on April 23, 2007 (which is the end of the day on April 23, 2007). Following the acceptance for payment of shares in the tender offer and completion of the transactions contemplated in the merger agreement, WebEx will become a wholly owned subsidiary of Cisco. The complete terms and conditions of the tender offer are set forth in the Offer to Purchase, Letter of Transmittal and other related materials filed by Cisco and Wonder Acquisition Corp. with the SEC on March 27, 2007. In addition, on March 27, 2007, WebEx filed a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC relating to the tender offer. Copies of the Offer to Purchase, Letter of Transmittal and other related materials, including the Solicitation/Recommendation Statement, are available free of charge from Georgeson Inc., the information agent for the tender offer, toll-free at (888) 264-7052 (banks and brokers call (212) 440-9800), or Lehman Brothers Inc., the dealer manager for the tender offer, at (888) 610-5877 (toll free). Computershare Trust Company of New York is acting as depositary for the tender offer. Securities Law Disclosure This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities. The solicitation and the offer to buy shares of WebEx common stock will be made only pursuant to an offer to purchase and related materials that Cisco Systems, Inc. and Wonder Acquisition Corp. have filed with the SEC on Schedule TO on March 27, 2007. WebEx also has filed a solicitation/recommendation statement on Schedule 14D-9 with respect to the offer. WebEx stockholders and other investors should read these materials carefully because they contain important information, including the terms and conditions of the offer. WebEx stockholders and other investors may obtain copies of these materials without charge from the SEC through the SEC's website at www.sec.gov, from Georgeson Inc., the information agent for the offer, toll-free at (888) 264-7052 (banks and brokers call (212) 440-9800), from Cisco (with respect to documents filed by Cisco with the SEC) by going to Cisco's Investor Relations Website at http://www.cisco.com/go/investors, or from WebEx (with respect to documents filed by WebEx with the SEC) by going to WebEx's Investor Relations Website at www.WebEx.com. Stockholders and other investors are urged to read carefully those materials prior to making any decisions with respect to the offer. About Cisco Systems Cisco (NASDAQ: CSCO) is the worldwide leader in networking that transforms how people connect, communicate and collaborate. Information about Cisco can be found at http://www.cisco.com. For ongoing news, please go to http://newsroom.cisco.com Cisco, Cisco Systems, and the Cisco Systems logo are registered trademarks or trademarks of Cisco Systems, Inc. and/or its affiliates in the United States and certain other countries. All other trademarks mentioned in this document are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. This document is Cisco Public Information. For direct RSS Feeds of all Cisco news, please visit "News@Cisco" at the following link: http://newsroom.cisco.com/dlls/podcasts/rss.html Press Contact: John Noh 408 853-8445 jnoh@cisco.com Investor Relations Contact: Laura Graves 408 526-6521 lagraves@cisco.com


 

Active Biotech (ACTI.ST) publishes a new paper* in the next issue of the scientific journal "The Prostate", in collaboration with Dr. John T. Isaacs of The Johns Hopkins University School of Medicine, Baltimore, MD, USA. The article presents pre-clinical data regarding Active Biotech's project TASQ for the treatment of prostate cancer. The objective for the TASQ project is to develop a pharmaceutical product that can be administered orally for the chronic treatment of prostate cancer. TASQ is currently in Phase I clinical trials in prostate cancer patients. Phase II studies are scheduled to commence during 2007. The tumor growth of a series of human prostate cancer xenografts in male nude mice given nothing vs. TASQ alone, or in combination with androgen ablation or with androgen ablation plus docetaxel (Taxotere®), were evaluated. Daily oral treatment with TASQ consistently inhibited the tumor growth of all of the six xenograft models tested in a dose dependent manner via an anti-angiogenic response. TASQ's anti-prostate cancer efficacy was enhanced when combined with androgen ablation or with androgen ablation plus docetaxel. The results also documented that differences in serum PSA in TASQ treated hosts vs. controls are related to inhibition of tumor growth. This indicates that in humans, changes in PSA velocity or doubling time may indicate a therapeutic response to TASQ. Lund, March 27, 2007 Active Biotech AB (publ) Sven Andréasson President and CEO * "The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and Taxotere without effecting serum PSA directly in human xenografts" , Dalrymple SL, Becker RE, Isaacs JT. (PMID: 17373719, pre-available as an e-publication at NCBI National Center for Biotechnology, http://www.ncbi.nlm.nih.gov/). Active Biotech AB is a biotechnology company focusing on research and development of pharmaceuticals. Active Biotech has a strong R&D portfolio with pipeline products focused on autoimmune/inflammatory diseases and cancer. Most advanced projects are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, as well as ANYARA for use in cancer immunotherapy with the primary indication non-small cell lung cancer. Further key projects in clinical development comprise the three orally administered compounds TASQ for prostate cancer 57-57 for SLE and RhuDex® for RA. In addition, the preclinical development of the I-3D project is being conducted in cooperation with Chelsea Therapeutics. Active Biotech AB Box 724, SE-220 07 Lund Tel: +46 46-19 20 00 Fax: +46 46-19 20 50 www.activebiotech.com


 

Notification of Substantial Shareholding Pursuant to the obligation placed on us by LR6.6.7 of the Listing Rules, we advise that on 26th March 2007 the Company received notification that Credit Suisse Securities (Europe) Limited has a notifiable interest in 2,256,783 ICG Units, representing 9.6% of the Company's issued share capital. The breakdown of registered holders has been notified as follows: Registered Holder .............No. of Shares held Credit Suisse Securities (Europe) Limited .........2,255,652 Credit Suisse International...................1,131 Tom Corcoran Company Secretary 26 March 2007 ---END OF MESSAGE---


 

Orlando, Fla. - At CTIA Wireless 2007, Nokia and Siemens are debuting in North America their future joint venture Nokia Siemens Networks just days before the new company's start of operations on April 1, 2007. The North American market is a global strategic opportunity for the future Nokia Siemens Networks. At a press conference on Tuesday, March 27 at 12 p.m., in Room 312B, Global CEO Designate Simon Beresford-Wylie and North American Region Head Designate Mark Louison will reveal the new company's regional plans to emerge as the leading communications infrastructure supplier in North America. They will discuss how the new company is equipped with best-in-class products, solutions, and end-to-end capabilities that target the unique challenges of North American operators. "The communications industry has a truly historic opportunity ahead of us to bring mobile and fixed broadband connections to the five billion people who will be 'always on' by 2015," said Simon Beresford-Wylie, CEO Designate. "Nokia Siemens Networks will begin operations as one of the top three infrastructure suppliers in the world with the scale and resources to emerge as the leader in critical markets like North America." On the show floor at Booth #2725 and in its Mobile Experience Center outside the convention center, representatives of the future Nokia Siemens Networks will present innovative, live demonstrations of how communications providers can bring fixed, mobile or converged networks to life for both consumers and businesses in North America. They will discuss how the convergence of fixed and mobile communications is fueling the creation of new services that are transforming the way people live and work. The future Nokia Siemens Networks will be at the forefront of this transformation, working to enable exciting services for everyone, anywhere, anytime. "North America will be a critical market in shaping the industry as telecom, the Internet, media, and IT continue to converge and create new companies and business models," said Mark Louison, Head of North America Designate. "Nokia Siemens Networks will be uniquely positioned to have the products, solutions, and people to work with operators to create new revenue streams as they transform their businesses in this converging world." Experience innovative converged technologies with the future Nokia Siemens Networks At Booth #2725 and in the Mobile Experience Center outside the convention center, there will be hands-on demonstrations of today's most compelling solutions for operators. Demonstrations will be organized in three main areas, Operational Fitness, New Revenue Opportunities and Transform Your Business: 1. Operational Fitness - "Fit for Business," a software-based tool that allows benchmarking and modeling of an operator's business and infrastructure plans and helps to assess an operator's market position, growth opportunities and ways to improve overall profitability. - Service Delivery Framework (SDF), to streamline the pre-integration of best-of-breed solutions in networks, reducing time-to-market and increasing time-in-market. - Operations Support Systems (OSS), which can help manage the complexity of fixed, mobile or converged networks, but also generate new revenue streams. 2. New Revenue Opportunities - IPTV/Home Entertainment Service, which makes it easy for consumers to enjoy IP-based real-time home entertainment and communication services, including integrated video telephony and video sharing based on the IP Multimedia Subsystem (IMS) and Service Delivery Framework (SDF). - Hosted IP Centrex, which demonstrates an operator hosted business communication solution that enables carriers to provide network-based enterprise PBX-like services supported on any next-generation network architecture. - Voice Call Continuity (VCC), which offers a competitive advantage for an operator by allowing them to differentiate their VoIP offering as VCC, is not restricted to just home or office use, but can be used in both locations due to being a hosted service provided by an operator. - Enhancing Developer Communities, an IMS developer program that accelerates the development and reduces the "time to market" for new IMS-based applications. 3. Transform your Business - Multimedia Broadcast Multicast Service (MBMS), showing a more efficient future for services such as podcasting and TV streaming using cellular access and mobile devices. - Mobile Backhaul, which demonstrates comprehensive new solutions and technology options for optimizing the broadband access via a new system to translate ATM, TDM and IP protocols to Carrier Ethernet, transport and backhauling of mobile services over 3G and also future radio technologies. - Radio Evolution, which showcases how operators can minimize network deployment and operational costs with the market leading Nokia Flexi Base Station, the smallest and most efficient multi-technology base station with a unique design and architecture that delivers the benefits of modularity to GSM/EDGE, WCDMA/HSPA and WiMAX operators by optimizing the total value of ownership and energy efficiency for radio access networks. WiMAX will be demonstrated in the Mobile Experience Center. - Long Term Evolution (LTE), is the next evolution for all FDD based mobile networks like GSM, WCDMA and CDMA. LTE promises delivery of new multimedia intensive and rich call applications with full mobility and a flat network architecture. Flat network architectures will be introduced with Internet-HSPA to provide reduction in operational costs and improved user experience in WCDMA and a smooth migration path to LTE. LTE will be demonstrated in the Mobile Experience Center with data speeds in the 160Mb/s range. For members of the media who would like to request interviews or experience demonstrations in the Mobile Experience Center at CTIA Wireless 2007, please call Lauren Barbier at +1 713-253-2442. Nokia Siemens Networks will start operations on April 1, 2007, excluding Argentina, Colombia and Russia where anti-trust approval may still be pending. About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. About Siemens AG Siemens AG (NYSE:SI) is one of the largest global electronics and engineering companies with reported worldwide sales of $96 billion in fiscal 2005. Founded nearly 160 years ago, the company is a leader in the areas Medical, Power, Automation and Control, Transportation, Information and Communications, Lighting, Building Technologies, Water Technologies and Services and Home Appliances. With its U.S. corporate headquarters in New York City, Siemens in the USA has sales of $18.8 billion and employs approximately 70,000 people throughout all 50 states and Puerto Rico. Eleven of Siemens' worldwide businesses are based in the United States. With its global headquarters in Munich, Siemens AG and its subsidiaries employ 460,000 people in 190 countries. For more information on Siemens in the United States: www.usa.siemens.com About Siemens Networks LLC Siemens Networks* engages in a dialog with its customers to create trendsetting communications solutions that help network operators and service providers achieve their business goals. Siemens Networks contributes its innovative strength, worldwide experience and notable implementation expertise in all areas of voice and data communications. As an innovation leader, Siemens Networks delivers customer value today and prepares customers for tomorrow with trendsetting solutions. Siemens Networks is a fully-owned subsidiary of Siemens AG and operates in about 100 countries. More about Siemens Networks at www.siemens.com/networks Forward looking Statements It should be noted that certain statements herein which are not historical facts, including, without limitation, those regarding: A) the timing of product and solution deliveries; B) our ability to develop, implement and commercialize new products, solutions and technologies; C) expectations regarding market growth, developments and structural changes; D) expectations regarding our mobile device volume growth, market share, prices and margins; E) expectations and targets for our results of operations; F) the outcome of pending and threatened litigation; G) expected timing, scope and effects of the merger of Nokia's and Siemens' communications service provider businesses; and H) statements preceded by "believe," "expect," "anticipate," "foresee," "target," "estimate," "designed," "plans," "will" or similar expressions are forward-looking statements. Because these statements involve risks and uncertainties, actual results may differ materially from the results that we currently expect. Factors that could cause these differences include, but are not limited to: 1) the extent of the growth of the mobile communications industry, as well as the growth and profitability of the new market segments within that industry which we target; 2) the availability of new products and services by network operators and other market participants; 3) our ability to identify key market trends and to respond timely and successfully to the needs of our customers; 4) the impact of changes in technology and our ability to develop or otherwise acquire complex technologies as required by the market, with full rights needed to use; 5) competitiveness of our product portfolio; 6) timely and successful commercialization of new advanced products and solutions; 7) price erosion and cost management; 8) the intensity of competition in the mobile communications industry and our ability to maintain or improve our market position and respond to changes in the competitive landscape; 9) our ability to manage efficiently our manufacturing and logistics, as well as to ensure the quality, safety, security and timely delivery of our products and solutions; 10) inventory management risks resulting from shifts in market demand; 11) our ability to source quality components without interruption and at acceptable prices; 12) our success in collaboration arrangements relating to development of technologies or new products and solutions; 13) the success, financial condition and performance of our collaboration partners, suppliers and customers; 14) any disruption to information technology systems and networks that our operations rely on; 15) our ability to protect the complex technologies that we or others develop or that we license from claims that we have infringed third parties' intellectual property rights, as well as our unrestricted use on commercially acceptable terms of certain technologies in our products and solution offerings; 16) general economic conditions globally and, in particular, economic or political turmoil in emerging market countries where we do business; 17) developments under large, multi-year contracts or in relation to major customers; 18) exchange rate fluctuations, including, in particular, fluctuations between the euro, which is our reporting currency, and the US dollar, the Chinese yuan, the UK pound sterling and the Japanese yen; 19) the management of our customer financing exposure; 20) our ability to recruit, retain and develop appropriately skilled employees; 21) the impact of changes in government policies, laws or regulations; and 22) satisfaction of the conditions to the merger of Nokia's and Siemens' communications service provider businesses, including achievement of agreement between Nokia and Siemens on the results and consequences of a Siemens compliance review, and closing of transaction, and Nokia's and Siemens' ability to successfully integrate the operations and employees of their respective businesses; as well as 23) the risk factors specified on pages 12 - 22 of the company's annual report on Form 20-F for the year ended December 31, 2005 under "Item 3.D Risk Factors." Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Nokia does not undertake any obligation to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required. Media Inquiries: Nokia Chantal Boeckman Tel. +1 469-789-9594 Email: chantal.boeckman@nokia.com Siemens Susan de Jong Tel. +1 561-350-5252 Email: susan.dejong@siemens.com For interviews Lauren Barbier Tel. +1 713-253-2442 --- End of Message --- NOKIA P.O. Box 226<br>FIN-00045 NOKIA GROUP Espoo WKN: 870737; ISIN: FI0009000681; Index: DJ STOXX Large 200, DJ STOXX 50; Listed: Nordic list (Large Cap) in THE HELSINKI STOCK EXCHANGE;


 

Ericsson (NASDAQ:ERIC) has been awarded two contracts for hosted services by SunCom Wireless, a leading wireless phone service provider in the southeast of the US, Puerto Rico and the US Virgin Islands. The first agreement is for prepaid services and the second for ringback tones. The agreements reinforce the global growth trend in managed services as vendors and service providers work as partners to reduce operating costs and bring services to market as quickly as possible. Ericsson will integrate, host, manage, maintain and support the systems for the two services, and provide service offering development, market segmentation and positioning support for SunCom's prepaid and ringback tones market introduction activities. Larry Britt, Vice President, Marketing, SunCom, says: "We continue to focus on delivering our customers a broad and complete portfolio of service plans, features, downloadables and much more. There's great demand for the flexibility, convenience and ease-of-use of prepaid service plans. "Customers enjoy personalizing the wireless experience with ringback tones and other popular SunCom features. Once we decided to move forward and develop our prepaid services, we moved quickly providing pay-as-you-go services to the market in about 90 days. Ericsson's track record in this area helped us expedite delivery of a customized program that meets the expectations of SunCom Wireless and our customers." Angel Ruiz, President of Ericsson in the US, says: "We are pleased SunCom Wireless has chosen Ericsson to host two more services for them; it proves that hosting is a good business model for operators when launching new services. Ericsson and SunCom have worked together in the hosting of Napster Mobile, and we look forward to further extending our strong partnership into the areas of systems integration and managed services." There's a great potential in net subscriber additions and many potential customers need a fast track to purchase minutes and package plans without a lengthy credit check. By teaming with Ericsson, a market leader in both charging systems and managed services, SunCom is now able to deliver a desirable prepaid service to its customers, which will generate a revenue source that will only grow. The ringback tones solution, based on Ericsson's Personalized Greeting Service, will enable SunCom Wireless customers to use songs or other sounds to replace the standard tone callers hear as they wait for their call to be answered. Ericsson takes responsibility for content aggregation, ingestion and publishing of the ringback tones service delivering a true end-to-end solution to SunCom. Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at http://www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com About SunCom Wireless SunCom Wireless is a leader in offering digital wireless communication services to consumers in the southeast of the US, Puerto Rico and the US Virgin Islands. With more than 1 million subscribers, SunCom is committed to being a different kind of wireless company focused on treating customers with respect, offering simple, straightforward plans and providing access to the largest GSM network and the latest technology choices. SunCom Wireless is a proud provider of Wireless AMBER Alerts. For more information about SunCom products and services, visit www.suncom.com. About Ericsson's managed services offering Ericsson has the telecom industry's most comprehensive managed services offering, ranging from designing, building, operating and managing day-to-day operations of a customer's network, to hosting service applications and enablers, as well as providing network coverage and capacity on demand. As the undisputed leader in managed services, Ericsson has, since 2002, officially announced more than 100 contracts for managed services. Excluding its hosting agreements, Ericsson is currently managing networks that together serve more than 100 million subscribers, worldwide.


 

Ericsson (NASDAQ:ERIC), the world's leading telecommunications supplier, and Cellular One from Dobson Cellular Systems, the largest independent provider of wireless services to rural America, today announced an agreement for hosted prepaid wireless service. Ericsson will host a full range of new features and flexible rate plans for prepaid subscribers of Cellular One from Dobson Cellular Systems and will migrate the company's existing prepaid customers onto its new, advanced hosted services platform. Under the new agreement, Cellular One prepaid subscribers will have access to Ericsson's industry leading portfolio of ringtones, wallpaper selections and downloadable games. Thomas K. Roberts, Chief Marketing Officer for Cellular One, says: "We are committed to providing our customers with the service, features and flexibility they want. Through our partnership with Ericsson, we are able to quickly move to meet our customers' needs. Offering these features to our prepaid subscribers will not only enable us to keep our customers longer, but will also help attract new subscribers." Cellular One from Dobson Cellular Systems will rely on Ericsson's powerful infrastructure, integration, management and hosting expertise to provide a seamless and smooth transition for its customers. Angel Ruiz, President of Ericsson in the US, says: "We are very pleased to be selected by Cellular One to host such a strategic service. More and more wireless service providers are migrating to hosted solutions and experiencing reduced costs and faster time to market with new features and additional revenue streams. We are committed to helping these operators gain a competitive edge and quickly meet consumer demand in an exciting and dynamic market." Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at http://www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com About Cellular One Cellular One is a trade name of Dobson Cellular Systems, a subsidiary of Oklahoma City-based Dobson Communications Corporation (NASDAQ: DCEL). The company owns and operates more than 70 wireless markets in 17 states. For more information on the products and services of Cellular One from Dobson Cellular Systems, visit: www.celloneusa.com. About Ericsson's managed services offering Ericsson has the telecom industry's most comprehensive managed services offerings, ranging from designing, building, operating and managing day-to-day operations of a customer's network, to hosting service applications and enablers, as well as providing network coverage and capacity on demand. As the undisputed leader in managed services, Ericsson has officially announced more than 100 managed services contracts with operators worldwide since 2002. In all current managed services contracts, excluding hosting, Ericsson is managing networks that together serve more than 100 million subscribers worldwide.


 

The Board of Directors of Komplett ASA confirms that the business review of inWarehouse AB has been completed with a satisfactory result, satisfying the requirement for making an offer for all shares in inWarehouse AB. On this basis, Komplett`s Board of directors has decided to publicly announce the offer described in more detail in the attached bulletin that has been released in the Swedish market. The plan is to submit the offer document to inWarehouse AB`s shareholders on 2 April 2007. The deadline for accepting to the offer will expire at 5 p.m. CET on Monday, 23 April 2007. As previously announced, Komplett is offering SEK 2.40 per share, and Komplett`s bid is conditional on 90 per cent of the shareholders in inWarehouse AB accepting the offer within the deadline and that the requisite approvals are granted by the authorities. For further information, please contact: Eric Sandtrø, CEO, + 47 91 82 24 24, es@komplett.com Gyrid Skalleberg, CFO, + 47 92 66 70 00, gs@komplett.com


 

Oslo, 27 March 2007 - Algeta ASA, the Norwegian cancer therapeutics company, is very pleased to announce that it has completed its listing on the Oslo Stock Exchange and that its shares begin trading today (ticker: ALGETA). The Company's listing in Oslo takes place in connection with its successful initial public offering, which raised gross proceeds of approximately NOK 250 million ($41 million) for Algeta. The IPO was more than two times oversubscribed at the offer price of NOK47, valuing the company at NOK 773.8 million ($127.1 million) post-IPO. Thomas Ramdahl, Algeta's President and CEO, commented: "We are delighted that our IPO has been such a success. We strongly believe that novel therapeutics based on alpha emitters, including our lead product Alpharadin, have significant medical as well as commercial potential. The interest the Company has had based on this potential from leading international investors during the IPO marketing process has greatly encouraged us as we begin life as a listed company." ### For further information, please contact Dr Thomas Ramdahl, CEO +47 23 00 79 90 / +47 913 91 458 (mob) Geir Christian Melen, CFO +47 23 00 79 84 / +47 913 02 965 (mob) post@algeta.com Dr Mark Swallow / Helena +44 (0)207 638 9571 Galilee mark.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta ASA is a Norwegian therapeutics company built on world-leading expertise in nuclear medicine and oncology and dedicated to the development of novel anticancer therapeutics based on alpha particle emitting radionuclides. By harnessing the unique characteristics of alpha emitters, such as high potency and short range, Algeta is developing new therapeutic candidates and technologies targeting metastatic and disseminated tumors and promising unrivalled potency without unacceptable toxicities. Algeta's lead product candidate, Alpharadin, has completed one Phase II trial and is currently in two further Phase II clinical trials as a potential new treatment of hormone refractory prostate cancer. Based on results to date, it is expected to progress to clinical Phase III trials. Alpharadin is a novel bone-seeking radiopharmaceutical based on the alpha particle emitter radium-223 and may potentially target skeletal metastases from multiple cancer types. Algeta is also developing other technologies for delivering alpha emitters including microparticles, liposomes and its receptor targeting technology, which is designed to enhance the potency of therapeutic antibodies and other tumor-targeting molecules by linking them to the alpha particle emitter thorium-227. The Company is headquartered in Oslo, Norway, and was founded in 1997 as Anticancer Therapeutic Inventions. Alpharadin and Algeta are trademarks of Algeta ASA. Important Notice This press release is not for distribution to United States, Canada or Japan news services or for dissemination in the same countries or elsewhere where such dissemination is not appropriate. This news release is not and under no circumstances is to be construed as a solicitation, offer, or recommendation, to buy or sell securities issued by Algeta. This press release may not be relied upon by any person to whom it was not intended to be provided. These materials are not an offer of securities for sale in the United States, Canada or Japan. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Algeta ASA has not registered, and does not intend to register, any portion of the offering in the United States. This news release contains forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on results of operations and the financial condition of Algeta. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Theses factors include, among other things, risks associated with technological development, the risk that research & development will not yield new products that achieve commercial success, the impact of competition, the ability to close viable and profitable business deals, the risk of non-approval of patents not yet granted and difficulties of obtaining relevant governmental approvals for new products. ###


 

Shareholders in Hakon Invest AB (publ) are hereby summoned to the Annual General Meeting to be held at 4.00 pm on Thursday April 26, 2007 in the Stockholm Conference Room at the Grand Hôtel in Stockholm, at S. Blasie-holmshamnen 8. Light refreshments will be served from 2:30 pm in conjunction with the meeting. The Nomination Committee in Hakon Invest proposes the re-election of Board members Lars Otterbeck, Cecilia Daun Wennborg, Anders Fredriksson, Jan-Olle Folkesson, Olle Nyberg, Jan Olofsson and Thomas Strindeborn. The Nomination Committee proposes that Lars Otterbeck be re-elected Chairman. More detailed information about the Board members is provided at www.hakoninvest.se. It is proposed that fees to the Board of Directors be unchanged and amount to SEK 1,800,000, of which SEK 500,000 to the Board Chairman, SEK 300,000 to the Vice Chairman and SEK 200,000 to the other members. Moreover, an additional SEK 250,000 is proposes to be distributed for committee work. The Board proposes the approval of the fundamental principles for remuneration and employment terms for senior executives in Hakon Invest. These principles are identical to those approved at the 2006 Annual General Meeting. In addition, an incentive program for 2007 is proposed for senior executives and certain key personnel comprising a bonus and call options program. A dividend of SEK 5.50 per common share is proposed. The complete notification is provided on the Group's website www.hakoninvest.se and attached to this press release. Documentation for certain decision points will be published on the website not later than April 10. For more information, contact: General Counsel Fredrik Hägglund tel. +46-8-553 399 08 Head of Investor Relations Pernilla Linger tel. +46-8-553 399 55 Hakon Invest, which is listed the Nordic Exchange, conducts active and long-term investment operations in retail-oriented companies in the Nordic region. Hakon Invest owns 40% of ICA AB, the Nordic region's leading retail company with focus on food. In addition have holdings in Forma Publishing Group, Kjell & Company, Hemma and Cervera. Further information about Hakon Invest is available at www.hakoninvest.se.


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------+--------------------------| | Company dealt in | Barratt Developments Plc | |----------------------------------------+--------------------------| | Class of relevant security to which | Ordinary Shares | | the dealings being disclosed relate | | | (Note 1) | | |----------------------------------------+--------------------------| | Date of dealing | 26th March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price paid | | securities | (Note 3) | (Note 3) | | purchased | | | |--------------------------+--------------------+-------------------| | 10,395 | 1,179.2p | 1,148.2p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 10,080 | 1,180p | 1,147p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 27th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

- Revenues in current financial year for the first time to reach 300 mill. Euro (2006: 241.8 mill. Euro) - Planned increase in EBIT to around 15 mill. Euro (2006: 10.1 mill. Euro) - Growth through product innovations and acquisitions Kölleda/Frankfurt, 27 March 2007. A few months into the new financial year, which have included a number of successful acquisitions completed over the past few weeks, Funkwerk AG (ISIN: DE0005753149) is once again set for growth. "We are now able to raise our sales and earnings targets for 2007 and expect sales for the first time to reach a record of 300 mill. Euro," announced Chairman of the Board, Dr. Hans Grundner, today at the press and analyst conference on financial statements in Frankfurt. As a consequence, the group's earnings before interest and taxes (EBIT) are anticipated to climb to around 15 mill. Euro (2006: 10.1 mill. Euro). "We did our homework in 2006 and organised Funkwerk accordingly to improve our profitability in all three business segments. This will have a positive effect on this year, but even more so from 2008," commented Dr. Grundner. Funkwerk leader in info systems for railway companies in Europe In addition to its latest acquisitions, Funkwerk plans to introduce a wealth of product innovations to contribute to this. New solutions in the area of Enterprise Communication (EC) and in Automotive Communication (AC), for example, were said to have generated some highly positive reactions at the recent CeBIT. Dr. Grundner: "Funkwerk will launch a number of new products in all three segments this year, which promise sustained growth impulses especially for 2008." In the current financial year, the Traffic & Control Communication (TCC) segment of Funkwerk, which had been restructured in 2006, is anticipated to advance most significantly. "The product groups acting as growth drivers here will be video monitoring and information systems. Our three acquisitions completed since the beginning of this year have enabled us to consolidate our position specifically in this field. We now hold the lead in info systems for transport companies in Europe," explained the Chairman. In 2007, TCC is expected to contribute 147 mill. Euro (2006: 97 mill. Euro) to the total sales of Funkwerk. Enterprise Communication with greatest potential in 2008 "Organic sales increases" are also anticipated in the Funkwerk segments Automotive and Enterprise Communication. In Automotive Communication, the stimulus is expected to come predominantly from innovative telematics solutions and the extension of OEM business with commercial vehicle manufacturers. The development of the North American market is also said to show first dividends. In 2007, AC is anticipated to generate revenues of around 56 mill. Euro (2006: 52.8 mill. Euro). According to Dr. Grundner, Enterprise Communication is likely to experience the greatest potential in the medium term. Here, Funkwerk specifically invests in integrated solutions, introduced as Integrated Access Devices (IAD) for combined Internet, telephone and TV access, for business with major European telecom companies. The devices will increasingly be marketed in 2007, with an anticipated upward effect on sales to around 97 mill. Euro (2006: 92 mill. Euro). Dr. Grundner: "The most significant jump in sales, however, is projected for 2008." Efficiency program shows effect Funkwerk will continue to pursue its efficiency program initiated in the preceding financial year. "We intend to carry on with it to ensure a lasting improvement of the profitability of Funkwerk. This is our ultimate goal for the current financial year," emphasised Dr. Grundner. In so doing, Funkwerk plans to further concentrate different functions in its segments and reduce costs, but also to increase its product portfolio and improve its market position. The measures implemented in 2006 already showed initial effects in the last quarter of the year. The fourth quarter reported record sales of 77.5 mill. Euro, with earnings before interest and taxes (EBIT) of around 8.5 mill. Euro. Dr. Grundner: "This satisfactory trend observed in the last quarter is due not merely to the seasonality of business. It also proved to us that we had drawn the right conclusions from the disappointing business trend in previous quarters." 2006 disappointing on the whole The forecast annual EBIT, which had been revised halfway through the year to 10.1 mill. Euro (2005: 17.1 mill. Euro), was matched almost exaclty over the year, while the sales volume of 241.8 mill. Euro remained at prior-year level (242.0 mill. Euro) and thus at the lower end of the target range. The consolidated annual net profit totalled 6.9 mill. Euro (2005: 11.6 mill. Euro), with earnings per share of 0.86 Euro (2005: 1.45 Euro). Dr. Grundner: "Despite the positive trend in the last quarter, the year on the whole was rather disappointing. However, we have set our course accordingly to ensure that 2007 will once again present us with higher earnings in all three segments." After the downward trend in investments on the customer side and the increasing price competition, along with problems in the completion of a number of projects in Traffic & Control Communication, Funkwerk had been compelled in July 2006 to revise its growth expectations. Following the disappointing first six months, the latter half of fiscal 2006 was characterised by the implementation of a set of measures to restore the earning power of Funkwerk specifically in its Traffic & Control Communication segment. While the restructuring initially led to additional one-off burdens, including compensations, "Traffic & Control Communication as the problem area" finally also managed a turnaround in its earnings trend by the end of the year. On the whole, Funkwerk generated sales in business with communication systems for transport companies, transport, logistics and the industry of 97.0 mill. Euro in 2006 (2005: 98.6 mill. Euro) and an EBIT of 1.6 mill. Euro (2005: 5.2 mill. Euro). After nine months, the TCC segment had still reported a loss of over 3 mill. Euro. Enterprise Communication was also able in the last quarter to bring about a significant improvement in its operating result and margin. At 4.0 mill. Euro, its EBIT for the year still remained below the prior-year figure (5.7 mill. Euro), yet ranged within the projections. Sales in this segment totalled 92.0 mill. Euro and thus stood at prior-year level due to the decision of abandoning pure trading transactions with low margins at a volume of around 4 mill. Euro. Despite the highly competitive environment and the lasting pricing and margin pressure, the Automotive Communication segment was able to hold up well with an EBIT of 4.5 mill. Euro (2005: 6.2 mill. Euro). On the whole, AC managed a slight gain in sales, from 51.4 mill. Euro in the previous year to 52.8 mill. Euro in 2006. This gain, however, was due exclusively to the new telematics product sector. Return to growth path in 2007 "After two years of consolidation, our objective for 2007 is to steer Funkwerk back onto its growth path," emphasised Dr. Grundner in his outlook. He maintained that the appropriate foundation for this had been laid in all three segments through innovations and the consolidation of an already strong market positions. Further options for a business expansion were said to include the opening up further regional markets such as in Eastern Europe and North America and advancing to previously untouched sectors. Dr. Grundner: "Funkwerk has also learned from its failure in 2006 to reach specific target and has adjusted its planning and risk management methods accordingly. Consequently, we feel very confident with our current target increase to 300 mill. Euro in sales and 15 mill. Euro for the EBIT. There are options for further growth beyond this, but whether or not this can be realised remains to be seen over the next few months." Further information on Funkwerk AG: Based in Kölleda near Erfurt, Funkwerk AG develops, produces and markets professional communication systems used in vehicles, transport and other companies and institutions. With its three segments Traffic & Control Communication (communication, management and information systems for transport and logistics companies), Automotive Communication (communication equipment for vehicles) and Enterprise Communication (personal security, messaging systems and access solutions for companies and institutions), Funkwerk occupies a strategically excellent position in future markets. For further information contact Funkwerk AG Im Funkwerk 5 99625 Kölleda/Thuringia Germany Katrin Schwarz Investor Relations Telephone: +49 (0) 36 35/6 00 -3 35 Fax:+49 (0) 36 35/6 00 -3 99 schwarz@funkwerk.com rw konzept GmbH Emil-Riedel-Straße 18 80538 Munich Germany Sebastian Brunner Tel: +49 (0) 89/13 95 96 -33 Fax: +49 (0) 89/13 95 96 -34 Mobile: 01 75/5 60 46 73 brunner@rw-konzept.de --- End of Message --- Funkwerk AG Im Funkwerk 5 Kölleda Germany WKN: 575314; ISIN: DE0005753149; Index: HDAX, MIDCAP, CDAX, Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

The board of Kitron ASA resolved the final annual financial statements in its meeting on 22 March 2007. The net result for the year is the same as in the preliminary results resolved on 8 February 2007. The board plans to hold the general meeting in Oslo on 8 May 2007 at 10:00 a.m. Notice and agenda for the meeting will be sent to the shareholders latest two weeks before the meeting. 27 March 2007 Kitron ASA Kitron is one of Scandinavia`s leading companies in development, industrialisation and production for the segments Data/Telecom, Defence/Marine, Industry and Medical equipment. The company runs production facilities in Norway, Sweden and Lithuania. Kitron had a turnover of NOK 1,7 billion in 2006 and has about 1,300 employees. See also www.kitron.com.


 

KESKO CORPORATION STOCK EXCHANGE RELEASE 27.03.2007 AT 11.00 Segment information on the Kesko Group's continuing operations In the Kesko Group's segment reporting, a business segment has been determined as the primary reporting format. Business segments are composed of the Group's business divisions, namely Kesko Food, Rautakesko, VV-Auto, Anttila and Kesko Agro. In addition, Konekesko, Intersport Finland, Indoor Group, Musta Pörssi, WellStep, Tähti Optikko Group, Kauko-Telko, and support functions are reported in other business operations. Anttila was determined as a separate segment at the beginning of 2007. Further information is available from Senior Vice President, CFO Arja Talma, telephone +358 1053 22113. The whole stock exchange release is published at www.kesko.fi. You can download the release in pdf format from the link below. Kesko Corporation Harri Utoslahti Communications Manager ATTACHMENTS Divisions' net sales 2006, continuing operations Divisions' operating profits 2006, continuing operations Divisions' operating profits 2006, excl. non-recurring items, continuing operations


 

Hamburg, Germany | Oxford, UK - Evotec AG (Frankfurt Stock Exchange: EVT) is going to broadcast its annual analyst and press conference in Frankfurt on the occasion of the publication of its fiscal year 2006 results live on the internet. The presentation will be held in English. Date: 29 March 2007 Time: 10.00 am CET (09.00 am GMT) To join the audio webcast and to access the presentation slides you will find a link on our home page www.evotec.com shortly before the event. For those who prefer to listen to the presentation via phone, please dial: From Europe: +49.(0)69.5007 1308 (Germany) +44.(0)20.7806 1956 (UK) From the US: +1.718.354 1389 The on-demand version of the webcast will be available on our website: www.evotec.com - Investors - Webcasts. Contact: Anne Hennecke, Senior Vice President, Investor Relations & Corporate Communications, Evotec AG, Phone: +49.(0)40.56081-286, anne.hennecke@evotec.com --- End of Message --- Evotec AG Schnackenburgallee 114 Hamburg Germany WKN: 566480; ISIN: DE0005664809 ; Index: Prime All Share, CDAX, HDAX, MIDCAP, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Mahwah, New Jersey, USA, and Martinsried/Munich, Germany. March 27, 2007. ADVA Optical Networking announced today that T-Com, the broadband/landline division of Deutsche Telekom, Germany's incumbent carrier and one of the world's leading service providers, will use the ADVA Fiber Service Platform (FSP) 3000 for the expansion of its optical metro and regional networks. In cooperation with ADVA Optical Networking and partner Siemens Communications, T-Com signed a multi-year framework contract for the implementation of Wavelength Division Multiplexing (WDM)-based transmission technology in its next-generation metro and regional networks. The flexibility of the ADVA FSP 3000 platform and its ability to efficiently handle multiple network interface protocols at data rates ranging from 8Mbit/s up to 40Gbit/s made it attractive to T-Com, which will now be able to provide new services both economically and efficiently. The ADVA FSP 3000 platform also offers consistent implementation of the new Optical Transport Hierarchy (OTH) network standard, which provides for transparent transmission as well as highly improved network monitoring functions. Triple Play services (data, voice and video) and other services for business and residential customers contribute to ever-higher traffic on the network today. Providers of these services require a flexible transport backbone network onto which they can integrate the numerous data protocols and transport media that access networks require. In addition, the integration of Ethernet and WDM in the FSP 3000 platform provide for a much more efficient use of available bandwidth. "As one of the largest network operators in the world, T-Com needed a flexible, scalable optical transmission technology to enable it to expand its network as customers demand more bandwidth to support new applications," explained Brian L. Protiva, CEO of ADVA Optical Networking. "Our innovative FSP product portfolio fulfills these exact requirements and is also able to transport advanced services over Ethernet and Internet Protocol (IP). We look forward to continued cooperation with T-Com as it scales its networks to meet future demand." # # # ABOUT ADVA OPTICAL NETWORKING ADVA Optical Networking (FSE: ADV) is at the forefront of providing Optical+Ethernet solutions that advance next-generation networks for data, storage, voice and video services. Our company's strength comes from passionate and dedicated employees, all sharing a common vision: a fast, customized response to customers' ever-changing needs. Our innovative Fiber Service Platform (FSP) and strong customer focus provide carriers and enterprises the ability to scale their networks and deliver intelligent, competitive new services. ADVA Optical Networking's solutions have been deployed at more than 200 carriers and 10,000 enterprises around the world. For further information about ADVA Optical Networking: www.advaoptical.com. PUBLISHED BY: ADVA AG Optical Networking, Martinsried/Munich and Meiningen, Germany ADVA Optical Networking Inc., Mahwah, New Jersey, USA ADVA Optical Networking Corp., Tokyo, Japan www.advaoptical.com FOR PRESS: Christine Keck t +1 201 258 8293 (U.S.) t +44 1904 699 358 (Europe) t +81 3 5408 5891 (Asia) public-relations@advaoptical.com FOR INVESTORS: Wolfgang Guessgen t +1 201 258 8300 (U.S.) t +49 89 89 0665 940 (Europe) t +81 3 5408 5891 (Asia) investor-relations@advaoptical.com


 

DJIA 12469.07 -11.94 -0.10% Nasdaq 2455.63 +6.70 +0.27% S&P 500 1437.50 +1.39 +0.10% FTSE 100 6291.90 -47.50 -0.75% Xetra DAX 6828.82 -70.24 -1.02% CAC40 5576.30 -58.45 -1.04% Above are closing prices Nikkei 225 17416.75 -105.21 -0.60% Hang Seng 19728.12 -37.73 -0.19% S&P/ASX 200 5955.00 -15.50 -0.30% Taiwan Index 7869.75 -8.07 -0.10% S.Korea Kospi 1452.72 +2.95 +0.19% Dow Future 12527.00 -6.00 -0.10% NASDAQ Future 1817.50 -0.75 -0.02% S&P Future 1445.00 -0.25 0.00% Above are as of 0450 GMT USD/JPY 118.14-17 +0.02% Range 118.36 - 118.06 EUR/USD 1.3331-36 -0.03% Range 1.3334 - 1.3323 AUD/USD 0.8091-94 -0.06% Range 0.8106 - 0.8079 GBP/USD 1.9684-88 -0.03% Range 1.9704 - 1.9674 USD/CHF 1.2158-61 +0.05% Range 1.2169 1.2155 Above are as of 0450 GMT vs NY close USD/JPY Vol Option Contract 8.10%/8.40% EUR/USD Vol Option Contract 5.90%/6.10% AUD/USD Vol Option Contract 7.85%/8.05% GBP/USD Vol Option Contract 6.23%/6.48% USD/CHF Vol Option Contract 6.90%/7.15% Above are 1-Mo prices as of 0425 GMT 2Y Tsy 100 11/32 +3/32 4.56% -4.3 5Y Tsy 100 22/32 +6/32 4.47% -4.3 10Y Tsy 100 11/32 +8/32 4.58% -3.4 10Y JGB 1.6500% +0.0050 Closing Treasury prices vs prior NY close; JGB as of 0450 GMT Asian Spot Gold $663.60 -$0.35 -0.05% Comex Gold $663.90 $0.00 0.00% Brent Crude Oil $64.35 -$0.06 -0.09% Above are as of 0400 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European stocks are likely to claw back most of Mondays losses following Wall Streets late recovery overnight. Meanwhile, government bond prices start on a mixed note, while the euro is holding its prior gains. Gold is steady in Asia and oil slightly lower. STOCKS: Investors are likely to take heart from New Yorks late comeback Monday and push European stocks moderately higher. However, caution about the U.S. economy continues to influence sentiment. U.K. spreadbettor CMC Markets is calling the FTSE up 35 points at 6327, the DAX up 46 at 6875 and the CAC up 40 at 5616. Wall Street pared steep losses Monday to end narrowly mixed after a surprise drop in new home sales for February triggered further concern that economic growth is slowing more than expected. The U.S. Commerce Department reported that sales of new single-family homes fell by 3.9 percent last month to a seasonally adjusted annual rate of 848,000. It was the slowest sales pace in nearly seven years and dimmed hopes for a rebound in the troubled housing market. "The market is already worried more about economic growth than inflation, so I think youre going to see reactions like this," said Todd Salamone, director of trading at Schaeffers Investment Research in Cincinnati. "Overall, its impressive from the comeback weve had. Theres been a whirlwind of attention about housings effects on the economy, it isnt anything new and these pullbacks are buying opportunities." Investors also are focused on a spate of economic data due this week, including Conference Boards consumer confidence survey on Tuesday and the gross domestic product report due on Wednesday. Major Asian stock markets were lower Tuesday, with export-related shares such as Samsung Electronics and Canon coming under pressure because of worry about the U.S. economy. The Australian market was slightly lower, but Mondays gains in commodities supported miners. FOREX: The euro is holding its sharp gains from Monday, when the dollar slid on the poor housing data, which in turn revived hopes for a Federal Reserve interest rate cut soon to bolster the slowing U.S. economy. The euro has some good buying interest looming at slightly lower levels, around $1.3310 to $1.3320, dealers reported, with some players set to short the dollar. Fed Chairman Ben Bernanke is expected to explain the U.S. central banks view of the housing market when he testifies Wednesday in front of the Joint Economic Committee of the U.S. Congress. Ashraf Laidi, chief currency strategist at CMC Markets, said, "The home sales report should place the burden on Bernanke to come up with a more detailed assessment regarding the deterioration of the U.S. housing slowdown, beyond simply describing it as the adjustment in the housing sector is ongoing as was done in last weeks Fed statement." Meanwhile, euro zone finance ministers Monday concluded their monthly meeting, seeing few risks that a strong euro will derail continued economic growth. BONDS: European government bond prices are likely to open mixed to slightly lower, with more data on tap, after recovering Monday from early losses following weaker-than-expected U.S. housing data. The market expects CPI data from the German states of Baden-Wuerttemberg and Saxony Tuesday, along with the March Ifo business survey, with pan-German CPI data expected Wednesday. "In the euro zone and especially in Germany, data this week should underscore the favorable economic situation," said an analyst at WestLB. "The Ifo business climate index will probably receive a lot of attention." Treasurys were slightly lower Tuesday in Asia, after rising on the U.S. housing data on Monday, when investors put more money on the prospect of an interest rate cut in the coming months. The fresh interest in short-dated Treasurys "comes against backdrop of a Fed thats removed its tightening bias," said Jim Caron, rates strategist at Morgan Stanley in New York. Fans of the short-dated Treasurys should make the most of a boost that is most likely only temporary, says Tom di Galoma, head of Treasurys at Jefferies & Co., as auctions of two- and five-year notes later this week could send yields back up again. The Treasury will sell $18 billion of two-year notes Wednesday, and $13 billion in five-year notes the following day. "The long end of the market will outperform going into the quarter end," di Galoma said, adding that he doubts the auctions will fly well. Richard Gilhooly, senior fixed income strategist at BNP Paribas in New York, said the yield curve could even dip back into negative territory over the next few days. But he added that its likely to steepen again over the coming month, helped by any further increase in oil prices. In Japan, government bonds moved little, with the 10-year yield in a range of 1.6350% to 1.6500 for now. Activity is likely to remain subdued as players await Fridays Japan CPI data, said Mitsubishi UFJ securities strategist Naomi Hasegawa. "JGBs are taking cues from the Nikkei, trading in a narrow range." Bank of Japan Governor Toshihiko Fukui said Tuesday that hes not worried right now that land prices will rise excessively near term and played down the possibility of more interest rate hikes due to land price rises. ENERGY: Oil prices were slightly weaker in Asian trade Tuesday, as traders braced for the impact on prices resulting from a potentially long standoff between Iran and the West over the detention of 15 British navy personnel. Light, sweet crude for May delivery on the Nymex fell 15 cents to $62.76 a barrel on mild profit-taking a day after it rose as high as $63.30 a barrel in New York Monday, Iran said it was questioning the 15 to determine if they had "intentionally" crossed over into Iranian waters, a sign that it could be seeking a way out of the impasse. Britain maintains the men were in Iraqi territory. "It doesnt look like its going to be resolved immediately," says Eurasia Group analyst Greg Priddy from Washington. Still, Priddy believes the standoff will be resolved without incident. "There is a potential for miscalculation but thats not the most likely outcome," he said. METALS: Spot gold was quoted $663.40 an ounce, holding most gains posted during New York trading. James Moore, analyst at TheBullionDesk, said the environment remains positive for gold, underpinned by a combination of rising energy prices, a softer U.S. dollar and increased geopolitical tensions in the Middle East. He added that further concerns about the U.S. housing market are also bullish longer term, raising the expectation the Fed will cut rates in the not too distant future, boosting golds appeal as investors look to assets offering better returns. LME 3-month copper rose $29 to $6,880 a ton, and may remain firm on strong fundamentals, dealers said. CALENDAR: GMT - Tuesday, March 27, 2007 Expected Previous 0645 FRA Feb Housing Starts 0830 GER Mar Ifo German Business Climate Index with 106.5 107.0 Ifo Business Survey in the German Services Sector 0830 UK 4Q Investment by insurance companies, pension funds & trusts 0830 UK Feb Major British Banking Groups Mortgage & Consumer Lending 0900 EU Feb Stock Market Capitalization 1145 US Mar 24 ICSC-UBS Chain Store Sales +0.4% 1255 US Mar 24 Redbook Retail Sales Index +0.5% 1400 US Mar Richmond Fed Mfg Index -10 1400 US Mar Conference Board Consumer Confidence 108.0 112.5 Index 2100 US Mar 16 ABC/Washington Post Consumer Confidence -5 Index N/A US Cleveland Fed Pres Pianalto speaks on the Internationalization of National Currencies in Prague N/A JPN Asian Development Outlook Launch N/A UK 4Q Business investment, revised N/A ITA Mar Business Confidence Survey 95.0 95.4 -By Dennis Baker; Dow Jones Newswires; dennis.baker@dowjones.com Brixton (BXTN.LN): FY Earnings Average NAV per share (Co, 6 analysts): 538p (514p) Note: The NAV rise is seen predominantly due to capital growth. Analysts will be looking at dividend policy which they expect to be raised progressively and managements view on the occupational and investment market. Analysts will also compare the figures to rival Slough Estates (SLOU.LN) which reported FY results on March 8. Cairn Energy (CNE.LN): FY Earnings Forecast range (DJ, 5 analysts): $54M net profit - $13.5M net loss Note: The huge variation in analysts forecasts is due to a fine - which is expected to be included in the companys earnings - for an unspecified amount relating to it operations at the Sangu gas field. Analysts say the earnings focus will be on their prospects for future earnings as well as the timing and execution of its operations in Rajasthan, "particularly any guidance on the issue of crude exports," says Phil Corbett at Oriel Securities. Fondiaria SAI (FSA.MI): FY Earnings Average net profit (FactSet, 9 analysts): EUR472M (EUR465M) Average revenue: EUR9.77B (EUR9.51B) Note: Revenue is expected to grow, after the company reported in late February, a 5% rise in premiums for 06, thanks to higher income from its bancassurance unit and double digit growth of life premiums. However, analysts say non-life margins are expected to show very little growth, while return on capital is expected to drop slightly from 05 levels. Eyes are likely to focus on growth in car insurance and life policies. Public Power Corporation (PPC.AT): FY Earnings Average net profit (DJ, 5 analysts): EUR74.01M (EUR135.7M) Average revenue: EUR4.68B (EUR4.29B) Note: Increased fuel and energy purchase costs as a result of higher oil and natural gas prices are seen driving profits lower. Meanwhile, revenues are seen higher on higher tariffs and volume growth. Analysts also focus on updates on the groups internal cost-cutting program as well as comments by newly-appointed chairman and CEO, Panagiotis Athanasopoulos. Rieter (RIEN.EB): FY Earnings Average net profit (DJ, 3 analysts): CHF132M (CHF127M) Average EBIT: CHF220M (CHF182M) Average sales: CHF3.58B (N/A) Note: A moderate improvement in bottom line is due to a one-off charge tied to the divestment of chemical fiber operations. A rise in 06 sales and a 21% increase in orders to CHF3.90B has already been reported. A possible dividend increase and outlook is eyed. Swiss Life (SLHN.VX): FY Earnings Average net profit (DJ, 4 analysts): CHF870M (CHF860M) Average operating profit: CHF1.2B (CHF1B) Note: The slow rise in net profit is due to the fact the year-earlier figure was inflated by a CHF21M tax gain. Meanwhile, operating profit is expected to jump from the year-earlier period thanks to healthy demand in France and other markets outside Switzerland. Net earned premiums are expected +5.3% to CHF14B from CHF13.3B. Analysts expect the company will reiterate its target for 08 and may provide more details about its growth plans which may also include acquisitions. OTHER SCHEDULED EVENTS: Acegas (AEG.MI): FY Earnings Air Berlin (AB1.XE): FY Earnings Alpha Airports (AAP.LN): FY Earnings Arkil Holding (ARKIL-B.KO): FY Earnings Atlantic Global (ATL.LN): FY Earnings Aubay (6373.FR): FY Earnings Banco di Desio e della Brianza (BDB.MI): FY Earnings Bank Of Siauliu (10225.LH): FY Earnings BETA Systems Software (BSS.XE): FY Earnings Brain Force Holding (BFC.VI): FY Earnings Brioschi Finanziaria (BRI.MI): FY Earnings CAD IT (CAD.MI): FY Earnings Calida Holding (CALN.EB): FY Earnings Caltagirone (CALT.MI): FY Earnings Caltagirone Editore (CED.MI): FY Earnings CENIT Systemhaus (CSH.XE): FY Earnings Cintra Concesiones de (CIN.MC): AGM Cofitem-Cofimur 3443.FR(): AGM ComBOTS (CMBT.XE): FY Earnings Compagnie Vaudoise (VAHN.EB): FY Earnings Credito Bergamasco (CB.MI): FY Earnings Cremonini (CRM.MI): FY Earnings CTS Eventim (EVD.XE): FY Earnings Curasan (CUR.XE): FY Earnings D/S Norden (DNORD.KO): FY Earnings DanTruck-Heden (DANTR.KO): FY Earnings Deutz (DEZ.XE): FY Earnings Development Securities (DSC.LN): FY Earnings Devoteam (7379.FR): FY Earnings Dr Hoenle (HNL.XE): AGM Eastern Drilling (EDRILL.OS): AGM Eesti Telekom (ETLAT.ET): FY Earnings Elco Holdings (ELCO.TV): Q4 Earnings elexis (EEX.XE): FY Earnings EM.TV (EV4.XE): FY Earnings Emak (EM.MI): FY Earnings EMAP (EMA.LN): Trading Update Entertainment Rights (ERT.LN): FY Earnings Euphon (EUP.MI): FY Earnings Evolution Group (EVG.LN): FY Earnings Exprivia (XPR.MI): FY Earnings Fastighets Tornet (TORN-TIA.OM): AGM Finmeccanica (FNC.MI): FY Earnings Flomerics Group (FLO.LN): FY Earnings Fluegger (FLUG-B.KO): Q3 Earnings Funkwerk (FEW.XE): FY Earnings Granitifiandre (GRF.MI): FY Earnings Gresham Computing (GHT.LN): FY Earnings Hasgrove (HGV.LN): FFY Earnings Haulotte Group (6675.FR): FY Earnings Hellenic Telecommunications (HTO.AT): EGM High Co (5423.FR): FY Earnings I Grandi Viaggi (IGV.MI): AGM & EGM Iberia (IBLA.MC): 4Q & FY Earnings IDB Holding (IDBH.TV): FY Earnings Impregilo (IPG.MI): FY Earnings Israel Chemicals (ICL.TV): FY Earnings ITS Seevia Group (7384.FR): FY Earnings James Fisher & Sons (FSJ.LN): FY Earnings Jolly Hotels (JH.MI): FY Earnings Juventus (JUVE.MI): 1H Earnings Komax Holding (KOMN.EB): FY Earnings La Doria (LD.MI): FY Earnings Leon de Bruxelles (3495.FR): FY Earnings Lindex (LDEX.SK): 2Q Earnings Locindus (LD.FR): FY Earnings Loewe (LOE.XE): FY Earnings Macfarlane Group (MACF.LN): FY Earnings Media & Research Group (MRG.OS): FY Earnings Medical Solutions (MLS.LN): FY Earnings Meetic (406309.FR): FY Earnings Michelmersh Brick (MBH.LN): FY Earnings MLP (MLP.XE): FY Earnings Monrif (MON.MI): FY Earnings Neopost (12056.FR): FY Earnings Northern Foods (NFDS.LN): Trading Update Northern Racing (NOR.LN): FY Earnings Oerlikon (OERL.VX): FY Earnings OKO Bank (OKOAS.HE): AGM Osiatis (404433.FR): FY Earnings Ostasiatiske Kompagni: AGM Pharmagest Interactive (7768.FR): FY Earnings Phytopharm (PYM.LN): AGM Pilat Media Group (PGB.LN): FY Earnings Pinewood-Shepperton (PWS.LN): FY Earnings Pininfarina (PINF.MI): FY Earnings Poligrafici Editoriale (POL.MI): FY Earnings Q-Cells (QCE.XE): FY Earnings Ratti (RAT.MI): FY Earnings Ruecker (RUK.XE): FY Earnings SBM Offshore (36061.AE): FY Earnings Sechilienne-Sidec (6040.FR): FY Earnings Sjaelso Gruppen (SJGR.KO): AGM Socotherm (SCT.MI): FY Earnings Stedim (DIM.FR): FY Earnings Talentum (TTM1V.HE): AGM Tamedia (TAMN.EB): FY Earnings Targetti Sankey (TS.MI): FY Earnings TAS (TAS.MI): FY Earnings UPM-Kymmene (UPM1V.HE): AGM USU Software (OSP2.XE): FY Earnings VetAffaires (7715.FR): FY Earnings Vianini Industria (VIN.MI): FY Earnings Vianini Lavori (VLA.MI): FY Earnings Vilniaus Vingis (10367.LH): FY Earnings Wienerberger (WIE.VI): FY Earnings WMH Walter Meier Holding (WMHN.EB): FY Earnings World of Medicine (WOM.XE): FY Earnings Amagerbanken (AMAG.KO): FY 2006 Ex-Dividend Date Castellum (CAST.SK): FY 2006 Dividend Payment Date Grupo Prisa: FY 2006 Dividend Payment Date Hyprop Investments (HYP.JO): FY 2006 Dividend Payment Date Kesko - A Shares (KESBV.HE): FY 2006 Ex-Dividend Date Lassila & Tikanoja Group (LAT1V.HE): FY 2006 Ex-Dividend Date Skanditek Industriforvaltning (STEK.SK): FY 2006 Ex-Dividend Date Skanditek Industriforvaltning (STEK.SK): Special Ex-Dividend Date Tekla Corporation (TLA1V.HE): FY 2006 Dividend Payment Date Tekla Corporation (TLA1V.HE): Special Dividend payment Date United Business Media (UBM.LN): Special Dividend Payment Date (END) Dow Jones Newswires


 

[Dow Jones] Nordic stocks are expected to open slightly higher recovering from Mondays tumble on weaker-than-expected US housing data. OMXN40 and OBX are seen opening slightly higher on positive sentiment following Wall Streets overnight comeback.


 

Oslo, 27 March, 2007 - VMETRO ASA (VME:OL) today announced that it expects the company's 1Q07 financial results to be below current market expectations. Preliminary estimates indicate that 1Q07 revenues will be approximately MNOK 45 with an operating loss of around MNOK 28, including onetime restructuring costs of about MNOK 4. The unsatisfactory result follows weak operational performance and lower than expected market demand, especially in the American defense and aerospace market. As a consequence of the weak performance, the company is implementing actions to reduce its running fixed cost by 10% by reducing staff and operating expenses in order to achieve at least a break even operating result in 2007. Management will reduce costs mostly in areas not related to sales and development. "Although the short term outlook for our industry is uncertain, the long term outlook is good, and I believe Vmetro have a good opportunity to play an important role in its traditional markets. The reduction of fixed costs together with a strong product roadmap and several strategic moves designed to ensure growth in existing and new markets, shall improve the company results and shareholder value going forward", says Christian Jebsen CEO of VMETRO ASA. The company will announce its 1Q07 financial results at 0815 (CET) on 25th April 2007. --- End of Message --- VMETRO Brynsveien 5 Oslo Norway ISIN: NO0003074601; ;


 

Crew Gold Corporation ("Crew" or "the Company") (TSX:CRU) (OSE:CRU) today announced it will report quarter and six months to 31 December 2006 results on Friday, March 30, 2007. A conference call/webcast will be held at 09:00 a.m. BST that will be carried on the Company's website. Live Conference Call Details for March 30, 2007: 09:00 (UK) and 10:00 (Norwegian) ----------------------------------------------------------------------------------------------------- UK freefone : 0800 387771 Direct dial-in number : 01296 317500 Passcode : 564 068 The quarter and six months to 31 December 2006 results will be available prior to the conference call in the Investor Relations section of the Company's website at www.crewgold.com. Additionally, there will be a replay of the conference call available until April 4, 2007. Replay Conference Call Details Freefone dial-in number : 0800 032 9687 (UK BYO) Direct dial-in number : 0207 136 9233 (UK BYO) Passcode : 36634863 In addition to this, an audio file of the conference call will be available on www.crewgold.com. Crew Gold Corporation is an international mid-tier gold company with operations, development projects and exploration activities in Guinea, Philippines, Greenland and Canada. The Company currently produces gold at their three operating mines; Lefa in Guinea, Nalunaq in Greenland and Masara in the Philippines. --- End of Message --- Crew Gold Corporation Abbey House, Wellington Way, Weybridge Surrey United Kingdom WKN: 226534105 ; ISIN: CA2265301036; ;


 

Final results for 2006: - Group revenues +14% to ¤ 2,225.0 million, EBITDA +10% to ¤ 471.9 million - Profit after tax +11% to ¤ 218.3 million, earnings per share +11% to ¤ 2.95 - Managing Board recommends 10% increase in dividend to ¤ 1.30 per share Outlook on 2007: - Positive market development in Europe, difficult conditions in the USA - Continuation of profitable growth course - Goals remain unchanged for 2007 Vienna, March 27, 2007 - Wienerberger AG, the largest producer of bricks in the world and number two in clay roof tiles in Europe, was able to meet its ambitious growth and earnings targets for 2006 in full. All earnings indicators rose by at least 10% and growth investments of ¤ 430 million were also realized. However, the year was characterized by a wide range of contrary effects, with a weak start followed by outstanding development in the second half-year. Positive factors included higher demand in Europe and the favorable effects of growth projects realized in previous years as well as the mild weather during the fourth quarter and resulting additional support for a strong increase in sales volumes. These factors were able to more than offset negative effects such as the severe winter at the beginning of the year, higher costs for plant start-ups and inventory reduction, a slump in new residential construction in the USA and higher energy prices. Revenues and earnings increase by more than 10% The Managing Board will present the annual financial statements for 2006 at a press conference today (10 am live in the web: www.wienerberger.com). The final operating results reflect the preliminary figures announced in mid-February. Group revenues rose by 14% to ¤ 2,225.0 million and operating EBITDA increased 10% to ¤ 471.9 million. Operating EBIT increased 11% to ¤ 299.6 million in spite of the high level of investment activity in the previous year. "Wienerberger was able to meet all its earnings goals for 2006 because of its strong geographic portfolio and numerous profitable growth projects", commented Wolfgang Reithofer, CEO of Wienerberger AG, with satisfaction on the past business year. Strong demand in Europe serves as growth driver in 2006 "The development of earnings was influenced by a number of different factors in 2006: support was provided by strong demand in Europe, and in particular by recovery in the German new residential construction market and sound development in Poland, Romania, Switzerland, Belgium and France. In contrast, a decline of 13% in US housing starts and significantly higher energy prices had a negative effect", commented Reithofer on the figures presented today. Reithofer considers it a clear confirmation of the Group's strategy that Wienerberger was able to utilize the good demand in Europe to substantially increase sales volumes and implement necessary price adjustments, and thereby more than offset an EBITDA decline of 5% in the USA as well as an additional charge of ¤ 47 million from higher energy prices. 11% improvement in profit after tax and earnings per share Wienerberger recorded an 11% increase in profit after tax to ¤ 218.3 million and earnings per share to ¤ 2.95, which resulted mainly from the improvement in operating earnings. Higher interest expense and lower income from investments, which were positively influenced by non-recurring effects in the previous year, led to a 10% deterioration in financial results to ¤ -20.2 million. The tax rate declined slightly to 21.3% (2005: 21.8%). Non-recurring expenses from the shutdown of plants in the USA and Czech Republic were almost offset by income from the sale of a non-operating property in the south of Vienna. Increase of 10% in dividend to ¤ 1.30 per share "We also want our shareholders to benefit directly from this development, and the Managing Board will therefore recommend that the annual General Meeting approve a 10% increase in the dividend to ¤ 1.30 per share", announced Reithofer. That represents a yield of 3.4% on the average share price for 2006 and a pay-out ratio equal to roughly 45% of net profit. "We also want to offer our shareholders an attractive minimum return on their invested capital in the future in the form of appropriate dividends", added Reithofer. Increase in equity chiefly from net profit Group equity including minority interest rose by 7% to ¤ 1,591.4 million. "This growth was supported by higher net profit, which was contrasted in particular by the dividend payment, negative foreign exchange differences and cash outflows for the share buyback program", explained Hans Tschuden, CFO of Wienerberger AG. Growth financed above all from free cash flow Wienerberger continued its expansion course during 2006 and invested a total of ¤ 430.2 million in roughly 50 growth projects. These investments include 53% of acquisitions and 47% of new plant construction and capacity extension. The growth program was financed from free cash flow of ¤ 272.1 million and additional debt. Net debt totaled ¤ 1,159.8 million as of December 31, 2006, which represents an increase of 24% over the previous year. "In order to guarantee sufficient financial flexibility for the continuation of our growth course and also strengthen our rating, we placed our first hybrid bond with a fixed interest coupon of 6.5% and a volume of ¤ 500 million in February 2007", indicated Tschuden. Increase in the value of the Company as a sustainable goal The focal point of the Wienerberger strategy is an increase in the value of the Company. "Despite the high level of growth investments in recent years, we have been able to generate a return that lies significantly above our 7.5% weighted average cost of capital. ROCE totaled 8.8% for 2006 and roughly matched the prior year level. After an adjustment for the acquisition of Robinson Brick during the year - which was fully reflected in capital employed, while we were only able to recognize six months of earnings - ROCE equaled 9.1%", explained Hans Tschuden. Further growth expected for 2007 "We expect continued growth in 2007 based on the favorable development of markets in Europe, which should help us to offset potential market declines in the USA. Our forecasts call for an increase of ¤ 30 million in energy costs, but we should be in a position to pass on the major part of these higher expenses through an adjustment to our selling prices, provided there are no significant declines on individual markets", indicated Wolfgang Reithofer optimistically. "The mild winter in large parts of Europe during the first quarter of 2007 is certainly helpful. However, it cannot be interpreted as an indication for the development of earnings in 2007 because of the low significance of this period for the full business year - experience shows that we generate only ca. 15% of our annual revenues during the first quarter", added Reithofer. Strong demand in Europe, optimization measures in the USA For 2007 Wienerberger expects continued growth in Central-East Europe and strong demand for bricks, especially in Poland, Romania and Bulgaria. In Russia construction has commenced on a second plant 800 km east of Moscow, and the Group's first plant near this city entered the start-up phase last October. "The signs are also good in Western Europe. Rising consumer confidence in Germany, stronger new residential construction in Belgium and France, and growth in the Netherlands and Great Britain from the current moderate level will provide support for the development of business this year", observed Reithofer. "We also intend to use the continued optimization of our plants as well as the full-year consolidation of Robinson Brick to generate earnings growth in the USA during 2007," stated Reithofer in spite of the difficult market conditions in the United States. Goal for above-average growth in earnings remains unchanged "Based on our strong geographic portfolio, I am confident that we will be able to meet our goal and again record an above-average increase in earnings during 2007. For this year we expect a total investment volume of ¤ 500 million, whereby ¤ 120 million will be directed to maintenance capex and at least ¤ 250 million to bolt-on projects - in particular the construction of new plants and extension of capacity. Approximately ¤ 130 million will be added to this amount if the UK competition commission approves the acquisition of Baggeridge Brick", added Reithofer in conclusion. Download the press release from: www.wienerberger.com Online Annual Report 2006: http://annualreport.wienerberger.com Live webcast of the press conference at 10.00 a.m. (CET): www.wienerberger.com For additional information contact: Thomas Melzer, Public and Investor Relations T +43(1)60192-463 | communication@wienerberger.com If you do not wish to receive the Wienerberger newsletter any longer, send an e-mail with subject: "unsubscribe newsletter" to communication@wienerberger.com


 

- Sales of EUR 539.5 million in 2006 - Net income for the period of EUR 87.7 million in the Company's core business; one-off extraordinary income of EUR 9.4 million - Production line V, which is currently under construction, will be expanded more rapidly: total nominal capacity will increase to 645 Megawattpeak (MWp) by the end of 2007 - 500 new employees and 50 new trainees by the year-end - Technology department will be increased to over 180 employees - Construction of the first Solibro factory decided Thalheim/Frankfurt am Main, 27 March 2007 - Q-Cells AG, the world's second largest manufacturer of solar cells, has presented the 2006 Annual Report today, 27 March 2007, as part of its Accounting Press Conference. In so doing, the company from Thalheim in the rural district of Bitterfeld (Saxony-Anhalt) has confirmed the provisional figures it presented on 5 February 2007. In 2006, Q-Cells AG produced solar cells with a total output of 253.1 MWp. This equates to an increase of 53% on the previous year. With this output the Company has strengthened its position as the world's No. 2 with a market share of approximately 10% and further reduced the gap between it and the Japanese market leader Sharp. Sales rose by 80% to EUR 539.5 million (2005: EUR 299.4 million), operating income (EBIT) and net income for the period (without one-off effect) grew even more strongly by 105% and 120% to EUR 129.4 million and EUR 87.7 million respectively (previous year: EUR 63.2 million and EUR 39.9 million respectively). In addition, Q-Cells posted a one-off extraordinary contribution to earnings of EUR 9.4 million as a result of accounting for the increased share in EverQ for the first time, so that net income for the period amounts to EUR 97.1 million in total. Expansion of production capacity is accelerated In view of the contracts for the supply of large quantities of metallurgical silicon, which were also concluded with the Norwegian company Elkem Solar at the beginning of February, Q-Cells AG is accelerating the expansion of its production capacity markedly. Production line V, which is under construction, will reach a nominal capacity of 225 MWp (which equates to a production capacity of 180 MWp) by the year-end 2007 by bringing forward construction of a third expansion phase. As a result, Q-Cells AG's total nominal capacity will rise sharply to total 645 MWp (production capacity 516 MWp) at the year-end 2007. "We shall have more than half a gigawatt of production capacity by the end of the year and will further expand our position on the global market", says Anton Milner, CEO of Q-Cells AG. "As a result, we shall prove yet again that by concentrating on cell production, we are able to react very rapidly to changes in the market situation. We are expanding capacity now in which we shall be able to process the additional quantities of silicon that Elkem will supply from 2008." Planning for line VI, which - with a nominal capacity of 300 MWp (which equates to a production capacity of 240 MWp) - will bring Q-Cells AG substantially closer to the 1 GWp threshold, is already underway. Further rapid growth in staff numbers - expansion of R&D expertise Because of this marked expansion in production capacity, Q-Cells AG will create many new jobs in Thalheim in 2007. In total some 500 new employees and, in addition, 50 new trainees will be appointed - in the core business alone. Just as many staff will also be employed at subsidiaries and affiliates. Many of the new employees will strengthen the Technology department, which will be increased from approximately 100 to around 180 employees at the year-end. As a result, Q-Cells will again boost its research and development expertise significantly. The Company views this as crucial to reducing production costs and consequently to making photovoltaics a competitive option for electricity customers in the foreseeable future. This is why Q-Cells AG is constructing a Research and Development Centre just next to production line V, which will serve to develop and commercialize new generations of far more powerful cells. Progress in new technologies Within the framework of the Accounting Press Conference, the Executive Board of Q-Cells AG was also able to report on progress in the Company's thin-film operations. The construction of the first Solibro GmbH factory in Thalheim with a production capacity of 25 to 30 MWp was resolved last week by the Supervisory Board. The company, which was established in November 2006 as a joint venture with the Swedish company Solibro AB, will produce thin-film modules based on Copper-Indium-Gallium-Diselenide (CIGS) technology. This technology offers a comparatively high potential efficiency rating and is particularly suitable for integration in façades, roofs and buildings thanks to its particularly attractive appearance. Q-Cells AG has also decided to exercise its option to acquire 51% of the shares in VHF-Technologies SA in Yverdon-les-Bains (Switzerland). The company develops and produces flexible thin-film modules on a plastic substrate under the brand name "Flexcell". A pilot line in Switzerland with a capacity of 2 MWp produces flexible modules for consumer markets such as nautical or outdoor equipment. Capacity in Switzerland will be increased by 5 MWp in 2007, which will make Q-Cells the global market leader in the consumer applications market. However, the major objective of the involvement in VHF-Technologies is the development of industrial-scale production. The decision on construction of an initial production line in Thalheim with a capacity of 25 MWp will be reached by the middle of the year. The modules produced there are to be used in building-integrated photovoltaics. Additional Information The 2006 Annual Report and a current company presentation are available for download from the Investor Relations section of Q-Cells AG's website at www.q-cells.com. Contact: Q-Cells Aktiengesellschaft Stefan Lissner Head of Investor Relations Guardianstraße 16 06766 Thalheim - Germany investor@q-cells.com Phone: +49 - (0)3494 - 668 887


 

On March 26, 2007, BB BIOTECH has concluded its third share buy-back program started on November 8, 2006. In this period, a total of 1.4 mn bearer shares were purchased over the second trading line. At the ordinary Shareholders' Meeting of March 26, 2007, it was decided to cancel 1.4 mn shares bought under the third buy-back program. BB BIOTECH will again actively manage the discount over the first trading line in order to limit the discount to a maximum of 10%. Should the discount deteriorate contrary to our expectations, BB BIOTECH will evaluate further measures. For further information please contact: Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland Adrian Brüngger, Tel. +41 44 267 67 00 --- End of Message --- BB BIOTECH AG Vordergasse 3 Schaffhausen Switzerland WKN: 888509; ISIN: CH0001441580; Index: SBIOM, IGSP, SLIFE; Listed: Investment Companies in SWX Swiss Exchange;


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- March 27, 2007 -- THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION IN THE UNITED STATES. Georgia Ventures Inc. (TSX VENTURE: GVI)(FRANKFURT: G4Y) ("Georgia" or the "Company") announces that it has entered into a letter of intent ("LOI") to acquire 100% of the shares of Creston Mining Corporation ("Creston"), a private Canadian Company that through its wholly owned Mexican subsidiary, Minera Exploraciones Global S.A. de C.V. ("Global"), owns 100% of the Creston Molybdenum deposit, located in Sonora, Mexico (the "Property"). The terms of the LOI provide that the Company may acquire a 100% interest in the Property, subject to a 3% net profits interest retained by Creston shareholders, in consideration for payment of the sum of US $20,000,000; issuing US $10,000,000 worth of Units (one share and 1/2 warrant) and granting 600,000 stock options to Creston shareholders. Additionally, Georgia must pay US$150,000 to Creston to defray Creston's carrying costs during the due diligence and closing period (US$100,000 having already been paid). The Creston Molybdenum deposit contains the following mineral resources at a 0.035% Mo Cut-off grade: Mo lbs Cu lbs Category Tonnes Mo% Cu% millions millions ---------------------------------------------------------- Indicated 92,873,000 0.083 0.060 169.9 122.8 Inferred 84,221,000 0.076 0.050 141.1 92.8 1. Mineral resources which are not mineral reserves do not have demonstrated economic viability. The estimates of mineral resources may be materially affected by environmental, permitting, legal, title, taxation, sociopolitical, marketing or other relevant issues. 2. The quantity and grade of reported inferred resources in this estimation are conceptual in nature and there has been insufficient exploration to define these inferred resources as an indicated or measured mineral resource and it is uncertain if further exploration will result in upgrading them to an indicated or measured mineral resource category. The mineral resources in this news release were estimated using the Canadian Institute of Mining Metallurgy and Petroleum (CIM), CIM Standards on Mineral Resources and Reserves, Definitions and Guidelines prepared by the CIM Standing Committee on Reserve Definitions and adopted by CIM Council December 11, 2005. The mineral resources are reported within a Whittle 4X optimized pit shell at a low strip ratio of approximately 1:1 (waste/ore), based on an open pit model by P&E Mining Consultants Inc. of Brampton Ontario ("P&E"). The 0.035% Mo Cut-off grade was calculated using a molybdenum price of US$6.50/lb, G&A of US$ 0.75/tonne, process cost of US$ 3.50/tonne and 87% process recovery. The mineral resources have been estimated in an NI 43-101 compliant technical report prepared for the Company in March 2007 by independent qualified persons Eugene Puritch, P. Eng., and Dr. Wayne Ewert, P. Geo., of P&E. The P&E mineral resource estimate utilized conventional statistical analysis, variography, and grade interpolation utilizing Gemcom block modeling. The mineral resources estimated by P&E are confined to the Main Molybdenum Zone. Significant potential exists for additional molybdenum mineralization in nearby areas such as the Red Hill Zone, a relatively untested target located 300 metres southwest of the main Creston deposit. The Red Hill Zone, which has been interpreted as the root zone of the Creston deposit, is open along strike in both directions and at depth. Upon completion of the transaction, Georgia plans to carry out a 10,000 metre drill program aimed at upgrading the inferred resources to the indicated category, thus allowing for the calculation of reserves and the preparation of a bankable feasibility study. The 2,441.49 hectares Creston Molybdenum property is located in north central Sonora State, Mexico, 135 kilometres northwest of Hermosillo, the state capital, and 40 km from a custom molybdenum processing facility. The main Creston deposit is covered by an "exploitation" concession valid until 2054. Access from Hermosillo is via 113 kilometres of paved highway and 22 kilometres of all weather gravel roads. The Creston Molybdenum deposit is located within a prolific belt of porphyry deposits which include Grupo Mexico's Cananea and La Caridad mines. Interest in the Creston area dates back to the early part of the 20th Century. Since then Creston was examined and evaluated by several mining companies, including Amax, Climax Molybdenum, Asarco, Cominco, Penoles, Guggenheim Exploration, and New Jersey Zinc. Three campaigns of drilling were carried out between 1974 and 1979 by Minera Opodepe (51% Penoles, 49% Amax), leading to the completion of a Preliminary Feasibility Study. In 1980 the project was turned over to Fresnillo (60% Penoles and 40% Amax). This company completed two horizontal adits to establish continuity of mineralization and collect metallurgical samples. A total of 66 holes have been completed on the property to date. Mineralization at Creston is associated with a 53 million year old porphyritic quartz monzonite stock that intruded a complex of Paleoproterozoic igneous and metamorphic rocks. Most of the molybdenum mineralization occurs within the 1.73 billion year old Creston Granite, as disseminations in quartz stockworks or in the matrix of breccia zones within areas of intense phyllic alteration. Metallic minerals include pyrite, molybdenite, subordinate chalcopyrite, and chalcocite. A discrete chalcocite blanket overlies the main molybdenum deposit. Following the emplacement of the mineralization the area underwent several episodes of tectonic activity. The most important structure at Creston is a low angle fault (Creston fault) that separates altered and mineralized upper plate rocks from lower plate lithologies. The transaction is subject to several conditions including due diligence, execution of a definitive agreement and acceptance of the TSX Venture Exchange. Closing of the transaction is scheduled to occur no later than May 15, 2007. There can be no assurance that the transaction will be completed as proposed or at all. A finder's fee will be paid in association with the acquisition. Dr. Luca Riccio, PhD., P. Geo, a Qualified Person as defined by National Instrument 43-101, is responsible for the technical information contained in this News Release. On behalf of the Board Jonathan W. George, President Forward-Looking Statements: The above contains forward-looking statements that are subject to a number of known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those anticipated in our forward looking statements. Factors that could cause such differences include: changes in world commodity markets, equity markets, costs and supply of materials relevant to the mining industry, change in government, and changes to regulations affecting the mining industry. Forward-looking statements in this release include statements regarding future exploration programs, operation plans, geological interpretations, mineral tenure issues, and mineral recovery processes. Although we believe the expectations reflected in our forward-looking statements are reasonable, results may vary, and we cannot guarantee future results, levels of activity, performance, or achievements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this release. Contacts: Georgia Ventures Inc. Mr. Jonathan George (604) 694-0005 (604) 684-9365 (FAX) Website: www.georgiaventures.com


 

WATERLOO, ONTARIO -- (MARKET WIRE) -- March 26, 2007 -- Descartes Systems Group (TSX: DSG)(NASDAQ: DSGX), a global on-demand software-as-a-service (SaaS) logistics solutions provider, announced that Arla Foods has selected Descartes' Transportation Management Solutions to enhance the efficiency of its logistics operations. Arla Foods' vision is to be the leading Dairy company in Europe through considerable value creation and active market leadership. "Descartes Transportation Management Solutions will play an important role in supporting our operational goals," said Jesper Erichsen, CIO, at Arla Foods. "Arla Foods' selection of our logistics solutions shows the value we can offer to companies looking to optimize their supply chains," said Arthur Mesher, CEO at Descartes. "This is a great example of how our initial successful relationship with a customer can lead to additional opportunities to create delivery efficiencies and fast time-to-value for our customers." About Arla Foods Arla Foods is a co-operative owned by approximately 10,600 milk producers in Denmark and Sweden. The Arla Foods Group is Europe's second largest dairy company. In the 2004/2005 financial year, the Group received 8.4 billion kg milk and a turnover of approx. DKK 46 billion. For more information, visit www.arlafoods.com About Descartes Descartes (TSX: DSG)(NASDAQ: DSGX), a leading provider of software-as-a-service (SaaS) logistics solutions, is delivering results across the globe today for organizations that operate logistics-intensive businesses. Descartes' logistics management solutions combine a multi-modal network, the Descartes Global Logistics Network, with component-based 'nano' sized applications to provide messaging services between logistics trading partners, "book-to-bill" services for contract carriers and private fleet management services for organizations of all sizes. These solutions and services help Descartes' customers reduce administrative costs, billing cycles, fleet size, contract carrier costs, and mileage driven and improve pick up and delivery reliability. Our hosted, transactional and packaged solutions deliver repeatable, measurable results and fast time-to-value. Descartes customers include an estimated 1,600 ground carriers and more than 90 airlines, 30 ocean carriers, 900 freight forwarders and third-party providers of logistics services, and hundreds of manufacturers, retailers, distributors, private fleet owners and regulatory agencies. The company has over 300 employees and is based in Waterloo, Ontario, with operations in Atlanta, Pittsburgh, Ottawa, Washington DC, Derby, Stockholm, Shanghai, Singapore and Melbourne. For more information, visit www.descartes.com. This release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements") that relate to Descartes' solution offering and potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, "Certain Factors That May Affect Future Results" in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Contacts: Descartes Systems Group Nicole German (416) 741-2838 ext. 298 Email: ngerman@descartes.com Website: www.descartes.com


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- March 26, 2007 -- BCM Resources Corporation (TSX VENTURE: B) reports that the Phase 2 drilling on the Shan molybdenum discovery located 20 km NE of Terrace, British Columbia has commenced. The planned exploration program will consist of approximately 14 drill holes totaling 4,600 meters. The first holes of the Company's Phase 2 exploration program will test the moly mineralization to depth under the discovery Holes 1 and 7 from the initial drill program. The results from those two holes included near-surface molybdenum grades of 59.7 meters of 0.118% Mo and 112.8 meters of 0.107% Mo, respectively. Alteration and mineralization encountered in Phase 1 drilling seems to fit well into the "Climax Molybdenum" model. The Climax molybdenum mine is located near Denver, Colorado. For a schematic of the Climax Model please refer to the Company's website at: www.bcmresources.com In addition to evaluating the Climax deposit model and testing for the high grade cap it would predict, this Phase 2 program will test the lateral extension of the mineralized area (both width and strike), drill the area of known mineralization to over 400 m depth and provide some in-fill drilling. Qualified Person Daryl Hanson, P.Eng. who is a Qualified Person as defined in NI 43-01, has reviewed the technical content of this news release. Potential investors should conduct their own investigations as to the suitability of investing in securities of BCM. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Contacts: BCM Resources Corporation Dale McClanaghan President & CEO (604) 646-0144 Website: www.bcmresources.com SOURCE: BCM Resources Corporation


 

LONDON -- (MARKET WIRE) -- March 26, 2007 -- New York Pizza, the leading Pizza Chain in the Netherlands, has selected Andromeda to provide its Rameses EPOS system, for all of its sites across the Netherlands. New York Pizza (NYPD) is the most successful pizza chain in the Netherlands. Headquartered in Amsterdam, the company has an estate of over 75 delivery and takeaway stores, plus 5 slice stores in high footfall tourist areas. The chain has also recently won a contract to provide pizza slices to hungry commuters in several mainline railway stations, replacing Pizza Hut. The company had been researching the market for a replacement POS provider, to replace the aging system which has been in use for many years. NYPD has evaluated systems from the US, UK & Europe, before selecting Andromeda's Rameses system for the roll out to its estate. NYPD's Managing Director Bart Jan Wijsman commented: "We have aggressive expansion plans and needed to find a system which would help us to achieve our objectives. "We have spent over a year carefully evaluating companies and visiting sites throughout Europe which had these systems installed, before deciding upon Andromeda. "We visited several of Andromeda's customers in the UK, including Papa John's Pizza and Famous Moe's. We were reassured by the fact that Andromeda had a lot of experience in rolling out a system into a large group of stores and would be able to install into all of our stores in a relatively short period with a minimum of disruption. They have the systems and procedures in place for pre-installation training of store staff, installation in the store followed by onsite training and then ongoing support after the installation is handed over. "The company is very professional and is extremely practical, due to the pizza background of its management. We have had several exchange visits with their technical people and by using the dedicated NYPD SharePoint site provided by Andromeda, we can all request and monitor progress on development requirements, such as integration with our website." Ben Portsmouth, CEO of Andromeda, commented, "We are very pleased to be working with New York Pizza, and look forward to a long and fruitful relationship. This roll out underlines Andromeda's commitment to the EPOS market in Europe." Andromeda, with headquarters in London & Dallas, is Europe's leading delivery EPOS provider. Andromeda's award-winning Rameses delivery POS software is suitable for delivery, counter service and restaurant operators, including Papa John's Pizza, Bombay Bicycle Club, Itsu Sushi, Lupa and many more successful companies. They can supply single operators up to large international chains. Additional services include fully integrated website ordering, ACE call handling system, credit card processing in under two seconds, automatic text messages to customers when their food leaves the store and a sophisticated loyalty card scheme. New York Pizza's website is at: http://www.newyorkpizza.nl. More information on Andromeda is available at: www.androtech.com, email on: sales@androtech.com, or call: Kevin Duck on +44 870 1188 010. Contact: Kevin Duck +44 870 1188 010 kevin.duck@androtech.com www.androtech.com


 

Highlights * net profit of US$ 216.3 million, versus US$ 225.8 million in 2005 (which included US$ 79.8 million exceptional gain on sale of FPSO Serpentina); * net operational profit up by 40%; * EBITDA of US$ 477.5 million compared to US$ 482.2 million in 2005; * EBIT of US$ 254.3 million compared to US$ 275.3 million in 2005; * EBIT margin 12.8% compared to 18.1% in 2005; * new orders totalled US$ 4,916 million, compared to US$ 1,510 million in 2005; * turnover up to US$ 1,990 million, compared to US$ 1,519 million in 2005 ; * investment in fixed assets of US$ 309 million, compared to US$ 399 million in 2005; * fourth execution centre opened in Kuala Lumpur; * Extended Well Test system taken into operation in the Caspian Sea; * FPSO Capixaba taken into operation offshore Brazil; * excellent performance of the FPSO fleet generated substantial bonus revenues; * new-generation deepwater installation vessel taken into operation; * new fifteen year lease contracts from ExxonMobil for two FPSOs for Kizomba 'C', Angola; * new fifteen year lease contract from Shell for an FPSO for Brazil; * new contracts for leases for new production concepts in new geographical areas. Contact person: Mr. Hans Peereboom, V.P. Investor Relations Telephone: (+377) 92 05 14 34 Mobile: (+377) 6 80 86 52 58 Fax: (+377) 92 05 89 40 E-mail: hans.peereboom@sbmoffshore.com Website: www.sbmoffshore.com To see the complete pdf version of this press release, please click on the link below:


 

26 March 2007 - Qurius is discussing the acquisition of Cedilla Systems, a leading UK supplier of Microsoft Business Solutions. Cedilla has about 30 staff members and is located near Manchester. Its profitable 2006 turnover was 4 million euro. Cedilla has references and exclusive distribution rights for the UK regarding the same Microsoft Dynamics Waste Management & Recycling solution that Qurius already distributes in a number of other countries. "Joining forces with Qurius enables us to provide a broader range of Microsoft solutions and services to our customers" says Mike Dickson, Managing Director of Cedilla. "In addition we will be able to serve larger and international companies in the verticals we focus on." One strong country organisation Qurius deploys autonomous growth and acquisitions to expand its European market leadership in Microsoft solutions and services. "Cedilla and Qurius are active in the same market segments, together we expand the geographical coverage in those sectors. Having cooperated in multiple projects, we are convinced that Cedilla fits well within our organisation. The Waste Management & Recycling solution is going to be one of our corporate verticals we want to support in every country where we have a presence. The combination of our current Dynamics AX activities with Cedilla's strong Dynamics NAV business means a significant step towards the number 1 position in Dynamics in the UK", says Qurius director Tom Stolk, responsible for the international business. Both parties aim to conclude the transaction in June. The transaction price is a combination of a fixed and a variable amount based on 2007 results and will be in the standard price range of 0,5 to 0,7 times turnover. Cedilla Systems Ltd Cedilla is one of the UK's leading Microsoft Gold Certified partners for Business Solutions and ISV, staffed by certified professionals dedicated to providing customised solutions, training and support services on Microsoft Dynamics NAV. It has a vertical focus includes Waste Management & Recycling, Metal, Professional Services and Leisure. Cedilla was founded in 1991. Further information is available on www.cedilla.co.uk. Qurius N.V. Qurius provides architecture, realization and systems management of Microsoft technology based business and IT solutions, including infrastructures. Qurius has over 725 staff members; its headquarters are located in Zaltbommel, the Netherlands. Its offices in Belgium, Denmark, Germany, Italy, the Netherlands, Norway, Spain, Sweden and the United Kingdom serve over 1,700 clients. Qurius has been publicly listed on Euronext Amsterdam since 1998. On 18 December 2006, Qurius' shareholders authorized the merger with Watermark, which created Europe's largest Microsoft Dynamics partner. For further information, see www.qurius.com. Contact Qurius, Fred Hermans: telephone +31 (0)418 683 500 or fred.hermans@qurius.com. The press release can be downloaded from the following link:


 

* New study results show more patients receiving both Tekturna and Diovan reached target blood pressure goal compared to those taking either agent alone[1] * Tekturna approved in the US as first direct renin inhibitor, works by directly targeting an enzyme which triggers a process that can lead to high blood pressure * Tekturna provides significant blood pressure reductions for a full 24 hours and generally well tolerated * Urgent need for new therapies like Tekturna since nearly 70% of patients with high blood pressure still not achieving treatment goals[2] Basel, March 26, 2007 - Results from a new study have shown patients taking two Novartis cardiovascular medicines - the recently US-approved drug Tekturna® (aliskiren) and the leading therapy Diovan® (valsartan) - experienced greater reductions in blood pressure levels than those using either agent alone[1]. The study also found more patients receiving both Tekturna, which received US approval in March and represents the first type of new high blood pressure medicine in a decade, and Diovan reached their treatment goal compared to either drug alone[1]. Data from this trial involving 1,800 patients - the first large-scale study to assess the benefits of combining these medicines - were presented for the first time at the American College of Cardiology 56th Scientific Session in New Orleans. Half of the patients in the eight-week trial taking both Tekturna and Diovan saw a reduction in blood pressure to the target of 140/90 mmHg (systolic/diastolic pressure), higher levels than seen in patients taking either of the medicines alone. Failure to properly control high blood pressure, also called hypertension, can increase the risk of heart attacks and strokes. Tekturna and Diovan work in different ways to target the Renin Angiotensin System, one of the body's key regulators of blood pressure. Tekturna targets renin, an enzyme responsible for triggering a process that can lead to high blood pressure. Diovan, an angiotensin receptor blocker (ARB) and one of the world's most-prescribed cardiovascular medicines, blocks a hormone later in this system that causes narrowing of blood vessels[3]. "These study results are exciting because they suggest the value of different mechanisms of action when Tekturna and Diovan are used together," said Suzanne Oparil, MD, Director of the Vascular Biology and Hypertension Program and Professor of Medicine at the University of Alabama at Birmingham in Alabama. "In addition to important blood pressure lowering, the combination of Tekturna and Diovan maintained a tolerability profile similar to that seen with either agent alone," Dr. Oparil said. Tekturna received US regulatory approval for treatment of high blood pressure as monotherapy or in combination with other high blood pressure medications. In an extensive clinical trial program involving more than 6,400 patients, Tekturna provided significant blood pressure reductions for a full 24 hours. This once-daily oral therapy is expected to be available by the end of March in US pharmacies as 150 mg and 300 mg tablets. A second study presented at the meeting compared Tekturna to ramipril, another high blood pressure medicine in a class known as ACE inhibitors. Results showed more patients treated with the Tekturna-based therapy reached their blood pressure goal than patients treated with the ramipril-based therapy (61.4% vs. 53.1% respectively)[4]. The need for new high blood pressure medicines is urgent given that this condition affects one in four adults globally and more than 70% of these patients remain uncontrolled[5]. In fact, many require two or more medications to reach their target blood pressure goal[2,6]. Uncontrolled high blood pressure can increase the risk of cardiovascular disease, the world's leading cause of death[6,7]. "We are very encouraged by these results since they show Tekturna and Diovan are effective when used together," said James Shannon, MD, Global Head of Development at Novartis Pharma AG. "Through our portfolio of high blood pressure medications, Novartis is committed to providing physicians with a wide range of tools to help patients lower their blood pressure." About Tekturna Tekturna received approval in March 2007 from the US Food and Drug Administration (FDA) for the treatment of high blood pressure as monotherapy or in combination with other high blood pressure medications. The use of Tekturna with maximal doses of ACE inhibitors has not been adequately studied. In September 2006, Tekturna - known as Rasilez® outside the US - was submitted to the European Medicines Agency (EMEA) for review in the European Union. In clinical trials, the approved doses of Tekturna were generally well tolerated. Tekturna was developed in collaboration with Speedel. About Diovan Novartis remains at the forefront of cardiovascular medicine through development of innovative products like Diovan, the most-prescribed member of the ARB class (angiotensin receptor blocker) in the world today. Diovan is available for the treatment of high blood pressure in more than 100 countries, for the treatment of heart attack survivors in more than 70 countries and in more than 90 countries for the treatment of people with heart failure. Disclaimer The foregoing release contains forward-looking statements which can be identified by the use of terminology such as "provides", "can", "effective", "is expected", or similar expressions, or by express or implied discussions regarding potential future regulatory filings, approvals or future sales of Tekturna/Rasilez, or potential future sales of Diovan. Such statements reflect the current views of the Novartis group of companies with respect to future events and are subject to certain risks, uncertainties and assumptions. There can be no guarantee that Tekturna/Rasilez will be approved for sale in any other market, or that Tekturna/Rasilez or Diovan will reach any particular sales levels. In particular, management's expectations regarding the approval and commercialization of Tekturna/Rasilez or Diovan could be affected by, among other things, unexpected clinical trial results, including additional analysis of existing clinical data and new clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; increased government, industry, and general public pricing pressures; and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. References [1] Oparil S, Yarows S, Patel S, et al. "The Direct Renin Inhibitor Aliskiren in Combination With the Angiotensin Receptor Blocker Valsartan Provides Additional Blood Pressure-Lowering Effects Compared With Either Agent Alone in Patients With Hypertension." Poster presented at American College of Cardiology 56th Annual Scientific Session, March 2007. [2] Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007; 49:69-75. [3] Diovan Website. http://www.diovan.com/info/about/about_diovan.jsp. Accessed November 28, 2006. [4] Andersen K, Weinberger M, Egan B, et al. "Aliskiren-Based Therapy Lowers Blood Pressure More Effectively Than Ramipril-Based Therapy in Patients With Hypertension: A 6-Month, Randomized, Double Blind Trial." Poster presented at American College of Cardiology 56th Annual Scientific Session, March 2007. [5] Rosamond W, Flegal K, Friday G, et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update. A report from the American Heart Association Statistics Committee and Stroke Subcommittee. Circulation. 2007:115. [6] Chobanian AV, Bakris GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42:1206-1252. [7] World Health Organization. "Main causes of death and global burden of disease (DALYs), world, all ages, projections for 2005." Available at: http://www.who.int/whosis/highlight05.png # # # Novartis Media Relations Richard Booton Novartis Pharma Communications +41 61 324 4356 (direct) +41 79 753 2593 (mobile) richard.booton@novartis.com Corinne Hoff Novartis Global Media Relations +41 61 324 9577 (direct) +41 79 248 5717 (mobile) corinne.hoff@novartis.com e-mail: media.relations@novartis.com Novartis Investor Relations International: Ruth Metzler-Arnold +41 61 324 7944 Katharina Ambühl +41 61 324 5316 Nafida Bendali +41 61 324 3514 Jason Hannon +41 61 324 2152 Thomas Hungerbuehler +41 61 324 8425 Richard Jarvis +41 61 324 4353 North America: Ronen Tamir +1 212 830 2433 Arun Nadiga +1 212 830 2444 Jill Pozarek +1 212 830 2445 Edwin Valeriano +1 212 830 2456 e-mail: investor.relations@novartis.com --- End of Message --- Novartis International AG Posfach Basel WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |-------------------------------------------------+-----------------| | Company dealt in | EMI Group Plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | 14p ordinary | | dealings being disclosed relate (Note 2) | | |-------------------------------------------------+-----------------| | Date of dealing | 23 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------+--------------------+---------------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------+------------+-------+------------+--------| | (1) Relevant | | | | | | securities | | | | | | | | | | | |------------------------+------------+-------+------------+--------| | (2) Derivatives (other | | | | | | than options) | 3,412,530 | 0.426 | | | | | | | | | |------------------------+------------+-------+------------+--------| | (3) Options and | | | | | | agreements to | 57,000,000 | 7.124 | 88,750,000 | 11.092 | | purchase/sell | | | | | | | | | | | |------------------------+------------+-------+------------+--------| | Total | 60,412,530 | 7.550 | 88,750,000 | 11.092 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | Convertible bonds due 2010 | | | |-----------------------------------+----------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (1) Relevant securities | 0 | 0.000 | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | Total | 0 | 0.000 | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Long | 250,000 | 228.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 22,195 | 231.2734 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ | Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | | name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| | option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 26/03/2007 | |------------------------------------------------+------------------| | Contact name | Julien Naginski | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9642 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 |240 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 |240 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 |240 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 10 000 000|260 GBp | American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 10 000 000|260 GBp | American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 7 000 |190 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased | 7 000 |200 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased | 1 750 |200 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 2 500 |220 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 2 500 |220 GBp | American |15/06/2007 | |option | |000 | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 15 000 000|240 GBp | American |21/09/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 15 000 000|240 GBp | American |21/09/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 15 000 000|260 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 30 000 000|260 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 15 000 000|300 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Oceanteam Power & Umbilical Limited of Aberdeen, announced today that it has signed a contract for the installation of the submarine cabling on E.ON's Robin Rigg Wind Farm in the Solway Firth. Robin Rigg Wind Farm lies in the Solway Firth some 13 kilometres north of Workington. The farm straddles the border between Scotland and England with 60 turbines installed. It will be the largest offshore wind farm in Britain. The contract has a value in excess of ¤25 million and will be executed in Q4 - 2007 and Q1 & 2 - 2008. The contract is Oceanteam's second wind farm project and confirms the company's position as a leading contractor in this market. The project will create employment for approximately 70 marine, installation and management personnel at the height of the installation. The contract requires cable collection and transportation to site from Norway and Italy, the construction of an underground, directionally drilled, conduit to navigate an active railway line and the beach at the shore landing, the installation and burial of two 132kv submarine cables for the export of the generated power to the National Grid connection, the installation and burial of 64 33kv inter connector cables. For further information, please contact: CEO Haico Halbesma +47 95 80 98 73 haico@oceanteam.no COO Jon Mears +44 77 74 44 22 56 jon.mears@oceanteam.net


 

KESKO CORPORATION STOCK EXCHANGE RELEASE 26.03.2007 AT 16.15 The organising meeting of Kesko Corporation's Board of Directors, held after the Annual General Meeting, decided to leave the compositions of its committees unchanged. The members of the Board of Directors' Audit Committee are Maarit Näkyvä (Chairman), Seppo Paatelainen and Keijo Suila. The members of the Board of Directors' Compensation Committee are Heikki Takamäki (Chairman), Pentti Kalliala and Keijo Suila. The committees' terms of office always expire at the Annual General Meeting. On the basis of the evaluation of independence carried out by the Board of Directors, all members of the Audit Committee are independent of the company and its significant shareholders. The members of the Board of Directors elected by the Annual General Meeting held on 27 March 2006 are retailer Pentti Kalliala, Ilpo Kokkila, Executive Vice President Maarit Näkyvä, Seppo Paatelainen, Keijo Suila (Deputy Chairman), retailer Jukka Säilä and retailer Heikki Takamäki (Chairman). The term of office of each Board member, in accordance with the Articles of Association, is three (3) years with the term starting at the close of the General Meeting electing the member and expiring at the close of the third (3rd) Annual General Meeting after the election (in 2009). Further information is available from Corporate Secretary, Director Mika Majoinen, telephone +358 1053 22206. Kesko Corporation Harri Utoslahti Communications Manager DISTRIBUTION Helsinki Stock Exchange Main news media


 

Ericsson (NASDAQ:ERIC) is bringing the first HSPA-enabled 3G/WCDMA commercial network in Brazil to the operator Telemig Celular (NASDAQ:TMB). Ericsson will also expand and modernize Telemig Celular's existing network across Brazil's Minas Gerais state. Under the sole-supplier agreement, Ericsson will provide new 3G/WCDMA core and radio networks, including HSPA. Ericsson will take end-to-end turn-key responsibility and provide network deployment, systems integration and business consulting services. Ericsson's HSPA solution will enable Telemig Celular to break through with a new generation of mobile broadband services, delivering true broadband speed of up to 14.4Mbps. Telemig Celular's subscribers will also enjoy a richer communication experience. André Mastrobuono, Telemig Celular's CEO, says Telemig Celular's aim is to enhance digital opportunities in Minas Gerais. "HSPA is the perfect technology for us to offer voice calls of superior quality, and exciting and multimedia-enriched mobile broadband. We will also be able to offer digital inclusion via PC cards that will bring internet to remote areas in a cost-efficient way, creating new ways for all users to connect to others and find information wherever they are. "In addition to that, our customers will experience a low-cost and high-performance data service, offering a competitive alternative to wireline broadband services. Telemig Celular is perceived by our customers as a premium company, and this perception motivates us to track innovation and quality as permanent goals. To ensure our success, we believe that Ericsson is best suited for this job." Johan Wibergh, President of Ericsson Brazil, says: "Building the first HSPA network in Brazil is an important milestone. Ericsson believes in an all-communicating world, and acts as the company that truly merges the internet with wide-area coverage and full mobility. We are pleased to provide Telemig Celular with our advanced solutions for WCDMA/HSPA, which will provide them with a solid platform for next-generation services and underline their innovative profile in the market." Ericsson's HSPA solution will enable download speeds of up to 14.4Mbps. The advanced technology lets operators more than double their system capacity and cuts response times for interactive services. On average, users will be able to download 20 times faster than with a GSM/GPRS connection. Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at http://www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com About Telemig Celular Telemig Celular is the leading provider of mobile phone service in the state of Minas Gerais. The company has both prepaid and contract customers among its 3.4 million users, and it also offers wireless Internet access. Telemig Celular S.A. is known for its innovative services and expansive coverage area. The company provides service to more than 550 cities. According to reports from third quarter 2006, Telemig Celular holds 32,7% of market share in its operation area. More information at www.telemigcelular.com.br.


 

KESKO CORPORATION STOCK EXCHANGE RELEASE 26.03.2007 AT 15.45 Kesko Corporation's Annual General Meeting today adopted the financial statements for 2006 and discharged the Board of Directors' members and the Managing Director from liability. The Annual General Meeting also decided to distribute ¤1.50 per share as dividends, as proposed by the Board of Directors. In addition, the Annual General Meeting approved the Board of Directors' proposals to amend the Articles of Association, to authorise the Board to issue shares and to grant stock options. A total of some 717 shareholders attended the Annual General Meeting. The whole stock exchange release is published at www.kesko.fi. You can download the release in pdf format from the link below.


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- March 26, 2007 -- Buffalo Gold Ltd. (TSX VENTURE: BUF.U)(OTCBB: BYBUF)(FRANKFURT: B4K) is pleased to announce that the March 23, 2007 edition of "The Australian", Australia's national newspaper, reports that the Labor party in the state of Queensland is backing away from its long-standing ban on new uranium mines. Premier Peter Beattie confirmed that he will support uranium mining in his state after a government-commissioned report from the Sustainable Minerals Institute at the University of Queensland showed uranium mining would not threaten the state's coal industry. The report noted Queensland had uranium reserves with an in-ground value of AUS$3.2 billion. The Queensland Government is therefore poised to allow new uranium mining if the Labor Party's national conference approves a change in its policy next month. Management of Buffalo is encouraged by this recent development as two of the company's four uranium projects, the North Maureen and the Juntala projects, are located in the Georgetown-Townsville (GTN-TSV) uranium field of northern Queensland. Both properties were vended in to Buffalo 100% by GoldFx in early 2006 with the foresight that the uranium mining ban would indeed be lifted. The GTN-TSV hosts Mega Uranium's Maureen and Ben Lomond uranium deposits as well as many prospects and other uranium occurrences. The Maureen deposit has a 1979 non-NI 43-101 compliant resource estimate from Getty Mining Pty Ltd. of 6.9 million pounds contained uranium (2.38 million tonnes @ 0.12% U3O8 with a cut-off of 0.035% U3O8). Ben Lomond has a NI 43-101 indicated resource of 1.32 million tonnes @ 0.27% U3O8 (7.9 million pounds) and inferred resource of 602,585 tonnes @ 0.21% U3O8 (2.8 million pounds) (ref: www.megauranium.com). At the North Maureen Uranium Project, Buffalo has 4,400 square kilometres of exploration permits under application adjacent to the Maureen Deposit, with approximately 60% of these having been granted. The property shows similar magnetic signatures to Maureen. Buffalo has identified several targets to be followed up with drilling. The 100% owned Juntala Uranium project located south of the Maureen Deposit covers approximately 700 square kilometres. A high amplitude uranium channel radiometric anomaly strikes for over 35 kilometres within the basement rocks of the Juntala Project area. Technical review of the project has highlighted the potential of the area for a sandstone-hosted roll-front uranium deposit within the package of sedimentary rocks which are in contact with the radiometric active basement. This package has over 50 kilometres of strike length of favourable sedimentary rocks. Damien Reynolds, Buffalo's Chairman and CEO, commented that "This development will allow Buffalo to accelerate exploration of its Queensland uranium properties in order to realise the value we perceived when we acquired them in early 2006." Mr. Mark Dugmore, VP Corporate Development for Buffalo Gold, is a qualified person for Buffalo projects and has approved the contents of this news release. To find out more about Buffalo Gold Ltd. (TSX VENTURE: BUF.U), please visit the company website at www.buffalogold.ca. On behalf of the Board of Directors of BUFFALO GOLD LTD. Damien Reynolds, Chair of the Board of Directors and Chief Executive Officer Cautionary note to U.S. investors - This news release contains information about adjacent properties on which we have no right to explore or mine. We advise US investors that the mining guidelines of the United States Securities and Exchange Commission ("SEC") strictly prohibit information of this type in documents filed with the S.E.C. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties. The TSX Venture Exchange has not reviewed and does not accept responsibility for the accuracy of this press release. Contacts: Buffalo Gold Ltd. Julie Hajduk Investor Relations (604) 685-5492 or Toll Free: 1-888-685-5492 (604) 685-2536 (FAX) Email: julie@buffalogold.ca Website: www.buffalogold.ca


 

Espoo, Finland - Nokia today announced that it will set up a manufacturing facility for mobile devices in the county of Cluj in Romania. Nokia anticipates investing an estimated EUR 60 million in the Cluj plant, which will be the company's 11th mobile device production facility globally. The decision to establish a new factory in Romania is a reflection of Nokia's strong volume growth globally, as well as the increasing demand for mobile devices in Europe, the Middle East and Africa. Nokia selected Cluj as the location for the plant because of the county's availability of skilled labour, its good inbound and outbound logistics connections, its overall efficiency, and the long industrial tradition in the area. The Memorandum of Understanding was signed today in Romania's capital, Bucharest. At the signing, Raimo Puntala, Senior Vice President for Nokia's Operations and Logistics, said: 'As the global market leader for mobile devices, Nokia is committed to ensuring good product availability and smooth deliveries to important markets in Europe, the Middle East and Africa.' Nokia's new facility in Cluj is located about 400 kilometers north-west of Bucharest. The construction work at Cluj will start in spring 2007 and production is expected to begin in the first half of 2008. Nokia foresees ramping up the factory gradually and will recruit approximately 500 employees there by the end of 2007. As part of the plans, Nokia is looking to establish an industrial village in the area, enabling a number of key suppliers and partners to locate their operations there. Nokia continuously develops its global manufacturing network to increase competitiveness and provide excellent logistics services for its customers. In 2006, the company completed expansions at its Reynosa plant in Mexico and its Dongguan plant in China, and ramped up production at the Chennai plant in India. In Europe, Nokia already has production facilities in Bochum in Germany, Komárom in Hungary and Salo in Finland. About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. Media Enquiries: Nokia Communications Tel. +358 7180 34900 Email: press.office@nokia.com www.nokia.com --- End of Message --- NOKIA P.O. Box 226<br>FIN-00045 NOKIA GROUP Espoo WKN: 870737; ISIN: FI0009000681; Index: DJ STOXX Large 200, DJ STOXX 50; Listed: Nordic list (Large Cap) in THE HELSINKI STOCK EXCHANGE;


 

Announcement no. 5 - 2007


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |------------------------------------------------+------------------| | Company dealt in | Freeport Plc | |------------------------------------------------+------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |------------------------------------------------+------------------| | Date of dealing | 23rd March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 118,247 | 406p | 406p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 120,383 | 406.25p | 406p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 26th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Freeport Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-------------------------------------------------+-----------------| | Company dealt in | Corus Group plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-------------------------------------------------+-----------------| | Date of dealing | 23rd March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 2,409 | 605p | 605p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 0 | | | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 26th March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Corus Group Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are expected to open a touch lower Monday, ahead of a string of data this week that could push the Dow Jones Industrial Average to new highs. CMC Markets is calling the DJIA to open down 15 points at 12,466, the Nasdaq 100 down five points at 1789 and the S&P 500 down 2.7 points at 1433.4. "Strong gains last week have pushed the DJIA through the big level at 12,350," says CMC Markets Geoff Langham. "We will be looking to the psychological 12,500 level on the upside." Data for release Monday include February new home sales and the Chicago Federal Reserve National Activity Index for February. "This week, investors will be looking at new home sales orders, durable goods orders and final GDP," says Philip Blows at Pacific Continental Securities. "If these reinforce the already buoyant investor mood, we could see the markets reaching new highs." EUROPEAN MARKETS: European shares are hovering around flat. In London, the FTSE 100 is up 0.1% at 6354.30, with miners BHP Billiton, Xstrata and Rio Tinto rising as gold and copper prices stay firm. In Frankfurt, the DAX is down 0.1% at 6892.48, taking a hit from Volkswagens losses and low-level profit-taking. In Paris, the CAC is down 0.2% at 5622.11. Bunds and gilts are trading in narrow ranges, paring earlier losses, ahead of U.S. new home sales. The June bund future is down 0.09 at 115.47, while the June gilt is down 0.05 at 108.40. In the currency market, the dollar is posting limited gains, helped by Fridays strong U.S. housing data, but constrained by continued uncertainty over just how hawkish the Federal Reserve will be. The market is now looking to see if the new home sales data are as strong as Fridays figures. The dollar is up at Y118.25, the euro is down at $1.3267 and the pound is down at $1.9596. =========================== TOP STORIES: TAYLOR WOODROW, GEORGE WIMPEY CONFIRM GBP5B MERGER: U.K. housebuilders Taylor Woodrow PLC (TWOD.LN) and George Wimpey PLC (WMPY.LN) confirmed the terms of a recommended GBP5 billion all-share merger to create the U.K.s largest housebuilder. (By Molly Dover) XSTRATA BUILDS NICKEL OPS WITH $4B BID FOR LIONORE: Mining group Xstrata PLC (XTA.LN) moved to bulk up its global nickel business with an agreed cash bid for LionOre Mining International Ltd. that values LionOre at C$4.6 billion (about $4 billion). (By Andrea Hotter and Leia Parker) E.ON RAISES ENDESA BID TO EUR40/SHARE: Germanys E.ON AG (EON) raised its takeover offer for Endesa S.A. (ELE) to EUR40 per share, valuing the Spanish utility at around EUR42.36 billion. (By Jan Hromadko) ACCIONA, ENEL PLAN JOINT BID FOR ENDESA: Spanish conglomerate Acciona SA (ANA.MC) said its reached an agreement with Italys Enel SpA (EN) to launch a joint bid for Endesa SA (ELE), if Germanys E.ON AG (EON) fails to acquire over 50% of Endesa shares through its current tender offer. (By David Roman) IRAN TENSIONS MAY UPSET OIL MARKETS: International tensions with Iran over its nuclear program and the seizure of 15 British sailors and marines could further roil oil markets this week as Tehran insisted it wouldnt back down on either front. (WSJ) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: The first rise in Japans land prices in 16 years heralds both the countrys economic recovery and the upward path of Japanese interest rates. (By Nicholas Hastings) =CHARTING EUROPE: ICE May Brent crude futures near this years $64.08 per barrel high, made on Jan. 2, and have so far reached $63.97 per barrel Monday morning. (By Axel Rudolph) =ASSET CLASS: The U.S. fixed income market is starting to worry about inflation. (By Alen Mattich) =========================== STILL TO COME ET/GMT COUNTRY/PERIOD 0730/1230 US Feb Chicago Fed Natl Activity Index 0900/1400 US Feb New Home Sales 0930/1430 US Mar Dallas Fed Mfg Production Index 1100/1600 UK BoE Deputy Gov of Fincl Stability Gieve speaks 1850/2350 JPN Feb Corp Svc Price Index =========================== OTHER NEWS: German business confidence is expected to deteriorate slightly in March, although from a high level, as companies assessment of their current trading conditions falls further. (By Nina Koeppen) German sports car maker Porsche AG (POR3.XE) Saturday said it intends to raise its stake in Volkswagen AG (VLKAY) to 31% from 27.3% to help block any potential takeover of the company, but it doesnt want to mount a full takeover yet itself. (By Steve McGrath, Matthias Krust and Stephen Power) Shares in property investment and development company Minerva PLC (MNR.LN) fell more than 5% despite a return to profit at the half-year stage, after the company announced a lower-than-expected investment property revaluation. (By Anita Likus) Sentiment among French business leaders improved in March from February, data released by the French national statistics institute Insee showed. (By Geraldine Amiel) Wolkers Kluwer NV (WKL.AE) will book between EUR550 million and EUR600 million in net profit on the sale of its Education unit, the company spokesperson Caroline Wouters said. (By Roberta B. Cowan) Aareal Bank AG (ARL.XE) said it is targeting more than a 60% increase in its pretax profit in 2007 compared with the year earlier. (By Ragnhild Kjetland) Swiss drugmaker Novartis AG (NVS) said it is selling the production facilities for the manufacturing of multiple sclerosis drug Betaseron to Germanys Bayer AG (BAY) for $200 million, and plans to introduce its own version of the medicine in 2009. (By Anita Greil and Gangolf Schrimpf) Sony Ericsson flagged its intention to enter the battle for low-end mobile phones with a licensing deal with Sagem, the mobile phone unit of Safran SA (7327.FR). (By Gren Manuel) Reuters Group PLC (RTRSY) launched its long-anticipated FXMarketSpace joint venture with the Chicago Mercantile Exchange, creating the worlds first centrally-cleared global foreign exchange market place. (By Jessica Hodgson and Katie Martin) Food producer Dairy Crest Group PLC (DCG.LN) said that its full-year trading performance has been in line with its expectations, with strong growth in its branded cheese operations offsetting a weaker performance is spreads. (By Michael Carolan)


 

26 March 2007 GLENCAR MINING PLC ('Glencar' or 'the Company') Holdings in Company Glencar received notification on 26 March, 2007 that Man Financial has increased its total aggregate holding in the share capital of Glencar to 8,408,000 ordinary shares, which represents 3.72% of the issued share capital. For Further Information contact: Glencar Mining plc Hugh McCullough Tel: +353 1 661 9974 e-mail: info@glencarmining.ie ---END OF MESSAGE---


 

KYOTO, Japan, March 26, 2007 (PRIME NEWSWIRE) -- Nidec Corporation ("Nidec") (NYSE:NJ) announced today that the Board of Directors of its Singaporean subsidiary, Brilliant Manufacturing Limited ("Brilliant"), agreed on a proposal to delist the shares of Brilliant common stock (the "Shares") from the Singapore Exchange Securities Trading Limited ("SGX-ST"). Nidec acquired Brilliant by means of tender offer in February 2007 and currently holds 87% of the Shares. Upon approval of shareholders at an extraordinary general meeting of Brilliant, Nidec intends to purchase all of the remaining Shares currently traded on SGX-ST to make Brilliant a wholly-owned subsidiary. Nidec believes the delisting of Brilliant will enable more efficient and competitive management of the HDD base plate production. The Nidec Corporation logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1734 CONTACT: Nidec Corporation Hiroshi Toriba, Senior General Manager, Investor Relations +81-75-935-6140 HIROSHI_TORIBA@notes.nidec.co.jp


 

The Annual General Meeting will be held at 4 p.m. on Tuesday April 24, 2006, at Scandic Hotel Star, Glimmervägen 5, Lund, Sweden. An agenda containing the matters that are proposed to be brought before the Meeting is included in the official notice to attend the Meeting, which is appended this press release and which will be published on March 27, 2007 in the newspapers Post- och Inrikes Tidningar and Svenska Dagbladet. As will be seen from the notice, inter alia the following proposals are submitted regarding matters at the Meeting: * In order to enable the company to make acquisitions of shares or assets in companies with payment (wholly or partly) in own shares, the Board proposes that it should be authorized to resolve upon an increase of the share capital with a maximum of SEK 1.6 million by issuing a maximum of 4 million shares, which at full exercise is equivalent to a dilution of just below 4.1 %. The issue may only be made for payment in kind. The further terms and conditions are set forth in the notice. * The Board proposes that the Meeting resolves on an incentive programme for the employees by way of issue of a maximum of 3.5 million warrants, which entitles to subscription for the equivalent number of new shares in the Company during the period from 1 January 2010 up to and including 31 May 2010 at a subscription price corresponding to 133 % of the average share price during the period 14-28 May 2007. The warrants shall be subscribed for by two of the Company's wholly-owned subsidiaries, which shall in their turn transfer option rights on market terms and conditions to the employees within the group in Sweden and the USA. On full subscription and full exercise of the warrants the share capital may be increased by a maximum of SEK 1.4 million, which is equivalent to approximately 3.6 % of the present share capital and votes. The further terms and conditions are set forth in the notice * The Board proposes that the Meeting resolves on guidelines for remuneration to management in accordance with the Board's proposal, which main terms are set out in the notice. For further information, please contact Lars Grönberg, Director of the Board, Precise Biometrics AB. Telephone +46 (0) 707 27 54 55 E-mail lars.gronberg@precisebiometrics.com Niklas Andersson, CFO, Precise Biometrics AB. Telephone + 46 (0) 730 35 67 02 E-mail niklas.andersson@precisebiometrics.com Ann-Sofi Höijenstam, Director IR & Communications Precise Biometrics AB Telephone + 46 (0) 734 35 11 47 E-post ann-sofi.hoijenstam@precisebiometrics.com Precise Biometrics AB (publ.) is an innovative security company that supplies world-leading systems for fingerprint and smart card-based authentication. The company's solutions replace keys, PIN codes and passwords and enhance the integrity of ID cards and passports. With its Precise Match-on-Card(TM) technology, the company is a market leader within smart ID cards. The product line includes systems for access control to buildings, computers and networks and for integration into ID cards and passports. The Precise Biometrics group has subsidiaries in Sweden, Great Britain, USA and a joint venture agreement in China. The group headquarters are in Lund, Sweden. Precise Biometrics is listed on the small cap list at the Nordic Exchange in Sweden (symbol: PREC). For more information, please visit http://www.precisebiometrics.com/ The full press release can be downloaded from the following link:


 

Wei-Ming Jiang, currently Senior Vice President Strategic Projects Asia at DSM's Corporate Planning Department, has been appointed President DSM China as of May 1, 2007. In this position he will succeed Stefan Sommer, who will continue his assignment as strategic advisor to DSM's Managing Board. The appointment of Wei-Ming Jiang underlines the strategic importance DSM attaches to China as an emerging market. "Increasing our presence in emerging economies is a key driver of our Vision 2010 strategy," said Jan Zuidam, Deputy Chairman of DSM's Managing Board. "For China our target is to achieve sales of more than USD 1 billion by 2010, which represents a doubling compared to 2005. I would like to thank Stefan Sommer for his valuable contribution to the fast development of DSM China. The appointment of Wei-Ming Jiang shows DSM's ongoing commitment to China and underlines our firm belief that China will contribute significantly to our Vision 2010 ambitions." Before he joined DSM, Wei-Ming Jiang worked for Novozymes for fifteen years in several management positions in Asia-Pacific and China. He was actively involved in the development of a biotech-industry platform in China. Mr. Jiang also contributed to an increased awareness and implementation of sustainable entrepreneurship in China, amongst other things in his capacity as vice-chairman of the China Business Council for Sustainable Development, a position which he will continue to fulfill as President of DSM China. Since the announcement of its strategy Vision 2010 - Building on Strengths, one of the three drivers of which is an increased presence in emerging economies, DSM has made concrete progress in China. In 2006, DSM's sales in China amounted to almost USD 775 million, an increase of 25% compared to 2005. DSM has significantly increased its product portfolio and manufacturing footprint in China, investing a total of more than USD 120 million over the last year. Mid-January 2007, DSM announced the building of a brand new DSM China Campus in Shanghai, which is another milestone underlining the company's commitment to China. With the new China Campus, DSM will grow its R&D activities in China. "I am proud to be the successor of Stefan Sommer, who showed good leadership and made a remarkable contribution to the development of DSM in China. I am looking forward to taking up this new challenge with great enthusiasm and I am confident that we will further strengthen DSM's leadership position in China," commented Wei-Ming Jiang. DSM DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa and the Americas. More information on DSM can be found at www.dsm.com. More information: DSM Corporate Communications DSM Investor Relations Nelleke Barning Dries Ausems tel. +31 (0) 45 tel. +31 (0) 45 5782864 5782017 fax +31 (0) 45 5782595 fax +31 (0) 45 e-mail 5740680 investor.relations@dsm.com e-mail media.relations@dsm.com


 

WASHINGTON, DC and NEW YORK, NEW YORK -- (MARKET WIRE) -- March 26, 2007 -- Hybrid Technologies, Inc. (OTCBB: HYBT) (www.hybridtechnologies.com), emerging leaders in the development and marketing of lithium powered products worldwide, is pleased to announce a vehicle contract that is part of the Canadian Federal Governments' ecoTransport strategy. Daimler Chrysler Lithium powered PT Cruiser and Mercedes Benz Lithium powered Smart Car to be evaluated. The Vehicles purchased under contract by the Ministry of Transportation Advanced Technology Vehicles Program include evaluating fuel efficiency, emissions and safety performance of these vehicles, identifying the market potential of advanced technologies, identifying barriers to using advanced technologies and proposing solutions, and raising public awareness of the advanced technologies available on current vehicles and vehicles of the future. About the Advanced Technology Vehicles Program: http://www.tc.gc.ca/programs/environment/ecotransport/ecotechnologyvehicles.htm "Canada's New Government is taking action to deliver real reductions in air pollutants, greenhouse gas emissions and harmful substances in our communities," said the Honorable John Baird, Minister of the Environment. "We will continue to work with provincial, territorial, and municipal governments as well as with the broader transportation community to develop a practical, cost- effective approach to protecting the environment so that present and future generations of Canadians benefit from a country that is cleaner, greener, and healthier." "The greatest source of untapped energy is the energy we waste, and when we cut waste, we cut emissions and we cut costs," said the Honorable Gary Lunn, Minister of Natural Resources. President of Hybrid Technologies, Holly Roseberry, stated: "We are proud that our vehicles were selected by the Canadian Government for extensive evaluation. Ours will be the only lithium vehicles in their research fleet." To view extended press release click here: http://www.hybridtechnologies.com/media.php?mediaID=070326 Forward-Looking Statements This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. Contacts: Hybrid Technologies, Inc. Media Contact 1-888-HYBTECH (1-888-492-8324) Email: pr@hybridtechnologies.com Hybrid Technologies, Inc. Investor Relations 1-888-669-1808 (702) 926-9508 (FAX) Email: info@hybridtechnologies.com Website: www.hybridtechnologies.com


 

Ericsson (NASDAQ:ERIC) and Compal Communications have signed a license agreement for the U310 mobile platform - a triple-band WCDMA mobile platform from Ericsson Mobile Platforms. The U310 platform is an advanced WCDMA/EDGE/GPRS platform designed for true mass-market deployment. It incorporates a flexible quad-band EDGE and triple-band WCDMA radio solution, which makes it possible to design mobile devices that are suitable for the global market. With a high level of silicon integration, it allows handset manufacturers to launch ultra-small WCDMA phones. Stephen Chen, Executive Vice President of Compal Communications, says: "We are very pleased with the mobile platforms from Ericsson. With the U310 we can further develop the 3G mobile device to include even more advanced features while maintaining very compact size and high performance. This will help us to provide cost-competitive products to our customers that can be released quickly to the market." Robert Puskaric, head of Ericsson's mobile platform business, says: "This is yet another proof point of Ericsson's strength in the mobile platforms business. Compal Communications is one of the leading original design manufacturers (ODMs) in the world. With the U310, Compal Communications will be able to offer attractive products incorporating the latest technology for mass-market deployment, with short time to market, making Compal Communications highly competitive in the mobile device arena." Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more a http://www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com Notes to the editor: About Compal Communications Compal Communications Inc. (CCI) (http://www.compal.com/) is an original design manufacturer (ODM) in the wireless and communication industry. Its product lines include phones, smartphones, PDAs, GPS devices, Voice over IP (VoIP) devices and ZigBee modules. CCI is proficient in wireless device design. The company is located in Taiwan and has a manufacturing facility in Nanjing, China. About Ericsson Mobile Platforms Ericsson Mobile Platforms offers complete, end-to-end interoperability tested platforms for 2.5G and 3G. A common software platform for GPRS, EDGE, WCDMA and HSPA terminals enables application portability, stability and security, and ensures best-in-class outcomes regarding power consumption and size. Ericsson Mobile Platforms has the smallest, most-cost-optimized HSPA chipset in the market, making it possible for its customers to enable ultra-small HSPA phones. The technology is based on Ericsson's global leadership of standardization work and the world's strongest intellectual property rights for 2.5G and 3G systems. Read more at http://www.ericsson.com/ericsson/press/facts_figures/doc/emp.pdf


 

Venture Drilling AS is a company owned 50/50 by Sinvest ASA and Petrolia Drilling ASA. Larsen Oil and Gas Ltd (Aberdeen), as drilling contractor for the drillship Deep Venture, have on behalf of Venture Drilling AS, agreed to a drilling contract with ExxonMobil , with a contract duration is for 18 months, where the last 12 months of the contract was subject to approval by the relevant government authority in the area of operation.(ref Stock exchange notice 2nd November 2006) Venture Drilling AS has been notified by Exxon, that the relevant approvals has been authorized. Venture Drilling AS estimates upstart of contract to be during May 2007. Contact Person: Lars Moldestad - phone +47 906 99 197 Bergen / Oslo - 26th Mars 2007


 

Fokker Services, a company of the Netherlands based Stork Aerospace, has completed the acquisition of Aerotron AirPower (LaGrange, Georgia USA), which was announced on 16 March 2007. This acquisition is part of Fokker Services strategy to expand it's postion in the growing US aerospace services market and follows the acquisition of AIRINC last year. The parties did not reveal the financial details of the transaction. Aerotron AirPower Inc. (www.aerotron.com, 95 employees) specializes in the maintenance, repair and overhaul of complex pneumatic, hydraulic, fuel, and electro-mechanical components installed on a wide variety of aircraft including Airbus, Boeing, Bombardier and Embraer. RC Cannady, founder of Aerotron AirPower Inc. commented: "Stork is a highly respected member of the global aviation services community. I am pleased Aerorton is now a part of a much larger and stronger enterprise which will be good for all of our employees and customers alike. I will be retiring now and I am very pleased that both my sons, Ron and Michael, have elected to stay with the company and will continue in their leadership roles at Aerotron and now as members of the Fokker Services team". Hans Berends van Loenen, President of Fokker Services commented: "We are most pleased with the acquisition of Aerotron AirPower Inc. The Cannady family and the entire Aerotron team have built a terrific company and we are pleased that they have elected to join forces with us. This addition enables Fokker Services to further expand its capabilities and customer base in the US market in order to deliver its ABACUS Logistic Program on non-Fokker aircraft. The ABACUS program ensures the availability of components through supply chain provisioning and repair management of unserviceable critical airframe and engine components. Stork Aerospace develops and produces advanced components and systems for the aviation and aerospace industry, and supplies integrated services and products to aircraft owners and operators. The group achieved a turnover of ¤ 549 million in 2006 with 3.532 employees out of the total Stork turnover of ¤ 2 billion. Press information: Stork N.V. Dick Kors Tel.: +31 (0)35 695 75 75 or +31 (0)6 519 840 54


 

(Oslo, 26 March 2007) Block Watne Gruppen ASA ("BWG") through a newly established Swedish wholly owned subsidiary, has entered into an agreement to acquire the leading Swedish residential house builder Prevesta AB ("Prevesta") from the Industri Kapital 2004 Fund ("Industri Kapital") and Prevesta's management. The agreed purchase price for Prevesta is SEK 1 900 million (NOK 1 731 million) on a cash and debt free basis ("enterprise value"). Prevesta has 530 employees and had revenues in 2006 of NOK 1 530 million and an EBIT of NOK 150 million. Highlights of the acquisition * The acquisition complements BWG's successful Norwegian operation and is in line with BWG's ambition to take an active part in consolidating the Scandinavian market for residential house building * Prevesta is Sweden's leading producer of prefabricated houses with the highly recognized brands Myresjöhus and SmålandsVillan * BWG becomes the leading Scandinavian residential house builder * Pro forma operating revenues in 2006 of NOK 3 059 million * Pro forma operating profit (EBIT) in 2006 of NOK 382 million * The acquisition is expected to contribute positively to earnings per share from 2007 and onwards (not including any synergies) * Potential to realise synergies through economies of scale in purchasing, best practice efforts, cross-selling of concepts, improved capacity utilization and productivity gains * BWG will continue its current policy of targeting a dividend ratio of 50 - 70 per cent of net profit after taxes Transaction structure The purchase price amounts to SEK 1 900 million (NOK 1 731 million) on a cash and debt free basis ("enterprise value") and will be financed through a combination of 6 502 242 new BWG shares to be issued to the sellers of Prevesta and approximately SEK 1 600 million (NOK 1 460 million) in cash including refinancing of existing debt in Prevesta. The entire purchase price is fully financed through committed credit facilities. The completion of the acquisition is not conditional upon approval of the annual general meeting in BWG due to the committed financing. The board of directors of BWG will recommend to its annual general meeting to be held 18 April 2007, to approve the directed issue of the 6 502 242 BWG shares to the sellers of Prevesta as well as a further share issue in the amount of NOK 500 - 800 million expected to be carried out in the second quarter of 2007. The proceeds from the share issue will be used to repay parts of the acquisition credit facilities. Newly issued shares will not carry any rights to the NOK 2.50 per share dividend for the financial year 2006 proposed by the board of directors of BWG. Lars Nilsen, the main owner and CEO of BWG, has through his wholly owned companies Lani Industrier AS, Lani Development AS and Lagulise AS, undertaken to vote for his entire holding in favour of the share issues commented above. Through these three companies, Lars Nilsen represents 50.13 per cent of the shares and votes in BWG. Closing of the transaction is conditional upon the Financial Supervisory Authority in Sweden and the Commissariat aux Assurances (Insurance Regulatory Authority) in Luxembourg approving the indirect change of ownership of two insurance companies, Gar-Bo Försäkring AB in which Prevesta owns 33.6 percent which in turns owns Agat Re SA. These two companies are owned jointly with other house developers in the Swedish market. BWG and Industri Kapital foresee no reason for such approvals not being granted within two months from when applications have been submitted to the relevant regulatory authorities. The applications will be submitted within one week from today, and closing of the transaction will take place shortly following the receipt of such approvals. The transaction will not require filing with any competition authorities. The leading Scandinavian residential house builder - BWG has on several occasions communicated its intention to actively participate in the consolidation of the fragmented Scandinavian residential house building market. Furthermore, BWG has communicated that the next logical step could be an entry into the Swedish market. BWG now acts on these intentions and takes a great leap in the consolidation of the Scandinavian residential house building market and simultaneously establishes BWG as the market leader within this market, comments Lars Nilsen, CEO of Block Watne Gruppen. - Prevesta, with its brands Myresjöhus and SmålandsVillan, fulfils the criteria we have defined for our acquisition evaluation process. Prevesta's management has managed to turn the company into a high performer over the last years. Management has also displayed an ability to handle growth without margin erosion and has created a sound operation. BWG's acquisition of Prevesta rests on a strong industrial logic and will support our future profitable growth, Lars Nilsen further comments. - Prevesta has been a fantastic investment for us. During Industri Kapital's ownership the company has improved its financial performance and has strengthened its position in Sweden to become the leading producer of single-family houses. The recent investments and restructuring efforts have also created the foundation for further growth and profitability for the company. We are also pleased to become a significant owner in BWG and are impressed with BWG's strong performance during the past few years. The combined company has excellent prospects for further successful growth and development, comments Michael Rosenlew, responsible partner at Industri Kapital. - Industri Kapital has been a good owner. The recent years have been an exciting time for the company and the restructuring effort during Industri Kapital's ownership has resulted in considerable investments and a strong financial performance. We are pleased that the new owner of Prevesta will be BWG, a successful industrial partner with a long- term focus. The two companies complement each other well in particular in terms of know-how and market positions and we look positively on the future, comments Mikael Olsson, CEO of Prevesta AB. Description of Prevesta Prevesta, Sweden's leading producer of prefabricated houses, with the highly recognized brands Myresjöhus and SmålandsVillan, is headquartered in Myresjö in the province of Småland. Since its inception in 1927, Prevesta has delivered more than 80 000 houses primarily in the Swedish market. In 2006, the Group had a turnover of SEK 1 756 million (NOK 1 530 million) and an operating profit of SEK 173 million (NOK 150 million). In addition Prevesta had an income from associates (Gar-Bo Försäkring AB) of SEK 18.5 million (NOK 16.1 million). The company has production facilities in Myresjö, Vrigstad and Sundsvall and currently has approximately 530 employees. Prevesta's operations are divided into two business areas: Myresjöhus: Development, production and marketing of prefabricated houses under the Myresjöhus brand for primarily the Swedish market, including both single family houses and housing estates. SmålandsVillan: Development, production and marketing of prefabricated houses using volume techniques under the SmålandsVillan brand for primarily the Swedish market. For further financial information on Prevesta, please refer to the pro forma financial information included with this press release. Background and reason for the acquisition of Prevesta BWG has for a period of time evaluated potential strategic opportunities in Scandinavia. Prevesta, with its highly recognized brands Myresjöhus and SmålandsVillan, and its healthy operational and financial performance, fulfils the criteria BWG has defined for attractive acquisition targets. These criteria are: * High quality in management * Sound historical operational and financial performance * Strong brand names and product portfolio * Focus on similar market segments * Financially attractive for BWG's shareholders; also on a stand-alone basis Prevesta is market leading in the Swedish market and also possesses the strongest brand in the market - Myresjöhus. Myresjöhus targets the same market segment as regards house size and price in Sweden as BWG does in Norway; affordable quality housing in the outskirts of cities and pressure areas. Prevesta's other brand, SmålandsVillan, targets the highly standardized and affordable segment of the market, similar to the segment that BWG is considering for the Hetlandhus brand in Norway. The most distinct differences between the Norwegian and Swedish operational models are prefabrication and the development of residential projects on own accounts. Block Watne AS has no prefabrication and the houses are built on site by carpenters employed by the company. For Myresjöhus, approximately 80 per cent of total house construction is on site and around 20 per cent is prefabricated. The corresponding figures for SmålandsVillan are 20 per cent on site and 80 per cent prefabrication. Following the acquisition of Prevesta, approximately 80 per cent of BWG's total house building will be built on site and approximately 20 per cent based on prefabrication. Over 90 per cent of Block Watne AS' sales are derived from residential project development where Block Watne AS controls the whole value chain including acquisition of land, development of the project, selling and constructing of the houses to end customers. For Myresjöhus approximately 40 per cent of the business is residential project development. A majority of the deliveries are turn-key solutions based on contractual work carried out by sub suppliers. SmålandsVillan is entirely single-family houses on the customers' own property. For the combined Block Watne and Prevesta, approximately 60 per cent of the volume will be residential project development. Synergy potential BWG will seek to utilise the synergy potential between its Norwegian and Swedish subsidiaries including: * Economies of scale within purchasing due to larger combined volumes * Implementing "best practice" in both the Norwegian and Swedish operations as regards standardization, pricing and potential for increased efficiency in the production * Cross-selling of concepts between Sweden and Norway * Increased capacity utilization of the Swedish production plants As a result of strong growth in the building market in recent years, there is currently a squeeze on resources. Synergies are hence expected be realized over a longer period of time than could have been expected in a "normalized market". Lock-up agreements Industri Kapital has entered into a six month lock-up agreement from the closing of the transaction for its BWG shares. All management shareholders of Prevesta have similarly entered into a 12 month lock-up agreement from the closing of the transaction for its BWG shares. Advisors Access Partners acted as financial advisor and White & Case Advokat AB and Thommessen Krefting Greve Lund have acted as legal advisors to BWG. KPMG Transaction Services assisted in the financial due diligence process. Further information from Lars Nilsen, CEO, Block Watne Gruppen ASA, tel: +47 23 24 60 00 Ketil Kvalvik, CFO, Block Watne Gruppen ASA, tel: +47 90 77 13 15 About Block Watne Gruppen Ranked as one of Norway's leading housebuilders, BWG covers the purchase and development of sites as well as the construction and sale of dwellings to private buyers. BWG has built over 84 000 homes in total, and completes more than 1 000 new houses a year and has a stock of building land corresponding to some 12 000 dwelling units. Around 400 of its 600 employees are skilled carpenters working in specialised teams. Each house is built from scratch using well-proven and cost-effective methods developed over many years. BWG operates from 21 regional offices around Norway, with the emphasis on attractive housing developments outside the most densely-populated areas. BWG 2006 turnover was NOK 1 529 million (approximately EUR 187 million) and the operating profit (EBIT) was NOK 241 million (approximately EUR 29 million), corresponding to an operating margin of 15.7 per cent. Block Watne Gruppen was listed on Oslo Børs in March 2006. Pro forma condensed financial information The pro forma accounts have been prepared to illustrate the effects of the consolidation of Prevesta had the transaction been completed on 1 January 2006. For principles applied and more details please refer to the enclosed supplementary information. Pro forma condensed income statement for the year 2006 BWG ASA Prevesta Pro forma New BWG NOK million Group Group adjustments Group Operating revenues 1 529.2 1 529.8 0.0 3 059.0 EBITDA 245.8 159.8 -8.7 396.9 EBITDA margin 16.1% 10.4% 13.0% EBIT 240.6 150.4 -8.7 382.3 EBIT margin 15.7% 9.8% 12.5% Income from associates 2.9 16.1 19.0 Net financial costs -25.8 -27.7 -103.3 EBT 217.7 138.8 -58.5 298.0 EBT margin 14.2% 9.1% 9.7% Net profit 162.8 100.1 -42.1 220.7 Net profit margin 10.6% 6.5% 7.2% Basic earnings per share, weighted 3.70 4.32 Number of shares 51 502 outstanding 45 000 000 242 Pro forma condensed balance sheet as at 31 December 2006 BWG ASA Prevesta Acquisition Eliminations Pro forma New BWG NOK million Group Group of Shares adjustments Group Assets Intangible assets 826.1 416.1 0.0 1,724.1 0.0 2,966.3 Tangible assets 30.9 67.4 0.0 0.0 0.0 98.3 Financial assets 11.2 34.3 1,384.0 -1,384.0 0.0 45.5 Total fixed assets 868.1 517.8 1 384.0 340.1 0.0 3 110.1 Current 1 assets 282.2 342.8 0.0 13.1 -58.5 1 579.6 Total 2 assets 150.4 860.6 1 384.0 353.2 -58.5 4 689.7 Equity and Liabilities Paid in capital 543.9 63.8 268.5 -6.4 0.0 869.8 Retained equity 170.9 -237.9 0.0 180.6 -42.1 71.4 Total equity 714.7 -174.1 268.5 174.2 -42.1 941.2 Liabilities Provisions 80.2 156.9 0.0 179.0 -16.4 399.7 Non-current liabilities 602.7 347.6 1 115.5 0.0 0.0 2 065.8 Current liabilities 752.7 530.2 0.0 0.0 0.0 1 282.9 Total 1 liabilities 435.6 1 034.7 1 115.5 179.0 -16.4 3 748.5 Total equity and 2 liab. 150.4 860.6 1 384.0 353.2 -58.5 4 689.7 The pro forma income statement and balance sheet shown above includes the issue of 6 502 242 BWG shares to the sellers of Prevesta and cash/debt financing of the remaining purchase price. Disclaimer The information contained herein is not for publication or distribution in or into the United States of America. The materials do not constitute an offer of securities for sale in the United States, nor may the securities be offered or sold in the United States absent registration or an exemption from registration as provided in the Securities Act of 1933, as amended, and the rules and regulations there under. There is no intention to register any portion of the offering referred to herein in the United States of America or to conduct a public offering of securities in the United States of America. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption of registration or qualification under the securities laws of any such jurisdiction.


 

TRADING SYMBOL: TORONTO & OSLO: CRU FRANKFURT: KNC OTC-BB-other: CRUGF LONDON, United Kingdom: March 26, 2007 - Crew Gold Corporation ("Crew" or the "Company") (TSE & OSE: CRU; Frankfurt: KNC; OTC-BB- other: CRUGF.PK. Crew is pleased to advise the successful re-commissioning of the Nugget Pond facility in Newfoundland and report the first gold pour. Crew acquired the Nugget Pond facility in October 2006 to process ore from its Nalunaq mine in southern Greenland and undertook a refurbishment programme of the plant which had been on care and maintenance since 2004. Shipping of ore commenced during February and to date, a total of three shipments to South Brook in Newfoundland have been completed for a total of 42,851dmt. Ore processing commenced in late February and to date, a total of 8,299 tonnes have been processed, including lower grade ore used to commission the plant. The plant is now achieving its designed throughput of 425 tpd. Plant expansion to 600tpd is scheduled to commence during Q2, 2007 and should be completed in Q3, 2007. Jan Vestrum, President and CEO of Crew stated, "The early and successful start up of Nugget Pond, several months earlier than originally anticipated, is a credit to the new Crew team at Nugget Pond and contractors associated with the project. Working capital requirements will be reduced with regular shipments of ore and create a regular cash flow from the Nalunaq operation. Additionally, the re-starting of the Nugget Pond facility will provide an important boost to the Baie Verte economy." Jan A Vestrum President & CEO Safe Harbour Statement This news release contains forward-looking statements which reflect the expectations of management and the board of directors, and are made pursuant to applicable and relevant national legislation (including the Safe-Harbour provisions of the United States Private Securities Litigation Reform Act of 1995) in countries where Crew Gold Corporation is conducting business and/or investor relations. Forward looking statements typically contain words such as "believes", "anticipates", "continue", "could", "expects", "indicates", "plans", "will", "may", "projects", "would" or similar expressions suggesting future outcomes or events, although not all forward-looking statements contain these identifying words. Such forward-looking statements reflect the current beliefs of management and the board of directors based on information currently available to them. Forward-looking statements involve inherent risks and uncertainties, and Crew cautions readers not to place undue reliance on these statements as a number of important factors could cause Crew's actual results to differ materially from the beliefs and expectations expressed in such forward-looking statements. Factors that could cause actual results to differ materially from the results discussed in the forward-looking statements, include, but are not limited to, the factors discussed under the heading "Risks and Uncertainties" in Crew's Annual Information Form dated October 10, 2006, as filed on SEDAR at www.sedar.com. Although the forward-looking statements contained in this news release are based upon what management and the board of directors believes to be current and reasonable assumptions, Crew cannot assure readers that actual results will be consistent with these forward-looking statements. The forward-looking statements contained herein are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Crew undertakes no obligation to publicly update or revise these forward-looking statements to reflect subsequent events or circumstances. Cautionary Note to US Investors - The United States Securities and Exchange Commission permits US mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms on this website (or press release), such as "measured", "indicated", and "inferred" "resources", which the SEC guidelines strictly prohibit US registered companies from including in their filings with the SEC. US Investors are urged to consider closely the disclosure from the SEC's website at http://www.sec.gov/edgar.shtml. --- End of Message --- Crew Gold Corporation Abbey House, Wellington Way, Weybridge Surrey United Kingdom WKN: 226534105 ; ISIN: CA2265301036; ;


 

LONDON -- (MARKET WIRE) -- March 26, 2007 -- Axiom Systems the leading provider of Service Fulfillment and Service Assembly solutions for telecommunications, and NVision Group, a market-leading Russian systems integrator, today announced that JSC Central Telegraph in Moscow has purchased AXIOSS®, an end-to-end service fulfilment software solution that will be implemented by NVisionGroup. The agreement provides Central Telegraph with a next-generation platform for service activation across all service domains and is the first agreement to implement AXIOSS in Russia. After a rigorous selection process that involved other OSS vendors and replaced a competitive solution, Central Telegraph selected AXIOSS in combination with NVision's integration expertise, for its proven track record in next-generation provisioning. Based on the terms of the agreement, NVision Group will install AXIOSS Service Activation, which includes service activation for delivery and design. Rustam Valishev, Deputy General Director, Central Telegraph commented: "AXIOSS Service Activation is pivotal to the day-to-day operations of any service provider. In the process of choosing a system for our business development we conducted a detailed analysis of existing products in the Russian market and took several factors into consideration: The volume of the existing subscriber base in our company and its future growth; the importance of managing just-in-time services to subscribers; and the dynamic changes of our services for end users. We also considered the functional advantages of a system that would support the development of new services within existing business units and also the vendor's worldwide expertise. The AXIOSS solution satisfies all of our requirements. " Alex Goltsov, Technical Director, NVision Group added: "The agreement confirming the implementation of AXIOSS in Central Telegraph is a first for Russia. Cooperating with Axiom Systems, we consider the company's products as innovative and thought leading for OSS/BSS solutions. The architecture of AXIOSS helps to organize the effective interaction between multiple applications and third parties systems and provides the agile support for software and equipment for outstanding worldwide manufacturers within the telecoms market." "Today's service providers need intelligent, automated IP provisioning solutions that are market-ready and provide a rapid return on investment," said Gareth Senior, CTO/CEO, Axiom Systems. "By delivering on these key requirements, Axiom Systems' innovative pre-integrated service fulfillment platform supports and expands Central Telegraph's continued business and customer service leadership in IP service offerings." NVision also operates as an AXIOSS Service Component Factory, which has become a Center of Excellence in Russia for the offshore development of 'building block' style components that streamline the creation and fulfillment of multi-vendor, multi-technology, and multi-play products and services. About Axiom Systems Axiom Systems is the leader in software for the design, assembly and delivery of exciting new Telco product and services. The company's AXIOSS Suite which incorporates modules for Order Management, Service Inventory, Service Activation, a Designer Tool and Active Catalog, provides customers with advanced solutions for new services that include IPTV, VoIP, IP VPN and Triple Play. Global customers include -- Cable & Wireless, Deutsche Telekom, TeliaSonera, AOL, Telekom Austria, TDC, Telecom New Zealand, NTL, Telecom Italia and TelMex. The company is headquartered in the UK, with regional offices in Rome, Munich, Paris, Madrid, Budapest, Seattle USA, Sydney and Singapore. www.axiomsystems.com About NVision Group NVision Group is a market-leading Russian system integrator that is uniquely focused on aligning the business needs of national companies with the power of best-in-class IT, networking and telecom solutions. NVision Group brings clients value-added consulting and system integration services, from planning of the network, to strategic consulting, system design, integration, and development. NVision Group leverages leading-edge technologies and business experience to drive clients' business process improvements and increase the value of clients' investments in information technologies. Founded in 2001, NVision Group is headquartered in Moscow, Russia. www.nvisiongroup.ru For more information, please contact: Martine Parsons Axiom Systems Mparsons@axiomsystems.com T : +44 (0) 118 9294133


 

MorphoSys AG (FSE: MOR; Prime Standard Segment) announced today that its current board member Professor Andreas Plückthun intends to resign from the Supervisory Board with effect of 16 May, 2007. Professor Plückthun is leaving the board at his own request, in order to devote additional time to his increasing number of academic research programs at the University of Zurich, as well as to be able to pursue other entrepreneurial opportunities. The Supervisory Board accepted Prof. Plückthun's decision with regret and thanked him for his long-lasting support and his contribution to the growth and success of the Company. As successor to Professor Plückthun, the Supervisory Board will propose the nomination of Dr. Walter Blättler, formerly Executive Vice President, Science and Technology of ImmunoGen, Inc., at the Company's next annual shareholder meeting in May. Professor Plückthun will remain connected to MorphoSys as an advisor on future technology development. Dr. Walter A. Blättler studied chemistry at the Swiss Federal Institute of Technology, Zurich (ETH Zürich), and subsequently held a research position as a post-doctoral fellow at Harvard University, Cambridge, U.S.A. Prior to joining ImmunoGen at its newly established laboratories, Dr. Blättler held various positions at the Dana-Farber Cancer Institute, Harvard Medical School, in Boston. In 1987 he joined ImmunoGen Inc., as Vice President and subsequently Senior Vice President, R&D. In 1996 he was promoted to Executive Vice President, Science & Technology. During his time with the company, ImmunoGen introduced several antibody-based drugs into clinical development and established several successful research and/or development collaborations with major pharmaceutical companies. "On behalf of the Supervisory Board of MorphoSys, I would like to thank Professor Plückthun for his long-lasting support and his very active contribution to the growth and success of the Company," commented Dr. Gerald Möller, Chairman of the Supervisory Board of MorphoSys AG. "At the same time, we are particularly glad to be able to nominate Dr. Walter Blättler, whose expertise in developing antibody-based drugs will be highly valuable for MorphoSys in its future development." "I would like to add my personal thanks to my co-founder Prof. Plückthun for his invaluable support and commitment to MorphoSys during his term on our board. With his broad scientific expertise in the field of antibody technologies, he has made an enormous contribution to the successful development of the Company to the state we see today, where the technology is fully established and successfully commercialized", commented Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG. Professor Plückthun co-founded the Company in 1992 and served on the Supervisory Board of MorphoSys since that time. During his term with MorphoSys Professor Plückthun played a prominent role in establishing and developing the proprietary antibody technologies MorphoSys possesses today. For further information please contact: Dr. Claudia Gutjahr-Löser, Head of Corporate Communications, Tel: +49 (0) 89 / 899 27-122, gutjahr-loeser@morphosys.com or Mario Brkulj, Manager Public Relations, Tel: +49 (0) 89 / 899 27-454, brkulj@morphosys.com About MorphoSys: MorphoSys develops and applies innovative technologies for the production of synthetic antibodies, which accelerate drug discovery and target characterization. Founded in 1992, the Company's proprietary Human Combinatorial Antibody Library (HuCAL) technology is used by researchers worldwide for human antibody generation. The Company currently has licensing agreements and/or research collaborations with Bayer-Schering (USA/Germany), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (USA), Centocor Inc. (USA), Daiichi Sankyo & Co., Ltd. (Japan), GPC Biotech AG (Germany), Hoffmann-La Roche AG (Switzerland), ImmunoGen Inc. (USA), Merck & Co., Inc. (USA), Novartis AG (Switzerland), Novoplant GmbH (Germany), OncoMed Pharmaceuticals, Inc. (USA), Pfizer Inc. (USA), ProChon Biotech Ltd. (Israel), Schering-Plough (USA), Shionogi & Co., Ltd. (Japan), Xoma Ltd. (USA) and others. Additionally, MorphoSys is active in the antibody research market through its AbD Serotec business unit. The business unit was founded in 2003 for the purpose of exploiting the MorphoSys non-therapeutic antibody markets. MorphoSys' activities in the research antibody segment were significantly strengthened through the acquisition of the U.K. and U.S.-based Biogenesis Group in January 2005 and Serotec Group in 2006. For further information please visit the corporate website at: http://www.morphosys.com/. Statements included in this press release which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements" for purposes of the safe harbour provided by Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The company cautions readers that forward-looking statements, including without limitation those relating to the company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors that may affect future operations and business prospects include, but are not limited to, clinical and scientific results and developments concerning corporate collaborations and the company's proprietary rights and other factors described in the prospectus relating to the company's recent public offering. HuCAL® and HuCAL GOLD® are registered trademarks of MorphoSys AG


 

Milan, Italy, March 26, 2007 - BioXell S.p.A. (SWX: BXLN) is pleased to announce that Niels Ackermann will be joining the Company as Chief Financial Officer as of April 16, 2007, and that Bertrand Lehuu has joined the Company as Chief Business Officer since March 1, 2007. Alex Martin, who has held the positions of CBO and, currently, CFO, will be returning to the United States for personal reasons. "We are delighted to welcome these two outstanding professionals to our management team. Their expertise will be instrumental in taking the Company forward through new stages in its maturation in the coming years," commented Francesco Sinigaglia, CEO of BioXell. Mr. Ackermann began his career in the investment banking division of Goldman Sachs. He subsequently joined Cardion AG, a private German biotech company, as CFO, and later became CFO of Wilex AG (DB: WL6), another German biotech company. He joins BioXell from Morgan Stanley in London where he was a Vice President in the firm's Global Capital Markets division, advising and covering corporate clients in the German-speaking region on equity-related financing structures, including IPOs and other equity capital measures. "I was extremely impressed with BioXell, including its people and its product pipeline. Its recent status as a public company provides resources and flexibility that I am confident I can help leverage," remarked Mr. Ackermann. Mr. Lehuu has 25 years of pharmaceutical industry experience acquired in big pharma and biotech, including 15 years of international business and corporate development expertise. He served as Global Licensing Director at the headquarters of F. Hoffmann-La Roche Ltd in Basel, Switzerland and subsequently as Senior Executive Licensing at the Roche spin-off Basilea Pharmaceutica Ltd. (SWX: BSLN). Mr. Lehuu later became VP Business Development at Flamel Technologies (NASD: FLML) and more recently VP Business Development at the private CNS company Neuro3d SA based in France. During his career, Mr. Lehuu successfully negotiated a significant number of important transactions for product licensing and company acquisitions. "This is an exciting time to join BioXell, as there will be important development data coming out over the next 18 months. Building new profitable partnerships will be an important aspect of our activities, in line with BioXell's business strategy," commented Mr. Lehuu. About BioXell BioXell (SWX: BXLN) is a biopharmaceutical company focused on the discovery and development of drugs that exploit novel mechanisms of action to treat important urological, inflammatory, and related disorders with significant unmet medical needs. The Company was founded in 2002 as a spin-out from Roche. BioXell's strategic goal is to become a fully integrated pharmaceutical company by maximizing the commercial potential of its product portfolio and leveraging existing platforms into profitable partnerships. BioXell's lead compound, Elocalcitol, derived from its proprietary VD3 (Vitamin D3) technology platform, is in Phase II clinical trials for Benign Prostatic Hyperplasia (BPH) and Overactive Bladder (OAB), with a third Phase II trial for Male Infertility scheduled for 2007. In addition, the Company has several follow-on programs based on both VD3 and other technological platforms. BXL746 is to enter Phase II trials for Post-Surgical Adhesions in 2008. In 2006, BioXell in-licensed from Lay Line Genomics S.p.A. a novel anti-TrkA monoclonal antibody, MNAC13, which represents an innovative new approach to the treatment of pain. BioXell also has an exclusive partnership with Merck & Co., Inc. since 2005 for the development of its TREM platform, with TREM-1 in development for the treatment of septic shock. In June 2006, BioXell listed its shares on the main segment of the SWX Swiss Exchange. BioXell currently employs 60 people and has sites in Milan, Italy and Nutley, NJ, USA. More information on BioXell can be found at: http://www.bioxell.com For further information, please contact: BioXell S.p.A. Rochat & Partners Alvise Sagramoso/Angela Evans Christophe Lamps/Jonathan Leighton Tel: +39 (0)2 210 49 51 Tel: +41 22 718 37 46 Fax: +39 (0)2 210 49 529 Fax: +41 22 786 54 58 alvise.sagramoso@bioxell.com clamps@rochat-pr.ch angela.evans@bioxell.com jleighton@rochat-pr.ch Disclaimer This press release does not constitute or form part, or all, of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities, nor shall part, or all, of these materials or their distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. This press release contains forward-looking statements based on the currently held beliefs and assumptions of the management of BioXell, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of BioXell, or industry results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Given these risks, uncertainties and other factors, recipients of this document are cautioned not to place undue reliance on these forward-looking statements. BioXell disclaims any obligation to update these forward-looking statements to reflect future events or developments. --- End of Message --- bioXell S.p.A via Olgettina 58 Milan Italy WKN: A0J3MW; ISIN: IT0004069933 ; Listed: Main Market in SWX Swiss Exchange;


 

* A Novartis-branded version of interferon beta-1b to be launched in first half 2009 * Move strengthens Novartis multiple sclerosis (MS) portfolio ahead of on-track submission in 2009 of once-daily oral therapy FTY720, currently in Phase III trials * Novartis will transfer manufacturing responsibility for Bayer Schering Pharma's interferon beta-1b (marketed as Betaseron®[1]) to Bayer Schering Pharma * Bayer Schering Pharma to pay approximately USD 200 million for transfer of production equipment, inventory and leasing of buildings at California site * Novartis to continue receiving royalties from global sales of Bayer Schering Pharma's Betaseron until October 2008 Basel, March 26, 2007 - Novartis has signed an agreement with Bayer Schering Pharma AG that will provide Novartis the opportunity to introduce in the first half of 2009 its own branded version of interferon beta-1b for patients with the debilitating neurological disease multiple sclerosis (MS). The planned launch of a Novartis-branded version, which requires approval from regulatory authorities, will give Novartis an increasing presence in helping patients with MS ahead of the anticipated submission in 2009 of its oral once-daily therapy FTY720 (fingolimod), which is currently in Phase III trials. Bayer Schering Pharma will support Novartis in the regulatory filing process of a Novartis-branded version of interferon beta-1b. They will also assume manufacturing responsibility for its interferon beta 1b from Novartis and supply Novartis with this product for its own branded version in return for a double-digit royalty payment. Novartis has the right to further develop new formulations and presentations of its branded version of this medicine. "This agreement gives us an opportunity to strengthen our Neuroscience portfolio and build our presence in multiple sclerosis while preparing for the submission of FTY720 as planned for 2009," said Thomas Ebeling, CEO of Novartis Pharma AG. "As a truly new treatment approach with once-daily oral dosing, we believe FTY720 can offer significant therapeutic benefits to MS patients." Under the terms of the agreement, Novartis will transfer manufacturing responsibility for interferon beta-1b to Bayer Schering Pharma, which will purchase the related equipment and lease certain buildings at a Novartis site in Emeryville, California, for a one-time cash payment of approximately USD 110 million. Bayer Schering Pharma will also purchase related interferon beta-1b product inventory for an estimated USD 90 million cash, which is subject to adjustment at closing. Bayer Schering Pharma will continue to pay Novartis royalties on worldwide net sales of Betaseron® until October 2008 when the original regulatory filing, development and supply agreement expires. Novartis plans to maintain in Emeryville the operations of its Vaccines and Diagnostics division, including the headquarters for its diagnostics business, as well as pharmaceutical research conducted by the Novartis Institutes for Biomedical Research (NIBR). This agreement with Bayer Schering Pharma is subject to regulatory approvals, including antitrust review, and is expected to be completed by the third quarter of 2007. Multiple sclerosis is estimated to affect more than 2.5 million patients worldwide and is one of the leading causes of neurological disability in young adults. This disease typically presents in relapsing forms involving acute self-limiting attacks of neurological dysfunction (or relapses), followed by complete or partial restoration of function.[2] Betaseron is marketed by Bayer Schering Pharma AG, which Bayer AG acquired in 2006. In 1993 Bayer Schering Pharma signed an agreement covering the regulatory filing, development and supply of Betaseron with Chiron, which Novartis acquired in 2006. Novartis assumed Chiron's rights to this product, and since then has continued to produce Betaseron. Disclaimer This release contains certain forward-looking statements relating to the business of Novartis, which can be identified by the use of forward-looking terminology such as "to launch", "to be launched", "on track", "will", "to pay", "to continue", "to introduce", "planned", "anticipated", "to further develop", "believe", "plans", "expected", or similar expressions, or by express or implied discussions regarding the potential regulatory approval and completion of the announced agreement with Bayer Schering, or regarding potential future regulatory submissions or approvals or regarding potential future revenues from interferon beta-1b, new formulations or presentations of interferon beta-1b, or FTY720. Such forward-looking statements reflect the current views of Novartis regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with interferon beta-1b or FTY720 to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that the announced deal will receive the necessary regulatory approvals, or if approved, will be completed, or that interferon beta-1b, new formulations or presentations of interferon beta-1b, or FTY720 will be submitted for approval or will be approved for sale for any indications or labeling in any market. Nor can there be any guarantee that interferon beta-1b, new formulations or presentations of interferon beta-1b, or FTY720 will achieve any sales or any particular level of sales. In particular, management's expectations could be affected by, among other things, unexpected clinical trial results, including additional analysis of existing clinical data or new clinical data; unexpected regulatory actions or delays or government regulation generally; competition in general; government, industry and general public pricing pressures; Novartis' ability to obtain or maintain patent or other proprietary intellectual property protection, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. References [1] Marketed as Betaferon® in Europe [2] Multiple Sclerosis International Federation http://www.msif.org/en/ms_the_disease/index.html # # # Novartis Media Relations John Gilardi Matt Meehan Novartis Global Media Relations Novartis Pharma Communications +41 61 324 3018 (direct) +41 61 324 4879 (direct) +41 79 596 1408 (mobile) +41 79 592 1813 (mobile) john.gilardi@novartis.com matt.meehan@novartis.com e-mail: media.relations@novartis.com Novartis Investor Relations International: Ruth Metzler-Arnold +41 61 324 7944 Katharina Ambühl +41 61 324 5316 Nafida Bendali +41 61 324 3514 Jason Hannon +41 61 324 2152 Thomas Hungerbuehler +41 61 324 8425 Richard Jarvis +41 61 324 4353 North America: Ronen Tamir +1 212 830 2433 Arun Nadiga +1 212 830 2444 Jill Pozarek +1 212 830 2445 Edwin Valeriano +1 212 830 2456 e-mail: investor.relations@novartis.com --- End of Message --- Novartis International AG Posfach Basel WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

Major Expansion Marks Latest Step in Global Investment Program; European Development Follows Capacity Projects in North America and Asia ST. LOUIS, March 26, 2007 (PRIME NEWSWIRE) -- The Saflex(r) unit of Solutia Inc. (OTCBB:SOLUQ), the world leader in the production and sale of polyvinyl butyral (PVB) interlayers, broke ground today for a new manufacturing line at its plant in Ghent, Belgium. This project marks another major step in Solutia's global investment program for its Saflex(r) PVB interlayers. "For 80 years, Solutia and its corporate predecessors have driven innovation in glass interlayers. As demand from our customers continues to grow, we are making significant investments in each world region to ensure capacity is in place to meet the demand," said Luc De Temmerman, president of Solutia's Performance Products Division. "This project is a key part of our growth strategy for the Saflex business, allowing us to continue our commitment of providing the highest degree of responsiveness, quality and innovation to our customers on every continent." The new Ghent manufacturing line will produce 3.2-meter-wide rolls of Saflex PVB interlayers. These specific interlayers are used primarily to make laminated glass for the growing European architectural market. The new line also will provide Saflex with greater flexibility in how it operates its plants worldwide. "The third Saflex manufacturing line at Ghent is an important step forward in our strategy to optimize our production on a global scale," said Dirk Duquet, vice president of manufacturing excellence for Saflex. "Along with our 2006 acquisition of the plant in Puebla, Mexico, and the new plant under construction in Suzhou, China, the expansion at Ghent will help us achieve the highest quality and lowest cost production for our customers in every world area." The new manufacturing line is being constructed at the Saflex Ghent plant, leveraging existing infrastructure and the plant's 40-plus years of experience in manufacturing Saflex products. In addition, the new line will employ the latest technology, enabling the production process to be highly automated. "Our customers recognize the Ghent plant as a trusted supplier of the world's premier PVB interlayers," added Duquet, "and this expansion will enable us to very efficiently take that tradition of quality to an even greater scale." The Saflex Ghent plant employs 300 people and began operation in 1961. The plant maintains ISO 14001 registration for its environmental management systems, OSHAS 18001 registration for its occupational safety and health management systems, as well as several registrations for its quality management systems, including QS 9000, ISO 9001 and TS 16949. Saflex manufactures PVB interlayers at Ghent, Belgium; Puebla, Mexico; San Jose Dos Campos, Brazil; Springfield, Mass., USA; and Trenton, Mich., USA. It also operates a PVB finishing and distribution center in Singapore. A new plant for Saflex PVB interlayers in Suzhou, China, will begin production later this year. With 80 years of experience in developing glass interlayers, Saflex is the world's largest producer and seller of PVB interlayers, and is known as the global leader in PVB innovation, quality and reliability. When laminated between layers of glass, PVB interlayers greatly enhance the performance characteristics of glass, providing benefits such as security, solar protection, sound attenuation and safety. Laminated glass made with Saflex PVB is used extensively in both the automotive and architectural markets. For more information, please visit the newly redesigned Saflex website at: http://www.saflex.com. NOTE TO EDITORS: Saflex is a registered trademark of Solutia Inc. Corporate Profile Solutia (http://www.Solutia.com) uses world-class skills in applied chemistry to create value-added solutions for customers, whose products improve the lives of consumers every day. Solutia is a world leader in performance films for laminated safety glass and after-market applications; specialties such as water treatment chemicals, heat transfer fluids and aviation hydraulic fluid; and an integrated family of nylon products including high-performance polymers and fibers. Solutia... Solutions for a Better Life. The Solutia Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2620 Forward Looking Statements This press release may contain forward-looking statements, which can be identified by the use of words such as "believes," "expects," "may," "will," "intends," "plans," "estimates" or "anticipates," or other comparable terminology, or by discussions of strategy, plans or intentions. These statements are based on management's current expectations and assumptions about the industries in which Solutia operates. Forward-looking statements are not guarantees of future performance and are subject to significant risks and uncertainties that may cause actual results or achievements to be materially different from the future results or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, those described in Solutia's most recent Annual Report on Form 10-K, under "Cautionary Statement About Forward Looking Statements," Solutia's quarterly reports on Form 10-Q, and in filings with the U.S. Bankruptcy Court in connection with the Chapter 11 case of Solutia Inc. and 14 of its U.S. subsidiaries. These reports can be accessed through the "Investors" section of Solutia's website at www.solutia.com. The bankruptcy court filings can be accessed by visiting www.trumbullgroup.com. Solutia disclaims any intent or obligation to update or revise any forward-looking statements in response to new information, unforeseen events, changed circumstances or any other occurrence. CONTACT: Solutia Inc. Media: Dan Jenkins (314) 674-8552 Investors: Tim Spihlman (314) 674-5206


 

Measurement Firm Finds Carrier Domains Rank Highly in UK; Americans Prefer Web Brands SEATTLE, WA and LONDON -- (MARKET WIRE) -- March 26, 2007 -- M:Metrics, the mobile market authority, today announced the launch of MeterDirect, the first research service to directly and continuously measure consumer mobile media behavior, unlocking mobile as a viable medium for advertisers. For the first time, media companies will be able to understand how, when and how often consumers engage with the mobile medium, including mobile Web audience rankings by site, the demographic composition of mobile Web domains and day of week and time of day behavior that defines mobile Web traffic. The MeterDirect service also collects detailed information about mobile application usage, including messaging, title and channel level music and video consumption. "Direct media measurement is critical to programmers, media planners and advertisers as they come to rely on the mobile channel as a component of their traditional and new media campaigns," said Andy Brown, CEO, KMR Group, advertising giant WPP's media research business. "While surveys are a reliable way to measure a wide audience, direct behavioral measurement offers the most precise method of understanding the details of consumer use of mobile content. Integrating the mobile channel into our broad scale campaigns has been a guessing game to date without the reach, frequency and duration data that we rely on in other media. MeterDirect get us there." The firm announced the first findings gleaned from MeterDirect in the United Kingdom and the United States, revealing key similarities and differences between the behaviors of American and British mobile Web users. In both geographies, Google ranks as the most popular mobile Web site, the 8 a.m. to 5 p.m. daypart has the largest audience of mobile Web users, and mobile media consumers spend more than eight minutes per session accessing the mobile Web, a surprisingly high figure. However, while mobile operator sites are most popular among British consumers, Americans prefer Yahoo! and Microsoft properties. Top Mobile Web Domains: February 2007 -------------------------------------------------------------------------- United States United Kingdom ----------------------------------- ------------------------------------- Domain Company Domain Company ---------- ----------------------- ------------ ----------------------- google.com Google Inc. google.co.uk Google Inc. yahoo.com Yahoo! Inc. o2.co.uk O2 (UK) Ltd msn.com Microsoft Corporation orange.co.uk Orange Personal Communications Services Limited live.com Microsoft Corporation bbc.co.uk British Broadcasting Corporation go.com The Walt Disney Company three.co.uk Hutchison 3G UK Limited Source: M:Metrics. Reports for the month of February are projected to represent the universe of Smartphone owners and are based on in-tab panel sizes of approximately 500 panelists in the United States and 600 panelists in the United Kingdom. UK google.com includes the google.co.uk domain. MeterDirect also provides insights into daily audience for more than 5,000 mobile Web domains. Friday is the most active day for mobile Web use among Americans, with more than half of all smartphone owners using their mobile Web browser, while in the United Kingdom, Tuesdays account for the highest level of traffic. The data also reflects that contrary to popular belief, usage of mobile Web browsing is higher in the United States which consistently shows a higher level of daily usage than among British smartphone users. Reach by Day of the Week: February 2007 ------------------------------------------------------- Day United States United Kingdom --- ------------- -------------- Sunday 41.32% 33.69% Monday 42.44% 39.64% Tuesday 45.67% 47.14% Wednesday 49.67% 43.22% Thursday 48.54% 39.27% Friday 50.98% 36.23% Saturday 47.16% 34.82% Source: M:Metrics. Reports for the month of February are based on a in-tab sample sizes of approximately 500 panelists in the United States and 600 panelists in the United Kingdom. MeterDirect is a syndicated media measurement service based on data collected from M:Metrics' proprietary panel of smartphone device owners, selected to represent a population which accounts for a highly disproportionate share of mobile data services usage. The patent-pending M:Meter continuously and unobtrusively monitors messaging, browsing, application and media usage. At launch, clients who subscribe to MeterDirect can access data collected from M:Metrics panels in the United Kingdom and the United States, through an interactive Web interface. "In the two years since we launched with our syndicated mobile market measures, the mobile medium has matured considerably," said Will Hodgman, CEO, M:Metrics. "With MeterDirect, M:Metrics further advances the medium as an essential part of the media mix." While smartphones are only a small portion of all handsets in active use, these terminals account for a disproportionately high portion of all mobile Web page views. According to Crisp Wireless, a mobile technology and solutions company that builds, hosts and powers many leading news and information mobile websites, about 42 percent of all page views for sites that it hosts come from smartphone-class devices, including BlackBerry, Palm and Windows Mobile operating systems. MeterDirect complements M:Metrics' flagship syndicated service, MobiLens, which is relied on by 150 brands including the leading mobile operators, handset OEMs, publishers, media companies and advertising agencies in the United States and Western Europe. With six countries under measurement, M:Metrics is the only firm to provide monthly mobile content consumption metrics across the U.S. and Western Europe. By employing identical methodologies and survey questionnaires to over 40,000 respondents each month, M:Metrics is uniquely able to provide directly comparable measurement of mobile content consumption from country to country. About M:Metrics M:Metrics is the mobile market measurement authority. As the only research firm to measure the audience for mobile media, M:Metrics provides the most accurate metrics on actual mobile content consumption by applying trusted media measurement methodologies to the mobile market. M:Metrics' monthly syndicated data service gives clients the critical insights and intelligence required to inform smart business strategies and the competitive benchmarks needed to evaluate the performance of competitors and partners. M:Metrics is a private, venture-funded corporation headquartered in Seattle, with offices in San Francisco and London. Authorized Uses Members of the press may cite research data or a portion of text provided that each is sourced to M:Metrics, for example, "Source: M:Metrics, Inc." or "According to M:Metrics, . . ." Copies of graphs, data tables or slides must include the following copyright notice affixed to all material: "Copyright © 2007, M:Metrics, Inc." Contacts: UK Richard Fogg CompanyCare Communications Tel. +44 (0)118 939 5900 Email richard@companycare.com US Jaimee Minney M:Metrics Tel. +1 206.757.1360 (office) Email jminney@mmetrics.com


 

26 March 2007 LSE ANNOUNCEMENT ISSUE OF OPTIONS The Company has today issued 335,365 options to UK Director - Mr Peter Freeman as approved by shareholders at the 2006 Annual General Meeting. Monto Minerals announced 5 October 2006 that the ASX had granted a waiver from Listing Rule 10.13.3 allowing Monto to issue these options more than one month after the Annual General Meeting. An appendix 3B for the issue of options is attached. An Appendix 3Y for Mr Freeman is attached representing the changes to his interests. Enquiries to: Geoffrey Moore Monto Minerals Ltd +61 (0)7 3034 3100 Richard Brown Ambrian Partners Limited 020 7776 6400 ---END OF MESSAGE---


 

ATLANTA, GA -- (MARKET WIRE) -- March 23, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will host a conference call and webcast to discuss key clinical findings from the ARISE Phase III trial of AGI-1067 on Tuesday, March 27, 2007, at 4:00 PM EDT. ARISE study results are scheduled to be presented by Jean-Claude Tardif, M.D., Director of Research; Professor of Medicine, Montreal Heart Institute; and Marc Pfeffer, M.D., Ph.D., Professor of Medicine, Harvard Medical School; Senior Physician in Cardiology at Brigham and Women's Hospital, at the Late Breaking Clinical Trials session (Room Hall A) at the American College of Cardiology (ACC) Annual Scientific Sessions in New Orleans on Tuesday, March 27 at 9:35 AM CDT. Webcast and Conference Call Details Date: March 27, 2007 Time: 4:00 PM EDT (3:00 PM CDT) Dial in: Domestic - 877-407-8031 International - 201-689-8031 Replay Dial in: Domestic - 877-660-6853 International - 201-612-7415 Replay Codes: Account # 286 Conference ID# 235811 This event will be accessible on the AtheroGenics website at: http://www.atherogenics.com/investor/index.html. About AtheroGenics AtheroGenics is focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. AtheroGenics' lead compound, AGI-1067, is being evaluated as an oral therapy for the treatment of atherosclerosis, in collaboration with AstraZeneca. AGI-1096 is a novel, oral agent in Phase I that is being developed for the prevention of organ transplant rejection in collaboration with Astellas. AtheroGenics also has preclinical programs in rheumatoid arthritis and asthma utilizing its proprietary vascular protectant® technology. For more information about AtheroGenics, please visit http://www.atherogenics.com. AtheroGenics, Inc. Donna Glasky Corporate Communications 678-336-2517 investor@atherogenics.com Media Inquiries Jayme Maniatis Schwartz Communications, Inc. 781-684-0770 ext. 6610 atherogenics@schwartz-pr.com Investor Inquiries Lilian Stern Stern Investor Relations, Inc. 212-362-1200 lilian@sternir.com SOURCE: AtheroGenics


 


 

Atorka Group has increased its share in Romag and holds now about 16% share in the company. The price of the additional shares are 235 million ISK and the total marketvalue of the holdings share is approximately 2 billion ISK. Romag is a UK leader in the manufacture of specialised glass products. The company has developed special photovoltaic glass that converts light into electricity. Both the company and the market in which it operates are growing rapidly and the photovoltic glass division grew 300% last year. The company is listed on the London Stock Exchange's AIM market. The purchase price will be paid in cash. For further information visit www.romag.co.uk For further information contact Magnús Jónsson, CEO og Atorka Tel., +354 540 6200


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |-------------------------------------------------+-----------------| | Company dealt in | EMI Group Plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | 14p ordinary | | dealings being disclosed relate (Note 2) | | |-------------------------------------------------+-----------------| | Date of dealing | 22 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------+--------------------+---------------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------+------------+-------+------------+--------| | (1) Relevant | | | | | | securities | | | | | | | | | | | |------------------------+------------+-------+------------+--------| | (2) Derivatives (other | | | | | | than options) | 3 184 725 | 0.398 | | | | | | | | | |------------------------+------------+-------+------------+--------| | (3) Options and | | | | | | agreements to | 57 000 000 | 7.124 | 88 750 000 | 11.092 | | purchase/sell | | | | | | | | | | | |------------------------+------------+-------+------------+--------| | Total | 60 184 725 | 7.522 | 88 750 000 | 11.092 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | Convertible bonds due 2010 | | | |-----------------------------------+----------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (1) Relevant securities | 0 | 0.000 | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-----------------------------------+--------+-------+--------+-----| | Total | 0 | 0.000 | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Long | 600 000 | 230.9652 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 2 250 000 | 228.0000 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +----------------------------------------------------------------------------------------+ | Product |Writing, |Number of |Exercise|Type, e.g.|Expiry |Option money | | name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| | option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+----------+--------------| | Call | | | | | | | | option | Writing | 15 000 000 | 260 | American |21/09/2007| 7.250 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| | Call | | | | | | | | option | Purchasing | 15 000 000 | 240 | American |21/09/2007| 14.000 GBp | +----------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 23/03/2007 | |------------------------------------------------+------------------| | Contact name | Julien Naginski | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9642 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 000 |240 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 000 |240 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 5 000 000 |240 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 10 000 000 |260 GBp | American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 10 000 000 |260 GBp | American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 7 000 000 |190 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased | 7 000 000 |200 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased | 1 750 000 |200 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 2 500 000 |220 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written | 2 500 000 |220 GBp | American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 15 000 000 |240 GBp | American |21/09/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased | 15 000 000 |240 GBp | American |21/09/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 15 000 000 |260 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 30 000 000 |260 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written | 15 000 000 |300 GBp | American |21/09/2007 | |call | | | | | | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

SOLTEQ PLC STOCK EXCHANGE RELEASE 23.3.2007 Solteq's Annual General Meeting approved the financial statement for period 1.1.-31.12.2006 and discharged those accountable from liability. Board of Directors' authorization-proposal of EUR 0,10 per share dividend or other distribution of funds was accepted. The General Meeting decided that the Board of Directors includes five members. Seppo Aalto, Ari Heiniö, Veli-Pekka Jokiniva, Jukka Sonninen and Ali U. Saadetdin were re-elected. KPMG Oy Ab continues as the auditor. In addition, the General Meeting approved the following proposals by the Board (Stock Exchange Release February 27, 2007). - proposal regarding transferring of funds between equity accounts - proposal regarding increase of share capital from the distributable equity fund - proposal regarding acquiring the company's own shares (authorization) - proposal regarding share issue (authorization) - proposal regarding lowering of share premium account In the Board meeting, held after the General Meeting, Ali U. Saadetdin was elected as the Chairman of the Board. Solteq Plc For further information please contact: Ali Saadetdin, Chairman of the Board Tel +358 20 1444 201 or +358 40 8444 201, e-mail ali.saadetdin@solteq.com Hannu Ahola, Managing Director Tel +358 20 1444 211 or +358 40 8444 301, e-mail hannu.ahola@solteq.com Distribution: Helsinki Stock Exchange Major Media


 

Kemira Water has today, on March 23, received a grant of approx. EUR 578.480 from the Finnish Ministry of Environment for more efficient phosphorous removal at the waste water treatment plants in St. Petersburg. St. Petersburg Water Works is Kemira's partner in the project. As a result of this project phosphorous load to the Gulf of Finland will be reduced with 300-500 tons annually, which amount corresponds 5-8% of the total phosphorous load to the Gulf of Finland. The aim of the project is to implement efficient biological chemical phosphorous removal in the biggest sewage treatment plant in St. Petersburg, and in other three smaller sewage treatment plants. The scope of the project is to find the most cost efficient method for phosphorous removal and to deliver the storing and dosing equipment, which can further be used in continuous operation at the plants. St. Petersburg Water Works and Kemira signed in 2006 an agreement extending to the year 2015 and having the objective of developing and producing new chemicals in St. Petersburg to be used in producing drinking water and cleaning waste water. Kemira has a production plant ZAO Kemira Eko in St. Petersburg, which produces 80,000 tones of liquid aluminum sulphate per year. ZAO Kemira Eko is also delivering the iron based chemicals used for cleaning wastewater. Kemira Water - Kemira's water treatment chemical business - is the world's leading supplier of inorganic coagulants and ranks third in water treatment polymers. We offer customized water treatment and sludge treatment solutions to municipal and private water treatment plants and industry. In 2006, Kemira Water had revenue of EUR 468 million and a payroll of approx. 2 000 people. It is present in 30 countries. For further information please contact Kemira Oyj Kemira Water General Manager Helena Lähteenmäki, Kemira Water, Russian affairs Tel. +358 (0)10 862 1314, GSM +358 (0)50 387 6219 Communications Manager Susanna Aaltonen, Kemira Oyj, GSM +358 (0)40 593 4221 Kemira is a chemicals group made up of four business areas: Kemira Pulp&Paper, Kemira Water, Kemira Specialty and Kemira Coatings. Kemira is a global group of leading chemical businesses with a unique competitive position and a high degree of mutual synergy. In 2006, Kemira recorded revenue of around EUR 2.5 billion and had a payroll of 9,000 employees. Kemira operates in 40 countries.


 

23 March 2007 - Enclosed please find recommendations from Aker Kværner ASA's Nomination committee in connection with the company's Annual General Meeting on 29 March 2007. ENDS AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

Leiden, The Netherlands, March 23, 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that children in the Ethiopian capital Addis Ababa, have received their first dose of Quinvaxem(TM) vaccine. Ethiopia is the most populous GAVI Alliance supported country to date to have Haemophilus influenzae type b (Hib) immunization included in its routine immunization programme. Quinvaxem(TM) is a new fully-liquid pentavalent vaccine which protects against five important childhood diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B and Haemophilus influenzae type b (Hib). Hib is a significant cause of life-threatening pneumonia and meningitis in children under 5 years of age with pneumonia being the leading cause of under-5 mortality. Quinvaxem(TM) has now been introduced in several Latin American and African countries vaccination programs supported and co-financed by supranational organizations. "The multiple year contracts that the supranational organizations have granted to Crucell, underline Crucell's place as a leading supplier of such important vaccines. Quinvaxem(TM) is the first internationally available fully-liquid vaccine containing these five life saving antigens and it will make a significant contribution to children's vaccination programs in the developing world," said Crucell's President and CEO, Dr. Ronald H.P. Brus. "Quinvaxem(TM) will be an important contributor to the company's 2007 total revenues, being estimated in excess EURO 200 million and our objective to be cash neutral in 2007." Quinvaxem(TM) was co-developed with Novartis and is produced in Crucell's laboratories in South Korea. Current demand for the vaccine exceeds 50 million doses. The total market potential is estimated to be 150 million doses per year in 3 to 4 years. About Crucell Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a biotechnology company focused on research, development and worldwide marketing of vaccines and antibodies that prevent and treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases, and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market. The Company has a broad development pipeline, with several Crucell products based on its unique PER.C6® production technology. The Company licenses this and other technologies to the biopharmaceutical industry. Important partners and licensees include DSM Biologics, sanofi aventis, GSK and Merck & Co. Crucell is headquartered in Leiden (the Netherlands), with subsidiaries in Switzerland, Spain, Italy, Sweden, Korea and the US. The Company employs over a 1000 people. For more information, please visit www.crucell.com. Forward-looking statements This press release contains forward-looking statements that involve inherent risks and uncertainties. We have identified certain important factors that may cause actual results to differ materially from those contained in such forward-looking statements. For information relating to these factors please refer to our Form 20-F, as filed with the U.S. Securities and Exchange Commission on July 6, 2006, and the section entitled "Risk Factors". The Company prepares its financial statements under generally accepted accounting principles in the United States (US GAAP) and Europe (IFRS). For further information please contact: Crucell N.V. For Crucell in the US: Leonard Kruimer Redington, Inc. Chief Financial Officer Thomas Redington Tel. +31-(0)71-524 8722 Tel. +1 212-926-1733 Leonard.Kruimer@crucell.com tredington@redingtoninc.com Barbara Mulder Director Corporate Communications Tel: 31-(0) 71 524 8718 barbara.mulder@crucell.com


 

Aker Yards is pleased to invite you to attend the Capital Markets Day on 28 March 2007 in Oslo. President & CEO, Mr Karl Erik Kjelstad and the management team will give you insights into Aker Yards' operations and strategy. Wednesday 28 March from 12:30 CET to 17:00 CET A light lunch will be served at 12:00. Location: Oslo Concert Hall, Oslo, Norway Following the presentations, there will be a Q&A session chaired by Terje Fatnes, analyst, SEB Enskilda and Arne Egil Rønning, Analyst, Fondsfinans. The event is organized by the Norwegian Society of Financial Analysts (NFF). Please register by sending an e-mail to eh@akeryards.com. After the event, all presentations will be available at www.akeryards.com. Best regards, Tore Langballe SVP Corporate Communications and Investor Relations Phone: +47 24 13 00 00 Aker Yards ASA is an international shipbuilding group focusing on sophisticated vessels. The Group has a strong position in terms of innovation, product range, technology, experience, and capacity. The product range includes cruise ships & ferries, merchant vessels, and offshore & specialized vessels. Aker Yards comprises 17 yards in Brazil, Finland, France, Germany, Norway, Romania and Ukraine. Aker Yards has approximately 20,000 employees. www.akeryards.com


 

Grand One is the largest and most important competition in the digital media industry in Finland. This year's award ceremony took place last evening at the Kaivohuone Restaurant in Helsinki. Color the World, a campaign site designed for Nokia by Satama, won first prize at the Grand One award ceremony. The website also came first in the Design category and was given a special mention in the Best B2C Campaign category. The Trainers' House website, designed jointly by Tequila and Satama, received a special mention in the Best B2B Service category and Husky Rescue's website bagged a special mention in the Best Design category. Favorite Website Awards (FWA), one of the most esteemed international awards in the world of digital design, chose the Grand One winner, Nokia's Color the World online campaign, as its Site Of The Day on 19 September 2006. The campaign site was designed to support the marketing of the Nokia 6131 mobile telephone and - true to its name - it gives every visitor the change to add more colour to the world. Visitors can paint and draw their own creations onto the never-ending canvas. The site is finished to a high degree and it is heavily influenced by international trends, resulting in a simple and fresh package. The site offers a unique user experience and gets visitors to spend time with the brand. Niina Simonen, Client Director at Satama, is pleased with the site's success at Grand One. "This was a perfect example of a case where all the pieces just fall neatly into place. We had an enthusiastic, bold client who believed in our idea just as strongly as we did. When good ideas are brought to life with care and due attention is given to even the smallest detail, the end results can be something truly magnificent, and Color the World is a great example of this. The finished product is addictive and extremely good, just like the team behind the creation." The Trainers' House website, which received a special mention in the Best B2B Service category, has been praised not just for its stunning visual design, but also for its first-rate usability. The aim of the website is to communicate the spirit of the organisation and to help business executives to understand how Trainers' House can help them. "The project was extremely exciting and successful. The end result is a dynamic package that emphasises story-telling, creativity and usability," says Marko Edfelt, Business Unit Director of Satama Flash Fabriek. The website of the Finnish group Husky Rescue bagged a special mention in the Best Design category in last night's award ceremony. The website was also nominated for the Silver Award in the digital media series of the Highlights of the Year (Vuoden Huiput) design competition in 2005. The website, which was designed and produced by Satama, transforms the group's music and unique spirit into a limpid rich media format, true to the group's arctic roots. For more information on the winners and the Grand One competition, please visit: Color The World campaign site: http://www.nokia.com/fitsyou Trainers' House: http://www.trainershouse.fi/ Husky Rescue: http://www.husky-rescue.com/ Grand One: http://www.rekaksois.com/grandone/ For more information, please contact: Niina Simonen Client Director Satama Marketing tel. +358 (0)40 772 3449 e-mail: niina.simonen@satama.com Marko Edfelt Business Unit Director Satama Flash Fabriek tel. +358 (0)40 861 9317 e-mail: marko.edfelt@satama.com


 

Bakkavör Group's Annual General Meeting will be held today at the Reykjavik Art Museum, Hafnarhusid, Tryggvagata 17, 101 Reykjavik. The meeting starts at 17:15. At the end of the meeting a range of our products will be on offer for you to sample. The Board of Directors of Bakkavör Group


 

Stora Enso Oyj Press Release 23 March 2007 at 11:15 GMT Stora Enso does not receive wood deliveries from disputed areas in Forest Lapland. The state-owned enterprise Metsähallitus has completed logging operations in Forest Lapland for the season. Currently, 43% of Forest Lapland's forests are strictly protected. The other forests are classified as commercial forests and forest management methods are carried out in a sustainable way. However, due to the concerns expressed by stakeholders, Stora Enso requests Metsähallitus to conduct a thorough analysis of ecological conditions in the disputed areas of Forest Lapland before recommencing logging. The completion of an additional analysis would help reassess which areas are suitable for commercial forestry and which are not. For further information, please contact: Matti Karjula, Senior Vice President, Stora Enso Wood Supply Finland, tel. +358 40 520 6240 Eija Pitkänen, Vice President, Sustainability Communications and CSR, tel. +358 2046 21348 www.storaenso.com www.storaenso.com/sustainability Previous press releases regarding Forest Lapland are available at www.storaenso.com/press - 12 March 2007: Stora Enso does not destroy old-growth forests


 

KESKO CORPORATION STOCK EXCHANGE RELEASE 23.03.2007 AT 13.00 1(1) Kesko Food Ltd and Rautakesko Ltd, major subsidiaries fully owned by Kesko Group, elected the members of their Boards of Directors in their Annual General Meetings held today. Kesko Food Ltd's Board of Directors as from 23 March 2007 Chairman: Matti Halmesmäki, President and CEO, Kesko Corporation Members: Juhani Järvi, Corporate Executive Vice President, Kesko Corporation Paavo Moilanen, Senior Vice President, Corporate Communications, Kesko Corporation Arja Talma, Senior Vice President, CFO, Kesko Corporation Rautakesko Ltd's Board of Directors as from 23 March 2007 Chairman: Matti Halmesmäki, President and CEO, Kesko Corporation Members: Juhani Järvi, Corporate Executive Vice President, Kesko Corporation Paavo Moilanen, Senior Vice President, Corporate Communications, Kesko Corporation Arja Talma, Senior Vice President, CFO, Kesko Corporation Further information is available from Corporate Executive Vice President Juhani Järvi, tel. +358 1053 22209. Kesko Corporation Harri Utoslahti Communications Manager DISTRIBUTION Helsinki Stock Exchange Main news media


 

The Seadrill jack-up drilling rig West Janus has secured employment with an E&P operator in Malaysia. The assignment has duration of 12 months and the estimated contract value is approximately US$67 million. Start-up of operations is scheduled in late second quarter of 2007. The West Janus is currently operating offshore Bangladesh. Analyst contact: Jim Dåtland Vice President Investor Relations Seadrill Management AS +47 51 30 99 19 Media contact: Alf C Thorkildsen Chief Operating Officer Seadrill Management AS +47 51 30 99 19 Seadrill Limited Hamilton, Bermuda March 23, 2007


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-------------------------------------------------+-----------------| | Company dealt in | Corus Group plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-------------------------------------------------+-----------------| | Date of dealing | 22nd March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 968 | 605.50p | 605p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 825 | 605p | 605.50p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 23rd March 2007 | |----------------------------------------------+-------------------| | Contact name | Edward Hodge | |----------------------------------------------+-------------------| | Telephone number | 0207 991 6661 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Corus Group Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Amsterdam (March 23, 2007) - Wolters Kluwer, a leading global information services and publishing company, today announced that the company is in exclusive talks with Bridgepoint Capital Limited with respect to the divestment of its Education division. Wolters Kluwer and Bridgepoint are working towards reaching an agreement. Parties expect to reach a purchase price for the division of between ¤750-¤775 million. Any transaction is subject to approval by regulatory bodies as well as consultation with employee representatives. Wolters Kluwer announced on March 16 that, as an outcome of the strategic review initiated in September 2006, it would pursue a divestment of the Education activities as the preferred option. Bridgepoint is a major private equity fund, with a track record of investing in European businesses. Wolters Kluwer Education, with revenues of ¤316 million and approximately 1,450 employees, holds leading positions in primary, secondary, and vocational education in seven European countries - the Netherlands (Wolters-Noordhoff), Sweden (Liber), the United Kingdom (Nelson Thornes), Germany (Bildungsverlag EINS, digital spirit), Belgium (Wolters Plantyn), Austria (Jugend & Volk), and Hungary (Muszaki Kiadó). About Wolters Kluwer Wolters Kluwer is a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal and regulatory, and education sectors. Wolters Kluwer has 2006 annual revenues of ¤3.7 billion, employs approximately 19,900 people worldwide and maintains operations across Europe, North America, and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. For more information, visit www.wolterskluwer.com. Forward-looking Statements This press release contains forward-looking statements. These statements may be identified by words such as "expect," "should," "could," "shall," and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.


 

Notice of Orkla's Ordinary General Meeting inclusive appendix is enclosed. The Annual General Meeting will be held at Gamle Logen, Grev Wedels plass 2, 0151 Oslo, on Thursday 19 April 2007 at 3.00 p.m. Printed version (hardback) of the Notice will be sent by post to all shareholders starting Friday 23 March. Contact: Siv M. Skorpen Brekke, Orkla Investor Relations, Tel: +47 2254 4455


 

YIT CORPORATION STOCK EXCHANGE RELEASE MARCH 23, 2007 11:30 YIT Corporation applies for the listing of the Series F share options issued in 2004 and Series K and L share options issued in 2006 on the Helsinki Stock Exchange such that trading would begin on April 2, 2007. YIT's Series E share options, issued in 2004, are listed on the Helsinki Stock Exchange, and in 2007 shares can be subscribed for with them as from April 2. Furthermore, YIT Corporation applies for the listing of an additional lot of the company's shares on the Helsinki Stock Exchange. The application concerns the new shares subscribed for with the Series E, F, K and L share options in 2007. Share subscriptions Each Series E and F share option entitles its bearer to subscribe for two (2) and each Series K and L share option one (1) YIT Corporation share. A total maximum of 360,000 shares can be subscribed for with Series E share options, max 840,000 shares with Series F share options, max 300,000 shares with Series K share options and max 900,000 shares with Series L share options. The subscription price of a share subscribed for with the Series E share options is EUR 6.80 per share and with the Series F share options EUR 6.15 per share. With either Series K or L share option the subscription price of a share is EUR 20.53. The shares can be subscribed for annually during the period from April 1 - November 30. The subscription period with the Series E share options is in 2006 and 2007, with Series F share options in 2007, and with Series K and L share options in 2007 and 2008. Share subscriptions will be made at Nordea Bank Finland plc's investment advisory branches. The shares entitle their holder to a dividend as from the date of subscription. Other rights will vest when the share capital increase has been entered in the Trade Register. Increases in the share capital It is intended that the increases in the share capital on the basis of the subscriptions will be carried out in 2007 as follows: +-------------------------------------------------------------------+ | Share subscription | Entry into the Trade | New shares | | deadline | Register | listed | |-------------------------+----------------------+------------------| | April 20 | April 30 | May 2 | |-------------------------+----------------------+------------------| | June 15 | June 26 | June 27 | |-------------------------+----------------------+------------------| | August 10 | August 20 | August 21 | |-------------------------+----------------------+------------------| | October 19 | October 30 | October 31 | |-------------------------+----------------------+------------------| | November 30 | December 10 | December 11 | +-------------------------------------------------------------------+ General information on the issuer Name: YIT Corporation Domicile: Helsinki Registration date: August 31, 1940 Legal form and applicable law: Public limited company, Finnish law Group to which the issuer belongs and its position in it: the YIT Group's parent company Field of business according to the Articles of Association: The objects of the Company are to engage in production in the construction industry, manufacture and leasing of and trade with building materials and components, and building engineering, network services and industrial turn-key projects, including operation, servicing and maintenance activities related to the foregoing in Finland and abroad. In addition to the foregoing activities, the Company shall buy and sell real estate property and shares in real estate and housing companies as well as lease and maintain apartments and properties complete with buildings and facilities and engage in other activities related to the foregoing. The Company may also trade in securities. The Company may engage in the activities in accordance with its declared objects either directly and/or through its subsidiaries and affiliated companies and joint ventures. In its capacity as the parent company in the Group, the Company may assume responsibility for the administration, human resources management, finances, legal affairs and communications on behalf of the Group and other joint services and tasks. Register in which the issuer is recorded and Business ID: Trade Register, Business ID 0112650-2 The terms of the share option programmes as a whole and YIT Corporation's Articles of Association are available on the company's internet site, www.yitgroup.com. The company's Corporate Governance is presented in the Annual Report and the company's internet site. For additional information, contact: Marja Salo, Director of Administration, tel. +358 20 433 2470, marja.salo@yit.fi Jaakko Mäkynen, Vice President, Finance, tel. +358 20 433 2307, jaakko.makynen@yit.fi YIT CORPORATION Virva Salmivaara Deputy to the Vice President, Communications Distribution: Helsinki Stock Exchange, principal media, www.yitgroup.com


 

Hafslund ASA has the 23rd of March 2007 acquired NOK 200 million of the bond FRN Hafslund 07/12, ISIN NO 0010359649, HNA67. After this transaction, Hafslund's balance of this bond is NOK 300 million. Hafslund ASA Oslo, 23 March 2007 For further information, please contact: Group Treasurer Ketil Wang, tel + 47 975 13 135


 

Metso Paper will supply a coated board line to Shandong International Paper & Sun Coated Paperboard Co., Ltd. in China. The machine, which will have an annual capacity exceeding 400,000 tonnes, will come on stream in the second quarter of 2008 in Yanzhou, Shandong province. The value of the order is close to EUR 60 million. The new PM 22 board line is a single-supplier delivery by Metso Paper, and it is based on a novel technology concept for the production of superior coated cartonboard grades. The production line will contain a complete 3-ply coated board machine with five coating stations, enabling the production of folding boxboard, art board and liquid packaging board grades. The line will have a wire width of 5,100 mm and a design speed of 900 m/min. Quality and machine controls, basis weight and moisture profilers are supplied by Metso Automation. A part of the delivery will be supplied by Metso Paper (China). Metso Paper and Sun Paper Group have a long-term business relationship. Earlier, Metso Paper has supplied two board machines, one paper machine and a coating line to the Group's Yanzhou mill. Sun Paper Group is one of the foremost paper and board producers in China with a combined production capacity of 1,500,000 tonnes per year. The Group consists of three companies: Shandong Sun Paper Co., Ltd., Shandong International Paper & Sun Coated Paperboard Co., Ltd. and International Paper & Sun Cartonboard Co., Ltd. Sun Paper Group employs more than 7,000 people at its Yanzhou mill. Metso is a global engineering and technology corporation with 2006 net sales of approximately EUR 5 billion. Its 25,500 employees in more than 50 countries serve customers in the pulp and paper industry, rock and minerals processing, the energy industry and selected other industries. www.metso.com Further information for the press, please contact: Tapani Kultaranta, Senior Sales Manager, Finishing Business Line, Metso Paper, tel. +358 40 503 4490 Further information for investors, please contact: Johanna Sintonen, Vice President, Investor Relations, Metso Corporation, tel. +358 20 484 3253


 

Ericsson (NASDAQ:ERIC) is today publishing the Annual Report for the year of 2006 under the heading of Driving Change and Create Opportunities. The company and its 63,800 employees generated a net sale of SEK 177.8 billion, which is an increase of 17% compared to last year. The operating income reached SEK 35.8 billion, up from last year's 33.1 You will find the annual report on http://www.ericsson.com/ericsson/investors/index.shtml New to this annual report is page 136, Compensations, which describes our remuneration system. Read more at: http://www.ericsson.com Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com Ericsson Investor Relations Phone: +46 8 719 4631 E-mail: investor.relations.se@ericsson.com


 

Micron Enviro Systems, Inc. (OTCBB: MENV) (Frankfurt Stock Exchange: NDDA --- WKN:A0J3PY---ISIN: US59510E2072) ("Micron" or the "Company") is extremely pleased to announce that it has acquired a 100% interest in 1,024 contiguous hectares (2,530 acres) of prime Athabasca Oil Sands land, which is the largest oil producing region in the world. This new significant acquisition is in very close proximity to existing leases held by Micron, and also close to where Royal Dutch Shell recently acquired leases for $450,000,000. This new lease was purchased at the recent land sales and paid for out of money that was in the bank. This new acquisition constitutes an additional approximate 50% increase in Micron's net Alberta Oil Sands acreage now under lease which had already increased by approximately 4,500% in 2007. Bernard McDougall, Micron's president stated, "This is a significant acquisition for Micron. To pick up 100% interest in this Oil Sands parcel displays managements continuing commitment to acquiring quality land in one of the largest know fields in the world. Our goal it to continue to acquire land in the Alberta Oil Sands as we feel the stock prices for all oil sands companies have not reflected the reality of the real investment dollars coming to the Alberta Oil Sands by the largest oil companies. We feel that since the biggest companies such as Exxon, Shell and Total are making massive investments into the Alberta Oil Sands, then that is where we want to be as well. Management is confident that when the market for the Oil Sands stocks comes back into focus, Micron will be one of the first to garner market share being one of the most leveraged and most active in acquisitions. Our current and potential shareholders need to understand that our perspective to grow the Company is a short as well as a long term one, but if we execute on our plan like we anticipate we will, Micron may present one of the best potential situations in the Alberta Oil Sands. As Micron continues to acquire land and develop current oil sands projects, management cannot see how that could be taken as anything but positive to Micron's future shareholder value." Micron is an emerging oil and gas company that now has exposure to eight separate leases consisting of interests in 24.5 gross sections (15,500 acres) in the Oil Sands of Alberta, Canada, which is one of the largest oil producing regions in the world. Micron also has minor production from multiple conventional oil and gas wells throughout North America. Micron's goal is to become a junior oil and gas producer that focuses on the exploration, discovery and delivery of gas and oil to the North American marketplace. Micron continues to look for additional projects that would contribute to building Micron's market capitalization, including additional Oil Sands projects. At this time, Micron is one of, if not the smallest, market capitalized company with multiple leases (eight) and now has positive operations underway in this world-class oil and gas producing region. This is quite an enviable position for a company of Micron's modest market capitalization, and therefore Micron offers tremendous leverage to one of the world's largest oil resources. Please visit our website for detailed maps of the locations of Micron's prospects at www.micronenviro.com If you have any questions, please call Micron at (604) 646-6903. If you would like to be added to Micron's update email list, please send an email to info@micronenviro.com requesting to be added. This news release contains forward-looking statements. Forward-looking statements are statements which relate to future events. In some cases, you can identify forward-looking statements by terminology such as ``may,'' ``should,'' ``expects,'' ``plans,'' ``anticipates,'' ``believes,'' ``estimates,'' ``predicts,'' ``potential'' or ``continue'' or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. Readers are referred to the sections entitled ``Risk Factors'' in the Company's periodic filings with the United States Securities and Exchange Commission, which can be viewed at <http://www.SEC.gov>. For all details regarding working interests in all of MENV's oil and gas prospects or any previous news releases go to the SEC website. You should independently investigate and fully understand all risks before making investment decisions. Contact Information: Bernard McDougall Micron Enviro Systems, Inc. ir@micronenviro.com TEL: (604) 646-6903 Fax: (604) 689-1733 www.micronenviro.com


 </